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“The impediment to action advances action. What stands in the way becomes the way.” 
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Owing to their unique properties, the synthesis and functionalization of aliphatic amines plays 
a central role in the field of visible light photoredox chemistry. In this thesis, the development 
of a novel, visible light mediated process for the synthesis of complex aliphatic amines is 
described. The novel multicomponent reaction between secondary amines, aldehydes and 
electron-deficient olefins efficiently furnishes complex aliphatic tertiary amine products. 
Selective generation of an α-amino radical species is achieved via photocatalytic single 
electron reduction of in situ generated all-alkyl iminium ions. Under optimized reaction 
conditions, the photocatalytic olefin-hydroaminoalkylation procedure was shown to be 
compatible with a broad range of benzyl amine, aldehyde, and olefin substrates. A detailed 
study of the mechanism of the transformation is described, revealing an unusual 1,5-hydrogen 
atom transfer step and an unprecedented redox-relay of iminium ions. In further studies, the 
reaction scope was expanded to include non-benzylic amines and enamines, enabling the 
generation of synthetically valuable α-tertiary amines. 
 
α-Tertiary amines are a common feature in a number of bioactive natural products. 
Immunosuppressant (−)-FR901483 (1) and muscarinic antagonist (+)-TAN1251C (2) are 
biosynthetically related di-tyrosine-derived alkaloids, which have attracted significant 
attention from the synthetic community by virtue of their biological activity and the 
challenges posed by their architecturally complex structures. The development of a variant of 
the multicomponent photocatalytic olefin-hydroaminoalkylation approach to couple primary 
amines, ketones and olefins, and its use in total synthesis, is described. The novel 
transformation enabled the rapid, divergent total synthesis of both (−)-FR901483 and (+)-
TAN1251C via a common spirolactam precursor. Finally, the reaction proved amenable to a 
number of primary amines and ketones, giving direct, modular access to a series of useful 








This thesis is comprised of an introduction followed by two main chapters of results and 
discussion. In the first chapter, an introduction of the chemical tools used in the main body of 
the work is given. The introduction is divided into two parts. In the first part, an overview of 
the field of photochemistry is given. The second part is a brief review of amine synthesis via 
visible light photoredox approaches, followed by a review of the development of visible light 
mediated α-amino radical generation as an attempt to provide a context for the work of this 
thesis to be viewed in. 
This is followed by the second chapter, which describes the work on and development of a 
novel photocatalytic amine synthesis via multicomponent olefin-hydroaminoalkylation, and 
discusses the results obtained over the course of the project. Chapter three describes in detail 
the use of a variant of this chemistry to access α-tertiary secondary amines, spirolactams, and 
a key precursor enabling the rapid total synthesis of the two alkaloids (−)-FR901483 and (+)-
TAN1251C.  
The main body of work in this thesis is followed by concluding remarks and a future outline 
of the discussed chemistry. In further sections, experimental procedures and data, and the 
references cited in the text are provided. This thesis includes four appendices, containing 
further experimental procedures, supplementary data, published articles from the work of this 
thesis, and 1H-NMR and 13C-NMR spectral data of what are considered to be key compounds 
























ATR attenuated total reflection 
AZADO 2‐azaadamantane N‐oxyl 
b.p. boiling point 
BArF tetrakis[3,5-bis(trifluoromethyl)phenyl]borate 














CFL compact fluorescence light 
cod 1,5-cyclooctadiene 
COSY correlated spectroscopy 
CSA camphor sulfonic acid 
Cy cyclohexyl 
d doublet 





DEAD diethyl azodicarboxylate 
DEPT distortionless enhancement by polarization transfer 
dF(CF3)ppy 3,5-difluoro-2-[5-(trifluoromethyl)-2-phenylpyridinato 
DFT density functional theory 
DIAD diisopropyl azodicarboxylate 







DMP Dess-Martin periodinane 
DMSO dimethylsulfoxide 





E1/2 half-wave potential 
ED50 median effective dose 
EDC 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
ee enantiomeric excess 
eq. equivalents  
equiv equivalents 
ESI electrospray ionization 
ESR electron spin resonance 
Et ethyl 
FAB-MS fast atom bombardment–mass spectrometry 
fac facial 
FT-IR fourier-transform infrared spectroscopy 
GC-MS gas chromatography–mass spectrometry 
glyme ethylene glycol dimethyl ether 
Grubbs I Benzylidene-bis(tricyclohexylphosphino)-dichlororuthenium 
h hour(s) 
HAT hydrogen atom transfer 
HFIP hexafluoroisopropanol 
HMBC heteronuclear multiple bond correlation 
HMPA hexamethylphosphoramide 
HOBt hydroxybenzotriazole 
HOMO highest occupied molecular orbital 
HRMS high resolution mass spectrometry 
HSQC heteronuclear single quantum coherence 
Hz Hertz 
i iso 
IC internal conversion 
IR infrared (spectroscopy) 
ISC inter system crossing 
J coupling constant 
k kilo 
KHMDS potassium bis(trimethylsilyl)amide 
kq quenching rate constant 
L neutral ligand or liter 
LA Lewis acid 
LC-MS liquid chromatography–mass spectrometry 
LDA lithium diisopropylamide 
LED light emitting diode 




L-selectride lithium tri-sec-butyl(hydrido)borate 
LUMO lowest unoccupied molecular orbital 
M molar or metal 
m multiplet 
m meta 
m.p. melting point 





MIDA N-methyliminodiacetic acid 
MLCT metal to ligand charge  transfer 
mol. sieves molecular sieves 
Ms mesyl 




NaHMDS sodium bis(trimethylsilyl)amide 
NBS N-bromosuccinimide 
NCS N-chlorosuccinimide 
NHC N-heterocyclic carbene 
NMM N-methylmorpholine 
NMO N-methylmorpholine N-oxide 
NMP N-methyl-2-pyrrolidone 
NMR nuclear magnetic resonance 
NOE nuclear Overhauser effect 






P.E. petroleum ether 
PCET proton coupled electron transfer 





pKa logarithmic acid dissociation constant 
PLC preparative thin-layer chromatography 
PMB p-methoxybenzyl 
ppm parts per million 
PPTS pyridinium p-toluenesulfonate 
ppy 2-phenylpyridinato 
Pr propyl 










R undefined group 
r.t. room temperature 
rac racemic 
Red-Al sodium bis(2-methoxyethoxy)aluminium hydride 
Rf retention factor 
ROESY rotating frame nuclear Overhauser effect spectroscopy 
s singlet 
sat saturated 
SCE saturated calomel electrode 
scint. scintillation 
SCX strong cation exchange 










TFA trifluoroacetic acid 
TFAA trifluoroacetic anhydride 
THF tetrahydrofuran 
TIPS triisopropylsilyl 
TLC thin-layer chromatography 
TMEDA tetramethylethylenediamine 
TMS trimethylsilyl 
TOCSY total correlated spectroscopy 
TPAP tetrapropylammonium perruthenate 





UV-Vis ultraviolet–visible spectrophotometry 
VR vibrational relaxation 
vs versus 
X halogen or anionic ligand 
λ wavelength 
τ excited state lifetime 




  Contents 
 
Declaration and Statement of Length ................................................................................ i 
Acknowledgements ............................................................................................................ v 
Abstract ........................................................................................................................... vii 
Overview .......................................................................................................................... ix 
Abbreviations ................................................................................................................... xi 
1. Introduction ....................................................................................................................... 1 
1.1 Photochemistry ........................................................................................................ 1 
1.1.1 Early photochemistry ..................................................................................... 1 
1.1.2 Overview and background ............................................................................. 3 
1.1.3 Photoredox catalysis ....................................................................................... 7 
1.1.4 Photoredox catalysis – From early work to recent developments .................. 9 
1.1.5 Photoredox catalysis in natural product synthesis ....................................... 18 
1.2 Amine synthesis and functionalization via photoredox catalysis .......................... 22 
1.2.1 Background .................................................................................................. 22 
1.2.2 Amine reactivity ........................................................................................... 22 
1.2.3 Functionalization of iminium ions ............................................................... 24 
1.2.4 α-Amino radicals .......................................................................................... 29 
1.2.5 α-Aminoalkyl radicals in transition metal – photoredox dual catalysis ....... 38 
1.2.6 Summary and outlook .................................................................................. 45 
2. Photocatalytic multicomponent olefin-hydroaminoalkylation ........................................ 46 
2.1 Introduction............................................................................................................ 46 
2.1.1 α-Aminoalkyl radicals via reductive pathways ............................................ 46 
2.1.2 Previous work ............................................................................................... 49 
2.2 Project Aims .......................................................................................................... 54 
xvi 
 
2.3 Results and Discussion .......................................................................................... 57 
2.3.1 Discovery and early studies ......................................................................... 57 
2.3.2 Reaction optimization .................................................................................. 59 
2.3.3 Scope of the reaction ................................................................................... 64 
2.3.4 Mechanistic studies ...................................................................................... 75 
2.3.5 Extended scope and functionalization of enamines ..................................... 81 
2.3.6 Functionalization of pharmaceutical agents ................................................ 85 
2.4 Summary ............................................................................................................... 86 
3. Total synthesis of alkaloids FR901483 and TAN1251C ................................................ 87 
3.1 Introduction ........................................................................................................... 87 
3.1.1 FR901483 – Structure, isolation, bioactivity and proposed biosynthesis .... 87 
3.1.2 FR901483 – Previous syntheses .................................................................. 89 
3.1.2.1 Overview .............................................................................................. 89 
3.1.2.2 Snider’s desmethylamino-FR901483 study ......................................... 90 
3.1.2.3 First total synthesis of (−)-FR901483 by Snider .................................. 91 
3.1.2.4 Sorensen’s synthesis ............................................................................ 93 
3.1.2.5 Ciufolini’s synthesis ............................................................................. 94 
3.1.2.6 Funk’s synthesis of (±)-FR901483....................................................... 96 
3.1.2.7 Fukuyama’s first generation synthesis of FR901483 ........................... 97 
3.1.2.8 Fukuyama’s second generation enantiocontrolled synthesis ............... 98 
3.1.2.9 Brummond’s formal synthesis of FR901483 ..................................... 100 
3.1.2.10 Kerr’s formal synthesis of FR901483 .............................................. 101 
3.1.2.11 Tu’s total synthesis of FR901483 .................................................... 103 
3.1.2.12 Huang’s Synthesis of FR901483 ...................................................... 104 
3.1.2.13 Other approaches towards the FR901483 core structure ................. 106 
3.1.3 TAN1251C – Structure, isolation, bioactivity and proposed biosynthesis 107 




3.1.4.1 Overview ............................................................................................ 109 
3.1.4.2 Kawahara and Nagumo’s first generation synthesis of TAN1251A .. 110 
3.1.4.3 Snider’s synthesis of TAN1251A, B, C and D ................................... 112 
3.1.4.4 Wardrop’s synthesis of TAN1251A ................................................... 116 
3.1.4.5 Kawahara and Nagumo’s 2nd generation synthesis of TAN1251A .... 118 
3.1.4.6 Ciufolini’s synthesis of TAN1251C ................................................... 119 
3.1.4.7 Honda’s formal synthesis of TAN1251A ........................................... 120 
3.1.4.8 Hayes’ formal synthesis of TAN1251A ............................................. 122 
3.1.4.9 Honda’s synthesis of TAN1251C and TAN1251D ............................ 123 
3.1.4.10 Kan’s total synthesis of TAN1251C ................................................. 125 
3.2 Summary and Project aims .................................................................................. 127 
3.3 Results and Discussion ........................................................................................ 130 
3.3.1 Strategy for the total synthesis of (−)-FR901483 and (+)-TAN1251C ...... 130 
3.3.2 Development of the primary amine multicomponent reaction .................. 134 
3.3.3 Completion of the total synthesis of (+)-TAN1251C ................................ 142 
3.3.4 Synthesis of the keto-aldehyde towards FR901483 ................................... 147 
3.3.5 Biomimetic aldol-reaction .......................................................................... 151 
3.3.6 Completion of the total synthesis of FR901483 ......................................... 158 
3.3.7 Additional studies ....................................................................................... 161 
3.4 Summary .............................................................................................................. 162 
4. Conclusions and Future Outlook ................................................................................... 165 
5. Experimental Section .................................................................................................... 169 
5.1 Materials and Methods ........................................................................................ 169 
5.2 Experimental procedures ..................................................................................... 171 
5.2.1 Photocatalytic olefin-hydroaminoalkylation .............................................. 171 
5.2.2 Total synthesis of (−) FR901483 and (+)-TAN1251C ............................... 196 
xviii 
 
5.2.2.1 Development of the multicomponent reaction ................................... 196 
5.2.2.2 Synthesis of TAN1251C .................................................................... 200 
5.2.2.3 Synthesis of FR901483 ...................................................................... 203 
6. References .................................................................................................................... 214 
Appendix I: Miscellaneous experimental procedures ............................................................ 231 
Appendix II: Supplementary data .......................................................................................... 244 
Appendix III: Published work ................................................................................................ 253 





Chapter One – Introduction 
 
  1 
1. Introduction 
1.1 Photochemistry 
1.1.1 Early photochemistry 
The scientific investigation of light mediated photochemical reactions can be traced back to as 
early as the late eighteenth century.[1] Perhaps the first genuine photoreactions were observed 
1790 by English theologian, natural philosopher, reformer, and chemist Joseph Priestley,[2-3] 
who identified that colorless “spirit of nitre” (nitric acid) could by darkened under the action 
of a focused beam of sunlight.[4] More than 40 years later, in 1831, Döbereiner discovered the 
first photoreduction of a metal salt. He observed the light-induced liberation of CO2 and 
precipitation of basic Iron-(II)-oxide from a solution of oxalic acid and iron-(III)-oxide.[5]  
 
Scheme 1. Examples of early photochemical reactions. 
Only a few years later, the earliest purely organic photoreaction was discovered, the 
photorearrangement of santonin (3) (Scheme 1a),[6-7] a sesquiterpene lactone first isolated in 
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1830 by Kahler[8] and Alms[9]. In 1834, Trommsdorff found santonin to turn yellow upon 
irradiation with sunlight, and its crystals to burst.[10] Remarkably, Trommsdorff established 
that only blue and violet light induces color change in santonin.[10] Santonin’s interesting 
photochemistry was investigated further by Sestini and Cannizarro,[11] but it was not until 
1963, that the reaction and its intermediates were fully understood.[12-14] In 1867, Fritzsche 
serendipitously discovered the photodimerization of anthracene 6 (Scheme 1b). He observed 
the precipitation microscopic crystals from a saturated solution of anthracene when it was 
exposed to sunlight.[15-16] Liebermann, who was familiar with Fritzsche’s work,[1] observed in 
1877 that when irradiated with sunlight, crystals of thymoquinone 8 would be converted into 
a white mass (Scheme 1c). Later elucidation would show that he had indeed discovered the 
first known organic [2+2] cycloaddition. In 1881, Perkin discovered the first example of 
another important photoreaction, olefin isomerization. He observed isomerization in his 
studies of 2-alkoxycinnamic acids upon exposure to sunlight. The reaction required either 
violet or ultraviolet light.[17] The rate of these conversions could be increased by the addition 
of iodine, as reported in 1895 by Liebermann.[18-19] A major contribution to light-induced 
quinone reactivity was made by Klinger when he was faced with reproducibility issues in his 
experiments with benzil.[20] Only vials in a part of his laboratory which was exposed to “direct 
sunlight in the early morning hours” showed a partial reduction of the dissolved benzil. His 
serendipitous discovery was the first report of a photochemical carbonyl reduction (Scheme 
1d). Giacomo Ciamician and Paul Silber reported photochemical carbonyl reductions of 
benzoquinone almost simultaneously with Klinger.[21]  
 
Figure 1. “Portraits of Giacomo Ciamician and Paolo Silber on the rooftop of the laboratory at the University of 
Bologna”, 1915-1920.[22]  
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At the dawn of the 20th century, Ciamician and Silber formed a very successful collaboration 
to systematically investigate photochemical reactivity (Figure 1). Their achievements 
surpassed all previous efforts, and virtually established the field of organic photochemistry as 
an independent field of research.[1, 23] Over the next 15 years, they published 85 notes, papers 
and memoirs on the subject of photochemistry, in what was the first comprehensive study of 
light-mediated chemical reactivity.[23-24] 
1.1.2 Overview and background 
Photochemistry can be defined as the branch of chemistry concerned with the physical and 
chemical change initiated by the absorption of light quanta (photons) by atoms and 
molecules.[25] Two fundamental laws have been formulated for photochemistry; according to 
the Grotthus-Draper law, only light that has been absorbed by the molecule can be effective in 
inducing chemical change in the system. The Stark-Einstein law states that every one photon 
that is absorbed will cause one chemical or physical reaction.[25] Accordingly, the absorption 
of a photon of light by a molecule leads to its transition from the electronic ground state to the 
excited electronic state. From the excited state, a number of processes can occur, most of 
which are photophysical processes, in which the chemical structure of the molecule remains 
unchanged, and some are photochemical processes,[26] which lead to an array of chemical 
structural changes.  
 
Figure 2. Schematic of molecular electronic excitation.[27] 
In a unimolecular process, chemical change can only occur from an excited state when the 
energy absorbed by the system exceeds the bond dissociation energy of the weakest bond in 
the molecule. Bond dissociation energies typically range from ca. 100 kJ/mol to 1072 
kJ/mol,[28] which can be translated into the correlating range of wavelengths 1200 – 110 nm in 
the electromagnetic spectrum. With these energies in mind, the determination can be made 
that UV light (10 – 400 nm), visible light (400 – 700 nm) and parts of infrared light (700 nm 
to 1 mm) will be suitable energy sources for photochemical transformations. In contrast to 
thermal reactions, which sometimes have to overcome large energy barriers, photochemical 
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reactions start from a high energy level, and can take an intrinsically complex reaction 
path.[29] 
While some substances, such as O3 or NO2 absorb visible light, most organic molecules only 
absorb in the ultraviolet region.[25] As an example, absorption of UV light of the wavelength 
254 nm can result in the π → π* transition in buta-1,3-diene (corresponding to 471 kJ/mol) in 
a typical molecular excitation process (Figure 2).[27] In this excitation of a multi-electron 
system, the total spin angular momentum of is conserved, which leads to a transition from a 
singlet ground state (S0) to a singlet excited state (S1). Transitions from S0 to triplet states T1 
are “spin-forbidden”, which results in lower population of these events than singlet-singlet 
transitions. The excited state cannot persist indefinitely, and due to being unstable in respect 
to the ground state the lifetime of the excited state is short (typically between 10-9 and 10-6 
s).[29] In an unimolecular example in which no chemical reaction occurs, the electronically 
excited molecule can either undergo radiative transitions or non-radiative transitions. 
Radiative transitions result in the emission of radiation that is typically lower in energy than 
the one absorbed to reach the excited state (“vertical transitions”). As every closed shell 
molecule possesses a S0 ground state, the most commonly observed emission results from the 
transition of the singlet excited state to the singlet ground state (i.e. S1 → S0), called 
fluorescence. If the emission occurs from the triplet excited state to the singlet ground state, 
the process is termed phosphorescence (i.e. T1 → S0). Non-radiative transitions involve 
conversions from one state to another state at constant energy (“horizontal transitions”). If the 
spin multiplicity of both states is identical, they are called internal conversion (IC). For 
conversions of different spin multiplicity, for example S1 → T1, the term inter system crossing 
(ISC) is used (see Jablonski diagram, Figure 3).  
 
Figure 3. Jablonski Diagram. Radiative transitions are depicted as straight arrows, non-radiative transitions as 
wiggly arrows.[27] 
If the ISC is to a vibrationally excited electronic state, with some excess vibrational energy 
over the (vibrationless) T1 level, a small amount of energy will be released via collisions with 
other molecules or solvent (vibrational relaxation, VR). Importantly, an excited molecule will 
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simply undergo de-excitation via radiation and return to its ground state, if no unimolecular 
chemical reaction can occur from the excited state.[27] In contrast, in a bimolecular process, 
where a species interacts with the excited state molecule (typically called a quencher), a new 
pathway will now compete with radiative transitions back to the ground state. The 
photoexcited state can engage in bimolecular electron transfer and energy transfer reactions 
which are disfavored from the singlet ground state S0. This becomes most apparent in the 
ability of the species to act as a single electron donor or acceptor, and hence a reductant or 
oxidant. These processes result in emission quenching and are particularly important in the 
field of transition metal catalyzed, visible light mediated photochemistry. The bimolecular 
processes also enable facile detection of an excited state interacting with a potential quencher 
by simply observing if the amount of emission is diminished in the presence of the quencher. 
An important practical aspect of photochemistry is the light source. In fact, the necessity of a 
devoted reactor and suitable light source still is the prime factor that photochemical reactions 
are oftentimes not considered for transformations on an industrial scale, if a thermal 
alternative is at all available.[29] One of the oldest artificial light sources, incandescent lamps, 
emit light by heating a tungsten wire by conduction which is protected from oxidation by a 
gas filled or evacuated bulb. These lamps emit a continuous spectrum between 400 and 600 
nm, in which most organic molecules do not absorb, and have no UV contribution. Thus, as 
UV-light is often required for classical photochemical applications, the most commonly used 
lamps are low-pressure mercury arc lamps. Arc lamps are ampules containing a filling gas and 
electrodes at both ends. Light is produced by sending electrical discharge through the ionized 
gas or plasma, achieved by modulation of frequency or current. In the case of mercury, 
emission of light is caused by transition of the singlet (185 nm) and triplet (254 nm) state.  
 
Figure 4. Low pressure mercury arc lamps. a. ‘black light’ (360 nm) b. phosphor-coated (305-310 nm) c. 
“germicidal lamp”, quartz, emitting 254 nm. Licensed reprint from Fagnoni et al.[29] 
As the 185 nm light is in almost all cases absorbed by mercury vapor itself, the architecture of 
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sources of 254 nm light.[29] This light is entirely absorbed by Pyrex and other laboratory 
glassware and only high purity quartz vessels can conserve the 254 nm emission. Arc lamps 
with phosphor coating on the inside ampule of the lamp are available to modulate emission 
(Figure 4). The coating absorbs the monochromatic 254 nm Hg-emission and emits longer 
wavelength light, in the case of a white phosphor UV-B (305 to 310 nm), or in case of a dark 
phosphor coating, “black-light” (350-370 nm). Due to self-absorption, mercury emission 
changes at higher pressures from monochromatic to longer-wave polychromatic. This is used 
in medium-pressure mercury arc lamps, which emit at 313, 366, 405, and 550 nm, with the 
254 nm line diminished. Sodium arc lamps (589 nm) and XeCl excimer arc lamps (308 nm) 
are also commercially available, but have only niche use in photochemistry due to their 
wavelength or cost.  
There are some obvious disadvantages when considering the use of UV-light, such as the 
necessary health and safety considerations, but also the prerequisite for dedicated, expensive 
quartz glassware and incompatibility of a broad range of functional groups and solvents due 
to their absorption of UV light. Thus, the interest in using visible light sources to drive 
chemical transformations, either via direct absorption, or via a mediator (sensitizer, vide infra) 
has sharply increased over the past three decades. To this end, visible light emitting household 
compact fluorescence light (CFL) bulbs have been used extensively in photochemistry (Figure 
5, left). CFL bulbs are also mercury-containing arc-lamps, with a phosphor coating emitting 
in the visible spectrum, and have mostly replaced incandescent lamps for general 
illumination. 
 
Figure 5. a. “Compact-Fluorescent-Bulb”.[30] b. “Blue light emitting diodes over a proto-board”.[31] 
Arguably the most important light source for visible light photochemistry today are light 
emitting diodes (LEDs, Figure 5, right), semiconductors that emit an incoherent 
a b 
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electroluminescence over a short wavelength range.[29] These relatively novel sources of light 
have been a transformative influence for the photochemical community, but also for general 
illumination over the last decade. While LEDs emitting in the UV are available (as low as 310 
nm), they are suffering from low efficiency and high cost. LEDs are an excellent light source 
for the visible light range, with a ten-fold higher efficiency than for UV applications, low 
cost, and long lifetimes (104 h). There is a high availability of LEDs emitting on any 
wavelength in the visible range. LEDs are also of a large advantage due to their narrow 
emission window, inherently focused emission, and robustness, and due to their ease of use 
the number of their photochemical applications has increased sharply over the last decade. 
1.1.3 Photoredox catalysis 
In the last decades the synthetic community has witnessed the revival of photochemistry due 
to the novel approach of visible light photoredox catalysis, which has also reignited the 
interest in radical and single-electron-transfer (SET) processes. This mode of catalysis relies 
on the capability of light-absorbing catalysts, such as polypyridyl metal complexes and a 
number of organic dyes,[32] to undergo photoexcitation with visible light and subsequently 
engage in SET or energy-transfer processes with organic substrates.[33] 
 
Figure 6. Common photoredox catalysts [Ru(bpy)3]2+ and Ir(ppy)3. 
Commonly employed visible light photocatalysts are iridium and ruthenium polypyridyl 
complexes, due to their favorable absorption in the visible range, bench stability, and long 
lived excited state,[34-35] for example, lifetimes of 1100 ns for [Ru(bpy)]2+ (12),[36] and 1900 ns 
for fac-Ir(ppy)3 (13, Figure 6).
[37] Common photoredox catalysts typically rely on the 
absorption of blue or green (λ = 450 – 550 nm) light to access high energy states. The 
relatively stable, long-lived photoexcited states can then evoke bimolecular electron transfer 
reactions, albeit in competition with other deactivation pathways. While the chemically inert 
ground state species of these complexes are poor single-electron oxidants and reductants, the 
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respective excited states can be remarkably potent SET reagents. This dual-character of 
photoredox catalysts enables powerful oxidative and reductive processes to occur 
concurrently in the same vessel via a redox-neutral catalytic cycle. This forms the basis of the 
exciting manifold of novel reactivity that has been achieved through photoredox chemistry, 
featuring astounding catalytic electron transfer cycles in high chemoselectivity initiated by 
simple, inexpensive household lights under mild chemical conditions.[33]  
Mechanistically, exemplified by [Ru(bpy)3]
2+, the excitation process constitutes a metal to 
ligand charge  transfer (MLCT) between the central RuII atom and the 2’,2’-bipyridine ligand-
sphere (Scheme 2). Thus, upon absorption of a visible light photon, an electron of the 
catalysts metal-centered t2g orbitals is promoted into a ligand-centered π* orbital,
[38] resulting 
in an oxidized RuIII central metal and a ligand sphere that has undergone single electron 
reduction.[39] The initially formed singlet MLCT state then undergoes rapid inter system 
crossing (ISC) to the respective triplet MLCT state. The transition of the triplet MLCT state  
back to the ground state is spin forbidden, which causes the species to exhibit a sufficiently 
long lifetime to engage in bimolecular electron transfer. 
 
Scheme 2. Simplified molecular orbital depiction of [Ru(bpy) 3]2+ photochemistry.[33-34] 
Due to the nature of the photocatalyst’s photoexcited state, a high energy electron is available 
in the ligand sphere. This electron is readily available for transfer to substrates, rendering the 
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photocatalyst a reductant. At the same time, the electron “hole”, which is created in the t2g 
orbital via excitation (Scheme 2), is low in energy and can be filled by an electron transferred 
to the system, establishing the oxidizing properties of the excited state. The propensity of a 
species to undergo oxidation or reduction can be described by their respective half-wave 
reduction potentials (E1/2
red). In the case of the excited state *[Ru(bpy)3]
2+, the reduction 
potential for the half reaction RuIII → *RuII is E1/2
III/II* = −0.81 V (vs saturated calomel 
electrode, SCE),[40] which shows that the excited state is a much stronger reductant than the 
ground state, E1/2
III/II = +1.29 V. Similarly, the reduction potential for the half reaction *RuII 
→ RuI of E1/2
II*/I = +0.77 V (vs SCE) demonstrates that *[Ru(bpy)3]
2+ is significantly more 
oxidizing than the ground state, E1/2
II/I = −1.33 V (vs SCE). Depending on whether the excited 
state photocatalyst first undergoes oxidation or reduction, via interaction with a reaction 
partner (quencher), the resulting catalytic cycles are termed oxidative quenching cycle, or 
reductive quenching cycle, respectively (Scheme 3). 
 
Scheme 3. Oxidative and reductive quenching cycles of [Ru(bpy)3]2+. 
1.1.4 Photoredox catalysis – From early work to recent developments 
While the respective iridium and ruthenium polypyridyl complexes were originally used for 
water-splitting, as early as in the 1970s,[41] their extended use in organic photochemical 
transformations has only emerged relatively recently. Photoredox chemistry was pioneered in 
early (1978 - 1993) examples by Kellog,[42-43] Deronzier,[44-46] and Okada,[47-49] and was 
further established in the 2000’s most notably by MacMillan, Yoon, and Stephenson, and 
complemented recently by developments using organic chromophores by Nicewicz.[32] As a 
result of this research, a myriad of novel visible light-mediated technologies have emerged.[50]  
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In 1978, Kellogg and co-workers investigated the reduction of sulfonium salts and activated 
halides by 1,4-dihydropyridines (Hantzsch Esters),[42-43] which led to the serendipitous 
observation that the reduction of methylphenacylphenylsulfonium tetrafluoroborate 14 with 
Hantzsch Ester 15 would not proceed if the reaction mixture is placed inside a UV 
spectrometer. It was suspected that room-lighting would be involved in the reaction. Further 
studies confirmed that the reaction could be carried out by irradiation with a light bulb much 
more efficiently compared to the “thermal protocol”, which often was also induced by low-
level light. Indeed, the reaction would not take place if set up in a dark room under red light. 
Remarkably, Kellogg and co-workers reasoned that due to the small absorption band of 
Hantzsch Ester 15 in the visible region, the reaction could be improved via the addition of 
sensitizers. Employing catalytic levels of tetraphenylporphyrine and Eosin disodium salt gave 
significant increase in reaction rate. Most strikingly, upon the addition of [Ru(bpy)3]Cl2, a 
reduction of the reaction half-time, from t1/2 = 48 h under normal irradiation, to t1/2 = 18 min 
was observed in the presence of photocatalyst.   
 
Scheme 4. Kellogg’s photocatalytic reductive desulfuration. 
Following Kellogg’s seminal report, Tanaka reported [Ru(bpy)3]Cl2 catalyzed 1-benzyl-l,4-
dihydronicotinamide (BNAH) reductions of benzyl bromide[51] and benzoquinones,[52] and a 
[Ru(bpy)3]Cl2 catalyzed 9,10-dihydro-10-methylacridine reduction of phenacyl halides.
[53] In 
addition, Pac and co-workers also published a series of reports on similar dihydropyridine-
[Ru(bpy)3]Cl2 catalyzed reductive systems for a variety of substrates.
[54-58] 
An early example of a transition metal catalyzed reaction featuring a oxidative quenching 
cycle was reported by Deronzier in 1984 (Scheme 5).[44] The photocatalyzed redox reaction 
was able to efficiently oxidize benzylic carbinols 19 to their respective aldehydes 21 using 
aryl diazonium salts 20 as oxidant. The reaction required collidine (2,4,6-trimethylpyridine) to 
proceed and gave good aldehyde yields for electron rich benzylic carbinols.  
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Scheme 5. Deronzier’s photo-oxidation of benzylic carbinols. 
The Deronzier group later published another example of the use of transition metal 
photocatalysis[45-46] with a study of phenanthrene (23) generation from aryl diazonium salts 
(22) via a photoinduced Pschorr reaction (Scheme 6).[59] Deronzier conducted extensive 
mechanistic studies, including Stern-Volmer quenching studies, in order to determine the 
mechanism of the reaction. It was concluded that electron transfer from the excited 
photocatalyst is most likely occurring, while a possible energy transfer pathway was not 
entirely rejected.  
 
Scheme 6. Deronzier’s photocatalytic Pschorr reaction. 
Arguably one of the most important, early reports of modern photoredox chemistry, and the 
first example of an intermolecular photoredox coupling, was disclosed in 1991 by Okada and 
Oda.[47] A novel radical addition methodology was developed by using a combination of 
[Ru(bpy)3]Cl2, a radical precursor bearing a N-(acyloxy)phthalimide (24), and 1-benzyl-1,4-
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dihydronicotinamide 29 as terminal reductant (Scheme 7). Irradiation was achieved by use of 
a 500 W Xenon lamp (λ > 460 nm). 
 
Scheme 7. Okada and Oda’s photosensitized decarboxylative radical addition.  
Okada and co-workers found that photocatalytic decarboxylation of 24, with formation of 
phthalimide and carbon dioxide, furnished a carbon centered radical, which was available for 
addition into radical acceptors, such as methyl vinyl ketone (25) (Scheme 7), 2-
cyclopentanone and methyl acrylate, to form e.g. addition product 26. Aqueous THF was 
found to be a suitable solvent for the reactions. Small amounts of side products were formed, 
such the reduced hydrocarbon 28, resulting from the reaction of BNAH with the alkyl radical, 
and low amounts of overalkylation product 27 were observed. Notably, the quantum yield of 
the experiments was over unity (Φ = 1.3 for the shown transformation), providing evidence 
for a radical chain process operating. This seminal study showed that N-
(acyloxy)phthalimides can be used as convenient alkyl radical precursors.  
Furthermore, Okada utilized the photocatalytic activation of these redox-active esters for a 
number of subsequent transformations, including chlorination (under UV light),[60] 
reduction,[48] and phenylselenenylation (Scheme 8).[49] Okada’s reports were the first instance 
of a general photoredox substrate activation strategy and showed the great potential of the 
area of visible light mediated catalysis. However, the field remained out of focus of the 
synthetic community for more than 15 years.  
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Scheme 8. Okada’s photocatalytic reductive decarboxylation and decarboxylative phenylselenenylation of N-
acyloxyphthalimides. 
The first of three significant, more recent, reports was Yoon’s disclosure of a photoredox 
catalyzed intramolecular [2+2] cycloaddition of enones in 2008.[61] On the basis of Krische’s 
report of  single-electron induced cobalt and copper catalyzed [2+2] cyclization of bis(enones) 
36,[62-66] Yoon and co-workers speculated that this cycloaddition might also be initiated by a 
photocatalytically generated photoexcited reductant, such as *[Ru(bpy)3]Cl2 (Scheme 9).  
 
Scheme 9. Yoon’s visible light photocatalytic [2+2] enone cycloaddition. 
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Under irradiation with a 275 W floodlight, and Lewis-acid activation, the reaction was 
achieved with a variety of substrates with excellent stereoselectivity (4:1 to >10:1 d.r.) and in 
high yields (54% to 98%). Due to the absence of conversion in the absence of DIPEA, even 
with elevated amounts of [Ru(bpy)3]Cl2, a reductive quenching cycle is proposed (Scheme 9). 
First, the excited state [Ru(bpy)3]Cl2* undergoes reductive quenching with the amine, 
generating the amine radical cation, and the reducing [Ru(bpy)3]
+ species (E1/2
II/I = −1.33 V vs 
SCE).  Subsequent reduction of the activated aryl enone 38 by [Ru(bpy)]+ generates the alkyl 
radical 39, from which cyclization to the products (37) occurs. Notably, the reaction could 
also be conducted using sunlight as the sole light source. Yoon and co-workers later 
suggested a chain propagation mechanism for the reaction.[67] 
Almost simultaneously, MacMillan and co-workers published their seminal work on the 
photocatalytic asymmetric α-alkylation of aldehydes.[68] The work combined, for the first 
time, the advantages of organocatalysis and photoredox through use of a dual catalytic 
processes (Scheme 10).  
 
Scheme 10. MacMillan’s direct asymmetric alkylation of aldehydes with mechanistic proposal. 
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MacMillan reported the efficient transformation to this product class using convenient and 
inexpensive irradiation with a household 15 W fluorescent light bulb (CFL bulb). The 
organocatalyst 50, a derivative of which has been used in α-oxidation of aldehydes,[69] was 
based on a design from prior work in the MacMillan group.[70-72] It was selected for its 
excellent levels of kinetic enantiocontrol while not participating in enamine formation with 
the 2,2’-disubstituted aldehyde alkylation product. This transformation enabled access to a 
variety of chiral α-alkylated aldehydes in high yields (63% to 93%) and high enantiomeric 
excess (88% to 99%). The reaction employs [Ru(bpy)3]Cl2, which leads to  generation of 
alkyl radical 44 from the respective halide 43 and oxidation of α-amino radical 47 to the 
respective iminium ion 48. At the same time, an organocatalytic cycle generates a chiral 
enamine 46, which can be trapped by the alkyl radical 44, leading to α-amino radical 47. 
Following oxidation, hydrolysis of the iminium ion 48 regenerates the organocatalyst and the 
product, enantioenriched α-alkylated aldehydes (49). A chain propagation mechanism was 
later proposed for the reaction by Yoon and co-workers.[67] 
Moreover, in 2009, Stephenson and co-workers reported the visible light mediated reductive 
dehalogenation of an alkyl halide, without the use of toxic tin-reagents.[73] The reaction uses 
[Ru(bpy)3]Cl2 as a photocatalyst, an excess of DIPEA and either Hantzsch Ester or formic 
acid to convert a number of activated alkyl halides via efficient reductive dehalogenation. 
Mechanistically, it was proposed that reductive quenching of the Ru(II)* species by the 
ammonium formate complex 56 gives the strongly reducing Ru(I) species and the radical 
cation of the ammonium formate complex 55. Subsequent reduction of the alkyl halide 53 by 
[Ru(bpy)3]
+ furnishes the alkyl radical 54 which in turn undergoes hydrogen atom transfer 
(HAT) with the radical cation 55 of the amine base via abstraction of hydrogen atoms from 
either of the methine positions, forming dehalogenated product 57 (Scheme 11). The reaction 
is tolerant to a number of functional groups, such as free hydroxyls, olefins, alkynes, aryl 
bromides and iodides, silyl ethers, and carbamates. In addition to its favorable selectivity the 
reaction is high yielding (79% to 99% yield) and can be carried out with a simple 14 W CFL 
bulb. Stephenson and co-workers conducted a series of reactions to probe the mechanism. 
When deuterated triethylamine (d15-NEt3) was used instead of DIPEA, the reaction gave low 
yield with no deuterium incorporation. Studies with deuterated formic acid confirmed DIPEA 
as the hydrogen atom source in the reaction. Finally, a radical clock experiment gave evidence 
for the presence of the alkyl radical.  




Scheme 11. Stephenson’s tin free reductive dehalogenation with proposed mechanism. 
The seminal reports of Yoon, MacMillan and Stephenson showcased the synthetic utility, 
operational convenience and benign conditions of photoredox reactions. Photoredox catalysis 
has since risen to the forefront of synthetic organic chemistry and has become an 
indispensable tool for many transformations.[74] A plethora of novel photoredox catalysts with 
easily modifiable electronic properties[75] allowed for new transformations, and enabled the 
discovery of a myriad of novel methodologies.[50] A considerable interest in single-electron 
chemistry has re-emerged in the wake of this development, and led to the development of 
cooperative catalysis stemming from classic transition-metal catalyzed reactivity coupled with 
photoredox systems to achieve novel transformations.[76-78] The unique possibility of 
employing excited-state photocatalysts simultaneously as reductant and oxidant has largely 
contributed to this surge of unprecedented reactivity.[74] 
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Underpinning the success of this new field, industry has developed several large-scale 
photochemistry flow platforms,[79] for the late-stage drug modifications as well as for the 
generation of key synthetic intermediates.[74] In particular, Merck have established this 
approach, demonstrated by DiRocco and co-workers, showing the direct photoredox C–H 
functionalization of biologically active heterocycles,[80] many of which are pharmaceutical 
and agrochemical agents.  
 
Scheme 12. DiRocco and Knowles’ photocatalytic indoline dehydrogenation for the synthesis of elbasvir. 
In a collaboration with Knowles and co-workers, a photocatalytic indoline dehydrogenation 
was subsequently reported as key step for the synthesis of elbasvir 60,[81] an inhibitor of the 
hepatitis C virus NS51 protein, which has been clinically studied as highly effective oral 
regimen for the treatment of hepatitis C virus infection (Scheme 12). The transformation 
could formerly only be conducted with KMnO4 as an oxidant without eroding the hemiaminal 
stereocenter, however this was problematic due to purification issues and detrimental 
environmental impact due to generated amounts of MnO2 on large-scale. The photoredox 
alternative was developed using high-throughput screening, and identified photocatalyst 
[Ir(dF-CF3)ppy)2(dtbbpy)](PF6) and tert-butylperbenzoate as the optimal catalyst/oxidant 
combination. On a Merck in-house flow reactor, ~100 g of indoline product 62 could be 
processed over a short period of time (5 hours) in high yield and without the loss of optical 
purity. The highly efficient process showcases the utility of photoredox chemistry as a novel 
tool for catalysis on process-relevant scales. 




Scheme 13. MacMillan’s photoredox-catalyzed deuteration and tritiation (not pictured) of pharmaceutical 
compounds. 
Another recent example of the development of pharmaceutical highly valuable methods 
through photoredox chemistry is MacMillan’s report of the photoredox catalyzed deuteration 
of pharmaceutical compounds.[82] Deuterated versions of existing drugs are an important and 
growing field interest due to their improved pharmacokinetics or toxicological properties, 
often due to the stronger deuterium-carbon bond altering their metabolism.[83] A combination 
of photocatalyst [1,2,3,5-tetrakis(carbazol9-yl)-4,6-dicyanobenzene] (4Cz-IPN, E1/2
red( 4Cz-
IPN–/4Cz-IPN) = +1.21 V vs SCE),[84] thiol 65, D2O and blue light-irradiation allows 
selective deuteration (and tritiation, with T2O respectively) of α-amino sp
3 C–H bonds 
(Scheme 13). With heavy water as convenient deuterium source, this operationally simple 
single step procedure has been demonstrated on 18 pharmaceutical compounds.  
1.1.5 Photoredox catalysis in natural product synthesis 
 
Figure 7. Examples of key bonds formed in natural products via photoredox catalysis. 
Given the success of the photoredox catalysis, it is maybe unsurprising that a series of novel 
photoredox reactions have been exploited in the context of natural product synthesis.[85]  Key 
bond-forming photoredox transformations have been used for a number of natural product 
syntheses in the recent years, exemplified by complex scaffolds such as (+)-gliocladin C, (±)-
heitziamide A, and (−)‐aplyviolene (Figure 7). 
Chapter One – Introduction 
 
  19 
In 2011,  Stephenson and co-workers disclosed their total synthesis of (+)-gliocladin C 
(66),[86] a natural product which is part of a class of alkaloids formally derived from two units 
of tryptophan. In line with the group’s prior work on the dehalogenation of 
bromopyrroloindolines,[73] the synthesis featured a visible light mediated photoredox coupling 
of pyrroloindolines with indoles. In the key step of the synthesis, an alkyl radical was 
generated from bromopyrroloindoline 69 and coupled with indole-2-carboxaldehyde 70 under 
irradiation of blue LED using photocatalyst [Ru(bpy)3]Cl2. A five-fold excess of the coupling 
partner was necessary to preclude reductive dehalogenation. The addition of tributylamine as 
stoichiometric reducing agent proved slightly superior to triethylamine, and yielded the 
desired product 71 in 82% yield on gram-scale exclusively via desired C3’ addition (Scheme 
14). 
 
Scheme 14. Photocatalytic key step in Stephenson’s total synthesis of (+)-gliocladin C. 
In their 2011 synthesis of (±)-heitziamide A (67),[87] Yoon and co-workers elegantly 
demonstrated the utility of a photoredox process to oxidize electron-rich dienophiles via SET 
to generate cationic radical intermediates, which readily underwent [4+2]-cycloaddition 
reactions, notably in opposite regioselectivity than the corresponding thermal Diels-Alder 
reaction. Key to the success was the use of ligand-modified ruthenium complex 
[Ru(bpz)3]
2+,[88] which, in contrast to [Ru(bpy)3]
2+, was able to directly oxidize the 
dienophiles with only air as co-oxidant through a proposed reductive quenching cycle, owing 
to its slightly greater excited state reduction potential (E1/2
red = up to +1.4 V vs SCE) (Scheme 
15b).  
While the thermal reaction between fagaramide (72) and myrcene (73) yielded the undesired 
regioisomer 74 (Scheme 15a), Yoon and co-workers commenced their concise synthesis from 
electron rich dienophile 75 (Scheme 15b). Under the reaction conditions, desired regioisomer 
76 was formed in a facile fashion in good yield, which could be elaborated to the natural 
product 67 in a series of standard operations (4 steps). In the proposed mechanism the 
electron-rich dienophile 77 is first oxidized to the its radical cation 78 by the photocatalytic 
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system. Yoon and co-workers hypothesized that a chain-propagation mechanism is operative, 
in which, after the radical cycloaddition step, the aryl radical cation 79 is quenched by starting 
dienophile 77 (Scheme 15c). Finally, the role of oxygen in the photocatalytic step has been 
determined to be the facilitation of catalyst turnover, since reactions conducted in degassed 
solvents, in the absence of air, give cycloadduct but will not proceed to the product.  
 
Scheme 15. Yoon’s total synthesis of (±)-heitziamide A. 
In 2012, the Overman group reported their synthesis of the diterpene natural product 
(−)‐aplyviolene (68) via a visible light-mediated tertiary radical conjugate addition 
strategy.[89] This was the second generation approach by Overman and co-workers after the 
group had achieved the first total synthesis of (−)‐aplyviolene in 2011.[90] After difficulties in 
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forming the critical key quaternary carbon stereocenter,[91] a radical addition strategy was 
chosen. Inspired by Okada’s early work[47] on fragmentation of N-(acyloxy)phthalimides, 
Overman opted to utilize a visible light mediated radical addition, employing N-
(acyloxy)phthalimide 81 as radical precursor, and chiral alkene 82 as radical acceptor 
(Scheme 16). Notably, the N-(acyloxy)phthalimide 81 was readily obtained from the 
corresponding carboxylic acid. 
 
Scheme 16. Photocatalytic key step in Overman’s second generation synthesis of (–)-aplyviolene. 
The reaction was first attempted under Okada’s initial conditions, in THF/H2O, which 
resulted in product formation, favorably as a single diastereomer, albeit in low yield due to 
hydrolysis and dehalogenation byproducts. After optimization, anhydrous conditions yielded 
the product 83 in an improved yield of 61% with only minor contamination of reductively 
dechlorinated byproduct. This vastly improved synthesis of key intermediate 83 enabled 
synthesis of the natural product 68 via Overman’s established route. Importantly, other 
avenues of generation of the tertiary alkyl radical, such as from bromide or iodide precursors, 
and Barton esters were found to be unsuitable for the transformation, showcasing the benign 
conditions for radical generation in photoredox catalysis can enable priorly inaccessible 
radical chemistry to elegantly solve this synthetic challenge.  
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1.2 Amine synthesis and functionalization via photoredox catalysis 
1.2.1 Background 
Since the revival of photoredox catalysis by the reports of Yoon, MacMillan and Stephenson 
in 2008 and 2009, the chemistry of amines has been intimately connected to this re-emerging 
field.[61, 68, 73, 92] Starting from early work in the field of photoredox methods, trialkylamines 
are used as inexpensive reductants, to drive photocatalytic turn-over.[93] Like most organic 
compounds, amines do not absorb visible light unless they feature a suitable chromophore, 
such as highly conjugated π-bond systems. Therefore, the photoredox catalyst has to engage 
in single electron transfer (SET) events with the amine, so that redox processes can be 
initiated. Amines are thus classically used as electron donors, quenching the photoexcited 
state of the catalyst, generating the respective aminium radical cation.  
Early use of this concept aimed at accessing a more highly reducing photocatalyst 
intermediate, enabling more potent reductions to be carried out. However, the use of amines 
in the last decade has shifted from their employment as mere reductive additives to their use 
as complex substrates and intermediates in a variety of photoredox transformations, including 
natural product applications.[93] Under photoredox conditions, the number of reaction 
pathways available to amines is vast, and can range from single-electron oxidation, C-H 
abstraction, deprotonation and β-scission to the formation of highly reactive intermediates 
such as α-amino radicals and iminium ions. Furthermore, due to the ubiquity of the amine 
functional group in alkaloids, pharmaceuticals and agrochemicals, the transformations of 
amines and thus the synthesis of new, complex amine derivatives have become a focal point 
of interest for the synthetic community.  
1.2.2 Amine reactivity  
The reactivity of the oxidation product, the aminium radical cation, can be explained by 
means of a simple trialkylamine example (Scheme 17). Single electron oxidation of 
triethylamine to the radical cation requires an reduction potential of E1/2
red = 0.83 V vs 
SCE,[94] and leads to dramatic acidification of the α-amino C–H bond, lowering the bond 
dissociation energy (BDE) of the α-amino C–H bond from 90.7 kcal/mol to an estimated ~42 
kcal/mol.[93] The oxidation accordingly entails a change of pKa of the α-amino proton from 
pKa = ≥ 40 to an estimated pKa = ~14.7. This remarkable activation can lead a number of 
subsequent mechanistic pathways. 
Chapter One – Introduction 
 
  23 
 
 
Scheme 17. Reactivity of amines under photocatalytic conditions.[93] 
Direct oxidation of the starting amine 84 by the photocatalytic system furnishes the aminium 
radical cation 85. In contrast, direct abstraction of a hydrogen atom from starting amine 84 
can lead to α-amino radical 86, a highly reactive nucleophilic open shell species. Both the 
aminium radical cation (85) and the α-amino radical 86 can easily be converted to the 
iminium ion 87, by hydrogen atom abstraction of the α-amino-C–H or photocatalytic one 
electron oxidation respectively. Lastly, via simple deprotonation of the acidic α-amino proton, 
the aminium radical cation can form the α-amino radical 86. Given the ubiquity of the use of 
tertiary amines in photoredox chemistry, and the interchangeable nature of the involved amine 
derived species, it is apparent that the α-amino radical and the iminium both have unique 
importance in photoredox chemistry as reactive intermediates. Moreover, α-amino alkyl 
radicals are more easily oxidized than the starting amines, and thus convert rapidly to the 
respective iminium ion if an excess amount of oxidant is present.[95] Notably, it should be 
considered that the aminium radical cation can also undergo a common non-productive 
process, called back electron transfer reaction, in which the radical cation accepts back one 
electron from the reduced photocatalyst. This major side reaction is competing against other 
productive downstream reactions. However, this problem can be circumvented via both 
photocatalyst and reaction design. Common photoredox catalysts today are intrinsically 
designed to somewhat mitigate back electron transfer reactions by employing ligands to retard 
this side reaction.[96-97] However, reaction design must ensure suitable and rapid downstream 
pathways are available, such as hydrogen atom abstraction via a good hydrogen atom 
acceptor. 
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A less common pathway for the aminium radical cation is β-scission. In this process, the 
amine radical cation undergoes cleavage of the β-amino C–C bond, leading to concomitant 
formation of both an iminium ion and α-amino radical (Scheme 18). There are a number of 
literature examples when this photoinduced process has been exploited in a synthetic 
fashion.[93, 98-99] 
 
Scheme 18. β-scission of aminium radical cations. 
1.2.3 Functionalization of iminium ions 
Conversion of amines into their respective, highly electrophilic iminium ions via visible light 
catalysis is a powerful synthetic method.[92] In 1980, early studies by the Whitten group 
explored the conversion of triethylamine to iminium ions (Scheme 19).[97] Irradiation of 
triethylamine 90 in the presence of ruthenium polypyridyl complexes, including 
[Ru(bpy)3](PF6)2, gave acetaldehyde when the reaction was carried out in the presence of 
water.  
 
Scheme 19. Whitten’s conversion of amine radical cations of triethylamine to iminium ions and acetaldehyde. 
Whitten and Giannotti concluded that irreversible oxidation to the iminium ion is taking 
place. Accordingly, reductive quenching by the of the photoexcited *[Ru(bpy)3]
2+ state would 
first produce the radical cation 91, which could abstract a hydrogen atom from the solvent 
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acetonitrile, ultimately leading to the generation of α-amino radical 93. Alternatively, radical 
cation 91 could undergo deprotonation to form the α-amino radical 93 directly. Subsequent 
one electron oxidation gives the central iminium ion 94 which in the presence of water is 
hydrolyzed to acetaldehyde and diethylamine (Scheme 19). Whitten and Giannotti were able 
to detect the open shell species Ru(I) and α-amino radical 93 via electron spin resonance 
(ESR) measurements with the aid of the spin-trap nitrosodurene to support their proposed 
mechanism.  
 
Scheme 20. Stephenson’s visible light mediated aza-Henry reaction. 
Later, in 2010, Stephenson and co-workers disclosed their photocatalytic functionalization of 
iminium ions in a visible light mediated aza-Henry reaction.[100] The oxidative coupling of 
nitroalkanes and N-aryl tetrahydroisoquinolines (97) was achieved via irradiation by visible 
light in the presence of photocatalyst [Ir(ppy)2(dtbbpy)]PF6  (99) to provide the aza-Henry 
products (98) in excellent yields (Scheme 20). Mechanistically, Stephenson proposed a 
reductive quenching cycle is operative, generating a powerful Ir(II) reducing agent (E1/2
red 
([IrIII(ppy)2(dtbbpy)]
+/ [IrII(ppy)2(dtbbpy)] = −1.51 V vs SCE) via the oxidation of 
tetrahydroisoquinoline 97. Control experiments indicated that both oxygen and the 
nitroalkane (via proposed reduction to nitrosomethane) can be involved in closing the 
photocatalytic cycle, as for example the vigorously degassed reaction still showed clean 
formation of the oxidative coupling product. Subsequent hydrogen atom abstraction from the 
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tetrahydroisoquinoline radical cation 100 furnishes iminium ion 101, which can be readily 
trapped by nucleophilic addition of deprotonated nitroalkane 102. This results in the aza-
Henry product 98. Stephenson and co-workers also reported one example of an N-aryl 
pyrrolidine undergoing the reaction, albeit in low yield.  
The transformation was subsequently reported by König using the organic dye Eosin Y (107) 
as photocatalyst,[101] and pairing the oxidative coupling system with malonate, phosphonate 
and cyanide nucleophiles (Scheme 21). The nature of the organic dye photocatalyst was 
further elaborated by Tan and co-workers, who employed Rose Bengal to catalyze the 
reaction.[102]  
 
Scheme 21. König’s tetrahydroisoquinoline functionalization with organic dye Eosin Y. 
Due to the privileged oxidation to the highly stabilized iminium ion, reports of oxidative 
tetrahydroisoquinoline functionalization sparked a number of further publications describing 
the oxidative coupling with a wealth of nucleophiles, including allyl silanes (108),[103] indoles 
(109),[103] enamines (110),[104] various phosphonates (105),[105] silyl enol ethers,[106] as well as 
alkynylation (111) and trifluoromethylation (112),[103, 107] and intramolecular trapping with 
alcohols and sulfonamides (113, Figure 8).[108] 
 
Figure 8. Examples of different nucleophiles in the visible light tetrahydroisoquinoline functionalization. 
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In 2012, DiRocco and Rovis reported an asymmetric α-acylation strategy for N-aryl 
tetrahydroisoquinolines (97), pairing N-heterocyclic carbene (NHC) and photoredox 
catalysis.[109] Reaction of the NHC-catalyst 116 with an aliphatic aldehyde 114 led to 
formation of a chiral acyl anion or homoenolate equivalent, the Breslow intermediate 117, 
which added to the photocatalytically generated iminium ion 101, forming a C–C bond 
(Scheme 22). m-Dinitrobenzene (m-DNB), a known oxidative quencher of the photocatalyst 
[Ru(bpy)3]Cl2, was employed stoichiometrically in the reaction.  
 
Scheme 22. DiRocco and Rovis’ α-acylation of tetrahydroisoquinolines via NHC and photoredox dual catalysis. 
An alternative approach to asymmetric functionalization of photochemically obtained 
iminium ions using anion binding catalysis was developed by Stephenson and Jacobsen in 
2014.[110] The authors postulated that the formation of halide counterions from oxidants 
BrCCl3 or CCl4 and their association with the oxidized substrate enabled stereoselective 
nucleophilic addition using thiourea catalysis. Stepwise oxidation to the respective iminium 
ion and subsequent solvent switch to enable stereocontrol via thiourea catalysis was 
necessary. Addition of silyl ketene acetal 123 to the photocatalytically pooled iminium ion in 
the presence of chiral thiourea 122 was achieved in the second step in MTBE, giving the 
enantioenriched products. 




Scheme 23. Stephenson and Jacobsen’s asymmetric functionalization of photocatalytically generated iminium 
ions via anion binding and photoredox dual catalysis. 
Xiao and Rueping independently reported that for tetrahydroisoquinolines bearing a N-
methylene group with one or two ester substituents (124 and 127), facile formation of the 
azomethine ylide can take place. Subsequent 1,3-dipolar addition was achieved in both cases 
with a range of dipolarophiles.[111-112]  
 
Scheme 24. Visible light mediated 1,3-dipolar addition independently reported by Xiao and Rueping. 
The azomethine ylides were formed from the initially photocatalytically generated iminium 
ions, by treatment with visible light and [Ru(bpy)3]Cl2 or [Ru(dtbbpy)3](PF6)2 and 125, and 
gave a series of fused pyrrolidines (Scheme 24a, 126) and, after oxidation with NBS, pyrrole 
products (Scheme 24b, 128), as exemplified by Xiao and co-workers. 
While tetrahydroisoquinolines are the most commonly exploited amine for photocatalytic 
amine functionalization, pioneering efforts by Li[113] and Rueping[114] investigated glycine 
derivatives as substrates for visible light enabled iminium functionalization (Scheme 25). In 
both cases, a visible light photoredox catalysis strategy for the α-functionalization of glycine 
Chapter One – Introduction 
 
  29 
derivatives with indoles using [Ru(bpy)3]Cl2 or [Ir(ppy)2(bpy)]PF6 was employed. Li opted 
for a 5 W blue LED as light source to successfully convert a series of N-aryl glycine 
derivatives, including esters and ketones 129, to the respective indole functionalized products 
131. Rueping’s conditions employed a 11 W CFL lamp, and zinc-(II)-acetate as a Lewis acid 
co-catalyst. Moreover, Rueping successfully tested a series of glycine derived dipeptides. 
 
Scheme 25. Functionalization of glycine derivatives independently reported by Li and Rueping. 
1.2.4 α-Amino radicals 
The chemistry of α-amino radicals, their nucleophilicity, synthetic utility and versatility have 
been of significant interest to the broader synthetic community for at least three decades.[92, 
115] In particular, the generation of α-amino radicals with UV light has been a longstanding 
field of interest (see Section 2.1.1).[116-118] As demonstrated in part 1.2.2 (Scheme 17), α-
amino radicals can play a key role in the visible light induced single-electron activation of 
alkylamines via photoredox chemistry, and thus have considerable synthetic potential.[119] In 
2011, the first synthetic utilization of a visible light promoted photoredox α-amino radical 
reaction was reported by MacMillan. The coupling process utilized the photocatalytically 
generated α-amino radical for this C–H arylation strategy using photoredox catalysis (Scheme 
26).[120] The method employed photocatalyst Ir(ppy)3 (13) in the presence of visible light, to 
couple cyanoarenes 135 and a series of tertiary amines such as 134 via radical-radical 
coupling. MacMillan and co-workers proposed an oxidative quenching cycle, in which the 
photoexcited *Ir(ppy)3 state transfers an electron to the cyanoarene 139, resulting in radical 
anion 140. It was proposed that photocatalytic cycle is closed by oxidation of the amine 134 
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to its radical cation 135. Radical-radical coupling produced the product 142 after elimination 
of cyanide.  
 
Scheme 26. MacMillan’s photoredox α-amino arylation reaction. 
In 2012, Pandey and Reiser,[121] and Nishibayashi[122] independently reported the first addition 
of α-amino radicals to α,β-unsaturated carbonyl compounds. In their seminal report, N-
phenyltetrahydroisoquinolines 97 engage in radical conjugate addition with α,β-unsaturated 
carbonyl radical acceptors, such as methyl vinyl ketone 25, to yield the respective α-amino 
alkylated products 143. Conceptionally this reaction represented an Umpolung strategy 
contrary to a number of previous examples employing N-aryltetrahydroisoquinolines to 
furnish the respective highly electrophilic iminium ions. Access to the nucleophilic α-amino 
radical is further complicated by the fact that the oxidation potential of the generated radicals 
is lower than those of the starting amines, showing the need for precise control over the single 
electron transfer events to prevent overoxidation.  
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Scheme 27. Pandey and Reiser‘s addition of N-aryltetrahydroisoquinoline derived α-amino radicals to Michael 
acceptors. 
Notwithstanding these challenges, under Pandey and Reiser’s conditions, amine 97 underwent 
facile oxidation under the action of visible light and [Ru(bpy)3]Cl2 or [Ir(ppy)2(dtbbpy)]PF6 
(Scheme 27). The authors proposed subsequent facile deprotonation to form key α-amino 
radical 144, which adds into radical acceptor 25 to yield the resulting alkyl radical 145. It was 
proposed that moderately electron poor 145 could be easily reduced by the photocatalyst, 
closing the catalytic cycle and forming the alkylated product 143 after protonation. 
 
Scheme 28. Conjugate addition of α-amino radicals into allenoates and alkenyl pyridines as reported by Li and 
Melchiorre respectively. 
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A number of similar reactions were subsequently published exploiting this pathway, notably 
by Rueping,[123] Yoon,[124] and Li.[125]  Various radical acceptors are compatible with α-amino 
radical coupling, such as allenoates,[126] and alkenyl pyridines,[127] as shown by the groups of 
Li and Melchiorre respectively (Scheme 28).  
In 2016, Melchiorre and Fagnoni published an elegant asymmetric radical coupling of α-
amino radicals with cyclic enones, utilizing a dual catalysis approach of photoredox and 
carbazole based organocatalysis (Scheme 29).[128]  
 
Scheme 29. Melchiorre’s enantioselective trapping of α-amino radicals via dual photoredox organocatalytic 
strategy. (Mes. mesityl-). 
In the reaction, cyclic enones 152 and substituted benzodioxoles or anilines 146 were reacted 
to form cyclic ketones 153 containing a quaternary carbon stereocenter in (Scheme 29). The 
authors proposed that the reaction is proceeded through initial formation of the protonated 
imine 159 from cyclic enone 152 and carbazole containing organocatalyst 158, followed by 
enantioselective addition of the photocatalytically generated α-amino radical 155. 
Remarkably, the resulting radical cation is readily reduced by an intramolecular electron-relay 
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producing the carbazoliumyl radical cation, and the competing electron back transfer is 
prevented by fast tautomerization of the resulting enamine to imine 157. Reduction by the 
photocatalyst and hydrolysis liberated the product ketones 153, closing the photocatalytic 
cycle and regenerating the organocatalyst. 
An alternative strategy to access α-amino radicals is the fragmentation of preinstalled 
functionality leading to radical formation in the desired position.[119] Pioneering work by 
Nishibayashi[129] in 2012, based on studies by Mariano,[118, 130] enabled utilization of α-amino 
alkylradicals generated from α-silylamines via the addition to α,β-unsaturated carbonyl 
compounds (Scheme 30).  
 
Scheme 30. Nishibayashi’s visible light mediated addition of α-aminoalkyl radicals generated from α-
silylamines to α,β-unsaturated carbonyl compounds. 
This strategy offers superior selectivity in radical generation compared to single electron 
oxidation and deprotonation due to its regiospecific nature. In the reaction, selective 
dissociation of C–Si bond in α-silylamine 161 was achieved in the presence of 
[Ir(ppy)2(dtbbpy)]BF4 (169) under irradiation of visible light, and the resulting α-amino 
radical 165 could be trapped by radical acceptor such as enone 162. Reduction of the resulting 
alkyl radical 166 closes the photocatalytic cycle and generates the product 168 after 
hydrolysis. Notably, the reaction was successfully carried out with trialkyl-derived α-
silylamines, with several competing α-C–H bonds available, underpinning the selectivity of 
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the process. Lastly, the intermediate silyl enol ether was isolated in some cases, leading to 
higher atom economy and potential synthetic applications. Nishibayashi also reported a 
variant of this reaction using secondary α-silyl amines in 2014.[131] 
Enantioselective variants of this type of radical addition reaction using α-silylamines and 
conjugated carbonyl acceptors were subsequently developed by Yoon[132] and Bach (Scheme 
31).[133]  
 
Scheme 31. Yoon’s and Bach’s enantioselective addition of α-silylamines into α,β-unsaturated carbonyl 
compounds. 
Yoon employed a scandium(III)-pybox derived chiral Lewis acid catalyst in conjunction with 
[Ru(bpy)3]Cl2 mediated photoredox catalysis for their enantioselective reaction of α-
silylamines 170 with crotonyl dimethylpyrazolidinone 171. Yoon and co-workers were able to 
achieve excellent enantioselectivities and yields for this transformation. Bach and co-workers 
opted for an alternative approach by using chiral template 176 to exert enantiocontrol in the 
addition of α-silylamines to 3-alkylideneindolin-2-ones (Scheme 31b). Interestingly the 
reaction was carried out in trifluorotoluene, which entailed the use of tetrakis[3,5-
bis(trifluoromethyl)phenyl]borate (BArF) as counterion for the photocatalyst 
[Ru(bpy)3](BArF)2 for solubility reasons. Moderate to good levels of stereoinduction could be 
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achieved via hydrogen bonding between the chiral template and the α,β-unsaturated 
indolinone 174.  
In 2014, MacMillan and co-workers disclosed multiple reports describing a photocatalyzed 
pathway to generate α-amino radicals, via the decarboxylation of α-amino carboxylic acids for 
subsequent arylation, conjugate addition, and vinylation.[134-136] This pathway was previously 
explored for UV light by Mariano.[118, 130] In the conjugate addition reaction, the authors 
proposed that deprotonation and subsequent oxidation of a carboxylic acid 177 by the 
Ir[dF(CF3)ppy]2(dtbbpy)PF6 photocatalyst excited state leads to α-carbamate radical 180 via 
extrusion of CO2 (Scheme 32).
[134] Addition to radical acceptor furnishes the resulting alkyl 
radical 181, whose facile SET reduction closes the photocatalytically cycle to furnish the 
respective enolate. Protonation yields the α-functionalized products. Notably, MacMillan and 
co-workers reported the synthesis of (±)-pregabalin 183 using this photocatalytic 
decarboxylative Michael addition method.  
 
Scheme 32. MacMillan’s visible light photoredox decarboxylative Michael addition, enabling a three step 
synthesis of (±)-pregabalin. 
An alternative pathway was described in 2012 by Akita and co-workers with the formation of 
α-carbamate radicals via direct photoredox mediated oxidation of organoborates.[137] In a 
subsequent report in 2014, coupling of potassium trifluoroborate derived α-carbamate radicals 
with α,β-unsaturated carbonyl compounds was reported.[138] The reaction utilized 
photocatalyst Ir[dF(CF3)ppy]2(dtbbpy)PF6 under irradiation of blue LEDs, enabling facile 
oxidation of potassium trifluoroborate 184 to the respective α-carbamate radical 187. Radical 
addition to a number of acceptors, such as perfluorinated arenes 191 and vinyl pyridines 192, 
gave the respective addition products in good yields (Scheme 33).  




Scheme 33. Akita and Koike‘s hydroaminoalkylation from trifluoroborate derived α-amino radicals. 
The general addition of photoredox generated α-amino radicals to radical acceptors is 
applicable to a wide range of radical-acceptor moieties.[119] Notable examples include 
Nishibayashi’s report of the addition of α-amino radicals to azadicarboxylate esters (Scheme 
34a),[139] Li’s photoredox coupling of dimethylanilines with isocyanates (Scheme 34b),[140] 
and Ooi’s asymmetric addition of α-aminoalkyl radicals to imines (Scheme 34c).[141]  
 
Scheme 34. Addition of photocatalytically generated α-amino radicals to azadicarboxylates, isocyanates, and 
imines. (Me2phen. 2,9-dimethyl-1,10-phenanthroline) 
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The addition of α-amino radicals to heteroarenes is relatively rare due to challenging control 
over the oxidation of the initially formed radical.[119, 142] Pioneering efforts towards the 
photoredox variant of this reaction were reported by MacMillan.[135] Additionally, Stephenson 
successfully carried out heteroaryl functionalization on pharmaceutically relevant 
scaffolds,[143] and Fu reported a decarboxylative coupling of amino acid N-
hydroxyphthalimide esters with heteroarenes.[144] Based on these studies, Phipps and co-
workers recently reported an elegant asymmetric Minisci-type addition of α-amino radicals to 
a series of heteroaromatics (Scheme 35).[145]  
 
Scheme 35. Phipps‘ photocatalytic enantioselective Minisci-type radical addition to heteroarenes. 
In the reaction, reduction of a redox-active α-amino N-hydroxyphthalimide ester 204 leads to 
fragmentation and concomitant formation of CO2 and α-amino radical 206. The authors 
proposed an asymmetric radical addition to the heteroarene via chiral Brønsted acid 
activation, resulting in radical cation 208. Subsequent deprotonation and oxidation closes the 
photocatalytic cycle and generates the Minisci product 210. The reaction exhibited high yields 
and excellent enantioselectivity, and was applicable for a wide range of amines, quinolines 
and pyridine acceptors. Phipps and co-workers also demonstrated the applicability of the 
method in a late-stage functionalization approach for pharmaceuticals. 
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A hydrogen-atom-transfer (HAT) activation pathway towards the generation of α-aminoalkyl 
radicals without the use of a dual metal-catalysis approach (vide infra) was recently reported 
by Rovis and Schoenebeck.[146] Key to the success of this strategy was the electrostatic 
activation of primary amines by CO2, which served as a transient protecting group to enable 
selective HAT to generate the α-carbamate radical. The reaction allowed for a CO2-promoted 
α-alkylation/lactamization of primary amines such as 211, under irradiation with blue LEDs 
with photocatalyst Ir[dF(CF3)ppy]2(dtbbpy)PF6. Site-selective HAT was achieved through a 
HAT-catalysis cycle using quinuclidine 214, whose radical cation 215 was found to engage in 
hydrogen atom abstraction from the in situ formed alkylammonium carbamate 220. Addition 
of the α-carbamate radical 216 into an α,β-unsaturated carbonyl acceptor, such as acrylate 
212, furnishes alkyl radical 217, which after reduction by the photocatalytic system, 
protonation and dissociation of CO2 affords the final γ-lactam products 218. An expansion of 
this HAT activation strategy for the α-position of primary amine derived 
trifluoromethanesulfonamides was published by the authors in 2019 (Scheme 36).[147] 
 
Scheme 36. Rovis and Schoenebeck’s α-alkylation of primary aliphatic amines enabled by CO2 and 
electrostatics. 
1.2.5 α-Aminoalkyl radicals in transition metal – photoredox dual catalysis 
Given the interest in novel photoredox transformations over the last decade and the success of 
the diverse and fruitful field of transition-metal catalysis in organic synthesis, it is perhaps 
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unsurprising that dual catalytic platforms exploiting both photoredox and alternative modes of 
catalysis have recently emerged as a particularly promising area of research.[78, 148-149] The 
intriguing synergy of photocatalysis with non-photochemical transition-metal catalysis, also 
termed metallaphotocatalysis, has led to unprecedented control over reactivity of the resulting 
photogenerated intermediates and contributed to realize a number of challenging, or 
previously elusive, bond constructions.[78, 148] Perhaps due to the intrinsic connection of amine 
redox chemistry with established photoredox methods, this novel mode of dual-catalysis has 
proven especially useful for the functionalization and cross coupling of α-aminoalkyl and α-
amidoalkyl radicals. In the following, a number of seminal reports published in this area will 
be highlighted.  
The first report to employ both photoredox and nickel catalysis in concert was disclosed in 
2014 by the groups of Doyle and MacMillan.[150] In their landmark report, an efficient cross-
coupling platform between an aryl halide and an α-carbamate radical using a dual catalytic 
system was reported (Scheme 37).  
 
Scheme 37. MacMillan and Doyle‘s coupling of α-carboxyl sp3-carbons with aryl halides. 
Due to the ability of Ni(II) complexes to rapidly combine with organic radicals,[151-152] the 
authors designed a system in which a photocatalytically generated α-carbamate radical 224 
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would converge with a Ni(II) complex 228 resulting from oxidative addition to an aryl halide 
227, to form a Ni(III)(Ar)(alkyl) species 225. Reductive elimination gives rise to the desired 
C–C bond formation to yield the α-arylated amine product 226 and regenerate the Ni(I)-
catalyst. The Ni(I) species is sufficiently oxidizing to receive an electron from the Ir(II) 
intermediate, regenerating the Ir(III) and Ni(0) catalysts, and closing both the respective 
catalytic cycles. The reaction was successfully conducted with iodo-, bromo-, and 
chloroarenes in the presence of Ir[dF(CF3)ppy]2(dtbbpy)PF6, irradiation by a 26 W CFL bulb, 
and nickel(II) chloride ethylene glycol dimethyl ether complex (NiCl2·glyme), and proceeded 
in good yields. Notably, the authors showed in the same report that the catalytic system is also 
compatible with direct amine oxidation, for example of dimethylaniline, successfully 
generating the resulting α-aminoalkyl radical.  
An enantioselective variant of this reaction was subsequently developed by MacMillan and Fu 
in 2016, by using in situ formed chiral Ni(II) complexes to achieve enantioselective arylation 
in α-position (Scheme 38a).[153]  
 
Scheme 38. a. Enantioselective decarboxylative arylation via photoredox dual catalysis by MacMillan and Fu; b. 
α-Arylation of chiral α-aminomethyltrifluoroborates via photoredox dual catalysis by Molander. 
The reaction was reported to furnish high levels of stereoinduction and was applicable to a 
series of α-amino acids and aryl halides. The authors also demonstrated the utility of this 
asymmetric coupling by producing two substrates containing known pharmacophores. 
Furthermore, a similar photoredox nickel dual-catalysis system utilizing potassium 
alkyltrifluoroborates as radical precursors was disclosed by Molander and co-workers,[154] 
enabling the radical cross coupling of chiral α-aminomethyltrifluoroborates (Scheme 38b).[155] 
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Following an earlier report from the MacMillan group of the decarboxylative vinylation using 
vinyl sulfones as radical acceptors (vide supra),[136] in 2015, Noble and MacMillan reported a 
photoredox and nickel dual catalysis approach for the decarboxylative vinylation of α-amino 
and α-oxy carboxylic acids.[156] Instead of vinyl sulfones, the reaction allowed the use of more 
readily available vinyl halides in the transformation (Scheme 39). A number of α-oxy and α-
amino were utilized to generate the respective vinylated products 240, including trans-Rose 
Oxide, a natural product and widely used fragrance. 
 
Scheme 39. Noble and MacMillan’s cross coupling of carboxylic acids with vinyl halides using photoredox dual 
catalysis. 
A photoredox-nickel dual catalysis α-amino acylation method was reported by Doyle and co-
workers in 2016, furnishing α-amino ketones (Scheme 40).[157] The reaction utilizes 
photocatalyst [Ir(ppy)2(dtbbpy)]PF6 and bis(1,5-cyclooctadiene)nickel(0) [Ni(cod)2] with 
dtbbpy ligand  as a catalytic system and employs quinuclidine as a base. 
 
Scheme 40. Doyle’s direct acylation of sp3 α-amino C–H bonds via nickel and photoredox catalysis. 
The reaction proceeds from tertiary aryl amines 134 with symmetric anhydrides 241 to 
produce the respective α-amino ketones 242 in good yields under irradiation of 34 W blue 
LED. Interestingly, Stern-Volmer quenching studies demonstrated that quinuclidine does not 
quench the photoexcited state of the photocatalyst in this system.  
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In 2015, Lu and Xiao reported an allylic substitution reaction using palladium and photoredox 
dual catalysis (Scheme 41).[158] The reaction efficiently couples allylic carbonates, esters, 
bromides, and phosphates (246) with  a series of tetrahydroisoquinoline (97) and secondary 
amine derived α-amino radicals using a [Pd(PPh3)4] and [Ir(ppy)2(dtbbpy)]PF6 co-catalytic 
system. Remarkably, in this redox-neutral transformation, allyl radical 250 is generated from 
the corresponding π-allylpalladium intermediate 249 via SET from the reduced photocatalyst 
species Ir(II), which in turn is regenerated by oxidation of the amine to the α-amino radical 
from the photocatalyst excited state *Ir(III). The authors propose that a central SET event 
closes both catalytic cycles and subsequent radical-radical coupling between allyl radical 250 
and α-amino radical 144 affords the α-allyl amine products 251. An alternative mechanism 
based on the reaction of nucleophilic α-amino radical 144 and electrophilic π-allylpalladium 
complex 249 could be considered.  
 
Scheme 41. Lu and Xiao’s redox-neutral α-allylation of amines combining palladium and photoredox catalysis. 
The merger of photoredox dual catalysis with a third catalytic system, selective HAT 
catalysis, was reported by MacMillan and co-workers in 2016, achieving selective α-
functionalization of amines and amides.[159] This approach allows formation of the α-
carbamate radical via selective hydrogen atom abstraction due to the activated nature of the 
C–H bond and coupling of the resulting radical species with an electrophile via the 
established nickel-photoredox dual catalysis platform (Scheme 42a).  
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Scheme 42. a. MacMillan’s triple catalytic functionalization of α-carbamate C–H bonds. b. MacMillan’s late-
stage functionalization of the drug derivative N-Boc Prozac. 
Photocatalyst Ir[dF(CF3)ppy]2(dtbbpy)PF6, nickel-(II)-bromide and ligand 262 were employed 
in the reaction. Single electron oxidation of the HAT catalyst, 3-acetoxyquinuclidine (255) by 
the photocatalytic system generates the corresponding radical cation, which is able to abstract 
an α-hydrogen atom from Boc-protected amine 252 with a high degree of kinetic selectivity. 
The resulting α-carbamate radical converges with Ni(II) complex 261 to generate the 
Ni(III)(Ar)(alkyl) complex 258, which undergoes facile reductive elimination to from the α-
functionalized amine product 259. SET to the resulting Ni(I) complex from the reducing Ir(II) 
species turns over both the nickel and photoredox catalytic cycles. Notably, under these 
conditions, the 3-acetoxyquinuclidine serves both as a HAT catalyst and a base and had to be 
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employed stoichiometrically. The reaction was applicable to a large scope of substrates and 
operates with remarkable selectivity, including preference of HAT at methyl over methylene, 
and methylene over methine. The reaction was further expanded to include alkylation with 
aliphatic halides as electrophiles, and has been utilized for an elegant late-stage 
functionalization of the drug derivative N-Boc Prozac 263 (Scheme 42b).[160] 
In 2017, the Rovis group reported their hydroaminoalkylation approach using a unified cobalt 
and photoredox catalytic system. The method enables coupling of photoredox generated α-
amino radicals with conjugated dienes to produce useful homoallylic amines, accessing this 
motif through readily available commercial starting materials (Scheme 43).  
 
Scheme 43. Rovis’ hydroaminoalkylation of conjugated dienes via a cobalt photoredox dual catalytic system. 
To achieve this transformation, Rovis and co-workers employed photocatalyst 
Ir[dF(CF3)ppy]2(dtbbpy)PF6 in concert with an in situ formed Co(dppp)Br2 complex (dppp: 
1,3-bis(diphenylphosphino)-propane, 273). Mechanistically, the reaction sets out via 
oxidation of a tertiary aryl amine 146 by the photocatalytic system, resulting in formation of 
α-amino radical 155 after deprotonation. The authors propose that the generated Ir(II) species 
(E1/2
red = −1.37 V vs SCE) is reducing enough to engage in single electron transfer with the 
Chapter One – Introduction 
 
  45 
formed Co(dppp)(OPiv)2 (E1/2
red = −1.29 V vs SCE), to generate a Co(I) species. Reaction 
with pivalic acid generates a transient Co(III) hydride, which affords a Co(III)-allyl species 
271 after migratory insertion of the diene 270 into the Co–H bond.[161] Reduction to the 
respective Co(II) allyl system (272) closes the photocatalytic system and results in 
convergence of α-amino radical 155 and 272 to form Co(III)(alkyl)(allyl) complex 268. 
Reductive elimination yields the homoallylic amine product 269 and regenerates the Co(I) 
catalyst.  
1.2.6 Summary and outlook 
A series of visible light absorbing photocatalysts, developed nearly 50 years ago for water 
splitting[162] and solar cell applications,[163] have, over the course of only the last decade, 
achieved a paradigm shift promoting the synthetic use of visible light in organic synthetic 
chemistry. Photoredox chemistry has advanced from an academic curiosity to a modern, 
indispensable synthetic tool to generate reactive radical intermediates, avoiding the 
traditionally employed toxic and hazardous chemical reagents. The unique ability to convert 
visible light into chemical energy, achieving selective activation of bonds and enable the 
discovery of novel bond forming reactions has led to the rise of photoredox chemistry to the 
forefront of organic chemistry. The industrial sector is adopting photoredox transformations, 
allowing for novel discoveries to be rapidly translated into pharmaceutical applications.[74] 
The use of visible light as an environmentally benign reagent enables chemists to design 
synthetic transformations in a safer, more efficient, and less wasteful manner to minimize 
impact of chemical production and research.[74] As a part of this development, underpinned by 
the recent dawn of transition metal and photoredox dual catalysis, metallaphotoredox 
catalysis,[78] modern advances in photoredox catalysis have led to a myriad of novel synthetic 
methodologies. The redox chemistry and synthesis of amines, one of the most important 
functional groups in organic chemistry,[164] are intimately interwoven with the field of 
photoredox chemistry, and a number of elegant amine functionalization pathways have 
emerged from this new area. However, despite the exponential growth of this field of research 
since 2008, limitations still exist, and further research is needed to enable environmentally 
benign photocatalytic pathways for amine functionalization. Due to the numerous 
pharmaceutical applications and bioactive properties of amines,[165] there is an ongoing need 
for versatile methodologies for their general and facile functionalization, which promise to 
have far-reaching impact in the synthetic and medicinal chemistry community. 
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2. Photocatalytic multicomponent olefin-hydroaminoalkylation 
2.1 Introduction 
2.1.1 α-Aminoalkyl radicals via reductive pathways 
The α-aminoalkyl radical is a synthetically useful intermediate and is involved in numerous 
photocatalytic protocols for the synthesis of complex amines.[119] Predominantly, the 
generation of α-amino radicals for synthetic purposes is achieved via fragmentation of 
preinstalled functional groups, such as α-aminosilanes and α-amino organoborates (see 
Section 1.2.4), or via N-oxidation and subsequent α-deprotonation of the aminium radical 
cation. While oxidative methods for α-amino radical generation offer advantages over 
prefunctionalization and have achieved wide-spread success in the field, the deprotonation of 
tertiary amine derived radical cations is an inherently unselective process.[166] This gives rise 
to significant issues when more than one non-equivalent α-amino C–H bond is available for 
radical generation, restricting many oxidative methods to the use of symmetric aryl amines[119] 
to avoid the resulting product mixtures after α-amino functionalization.[167] While catalytic 
HAT processes, pioneered by MacMillan,[159-160] have shown excellent selectivity for α-amino 
radical generation in some cases, kinetic selectivity for the desired α-amino position is 
required. Furthermore, the selectivity of HAT processes is substrate dependent and can lead to 
the isolation of inseparable regioisomeric mixtures of α-amino functionalized products.[160] 
On the other hand, generation of α-amino radicals through single electron reduction of C=N 
bonds occurs regiospecifically, but is far less common due to several challenges associated 
with the method. The generation of α-amino radicals has been achieved using strong 
stoichiometric reductants, or electrochemical methods, or with UV light.[168] In an early 
example, Kunai and co-workers reported the electrochemical reduction of a tetrasubstituted 
iminium salt on a mercury surface and the subsequent addition of the resulting α-amino 
radical to Michael acceptors.[169] Cyclohexylidenepyrrolidinium perchlorate (274) was 
electrochemically reduced at −1.80 V in the presence of methyl acrylate in acetonitrile. Albeit 
the radical addition product 275 via α-amino radical 277 was observed in Kunai’s study, the 
reaction proved challenging due to polymerization and multiple addition of acrylate (Scheme 
44a). A later example by Yoshida[170] demonstrated the utilization of the cation-pool method 
at cryogenic temperatures for the electrochemical reduction of pyrrolidine derived 
acyliminium ions 279. An excess of olefin was necessary to obtain good yields in the addition 
of the resulting α-carbamate radicals to electron deficient alkenes (Scheme 44b). 
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Scheme 44. a. Electrochemical reduction of iminium ions by Kunai; b. Electrochemical reduction of iminium 
ions via Yoshida’s cation pool method. 
The stoichiometric chemical reduction of iminium ions for subsequent radical addition 
reactions is classically achieved via the use of strong reducing agents, particularly samarium 
diiodide[171] and titanocene complexes.[172] In 1988, Martin and co-workers published an early 
example of a reduction of an alkyl iminium salt using samarium iodide. Lactam 281 was 
subjected to phenylmagnesium bromide followed by perchloric acid to yield pyrrolidinium 
perchlorate 282. Reduction with samarium diiodide in acetonitrile, in the presence of camphor 
sulfonic acid (CSA), induces 5-exo-trig radical cyclization to yield the bicyclic product 283 
and traces of over-reduced tertiary amine 284. The authors proposed that protonation of the 
intermediate α-amino radical is beneficial for the reaction to proceed cleanly. 
 
Scheme 45. Martin’s generation and cyclization of N-homoallyl α-amino radicals.  
Starting from the late 1970s, Mariano and co-workers have reported numerous studies on the 
electron transfer and energy transfer reactivity of the photoexcited state of iminium ions, 
accessed via irradiation by high energy UV-light.[173-174] Iminium ions can undergo π → π* 
transition, which occur in the wavelength regions of the UV, and, for some conjugated 
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iminium ions, visible light spectral range. For example, for the iminium ions 285, 286, and 
287, the absorption maxima lie at 222 (dioxane),[175] 275,[176] and 317 nm[177] respectively 
(Figure 9).[173]  
 
Figure 9. Absorption maxima of iminium ions and photophysical properties of iminium ions. 
Calculations confirm that,[178-179] due to the electronegativity of the nitrogen atom, both 
HOMO and LUMO energies of the iminium ion are lower than for the respective alkenes 
(Figure 9). The low lying LUMO in these species thus renders iminium ions particularly 
susceptible to single electron reduction, resulting in the formation of the stabilized α-amino 
radical.[180] Good correlation has been established between the degree of conjugation in 
iminium ions and the shift of the respective reduction potentials to more positive values.[181] A 
comprehensive survey of the electrochemical properties of iminium ions was achieved 
through a series of reports by Andrieux and Saveant,[182-185] placing iminium half wave 
potentials in the range of −1.71 to −0.65 V (vs SCE). 
Mariano and co-workers achieved a series of UV light promoted olefin-iminium salt 
photoaddition reactions.[186-190] Exemplified by the UV-mediated photoaddition to iminium 
ion 288 (Scheme 46), electron transfer from electron-rich olefins, such as isobutene (289), to 
the photoexcited state of pyrrolidinium perchlorate type iminium ions is energetically 
favorable, and can occur under the irradiation of UV light. This is consistent with Mariano’s 
observation that electron-rich olefins are excellent quenchers of the 2-phenyl-1-pyrrolidinium 
perchlorate (288) excited state.[187] The process is efficient with rate constants near diffusion 
control. The generated radical pair 290 is readily intercepted by the solvent MeOH, which 
attacks the isobutene radical cation at the least substituted, charged position, forming adduct 
291. Radical-radical recombination occurs to form the product amine 292 in good yields and 
exclusive anti-Markovnikov selectivity.  
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Scheme 46. Olefin-iminium salt photoaddition reaction by Mariano and co-workers. 
2.1.2 Previous work 
With the emergence of visible light photoredox catalysis, a relatively small number of 
reductive pathways to access α-amino radicals via single electron transfer to C=N double-
bonds were reported. In a seminal report in 2014, the MacMillan group detailed the first 
visible light photoredox mediated reduction of a C=N double-bond in their organocatalytic 
coupling of benzylic ethers with benzaldimines (Scheme 47).[191] Benzyl ether 293 and aryl 
imines 294 generate the β-amino ether products 295 under irradiation with blue LEDs with 
photocatalyst [Ir(ppy)2(dtbbpy)]PF6 (1 mol%), methyl thioglycolate 296 and catalytic lithium 
acetate. The catalytic cycle sets out with reductive quenching of the photocatalyst by thiol 
296, generating the thiyl radical 297 and the reducing Ir(II) species (E1/2
red = −1.51 V vs 
SCE). Although the authors propose direct reduction of the imine 294, due to a significant 
difference in reduction potential between the Ir(II) reductant and imine 294 (E1/2
red = ca. −1.91 
V vs SCE),[94] it is deemed more likely that imine 294 first undergoes activation through 
protonation (299), lowering the effective reduction potential required.[168] A proton-coupled 
electron transfer[192] pathway can also be considered to mitigate the difference in 
potentials.[193] The resulting α-amino radical 300 subsequently undergoes radical-radical 
coupling with the benzylic radical 298 furnished via HAT with thiyl radical 297, generating 
the β-amino ether product and closing the organocatalytic cycle. In 2015, the MacMillan 
group expanded this methodology to couple aldimine derived, reductively generated α-amino 
radicals with β-enaminyl radicals to generate γ-aminoketones through the use of 
[Ir(ppy)2(dtbbpy)]PF6 and DABCO as a HAT catalyst.
[194] 




Scheme 47. MacMillan’s photoredox coupling of benzylic ethers with imines. 
In 2015, Rueping and co-workers reported the homocoupling of reductively generated ketyl- 
and α-amino radicals to furnish the respective pinacol and imino-pinacol products via visible 
light photoredox catalysis (Scheme 48).[195] In the imino-pinacol variant of the reaction, the 
preformed N-benzyl aldimine starting material 301 and Ir-photocatalyst 303 were subjected to 
irradiation with blue LEDs in the presence of tributylamine. The authors propose that the two 
α-amino radicals required for the homocoupling are generated via single electron reduction of 
the respective activated imines by the photocatalytic system. According to the mechanistic 
hypothesis, the excited state photocatalytic *Ir(III) species quenches, reductively, with the 
amine additive tributylamine (304), to generate the respective aminium radical cation 305. 
Rueping suggests imines are rendered susceptible to SET via Lewis acid activation by the 
radical cation 305 through a two-center/three electron bond (306),[196-197] enabling single 
electron reduction to furnish both the α-amino radical 307 and the ground state Ir(III) species. 
Radical-radical recombination yields the imino pinacol products 302. 
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Scheme 48. Rueping’s photoredox reductive homocoupling of imines using visible light. 
In 2015, Ooi and co-workers reported a dual catalytic system for the asymmetric coupling of 
N-sulfonyl imine derived α-amino radicals with N-arylaminomethanes.[141] The authors opted 
for [Ir(ppy)2(Me2phen))]BArF,
[198] bearing a 2,9- dimethyl-1,10-phenanthroline (Me2phen) 
ligand, as a photocatalyst with irradiation by white LEDs and employed a chiral P-spiro 
arylaminophosphonium barfate 202 (BArF = [3,5- (CF3)2C6H3]4B) in their stereoselective 
protocol (Scheme 49). The mechanistic cycle sets out with the oxidation of the N-
arylaminomethane 198 by the photoexcited *Ir(III) species to generate an Ir(II) species and 
the α-amino radical 310 after deprotonation. The authors argue that the Ir(II) catalytic species 
should be sufficiently reducing (E1/2
red = ca. −1.40 V vs SCE) to reduce the N-sulfonyl imine 
308 (E1/2
red = −1.45 V vs SCE) to form the resulting anionic radical 309. Prompt ion exchange 
with the aminophosphonium ion 202 due to its strong H-bond donor ability affords chiral ion 
pair 311. A final radical-radical combination reaction between the α-amino radical 310 and 
chiral ion pair 311 under guidance of chiral ion 202 enantioselectively furnishes the 1,2-
diamine product 312. A conceptionally similar coupling was published in 2016 by the 
Rueping group.[199] 




Scheme 49. Ooi’s asymmetric coupling of N-arylaminomethanes and aldimines (Me2phen. 2,9- dimethyl-1,10-
phenanthroline). 
In contrast to radical-radical coupling reactions, the addition of reductively generated, 
carbonyl derived α-amino radicals into Michael acceptors via visible photoredox chemistry 
was first reported by Chen and co-workers in 2016.[200] In their report, allylation of aldehydes, 
ketones and imines is described, utilizing photocatalyst [Ir(dtbbpy)(ppy)2]PF6 and Hantzsch 
Ester (316) as a terminal reductant (Scheme 50). Mechanistically, the authors propose that the 
cycle begins with reductive quenching of the excited state photocatalyst through facile 
oxidation of Hantzsch Ester 316 to its radical cation 317. The resulting Ir(II) species can then 
engage in single electron reduction of imine 318, which is activated by the Hantzsch Ester 
radical cation (319).[201-202] The resulting α-amino radical 320 adds to the Michael acceptor 
314 to furnish the desired addition product 322 and generating sulfur radical 321, which 
converges with the Hantzsch Ester radical cation to form the respective pyridine 320. Notably, 
a series of alkyl imines tested by Chen and co-workers underwent the reaction smoothly in a 
multicomponent fashion to produce the respective alkylamine products. A conceptionally very 
similar multicomponent reaction using organophotocatalyst Eosin Y was subsequently 
reported by Dixon co-workers.[203] 
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Scheme 50. Chen’s visible light photoredox allylation of imines enabled by Hantzsch Ester. 
In a recent report, Ngai and co-workers detailed the reductive coupling between carbonyl 
derivatives and alkenylpyridines under Lewis acid and photoredox dual catalysis.[204] The 
reaction efficiently couples imines 323 with 4-vinyl pyridine 324 (Scheme 51). The authors 
propose catalytic generation of the Hantzsch Ester radical cation, which critically activates the 
imine for single electron reduction. After addition of the α-amino radical to the vinyl pyridine, 
the resulting benzyl radical undergoes HAT with Hantzsch Ester to form the desired product 
325 and regenerate the catalytic Hantzsch Ester radical cation. 
 
Scheme 51. Ngai’s visible light photoredox coupling reaction between imines and 4-vinylpyridines. 
While some advances in the reductive generation of α-amino radicals have been achieved 
through the methods outlined above, it is notable that in contrast to the plethora of oxidative 
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α-amino radical formation, photocatalytic reduction of C=N bonds remains limited. As 
outlined by Arnold,[181] in all cases shown above conjugation of the C=N system with, 
particularly aromatic, π-systems was necessary to lower the required reduction potentials into 
the compatible range of the involved photocatalytic systems. Furthermore, protonation of 
imines, or a PCET mechanism[192] was often required to overcome the vast potential 
differences. This renders all-alkyl iminium ions, (alk)2C=N(alk)2, particularly challenging 
candidates for reductive photoredox α-amino radical generation, as these species lack the 
necessary orbitals to engage in protonation or PCET, and are by definition devoid of any π-
system conjugation, resulting in high reduction potentials. To the best of our knowledge, prior 
to the study outlined below, only a sole example of the reduction of an all-alkyl iminium ion 
via photoredox existed in the literature, reported by Wenger and co-workers in 2018.[205] 
Wenger’s reductive amination approach utilizes [Ru(bpy)3]Cl2, ascorbic acid, 3-
mercaptopropionic acid and methanol under blue LED irradiation, to achieve the 
photocatalytic reduction of the in situ formed imine of cyclohexylcarboxaldehyde 326 and 
pyrrolidine 327 via a polarity matched HAT (Scheme 52).  
 
Scheme 52. Wenger’s reductive amination by photoredox catalysis via polarity-matched HAT. 
2.2 Project Aims 
Based on the literature reports outlined above, it was recognized that application of α-amino 
radicals derived from C=N bond single electron reduction of imines and iminium ions has 
been hindered by the large reduction potential of these species (e.g. E1/2
red = −1.91 V vs SCE 
for N-benzylideneaniline,[94] and up to E1/2
red = −1.71 V vs SCE[182, 206] for alkyl-
idenepyrrolidinium perchlorates) and hence the requirement for toxic reducing agents and/or 
harsh reaction conditions.[168] While photoredox enabled C–C bond formation via α-amino 
radicals derived from heavily conjugated imines and iminium ions is well explored (vide 
supra), our interest was piqued in particular by the class of all-alkyl aldiminium and 
ketiminium ions, which are readily accessible from feedstock starting materials. The 
corresponding α-amino radicals of this class of iminium ions were, with the exception of a 
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single substrate reported,[205] hardly explored.  Furthermore, C–C bond forming reactions 
from reductively photoredox generated ‘all-alkyl’ α-amino radicals are unprecedented in the 
literature. It was envisaged that a visible light mediated reaction via regiospecific C=N bond 
reduction, should it be realized, would offer significant advantages over oxidative α-amino 
radical formation, a method inherently plagued by selectivity issues.[119, 167] Through a 
multicomponent approach, the site of radical formation could be determined specifically by 
the location of the C=N double bond, making the system more efficient than 
prefunctionalization approaches,[119] and would allow greater site-control than HAT-activation 
methodologies (Scheme 53).[159]  
 
Scheme 53. Catalytic photoredox methods for the generation of all-alkyl α-amino radicals. 
However, several challenges could impede the development of this desirable technology. 
Firstly, high reduction potentials of the involved species would require a strongly reducing 
photocatalyst, while ensuring compatibility with the reaction conditions. Moreover, 
alkyliminium ions are known to exist in (often unfavorable) equilibrium with the 
corresponding enamines, which, importantly for photoredox systems, can also undergo SET 
reactions to form radical species via oxidation.[207] This can present competing pathways and 
can lead to the buildup of side-product or prevent the desired catalytic cycle from being 
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operative. Finally, for the development of a C−C bond forming reaction derived from all-alkyl 
α-amino radicals, the addition of α-amino radicals to simple alkenes is often known to be low-
yielding owing to dimerization of α-amino radicals,[208] or oligomerization of the resulting 
alkyl radical.[125] 
 
Scheme 54. Design plan for the photoredox catalyzed multicomponent olefin-hydroaminoalkylation. 
Notwithstanding these challenges, we were intrigued by the potential gains of a methodology 
utilizing the reductive generation of all-alkyl α-amino radicals. Accordingly, the aim of the 
project described in this chapter was to develop a multicomponent approach for the visible 
light photoredox reduction of in situ generated all-alkyl iminium ions. α-Functionalization via 
radical reactions, such as conjugate addition, of the resulting elusive all-alkyl α-amino 
radicals 338 is explored (Scheme 54). The resulting complex tertiary amine products 339 
belong to a compound class that has become ubiquitous among pharmaceutical agents, small-
molecule probes and pre-clinical candidates. It was envisaged that an operationally 
straightforward photoredox method to enable the construction of complex tertiary amines 
from simple starting materials would have far-reaching implications both in the synthetic 
and medicinal chemistry community. 
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2.3 Results and Discussion 
2.3.1 Discovery and early studies 
The initial reaction that led to the discovery and design of the multicomponent 
hydroaminoalkylation reaction described in this chapter was conceived by Dr A. Trowbridge. 
These initial studies investigated the intramolecular 5-exo-trig cyclization of the α-amino 
radical 344 resulting from the condensation and visible light photoredox reduction of N-
benzylbut-3-en-1-amine (340) and butyraldehyde 114 (Scheme 55). An initial hit was 
observed when the reaction was conducted with equimolar amounts of amine and aldehyde in 
the presence of 1.5 equivalents of Hantzsch Ester, activated molecular sieves (4 Å) and 
strongly reducing photocatalyst Ir(ppy)3 (1 mol%) in dichloromethane under irradiation of a 
30 W CFL light bulb.[193] Remarkably, substituted pyrrolidine product 342 was observed in 
53% (d.r. 2.4:1), which indicated that indeed consecutive condensation, single electron 
reduction, 5-exo-trig cyclization, and HAT reaction of the resulting primary radical 345 
occurred in the reaction. Interestingly, only a small amount of reductive amination product 
341 was obtained in the reaction. Contrary to Wenger’s work,[205] this suggests that the 
hydrogen atom donor, a relatively electron rich Hantzsch Ester, may selectively engage in a 
polarity matched HAT with primary alkyl radical 345 over the electron-rich α-amino radical 
344. The obtained stereoselectivity was consistent with that of Beckwith model for radical 
cyclizations.[209] 
 
Scheme 55. Initial result of the photoredox catalyzed reductive cyclization of N-benyzlbut-3-en-1-amine with 
butyraldehyde. ◊Reaction conducted by Dr A. Trowbridge. 
Dr A. Trowbridge subsequently conducted early studies[193] investigating different hydrogen 
atom donors, such as N-benzyl-1,4-dihydronicotinamide (BnNADH), and photocatalyst 
loading, but found that neither variation was superior over the initial conditions. Furthermore, 
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a brief solvent screen was performed, indicating dichloromethane as favorable solvent for the 
outlined reaction. Ir(ppy)3 gave the highest yield in a brief screen of photocatalysts, with 
[Ru(bpy)3](PF6)2 only giving poor results. A slight increase in yield could be achieved by 
using 2.0 equivalents of butyraldehyde 114, resulting in 62% yield of radical cyclization 
product 342 to be obtained. Raising the equivalents of Hantzsch Ester 316 proved detrimental 
to the reaction. Finally, a number of control reactions were carried out, demonstrating that no 
reaction is observed in the absence of either photocatalyst or when the reaction is conducted 
in the dark. Interestingly, 16% of radical cyclization product were observed when the reaction 
was carried out without Hantzsch Ester. 
This intramolecular cyclization reaction based on this photoredox catalyzed reductive 
generation of α-amino radicals was then further pursued by N. J. Flodén, Dr D. Willcox, and 
Dr S. M. Walton, and Y. Kim.[210] 
This photoredox catalyzed reduction of in situ formed iminium ions to the respective α-amino 
radicals was next attempted in a multicomponent fashion. According to the design plan of this 
reaction, a secondary amine, aldehyde and electron deficient alkene could undergo a 
photocatalytic three-component coupling in the presence of photocatalyst and a stoichiometric 
reductant to give the formal olefin-hydroaminoalkylation products as α-amine functionalized 
tertiary amines. For the reaction, dibenzylamine 346, due to its synthetic versatility, was 
selected together with butyraldehyde 114 for the in situ formation of the required iminium 
ion. As the radical acceptor component, n-butyl acrylate 347 was employed. Remarkably, 
under irradiation with a 30 W CFL bulb at room temperature with fan cooling, and in the 
presence of Ir(ppy)3 photocatalyst, molecular sieves and Hantzsch Ester (1.5 equiv), the 
reaction proceeded to yield up to 47% yield of desired coupling product, if a two-fold excess 
of aldehyde 114 and acrylate 347 was used (Scheme 56). 
 
Scheme 56. Initial conditions for the photoredox catalyzed multicomponent olefin-hydroaminoalkylation. aYield 
determined by 1H NMR against internal standard 1,1,2,2-tetrachloroethane. ◊Reaction conducted by Dr A. 
Trowbridge.  
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2.3.2 Reaction optimization 
Encouraged by these promising results, we turned our attention to the optimization of the 
multicomponent olefin-hydroaminoalkylation reaction. Initial experimentation included 
investigation of the desiccant, to establish if the condensation step is the limiting factor in the 
reaction. Indeed, it was found that molecular sieves were integral to the reaction and that no 
product 348 was obtained in their absence (Table 1, entry 2). 
Table 1. Initial study investigating role of desiccant and vessel. a Yield determined by 1H NMR against internal 
standard 1,1,2,2-tetrachloroethane. 
 
Entry conditions reaction time vessel yield 348a[%]a 
1 standard 12 h 10 mL MW tube, round 59 
2 no mol. sieves  12 h 10 mL MW tube, round trace 
3 with H2O (2.0 equiv) 12 h 10 mL MW tube, round 70 
4 with benzoic acid (1.0 equiv) 12 h 10 mL MW tube, round trace 
5 no mol. sieves, with HOAc (0.1 equiv)  12 h 10 mL MW tube, round trace 
6 standard (various repeats) 12 h 10 mL MW tube, conical 30-65 
7 standard (various repeats) 12 h 4 mL scint. vial 69-84 
8 in the dark, 45 °C (oil bath) 12 h 4 mL scint. vial 0 
9 2 lamps, 54 °C (no fan)  12 h 4 mL scint. vial 66 
10 3 lamps, 40 °C (oil bath) 12 h 4 mL scint. vial 74 
 
It was noticed, that under standard conditions, 59% yield was obtained, determined by 1H-
NMR, which was considerably higher as previously observed (Table 1, entry 2). This 
inconsistency became even more apparent when the reaction was conducted in the presence of 
two equivalents of water (Table 1, entry 3), in which case a 70% yield was observed. While 
this led to the conclusion that the reaction was not sensitive to moisture, a reproducibility 
issue was suspected. Benzoic acid, a common Brønsted acid catalyst to aid condensation in 
organocatalytic applications, was incompatible with the reaction conditions (Table 1, entry 4). 
It was suspected that trace acidity of molecular sieves could be crucial for the reaction, and 
replaced the molecular sieves with catalytic acetic acid, but no product formation was 
observed (Table 1, entry 5), confirming the initial hypothesis that the desiccant is essential. It 
was reasoned that the difference in obtained yields could stem from a varying degree of 
irradiation of the reaction vessels, which would affect the photon-flux and hence the obtained 
yields. According to the Bouguer–Lambert–Beer law, the penetration of visible light through 
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a reaction medium decreases exponentially with increasing path length.[211] Hence, increasing 
the exposed surface area could increase photon transport into the reaction mixture.[79] To test 
this hypothesis, the round bottom microwave (MW) tube reaction vessel was exchanged for a 
conical MW reaction vessel, which exposes higher surface area to the 30 W CFL bulb. In a 
series of experiments, yields ranging from 30 to 65% (Table 1, entry 6) were obtained, which 
confirmed the suspected low reproducibility. Due to its thin glass walls in respect to the round 
and conical MW tubes, smaller (4 mL) scintillation vials were subsequently employed in the 
reaction, and, pleasingly, higher yields (69-84%) with slightly increased reproducibility 
(Table 1, entry 7) were observed. To exclude thermal contributions to the reaction, it was 
established that no reaction occurred when the reaction was conducted in the dark in a 45 °C 
oil bath (Table 1, entry 8). If two, or three lamps were used at a time, slightly higher yields 
were obtained, and the temperature of the reaction mixture was found to have little to no 
impact (Table 1, entry 9 and 10). 
In a further study investigating the photon-flux, the position of the vial in respect to the lamp 
was shown to considerably affect the 1H-NMR yield of 348a, resulting in differences as large 
as 54% to 71% due to respective position (Figure 10).  
  
Figure 10. Photon-flux study varying the position of the reaction vessel, a (4 mL) scintillation vial, around the 
lamp. Yields determined by 1H NMR against internal standard 1,1,2,2-tetrachloroethane. 
On the basis of these studies, it was proposed that poor photon-flux was hampering the 
reaction, which was potentially further compounded by the heterogenous nature of the 
reaction mixture itself. It was therefore decided to employ a stronger, focused light source 
which should have more favorable overlap with the absorption spectrum of the Ir(ppy)3 
catalyst. The Kessil A160WE, a 40 W blue LED lamp commonly used for photoredox 
applications, was selected.[212]  
71%    57% 
69%    54% 
56%    68% 
54%    57% 
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Figure 11. Improved reaction setup featuring a 40 W blue LED lamp (Kessil A160WE). 
We were delighted to find that, using the new 40 W blue LED lamp distanced 5 cm from the 
reaction mixture with fan cooling, the reaction furnishes essentially quantitative yield of 
tertiary amine product 348a by 1H-NMR under otherwise unchanged conditions (Table 2, 
entry 1 and 2).  
Table 2. Optimization studies with light source, stoichiometry, catalyst loading and reaction time. a Yields 
determined by 1H NMR against internal standard 1,1,2,2-tetrachloroethane. 
 
# eq.346 eq. 114 eq. 347 eq. HE [Ir] time lamp distance vessel 348a[%]a 
1 1.0 2.0 2.0 1.5 1 mol% 13 h 6 – 8 cm 4 mL scint. vial 88-96 
2 1.0 2.0 2.0 1.5 1 mol% 13 h 5.0 cm 4 mL scint. vial 99 
3 1.0 1.5 1.5 1.5 1 mol% 14 h 5.0 cm 4 mL scint. vial 99 
4 1.0 1.1 1.1 1.5 1 mol% 14 h 5.0 cm 4 mL scint. vial 99 
5 1.0 1.1 1.1 1.3 1 mol% 14 h 5.0 cm 4 mL scint. vial 85 
6 1.0 1.1 1.1 1.1 1 mol% 14 h 5.0 cm 4 mL scint. vial 79 
7 1.0 1.1 1.1 1.5 0.1 mol% 14 h 5.0 cm 4 mL scint. vial 67 
8 1.0 1.1 1.1 1.5 - 14 h 5.0 cm 4 mL scint. vial 0 
9 1.0 1.1 1.1 1.5 1 mol% 2 h 5.0 cm VWR 4 mL 98 
 
The new irradiation setup enabled us to increase efficiency by running the reaction in near 
equimolar stoichiometries of amine 346, aldehyde 114, and acrylate 347, while obtaining near 
quantitative 1H-NMR assay yields (Table 2, entry 3 and 4). Reduction of equivalents in 
Hantzsch Ester resulted in detriment in yield (Table 2, entry 5 and 6). Similarly, with a 0.1 
mol% photocatalyst loading, only 67% 1H-NMR yield was observed, and no reaction 
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occurred with the LED light source if no photocatalyst was employed (Table 2, entry 7 and 8). 
The reaction time was reduced to 2 hours, furnishing the reaction product 348a in 98% assay 
yield (Table 2, entry 9). In order to increase reproducibility and operational simplicity, the 
reaction vessel was changed to commercial septum capped  4 mL VWR clear-glass vials (for 
details see chapter 5.1). 
Interestingly, it was found that if the reaction was conducted with freshly distilled 
butyraldehyde, no formation of tertiary amine product 348a took place (Table 3, entry 1). This 
led to the conclusion that a trace amount of butyric acid, likely present as contaminant in 
butyraldehyde 114, is functioning as a critical Brønsted acid catalyst in the reaction. To test 
this hypothesis, known amounts of butyric acid were added as an additive to the reaction 
mixture using freshly distilled butyraldehyde. Reactivity was restored upon addition of trace 
butyric acid, and tertiary amine product 348a was obtained in near quantitative assay yield 
upon addition of 0.1 equivalents of butyric acid (Table 3, entry 2-4). Propionic acid was tested 
and provided the same result (Table 3, entry 5). 
Table 3. Study to establish the critical Brønsted acid additive. a. Yields determined by 1H NMR against internal 
standard 1,1,2,2-tetrachloroethane. 
 
Entry reaction time acid additive amount acid (equiv) 348a[%]a 
1 14 h - - 0 
2 4 h butyric acid 0.05 83 
3 4 h butyric acid 0.1 99 
4 2 h butyric acid 0.1 97 
5 2 h propionic acid 0.1 98 
 
Having established this critical reaction component, a number of Brønsted acid additives were 
investigated. As the reaction was optimized to quantitative yield with butyraldehyde 114, 
freshly distilled cyclohexyl carboxaldehyde 349 was chosen as carbonyl component, which 
gave moderate yields under standard conditions (Table 4, entry 1). Varying the stoichiometry 
of propionic acid, it was found that a loading of 0.2 equivalents afforded the optimum yield of 
66% tertiary amine product 348m observed by 1H-NMR (Table 4, entry 2-4). It is known that 
the rate of condensation reactions is highly dependent on the pH value of the reaction 
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medium.[213] Therefore, a variety of Brønsted acids in the pKa range from 0.23 (trifluoroacetic 
acid, TFA) to 7.97 (hexafluoroisopropanol, HFIP) were tested (Table 4, entry 5-10). While 
product was observed for all tested Brønsted acids, only modest yields were obtained for TFA 
and (±)-10-camphorsulfonic acid with 47% and 43% yield respectively. Weak acids 
pyridinium p-toluenesulfonate (PPTS, 53% yield) and HFIP (36% yield) also afforded 
significantly lower yields than the standard conditions with 0.2 equivalents of propionic acid. 
Carboxylic acids such as octanoic acid and adamantanecarboxylic acid gave better results, 
61% and 63% yield respectively, but were not superior to the initially tested propionic acid 
system. It was concluded that the addition of 0.2 equivalents of propionic acid proved to 
provide the best results was thus established as part of the standard conditions. 
Table 4. Reaction optimization: Brønsted acid screen. a Yields determined by 1H NMR against internal standard 
1,1,2,2-tetrachloroethane. 
 
Entry acid additive amount acid (equiv) acid pKa (H2O) yield 348m[%]a 
1 propionic acid 0.1 4.88[214] 55 
2 propionic acid 0.2 “ 66 
3 propionic acid 0.5 “ 62 
4 propionic acid 1.0 “ 57 
5 TFA 0.1 0.23[215] 47 
6 CSA (±) 0.1 1.2[216] 43 
7 octanoic acid 0.2 4.89[217] 61 
8 adamantanecarboxylic acid 0.2 4.8-4.9 63 
9 PPTS 0.2 5.21 53 
10 HFIP 0.2 7.97 36 
 
The requirement of an external Brønsted acid catalyst provided some mechanistic insight at an 
early stage of the investigation. It is predicted that the Brønsted acid is an initial proton 
source, aiding the condensation of secondary amine 346 and aldehyde 350 to give hemiaminal 
351 (Scheme 57).  
 




Scheme 57. Proposed Brønsted acid catalysis operative in the reaction. 
Protonation of the hemiaminal intermediate 351 then allows an equivalent of water to be 
liberated to form iminium ion 352. Furthermore, after reductive quenching and subsequent 
HAT of the starting Hantzsch Ester 316, Hantzsch Ester pyridinium salt 353 is formed which 
serves as a proton source for the reaction.  
2.3.3 Scope of the reaction 
With the optimized conditions in hand, the generality of the reaction was investigated. Due to 
the multicomponent nature of the reaction, each of the three starting materials, aldehyde, 
amine, and radical acceptor can be varied to provide a comprehensive study of the scope of 
the reaction. To aid purification, some of the reactions in the substrate screen were carried out 
using modified Hantzsch Ester 356 bearing 2-methoxyethyl esters, rather than ethyl esters 
(316), as this led to the generation of more polar pyridine derivatives which could be 
separated more easily (Figure 12).  
 
Figure 12. Hantzsch Esters 316 and 356 used in this substrate scope. 
First, the aldehyde component was investigated. It was found that a series of aliphatic 
aldehydes could be accommodated under the reaction conditions, such as butyraldehyde 
(114), giving resulting amino ester 348a in isolated in 84% yield (Scheme 58). Furthermore, 
methyl 4-oxobutanoate (357b), and 4-((tert-butyldimethylsilyl)oxy)butanal (357c), afforded 
Chapter Two –Photocatalytic multicomponent olefin-hydroaminoalkylation 
 
  65 
the corresponding complex tertiary amines 348b and 348c in 59% and 81% yield respectively. 
TBS-Protected 3-hydroxy propanal 357d and 2-hydroxy acetaldehyde 357e were 
unproductive under the reaction conditions, potentially due to the activation of the β- and γ-
amino positions after condensation, promoting side reactions. Similarly, benzoxyacetaldehyde 
357f, N-Boc protected 2-amino acetaldehyde 357g and 3-phthalimidopropionaldehyde 357h 
did not yield the desired product under the reaction conditions due to decomposition. 
Acetaldehyde 357i proved too reactive, forming a black precipitate upon addition to the 
reaction mixture, presumably from polymerization of the in situ formed enamine. 
Additionally, ethyl glyoxylate 357k, employed as a freshly distilled solution in toluene, also 
did not lead to product formation. It was concluded that despite broad functional group 
tolerance, the reaction is sensitive to heteroatom substitution of the aldehyde in the α or β-
position. 
 
Scheme 58. Aliphatic aldehyde scope for photocatalytic multicomponent synthesis of alkyl tertiary amines. 
aamine:aldehyde:acceptor (1:1.1:1.1). ◊Reaction conducted by Dr A. Trowbridge. 
Next, a number of α-branched aldehydes was tested to study the effect of the steric 
encumbrance of this center on the reaction (Scheme 59). Good yields were obtained with 
isobutyraldehyde 357l and cyclohexylcarboxaldehyde 357m under the standard conditions, 
with the desired tertiary amine products 348l and 348m isolated in 62% and 71% yield 
respectively. 4-N-Boc-piperidine- and 4-tetrahydropyrane carboxaldehyde (357n and 357o) 
afforded similar yields, with 70% for tertiary amine 348n, and 79% for tertiary amine 348o, 
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albeit with 2 equivalents of aldehyde and radical acceptor used. Four-membered ring systems 
have become a prominent structural feature for drug discovery and medicinal chemistry 
applications, and can lead to enhanced pharmaco-kinetic properties of drugs.[218-220] 
Accordingly, the four membered ring containing aldehydes N-Boc-azetidine carboxaldehyde 
(357p) and 3,3-difluoro-cyclobutane carboxaldehyde (357q) were subjected to the reaction 
conditions, furnishing the corresponding products 348p and 348q in 64% and 80% yield 
respectively.  
 
Scheme 59. α-Branched aldehyde scope for photocatalytic multicomponent synthesis of alkyl tertiary amines. 
aamine:aldehyde:acceptor (1:1.1:1.1); b amine:aldehyde:acceptor (1:2:2); c methoxyethyl-Hantzsch ester 356 
used (1.5 equiv.). 
If cyclopropane derived carboxaldehydes 357r and 357s were used, no product formation was 
observed, likely due to fragmentation of the three membered rings from the α-amino radical 
intermediate and the subsequent side reactions. Furthermore, MIDA-boronate ester 357t 
proved unproductive under the reaction conditions, potentially due to the large steric demand 
of the aldehyde α-position in this substrate. Lastly, no product formation was observed if 
pivaldehyde 357u was employed as the carbonyl component. Overall, α-branched aldehydes 
were amenable to the reaction, albeit in slightly lower yields. 
Having established the reactivity for aliphatic aldehydes, aryl containing aldehydes, both 
remote and in conjugation with the aldehyde, were investigated (Scheme 60). 
Dihydrocinnamaldehyde 357v gave complex tertiary amine product 348v in excellent 81% 
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isolated yield. Other β-aryl substituted aldehydes also were good substrates for the reaction, 
such as 3-(N-Boc-3-indolyl)propional 357w and 3-(5-methylfuran-2-yl)propanal 357x, 
resulting in formation of products 348w and 348x in impressive 81% and 84% yield 
respectively. However, the reaction proved incompatible with the analogous 2-pyridine 
substrate 357y, which failed to undergo the desired transformation. Moving the aryl group to 
the α-position of the aldehyde, such as in arylacetaldehydes 357z and 357aa resulted in 
complete suppression of product formation. Arguably, this effect may have been caused by 
the vastly increased stability of the respective enamine, which is in an (proton loss induced) 
equilibrium with the iminium ion.  
 
Scheme 60. Aryl containing aldehyde scope for photocatalytic multicomponent synthesis of alkyl tertiary 
amines. a amine:aldehyde:acceptor (1:1.1:1.1); b amine:aldehyde:acceptor (1:2:2); c methoxyethyl-Hantzsch ester 
356 used (1.5 equiv.). 
A number of aromatic aldehydes such as benzaldehydes 357ab, 357ac and 357ad were tested 
but did not result in formation of the desired products. The fact that aromatic aldehydes in 
general were unsuitable substrates for the reaction was contrary to some literature protocols 
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involving benzaldimines, but was corroborated further by the failure of nitrogen-
heteroaromatics-containing aldehydes 357ae, 357af, 357g, and 357ah to lead to the desired 
products. Although the reaction with aryl aldehydes is subject to ongoing studies in our 
laboratory, we hypothesize that the resulting benzylic α-amino radicals are less nucleophilic 
due to conjugation with the aromatic system and do not undergo the subsequent radical 
addition to acrylates. Finally, when propargylic aldehyde 357ai as was tested, no product 
formation was observed.  
Our interest was piqued by the possibility of developing a hydroaminomethylation procedure 
from this protocol, which could be realized if formaldehyde could be used as carbonyl source 
in the present reaction. A hydroaminomethylation system was tested using dibenzylamine 
346, formaldehyde 357ak and n-butyl acrylate 347 as a potentially useful modular reaction 
platform. We were mindful of the high reactivity of formaldehyde derived iminium ions, 
particularly towards reductive processes and polymerization. When simple formalin solution 
(37% formaldehyde in H2O, stabilized with 10-15% MeOH) was employed, the 
aminomethylation product 348ak was observed in low but significant 23% yield (Scheme 61). 
Extensive studies were performed to identify the ideal delivery method for the formaldehyde 
gas to be available under the reaction conditions. Unfortunately, the efforts were complicated 
by the fact that gaseous formaldehyde would polymerize to form paraformaldehyde 
precipitate in the reaction solvent, dichloromethane.  
 
Scheme 61. Photocatalytic multicomponent hydroaminoalkylation using different formaldehyde sources. 
Nonetheless, a suitable protocol was identified, when solid paraformaldehyde was used as 
formaldehyde source. The best results were obtained using a two-step procedure, in which the 
reaction mixture containing excess paraformaldehyde was first heated to 45 °C in the dark, 
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followed by immediate irradiation of the reaction mixture at room temperature. Using this 
method, aminomethylation product 348ak was obtained in 41% isolated yield (Scheme 61). 
Having established the aldehyde part of the reaction scope, we turned our attention to the 
alkene coupling partners 358. A number of potentially suitable alkenes and known radical 
acceptors were tested in this study led by Dr A. Trowbridge (Scheme 62).  
 
Scheme 62. Radical acceptor scope for photocatalytic multicomponent synthesis of alkyl tertiary amines. a 
amine:aldehyde:acceptor (1:1.1:1.1); b amine:aldehyde:acceptor (1:2:2); c methoxyethyl-Hantzsch ester 356 used 
(1.5 equiv); d performed on gram-scale. ◊Reaction conducted by Dr A. Trowbridge. 
It was established that simple acrylates, such as t-butyl- or benzyl acrylate 358a and 358b 
functioned as excellent radical acceptors in the reaction, both affording yields of 84%. 
Importantly, despite the often problematic scale up of photoredox protocols, the reaction 
involving benzyl acrylate could be performed on gram-scale giving the same result with a 
catalyst loading of 0.5 mol% Ir(ppy)3. Several common radical acceptors were subsequently 
tested, such as vinyl sulfone 358c, acrylonitrile 358d and vinyl phosphonate 358e and were 
well tolerated with 82%, 88%, and 60% yield obtained respectively. Perfluorinated alkenes 
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such as 358f afforded excellent yield of coupled product 359f (80%), enabling the 
multicomponent incorporation of perfluorinated alkane chains through this methodology. 
Furthermore, a number of α-substituted acrylates and acrylonitriles 358g-l were screened, of 
which only ethyl methacrylate 358g gave satisfying results with an 80% yield of coupling 
product 359g  in 2.3:1 diastereomeric ratio. Phenyl, malonyl, and chloro substituents were 
unsuccessful under the reaction conditions (358h-l) due to high reactivity towards 
polymerization-type side reactions. Unsurprisingly, non-activated alkenes 1-octene 358m and 
methylidene cyclopropane 358o did not deliver the respective products due to their low rate 
for radical additions.[221] Moreover, methyl vinyl ketone 358q led to polymerization without 
product formation, and dimethyl-acrylamide 358q proved a poor radical acceptor for the 
reaction with only trace product observed. Finally, using vinyl boronate 358r, no product 
formation was observed. 
Moreover, internal alkene radical acceptors were investigated (Scheme 63).[193] Crotonic acid 
derived internal alkenes 358s and 358t were viable substrates, delivering the coupling 
products 359s and 359t in 42% and 67% yield (d.r. 1:1). Similar reactivity was observed for 
internal vinyl sulfone 358u, cyclohexenone 358v and butenolide 358w, with moderate yields 
of 54%, 65% and 46% in coupling products 359u-w obtained respectively (1:1 d.r.). The 
ketone in cyclohexanone product 359v was well tolerated, with excellent selectivity of the 
reaction for the aldehyde. Fumarates, 3-methoxyacrylates and cinnamates 358x-z all proved 
unreactive under the reaction conditions. Additionally, highly reactive alkylidene malonates 
and malonitriles 358aa and 358ab were incompatible and did not deliver the respective 
coupling products. Lastly, maleic acid derivatives 358ac and 358ad were subjected to the 
reaction conditions but did not afford the desired amine products. 
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Scheme 63. Internal alkene radical acceptor scope for photocatalytic multicomponent synthesis of alkyl tertiary 
amines. a amine:aldehyde:acceptor (1:1.1:1.1); b amine:aldehyde:acceptor (1:2:2); c methoxyethyl-Hantzsch ester 
356 used (1.5 equiv); d performed on gram-scale. ◊Reaction conducted by Dr A. Trowbridge. 
Next, due to their ubiquity of aromatic and heteroaromatic moieties in medicinal 
chemistry,[220] possible vinyl arene acceptors were studied (Scheme 64). Gratifyingly, vinyl 
pyridines 358ae-358ag were compatible with the reaction, producing the respective pyridine 
products 359ae-359ag in 47%, 45% and 42% yield. Notably, vinyl pyridine 358ah was used 
to directly access coupling product 359ah in 75% yield (d.r. 2.3:1), a derivative of the first 
generation antihistamine chlorphenamine. Unfortunately, it was found that both vinyl 
pyrazine 358ai and vinyl thiazole 358ak are less amenable as coupling partners, not 
delivering the desired product scaffolds. The addition of α-amino radicals into alkynes is 
underdeveloped,[222] therefore we were pleased to find that radical addition with alkyne 358al 
proceeded smoothly under the standard conditions, giving the product 359al in 66% yield. 
Regrettably, analogous internal alkyne 2-butynoate (358am) only gave trace product in a 
complex mixture. It was established that 1,4 addition under the reaction conditions is feasible 
using vinylcyclopentenone 358an, which furnished the unsaturated product 359an, albeit in 
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low yield of 24%. However, the reaction proved unsuccessful for related ethyl sorbate 358ao 
and phenylbutadiene 358ap. 
 
Scheme 64. Aryl and alkyne conjugated radical acceptor scope for photocatalytic multicomponent synthesis of 
alkyl tertiary amines. a amine:aldehyde:acceptor (1:1.1:1.1); b amine:aldehyde:acceptor (1:2:2); c methoxyethyl-
Hantzsch ester 356 used (1.5 equiv); d performed on gram-scale. ◊Reaction conducted by Dr A. Trowbridge. 
The synthesis of enantioenriched non-natural amino acids is a longstanding area of interest in 
the synthetic community and can be a formidable challenge, depending on the desired side 
chain to be installed.[223] To this end, it was reasoned that the use of a suitable chiral radical 
acceptor to access this desirable class of compounds via the modular multicomponent reaction 
would be a valuable protocol. Accordingly, chiral cyclic dehydroalanine 360, first described 
by Beckwith[224-225], based on work by Karady[226] and Seebach,[227] was identified as a 
privileged acceptor towards the synthesis of chiral α-amino acid. 360 is readily accessible 
from S-benzyl cysteine[228] and was produced on a multi-gram scale in our laboratory (see 
Section 3.3.2, Scheme 137).  
Chapter Two –Photocatalytic multicomponent olefin-hydroaminoalkylation 
 
  73 
 
Scheme 65. Synthesis of enantioenriched non-canonical amino acids via multicomponent photocatalytic olefin-
hydroaminoalkylation of dehydroalanine 360. ◊Reaction conducted by Dr A. Trowbridge. 
Gratifyingly, dehydroalanine 360 proved an amenable radical acceptor for the reaction. 
Reaction with dibenzylamine 346 and formaldehyde 357ak under the standard conditions 
afforded protected 2,4-diamino butyric acid product 359aq in 56% in excellent diastereomeric 
ratio (Scheme 65). As previously explored for this compound by Beckwith,[224] 
diastereoselective HAT is occurring from the re-face due to steric control exerted by the tert-
butyl substituent (see also Scheme 133). 
 
Scheme 66. Benzylamine scope for the photocatalytic multicomponent synthesis of alkyl tertiary amines. a 
amine:aldehyde:acceptor (1:1.1:1.1); b amine:aldehyde:acceptor (1:2:2); c methoxyethyl-Hantzsch ester 356 used 
(1.5 equiv.); ◊Reaction conducted by Dr A. Trowbridge. 
With the scope of aldehydes and electron deficient alkenes firmly established, we turned our 
attention to the secondary amine scope. A study led by Dr A. Trowbridge investigated a 
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number of benzylic and aliphatic secondary amines under the established reaction conditions 
(Scheme 66).[193] It was found that ester, fluorine and phenol ether substituent containing 
dibenzylamines 361a and 361b are excellent substrates, giving the corresponding products 
362a and 362b in 81% and 83% yield respectively. Thiophene 361c and silyl-oxazole 361d 
were tolerated well under the reaction conditions affording similarly high product yields. A 
series of heteroaromatic benzyl surrogates 361e-h were tested, containing 4-pyridine, 2-
pyridine, bromo-indazole and 7-azaindole moieties, which all proved amenable under the 
reaction conditions, affording moderate to high yields. Remarkably, bromine substituents 
commonly undergoing dehalogenation and radical coupling side reactions under similar 
conditions were stable under the reaction conditions. 
 
Scheme 67. Further amine scope for the photocatalytic multicomponent synthesis of alkyl tertiary amines. a 
amine:aldehyde:acceptor (1:1.1:1.1); b amine:aldehyde:acceptor (1:2:2); c methoxyethyl-Hantzsch ester 356 used 
(1.5 equiv.); ◊Reaction conducted by Dr A. Trowbridge. 
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To expand the secondary amine scope beyond dibenzylamines, a series of N-benzyl 
alkylamines and N,N-dialkylamines were tested. Butyl-benzylamines 361i and 361k gave 
good conversion to the respective products 362i and 362k 58% and 65% yield. Silylether- and 
nitrile functionalized N-benzyl alkylamines 361l and 361m were compatible with the reaction 
conditions and delivered the target amines in good yields. Despite its sensitivity towards acid, 
oxetane bearing N-benzylamine 361n delivered the desired product 362n, albeit in decreased 
yield of 36%. Furthermore, glycine derived benzylamine 361o cleanly generated the desired 
coupling product 362o in 70% yield.  2,2,2-Trifluorobenzylamine 361p failed to deliver 
desired product, arguably due to the low nucleophilicity of the secondary amine towards the 
necessary condensation step.[229] It was noted that tetrahydroisoquinoline 361q showed 
significant decomposition under the reaction conditions due to facile oxidative aromatization. 
Given the established reactivity of benzylamines in the reaction, a number of symmetric 
dialkylamines such as diallylamine 361r, diethyl iminodiacetate 361s, and 
bis(cyclohexylmethyl)amine 361t were investigated, but regrettably none of the N,N-dialkyl 
amines afforded the desired amine products. It was found that bis(para-methoxybenzyl) 
amine 361u was also incompatible with the reaction conditions. In line with other N,N-
dialkylamines, 4-phenyl piperidine 361v proved incompatible with the methodology, 
underpinning the apparent requirement of a benzylamine. Before concluding, 2-
phenylpiperidine 361w was investigated as a substrate, but it produced an inseparable mixture 
of tertiary amine products 362w and 362w’, and attempts to isolate the material failed. 
2.3.4 Mechanistic studies 
Given the requirement for a benzylic substituent on the starting nitrogen of the amine 
substituent, the underlying mechanistic explanation for this unexpected outcome was 
investigated. Firstly, it was important to confirm that the single electron reduction of the 
iminium ion (rather than an enamine oxidation-type mechanism) is indeed the operative 
pathway to arrive at the initial α-amino radical. Some evidence had already been obtained at 
this point, given that formaldehyde, which is unable to form enamines, is a suitable substrate 
for the reaction. This suggested that the single electron reduction of the Eschenmoser-like 
iminium salt is indeed operative, at least when formaldehyde is the substrate. Furthermore, 
MacMillan reported that similar enamines from condensation of secondary amines and 
aldehydes are not quenching the photoexcited state of catalyst fac-Ir(ppy).[230] 
To unambiguously demonstrate the iminium ion as immediate precursor of the α-amino 
radical, the reaction was performed from an isolated preformed dibenzyl iminium salt. 
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Ultimately, the iminium tetrafluoroborate salt 364, derived from dibenzylammonium 
tetrafluoroborate 363 and isobutyraldehyde 357l, was successfully obtained following a 
modified procedure based on work by Melchiorre and co-workers (Scheme 68).[231] The 
preformed iminium tetrafluoroborate 364, which was highly moisture sensitive but exhibited 
sufficient stability in solution under strictly anhydrous conditions, afforded the desired 
coupling product 348l with butyl acrylate 347 when subjected to the standard reaction 
conditions, albeit in low quantities. The main reaction product 365 was generated by polar 
reduction of the iminium ion with Hantzsch Ester (evidenced by GC-MS), which occurred in 
the dark. Critically, this pathway could largely be mitigated by conducting the reaction at 
0 °C, affording the desired product in 40% yield by 1H-NMR.  
 
Scheme 68. Synthesis of iminium tetrafluoroborate and stoichiometric control reaction yielding desired coupling 
product 348l. 
While this experiment proved the involvement of the iminium ion as the precursor for the 
single electron reduction, the fast polar reduction of the iminium with Hantzsch Ester was 
somewhat surprising as these reduction products were not observed under the standard 
conditions. It was suspected that the iminium ion may only be formed in small quantities and 
replenished by protonation of the enamine. An investigation of the crude reaction mixture of 
dibenzylamine 346, butyraldehyde 114, propionic acid and molecular sieves in d2-
dichloromethane was performed to identify the predominant species in the reaction. 
Interestingly, it was found that after a 105 minutes incubation period, 70-90% of the starting 
materials were converted to the respective enamine 366, which was the dominant species in 
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the reaction mixture at the recorded time (Scheme 69, for data see Appendix II, Figure 24). 
Respective transient iminium ion 367 was not observed under the reaction conditions within 
the sensitivity of 1H-NMR. In agreement with MacMillan’s findings that 366-type enamines 
do not quench the Ir(ppy)3 excited state,
[230] it was proposed that the majority of condensation 
product generated by secondary amine and aldehyde resides in the reaction mixture as the 
corresponding enamine, inert to the photocatalytic cycle, thus precluding the polar reduction 
of the respective iminium ion by Hantzsch Ester.  
 
Scheme 69. 1H NMR study showing enamine 366 as predominant species in the reaction mixture. Crude mixture 
of dibenzylamine, butyraldehyde, propionic acid (0.2 equiv) in CD2Cl2. Yields determined by 1H NMR against 
internal standard 1,1,2,2-tetrachloroethane. 
To further investigate the role of the iminium ion in the reaction mechanism, Stern-Volmer 
quenching studies between the Ir(ppy)3 photocatalyst and preformed iminium 
tetrafluoroborate 364 were performed (Figure 13, for details and data see Appendix II). It was 
found that the excited photocatalyst was effectively quenched by the iminium ion with a 
quenching rate constant of kq = 6.2 x 10
5 L·mol-1s-1. This quenching could either result from 
an energy-transfer mechanism between the photoexcited *Ir(ppy)3
 to the iminium ion, or from 
single electron reduction of the iminium ion. Although the *Ir(III) species would be 
potentially reducing enough (Ir(IV)/*Ir(III), E1/2
red = −1.73 V vs SCE)[37] to induce SET to 
some all-alkyl iminium ions,[182] it was reasoned that quenching with the Hantzsch Ester 
would occur far more likely due to its higher relative concentration in the reaction mixture 
and significantly larger quenching rate constant (kq = 1.7 x 10
7 L·mol-1s-1).[193] Overall, in 
line with a number of literature reports,[232] the results indicate that a reductive quenching 
cycle through initial oxidation of Hantzsch Ester is operative. UV-Vis analysis performed 
by Dr A. Trowbridge on Hantzsch Ester 316 and iminium tetrafluoroborate 364 further 
excluded the presence of a donor-acceptor complex (for details see Appendix II). 




Figure 13. Stern Volmer quenching study demonstrating quenching of the photoexcited *Ir(ppy)3 by iminium 
tetrafluoroborate 364. 
Next, an investigation into the mechanistic role of the N-benzyl substituent was performed. 
Therefore, a deuterium labelling study with d2-4,4-Hantzsch Ester (d2-316) was pursued to 
reveal possible intramolecular HAT events. When the reaction was performed with 
dibenzylamine 346, butyraldehyde 114, butyl acrylate 347, and deuterated Hantzsch Ester d2-
316, mono-deuterated product d1-348a was exclusively obtained as single regioisomer (rather 
than expected regioisomer d1-348a’), with quantitative deuterium incorporation (Scheme 70, 
for data see Appendix II, Figure 27).  
 
Scheme 70. Deuterium labelling studies indicating a 1,5 HAT process. aprepared by Dr M. Taylor.  
The results strongly indicated a 1,5-HAT process was operative subsequent to the radical 
addition, migrating the alkyl radical from the α-ester position to the benzylic position, where 
it undergoes HAT with Hantzsch Ester to furnish the product. To corroborate this result, d4-
dibenzylamine d4-346 was prepared. Using the standard conditions, the reaction between d4-
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dibenzylamine d4-346, butyraldehyde 114, butyl acrylate 347, and Hantzsch Ester 316 led to 
exclusive formation of respective deuterated product d4-348a (Scheme 71, for data see 
Appendix II, Figure 28), confirming the 1,5-HAT pathway.  
 
Scheme 71. Deuterium labelling studies using d4-dibenzylamine d4-348a, confirming a 1,5-HAT process. 
Lastly, a mechanistically relevant observation was made when N-Boc-3-
aminopropionaldehyde 368, bearing the pendant nucleophilic N-Boc group in 3-position, was 
employed as aldehyde component in the reaction. Unexpectedly, along with formation of the 
desired product 369 (29% yield), we observed generation of unusual cyclic aminal 370 in 
22% yield (d.r. 5.5:1) (Scheme 72). While this result gave further proof that the benzylic 
amine substituent is non innocent in the reaction, the observed reaction was unlikely the result 
of a cyclization of the benzylic radical. It was reasoned that this interesting C–N bond 
formation would most probable be caused by nucleophilic addition of the carbamate nitrogen 
into benzylidene iminium ion 371. Iminium ion 371 could in turn be derived from the 
respective benzylic radical via single electron oxidation.  
 
Scheme 72. Iminium ion cyclization to form cyclic aminal 370. 
Based on the results from these mechanistic studies, a proposed mechanism was outlined for 
the photocatalytic multicomponent olefin-hydroaminoalkylation (Scheme 73). The catalytic 
cycle begins with visible light excitation to afford the photoexcited *Ir(III) species. Efficient 
reductive quenching with Hantzsch Ester 316 (*Ir(III)/Ir(II), E1/2
red = +0.31 V vs SCE)[37] 
generates the radical cation 317 and the highly reducing Ir(II) species. Brønsted acid mediated 
condensation of amine 346 and aldehyde 114 leads to formation of iminium ion 367. The 
equilibrium is predominantly on the side of the enamine form 366, which is inert under the 
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reaction conditions.[230] It is proposed that the enamine is thus an off-cycle precursor to the 
iminium ion 367, with the acid maintaining a low concentration of iminium ion 367 by 
protonation of the enamine 366. Importantly, the generated Ir(II) species is sufficiently 
reducing (Ir(III)/Ir(II), E1/2
red = −2.19 V vs SCE)[37] to undergo SET with the full range of 
alkyliminium ions,[182] leading to α-amino radical 372.  α-Amino radical 372 now engages in 
addition to acrylate 347, furnishing alkyl radical 373. Stabilization via 1,5-HAT reaction to 
form the respective benzylic radical 374 precludes the propensity of alkyl radical 373 to 
undergo oligomerization,[125] and serves as a thermodynamic driving force[180] to promote the 
reversible radical addition process. Similar 1,5-HAT assisted approaches to aid radical 
addition processes have been reported by Tan and Liu,[233-234] as well as Chiba and 
Gagosz.[235]  
 
Scheme 73. Proposed mechanism for the photocatalytic olefin-hydroaminoalkylation. 
Intermolecular HAT between benzyl radical 374 and Hantzsch Ester 316 or its radical cation 
317 then affords the product tertiary amine 348a alongside protonated Hantzsch pyridine 353, 
which serves as a proton source. However, facile oxidation of benzylic radical 374 (E1/2
red = 
−0.9 V vs SCE)[95] can lead to formation of benzylidene iminium ion 375, which can in turn 
undergo photocatalytic or polar reduction by Hantzsch Ester 316 to produce the tertiary amine 
product 348a. Notably, this formal redox-relay process in which the starting iminium ion is 
translated into a new iminium ion in a redox-neutral fashion, is, to the best of our knowledge, 
unprecedented. 
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While the outlined mechanism is proposed as the most likely mechanistic pathway, a minor 
oxidative pathway originating from the oxidative quenching of the photoexcited *Ir(III) with 
iminium ion 367 cannot be ruled out. Furthermore, energy transfer processes, such as from 
photoexcited *Ir(III) to Hantzsch Ester 316, cannot be entirely discounted. This could be 
exemplified by an energy-transfer process leading to the photoexcited Hantzsch Ester species, 
which has been shown to act as a powerful reductant with reduction potentials up to E1/2
red = 
−2.28 V,[236] formally capable to engage in iminium reduction. Finally, a possible chain 
propagation mechanism involving 317 cannot be excluded. 
2.3.5 Extended scope and functionalization of enamines 
The intriguing mechanistic results obtained from the studies, in particular in regard to the 
operative 1,5-HAT process, showed the serendipitously placed benzyl group as crucial 
promoter for the radical addition, overcoming the inherent challenges of this addition 
reaction. Fortuitously, the benzyl group can be easily removed via hydrogenolysis and thus 
acts as a protecting group, enabling for example later functionalization on the nitrogen after 
selective deprotection.[237] However, it was reasoned that the use of an alkene that would 
produce a less-electrophilic radical should favor direct reaction with the Hantzsch ester 316 or 
its radical cation 317, obviating the need for the 1,5-HAT process, and hence permitting the 
use of various dialkylamines and expanding the methodology to a wealth of non-benzylic 
amines. 
Accordingly, for this extended amine substrate scope, 1,1-diphenylethylene was selected as 
radical acceptor under otherwise unchanged reaction conditions. This hypothesis was tested in 
a photocatalytic coupling of non-benzylic amine 4-phenyl piperidine 361v (an unsuccessful 
substrate in the previous addition to acrylates), butyraldehyde 114 and diphenylethylene 
radical acceptor 377a using standard conditions. Pleasingly, it was found that the desired 
tertiary amine product 378a was obtained in 51% yield. Notably, the resulting 3,3-
diarylpropylamines are of significant importance as part of the first-generation family of H1 
antihistaminic agents.[238-240] Continued investigation showed that substituted heterocyclic 
aliphatic amines such as trifluoromethyl substituted piperidine 376b, Boc-piperazine 376c and 
dimethyl morpholine 376d afforded the desired products 378b, 378c, and 378d in 54%, 38%, 
and 60% respectively. Azabicylco[3.1.0]hexanes, azepines, tropinones and azetidines all were 
amenable substrates for the reaction furnishing the desired substituted 3,3-diarylpropylamines 
378e-h in moderate to good yields.  Non-cyclic aliphatic secondary amines such as N-
cyclohexyl-ethylamine 376i, 2-(methoxyethyl)methylamine 376k and dimethylamine 376l 
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delivered high yields of the respective products. Importantly, coupling between hindered 
secondary tetramethylpiperidine 376m, formaldehyde 357ak, and dehydroalanine acceptor 
360 gave the desired product 378m in 61% yield (d.r. >20:1), demonstrating that 
dehydroalanine acceptor 360 does not require the 1,5-HAT process to be operative. The 
product 378m can be deprotected to the enantioenriched amino acid.[193] 
 
Scheme 74. Extended non-benzylic amine scope for the photocatalytic multicomponent synthesis of alkyl 
tertiary amines. a amine:aldehyde:acceptor (1:2:2); b acceptor (1.5 equiv); c methoxyethyl-Hantzsch ester 356 
used (1.5 equiv.); d amine hydrochloride and NEt3 (1.0 equiv) used. e paraformaldehyde (5 equiv) used, 
preheated for 1 h; ◊Reaction conducted by Dr A. Trowbridge. 
While this process successfully extended the amine scope beyond benzylamines, we were 
intrigued by the opportunity to employ dialkylketones in the reaction to produce a number of 
synthetically intractable, α-tertiary amines. This prospect is particularly promising due to the 
high desirability of the α-tertiary amine motif, which is present in a large number of naturally 
occurring bioactive compounds,[241] but also due to the fact that this class C–N bond is 
inaccessible via traditional reductive amination[242] approaches due to the α-tertiary center. 
Despite our extensive efforts, dialkylketones proved entirely unreactive in the 
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multicomponent approach, arguably due to the considerably slower condensation rates of 
ketones compared to aldehydes with the only moderately nucleophilic benzylamines.  
It was reasoned that due to the more forcing conditions required to access ketiminum ions, 
protonation of preformed alkylenamines, which can be readily prepared[243-244] and 
commercially available, could provide a more accessible source of the necessary ketiminium 
ion intermediate. Indeed, under standard conditions, a number of alkylenamines 379 
underwent smooth coupling with alkene acceptors 377 to form the desired α-tertiary amine 
products 380 (Scheme 75).  
 
Scheme 75. Enamine scope for the photocatalytic multicomponent synthesis of alkyl tertiary amines. a Reaction 
conducted using enamine:acceptor (1:2 equiv); b Reaction conducted using enamine:acceptor (1:1.1 equiv); c 
methoxyethyl-Hantzsch ester 356 used (1.5 equiv.); ◊Reaction conducted by Dr A. Trowbridge. 
The coupling of 1-cyclohexenyl pyrrolidine 379a with 1,1-diphenylethylene 377a was 
established to give the target α-tertiary amine product 380a in 53% yield. Encouraged by this 
result, cyclohexenyl morpholine 379b was subjected to the same conditions, affording 59% 
yield. Methyl-piperazine derived enamine 379c was coupled successfully with aryl substituted 
vinyl pyridine acceptor 377c, furnishing the highly polar complex α-tertiary amine product 
380c in synthetically useful 32% yield. Moreover, coupling of N-benzyl enamine 379d and 
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cyclohexenone derived enamine 379e with vinyl pyridine 377d and chiral dehydroalanine 
acceptor 360 were achieved in good yields. 
Given this novel mode of reactivity, it was decided to briefly investigate the mechanistic 
aspect of the enamine reaction in a deuterium labeling experiment. Firstly, cyclohexenyl 
morpholine 379b was subjected to standard reaction conditions using d2-Hantzsch Ester d2-
316. Only a low yield of 17% product d1-380b was isolated under these conditions (Scheme 
76, for data see Appendix II). In line with the hypothesis that an alkene producing a less 
electrophilic radical should favor direct reaction with Hantzsch ester 316 or its radical cation 
317 (and their deuterated analogues), obviating the need for the 1,5-HAT process, 41% 
deuterium incorporation was observed (by 1H-NMR) in the bis-benzylic position. It is likely 
that H/D scrambling occurs from this position either under reaction conditions or during 
purification.[245] 
 
Scheme 76. 1,1-Diphenylethylene acceptor deuterium labeling study with enamines. aprepared by Dr. M. Taylor. 
Given the reduction potential of the bis-benzylic radical (E1/2
red = −1.34 V vs. SCE)[246] was 
likely to be in the range of the photoexcited state of the catalyst, it was investigated if 
deuterium incorporation in bis-benzylic position would occur using d-N-Hantzsch Ester[247-248] 
d-N-316 and d4-acetic acid (Scheme 77, for data see Appendix II). Under these conditions, 
major deuterium incorporation was observed at the enamine β-carbon, confirming the 
protonation-reduction pathway. Only minor incorporation was observed in the bis-benzylic 
position, suggesting HAT with Hantzsch Ester or its radical cation is the major reaction 
pathway for the bis-benzylic radical.  
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Scheme 77. 1,1-Diphenylethylene acceptor deuterium labeling study with enamines using deuterium-labelled 
Brønsted acids. 
2.3.6 Functionalization of pharmaceutical agents 
 
Scheme 78. Functionalization of pharmaceutically active compounds via photocatalytic multicomponent olefin-
hydroaminoalkylation. a amine:aldehyde:acceptor (1:2:2); b acceptor (1.5 equiv.); c methoxyethyl-Hantzsch ester 
used (1.5 equiv.); d amine hydrochloride and Et3N (1 equiv.) used; e paraformaldehyde (5 equiv.), preheated for 1 
h; ◊Reaction conducted by Dr A. Trowbridge. 
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Lastly, with a non-benzylic amine scope established, we were interested in demonstrating 
the utility, mild conditions, and broad functional group tolerance of the developed 
photocatalytic olefin-hydroaminoalkylation on a small number of pharmaceuticals 
featuring a free secondary amine group. Subjecting the pharmaceutical agents paroxetine, 
desloratadine, amoxapine and ciprofloxacin to the reaction conditions, it was found that the 
corresponding complex tertiary amines 381, 382, 383, and 384 were formed in moderate to 
good yields, demonstrating the potential to construct ‘drug-like’ molecules in a single step 
from readily available materials (Scheme 78). Notably, the dehydroalanine acceptor 360 
proved especially useful in these transformations, without a 1,5-HAT pathway operative.  
 
2.4 Summary 
In summary, this chapter details the development of a visible light photoredox reductive 
processes to access α-amino radicals from all-alkyl C=N double-bonds. Several challenges 
complicate this type of reaction, such as the high reduction potentials and competing single-
electron reactivity of the corresponding enamines. A stark contrast exists to reported work to 
date in the field, which utilizes conjugated and functionalized imines and iminium ions. A 
versatile and general approach for a photocatalytic olefin-hydroaminoalkylation was 
developed, based on the coupling of reductively, and hence regiospecifically generated α-
amino radicals from all-alkyl iminium ions.[249] After optimization of the reaction conditions, 
a broad range of amine, aldehyde and electron deficient alkene coupling partners was 
explored. The reaction proved compatible with a large number of functional groups due to 
mild conditions, enabling the one-step generation of complex tertiary amine products from 
readily available feed-stock starting materials. Aromatic aldehydes proved incompatible with 
the reaction. A series of mechanistic experiments were performed, including Stern-Volmer 
quenching studies and deuterium labelling studies, leading to a proposed mechanism featuring 
a 1,5-HAT process and a unprecedented iminium redox-relay. Due to the mechanistic 
rationalization, the substrate scope of the reaction could be significantly expanded to include 
simple cyclic and acyclic alkylamines. Furthermore, alkyl-enamine starting materials yielded 
complex α-tertiary amines in a single step. Finally, we utilized the novel photocatalytic olefin-
hydroaminoalkylation approach to successfully functionalize a small number of 
pharmaceutical agents.  
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3. Total synthesis of alkaloids FR901483 and TAN1251C 
3.1 Introduction 
3.1.1 FR901483 – Structure, isolation, bioactivity and proposed biosynthesis 
(−)-FR901483 (1, Figure 14) is an immunosuppressant indolizine alkaloid first isolated from a 
fermentation broth of Cladobotryum in 1996 by chemists of the Fujisawa Chemical Co (now 
Astellas).[250-251] Structural determination was achieved by X-ray crystallography, however the 
absolute stereoconfiguration of FR901483 was not established until Snider and co-workers 
achieved its first enantiocontrolled total synthesis in 1999.[252] 
 
Figure 14. Two equivalent representations of the structure of (−)-FR901483, including the numbering used in 
this work featured in the left structure. 
The isolation work by the Fujisawa group investigated Cladobotryum sp. No. 11231, a fungal 
strain obtained from litter collected at Iwaki city, Fukushima, Japan. Fermentation of the 
organism was carried out on large scale for 96 hours, yielding 160 liter of fermentation broth 
(max. yield 50 µg/mL).[250] After filtration, extraction, and several sequential purification 
steps concluded by crystallization, 230 mg of FR901483 were obtained as colorless needles. 
The molecular formula was first established by FAB-MS and elemental analysis. Structural 
elucidation was achieved by combination of spectral (IR, NMR, UV-Vis) and chemical 
methods and was confirmed by X-ray crystallographic analysis, which also revealed the 
relative stereochemistry present in the natural product.[250] 
From a structural perspective, FR901483 exhibits a unique azatricyclic core structure, with a 
morphan and indolizidine moiety sharing a central piperidine ring system. The 5-
azatricyclo[6.3.1.01,5]dodecane system carries an unusual phosphate ester residue located on 
the morphan ring.[253] Further notable features are the presence of a synthetically challenging 
α-tertiary amine moiety in the skeleton,[241] a total of 6 stereocenters, and the presence of a N-
secondary, N-tertiary diamino alcohol.  
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FR901483 was discovered in efforts of Fujisawa Chemical Co to identify immunosuppressant 
agents following the discovery of tacrolimus[254-255] and asomycin,[256-257] two successful 
immunosuppressant drugs, both isolated by the same team in 1987 and 1988. Significant 
effort was placed in the assessment  of the immunosuppressant activity of FR901483 in its 
isolation reports.[250-251] FR901483 possesses immunosuppressant activity useful for the 
treatment of immune-mediated diseases such as the resistance to organ and tissue transplant 
and graft-vs-host disease, and autoimmune diseases such as rheumatoid arthritis, lupus, 
multiple sclerosis and type I diabetes. While the compound has not been employed as a drug 
to date, it is also seen as potentially useful for the treatment and prophylaxis of inflammatory 
and hyperproliferative skin diseases and immunologically-mediated illnesses (such as 
psoriasis, dermatitis, eczema, and acne), asthma, bronchitis, inflammatory bowel disease, 
intestinal inflammations and allergies (such as Coeliac disease and Crohn’s disease), and 
Guillain–Barré syndrome.[251] In the initial studies, FR901483 was found to have a highly 
potent inhibitory effect on lymphocyte proliferation, up to 100 times more potent on a molar 
basis than cyclosporin.[250, 258] Importantly, FR901483 exhibits a different mechanism of 
action than the immunosuppressants cyclosporin and tacrolimus, which both directly or 
indirectly interfere with interleukin-2 (IL-2) pathways, a signaling molecule responsible for 
regulating activity of white blood cells. The possible mode of FR901483’s 
immunosuppression is considered to be via inhibition of a purine biosynthesis pathway by 
interference with adenylosuccinate synthetase and/or adenylossuccinase.[250] Two studies 
confirmed immunosuppressant activity of FR901483 in-vivo, including a skin allograft 
survival study in rats, in which FR901483 showed significantly increased graft survival time. 
Oral administration of FR901483 has failed to lead to effective immunosuppression, this is 
supposedly due to deactivation of the active form by hydrolysis of the phosphate ester. This 
result is supported by the fact that the dephosphorylated form of FR901483 has been found to 
be entirely inactive, suggesting an essential role of the phosphate ester in FR901483’s 
bioactivity.[250] The labile C-8 phosphate ester and its propensity to undergo hydrolysis has 
reportedly hampered the development of FR901483 as a drug.[259] 
There is widespread consensus considering the presumed biosynthesis of FR901483. 
Retrosynthetic analysis reveals that FR901483 is most likely derived from a tyrosine-tyrosine 
dipeptide (Scheme 79).[252, 260] Intramolecular oxidative amidation of tyrosinyl-tyrosin 388 is 
envisioned to form spirolactam 386 followed by appropriate redox-modulations to give 
aldehyde 385. The intramolecular coupling presumably proceeds first with an oxidative 
activation of the tyrosine phenol, giving a highly electrophilic activated phenol species, 
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shown in Scheme 79 simplified as 387, which is intercepted by nucleophilic attack of the 
amide to form 386.  
 
Scheme 79. Likely biosynthetic pathway for the generation of FR901483. 
The tricyclic core structure in 1 is then most likely generated via an intramolecular aldol 
reaction of 385 to form the C6–C7 bond. In accordance with this biosynthetic pathway, many 
reported synthetic approaches to FR901483 are hence, at least in part, biomimetic. The aldol 
step has been employed in Snider’s initial synthesis,[252] but also by Sorensen[261] and 
Ciufolini.[262-263] Ciufolini and co-workers, given their prior work on oxidative amidation 
chemistry,[264] have extensively reviewed the biosynthesis of FR901483[258-260] and achieved a 
biomimetic approach utilizing both aldol and oxidative coupling key transformations. The 
Sorensen synthesis also uses a similar biomimetic approach.[261] 
3.1.2 FR901483 – Previous syntheses 
3.1.2.1 Overview 
Due to its favorable bioactive properties and unique structural features, significant synthetic 
effort has been placed in the total synthesis of FR901483 since its isolation.[265] The first 
enantiocontrolled total synthesis was achieved by Snider in 1999, and a considerable number 
of other elegant and inventive accounts have been dedicated to the total synthesis of the 
alkaloid since. At the time of this work, a total of 10 total syntheses of FR901483 are 
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reported, comprising of six enantiocontrolled syntheses, two racemic syntheses, and two 
enantiocontrolled formal syntheses. An overview is given in Table 5.  
Table 5. Overview of syntheses of FR901483. 
Main author  Year Ref Enantiocontrol note 
Snider 1999 [252] (−) first 
Sorensen 2000 [261] (−) - 
Ciufolini 2001 [262-263] (−) - 
Fukuyama 2012 [266] (−) - 
Tu 2012 [267] (−) - 
Huang 2013 [268-269] (−) - 
Funk 2001 [270] rac - 
Fukuyama 2004 [271-272] rac - 
Brummond 2005 [273] (−) formal 
Kerr 2009 [274] (−) formal 
 
3.1.2.2 Snider’s desmethylamino-FR901483 study 
Prior to their pioneering total synthesis of FR901483, Snider and co-workers published their 
first study on the subject with the synthesis of desmethylamino-FR901483 in 1998.[275]  
 
Scheme 80. Snider’s desmethylamino FR901483 model study on formation of the spirolactam 393 and the 
biomimetic aldol reaction. 
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The work investigated the stereochemical outcome of the construction of the spirolactam 
scaffold via [3+2] cycloaddition between racemic nitrone 390 and ethyl acrylate,[276-277] and 
displays one of the most significant contributions probing the stereochemical outcome of the 
biomimetic aldol reaction forming the C6–C7 bond (Scheme 80). After a sequence of steps, 
Snider and co-workers opted for defunctionalization on the C2 position and established a 
simplified model system with keto aldehyde 393 to probe the aldol reaction (Scheme 80). The 
reaction gave a satisfactory yield (51%) of the desired diastereomer 394b under basic 
conditions (sodium methoxide) in methanol.  Potassium tert-butoxide in toluene, however, 
failed to give any desired product and yielded predominantly diastereomer 394a, with 
opposite stereoconfiguration at the C6 alcohol in regard to the natural product. Importantly, it 
was determined that the aldol reaction seems to preferably occur from carbon a (Scheme 80), 
which might be due to the stabilizing effect of the equatorial p-methoxy benzyl group in the 
products 394a and 394b.  
3.1.2.3 First total synthesis of (−)-FR901483 by Snider 
 
Scheme 81. Snider‘s retrosynthetic strategy. 
In continuation of the positive results of their model study, Snider and coworkers proceeded 
to publish the first report of the enantiocontrolled total synthesis of FR901483 in 1999, which 
also established the until then unknown absolute stereoconfiguration of the compound.[252] It 
was hypothesized that, in the biosynthesis, stereocenters at C2 and C5 were both L-tyrosine 
derived, and Snider’s retrosynthetic strategy was laid out accordingly (Scheme 81). 
Condensation of optically active hydroxylamine 398 with ketone 397 followed by [3+2] 
cycloaddition with ethyl acrylate yielded an inseparable 6:1 mixture of diastereomers of 
spirolactam 400. Unfortunately, the selectivity was slightly lower than in the model study (9:1 
d.r.). Hydrogenolysis gave chiral spirolactam 401, which unfortunately was also inseparable 
from its diastereomer, resulting in a 6:1 mixture. Furthermore, due to partial racemization in 
the cycloaddition step, enantiomeric excess in 401 was found diminished to 87% ee.  




Scheme 82. Snider‘s total synthesis of (−)-FR901483.[252] 
The 6:1 mixture was carried forward in the synthesis, and after displacement of the tosylated 
C2 alcohol with azide easily separated. Consecutive reduction, Boc-protection and 
methylation installed the challenging C2-amine functionality in the correct 
stereoconfiguration resulting in Boc-amine 402. This was followed by reduction of the methyl 
ester and treatment with aqueous acid, revealing the C8 ketone but also removing the desired 
Boc-group, which had to be reinstalled in the next step. Dess Martin oxidation then set the 
stage for the key step from keto aldehyde 395, intramolecular aldol addition to form the 
azatricyclic framework. The aldol reaction gave similar results in regards to the model 
system,[275] however slightly better selectivity was observed using KOtBu in tert-butanol in 
place of NaOMe in methanol, yielding an inseparable 7:1 mixture of the desired aldol product 
403. Reduction to the equatorial alcohol and Cbz protection gave carbamate 404, which could 
be cleanly separated from the mixture. Inversion of the C8 alcohol was achieved through C8 
nosylation, TES-protection of the alcohol at C6, nucleophilic substitution of the C8 nosylate 
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by treatment with cesium acetate and 18-crown-6, and finally basic solvolysis of the resulting 
acetate to yield axial alcohol 405. Installation of the phosphate was achieved through 
phosphoramidite addition and subsequent oxidation to the phosphate furnishing 
dibenzylphosphate ester 406. TES deprotection and consecutive hydrogenation under acidic 
conditions gave the first fully synthetic sample of (–)-FR901483 (1) as its HCl salt, 
confirming Snider’s hypothesis regarding the absolute stereoconfiguration.  
In conclusion, Snider elegantly achieved the first synthesis of the natural product in ca. 22 
steps in the longest linear sequence. Highlights of the synthesis are its inventive [3+2] nitrone 
cycloaddition, the biomimetic intramolecular aldol step, and the resulting brevity of the 
approach. Snider’s basic intramolecular aldol conditions are still the standard method to 
directly obtain significant amounts of the desired aldol product to date, and despite vast 
efforts by many authors could not be significantly improved upon in the 20 years since 
Snider’s report. The main challenges of Snider’s approach include difficulties in obtaining the 
central spirolactam 401, both in sufficient diastereomeric and enantiomeric purity, the 
problematic inseparable 7:1 aldol product mixture, and a variety of necessary inversion 
operations at the C2 and C8 centers.  
3.1.2.4 Sorensen’s synthesis 
 
Scheme 83. Sorensen’s retrosynthetic strategy. 
In 2000, the Sorensen group reported their total synthesis of (−)-FR901483.[261] The general 
approach was biomimetic, starting from a tyrosine-tyrosine dimer which could undergo 
oxidative cyclisation to generate the central spirocycle 407. The route also featured the 
Snider-type aldol addition to assemble the tricyclic scaffold of 1 (Scheme 83).  
The central oxidative azaspiroannulation step of tyrosine-tyrosine dimer 411 proceeded under 
remarkably simple conditions, using hypervalent iodine oxidant PhI(OAc)2 at ambient 
temperature, to yield 412 (Scheme 84). After a sequence of standard operations, 
intramolecular aldol reaction was carried out in a similar fashion to Snider’s work, resulting in 
34% of the isolated desired stereoisomer 413. To invert the C8 alcohol in 414 Sorensen’s 
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team developed a useful Mitsunobu reaction to install the dibenzyl phosphate in the correct 
stereoconfiguration in the presence of the free C6 hydroxyl group.[278] Although the reaction 
gave only modest yield of 415, the direct transformation is advantageous and has been used 
by a number of later syntheses of FR901483. Finally, hydrogenation and Boc-deprotection 
with HCl-dixoane yielded the natural product 1, concluding the total synthesis.  
 
Scheme 84. Sorensen’s synthesis of (−)-FR901483. 
In summary, Sorensen and co-workers deliver an efficient enantiocontrolled total synthesis, 
significantly shorter than Snider’s initial report. Sorensen’s work still displays one of the most 
efficient approaches to FR901483. The main challenges of the route are the protecting group 
strategy and the moderate yield of the azaspiroannulation step.  
3.1.2.5 Ciufolini’s synthesis 
In 2001, the Ciufolini group published their total synthesis of (−)-FR901483,[262-263] taking an 
approach similar to Sorensen’s work. The strategy includes an oxidative cyclisation step from 
oxazoline 417 and makes use of the biomimetic aldol reaction (Scheme 85).  
 
Scheme 85. Ciufolini’s retrosynthetic strategy. 
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Oxazoline 417 was prepared using the Vorbrüggen method from amino alcohol 418 and acid 
419 (Scheme 86).[279] Exposure to hypervalent iodine oxidant achieved oxidative cyclisation, 
which after acetalization resulted in spirocycle 420. The tosyl protecting group was necessary 
to suppress side reactions in the cyclisation step.[280] After a brief sequence of operations, the 
aldol reaction was carried out in aqueous methanol, affording 44% of the desired diastereomer 
422. The authors proposed that this slightly increased selectivity of the aldol reaction 
compared to previous work was due to the polar nature of the aqueous methanolic solvent. 
The reaction product was subjected to vigorous metal hydride reduction, which resulted in a 
mixture of diastereomers on the C8 alcohol in 422. The mixture was carried forward using 
Sorensen’s Mitsunobu reaction. The difficulty in handling the products due their high polarity 
could be remedied by conversion into the respective benzyl carbamates 423, at which point 
the mixture could be readily separated. Hydrogenation under acidic conditions then concluded 
the synthesis of 1.  
 
Scheme 86. Ciufolini’s synthesis of (−)-FR901483. 
Ciufolini and co-worker’s enantiocontrolled synthesis of FR901483 is similar to the Sorensen 
approach in its successful biomimicry leading to a concise synthesis. Furthermore, Ciufolini’s 
aldol reaction featuring the C2 sulfonamide group seems to be slightly less problematic and 
allows slightly higher yield in comparison to Snider and Sorensen. With the use of Sorensen’s 
Mitsunobu reaction Ciufolini achieved a synthesis similar in efficiency and brevity to the 
Sorensen synthesis.  
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3.1.2.6 Funk’s synthesis of (±)-FR901483 
 
Scheme 87. Funk’s retrosynthetic strategy. 
Funk and co-workers published their contribution to the racemic series in 2001.[270] In a novel 
approach to the triazacyclic system, an amidoacrolein cycloaddition delivered the starting 
material for two concomitant biomimetic aldol reactions, rapidly giving rise to the FR901483 
scaffold (Scheme 87).  
 
Scheme 88. Funk’s racemic synthesis of FR901483. 
In the key step, dioxin enamine 428 underwent retro Diels Alder reaction to generate 
amidoacrolein 429 (Scheme 88), which was reacted in situ with 2-triisopropylsiloxy-
butadiene to afford silylenolether 430. After ring closure, Evans-Saksena reaction[281-282] 
installed the axial C8 alcohol, which was silyl protected. Funk achieved selective deprotection 
of the C6 silylether with TBAF to afford 432. Subsequent oxidation of the C6 alcohol was 
followed by α-benzylation of the ketone to install the para-methoxy benzyl group selectively 
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in equatorial position of 433. Inversion at the C6 position similar to Snider’s work,[252] yielded 
the silylether 434 in correct relative stereoconfiguration. The conjugated lactam was then 
hydrogenated, and azidation of the resulting lactam furnished azide 435. The diastereomeric 
ratio of the azidation step was moderate (2.5:1) in favor of the desired diastereomer. After a 
series of standard operations, deprotection of the C8 alcohol followed by phosphorylation 
gave dibenzylphosphate 437, which was readily converted to the racemic natural product 1 
via hydrogenolysis.  
Funk and co-workers assembled the challenging aza-tricyclic skeleton in only four steps using 
two (retro)-cycloaddition and two aldol steps. Challenges of the synthesis are the 
stereoinversion at C6, a number of redox fluctuations and the low diastereomeric control for 
the installation of the C2 nitrogen.  
3.1.2.7 Fukuyama’s first generation synthesis of FR901483 
Fukuyama and co-workers published their first racemic total synthesis of 1 in 2004.[271-272] 
Fukuyama’s approach features the synthesis of the starting spirocycle via Dieckmann 
condensation to enable an biomimetic intramolecular aldol reaction (Scheme 89).  
 
Scheme 89. Fukuyama’s first generation retrosynthetic strategy. 
At the beginning of the synthesis, Dieckmann condensation and consecutive decarboxylation 
gave rise to spirolactam 440. Following allylation of the amide, ozonolysis gave access to 
keto aldehyde 438. Fukuyama’s acidic aldol conditions were similar to Funk’s,[270] and 
offered excellent yield of single isomer 439, albeit with the incorrect stereochemistry on the 
C6 alcohol center. Fukuyama also employed the Evans-Saksena reduction[281-282] to set the 
axial C8 alcohol successfully, followed by silylation and Funk’s selective deprotection of the 
C6 silylether resulting in alcohol 440. Further similarities between the two syntheses followed 
with Swern oxidation and α-benzylation to install the equatorial para-methoxy benzyl group. 
Fukuyama elegantly reduced resulting ketone 441 to the desired alcohol in correct 
stereoconfiguration, overcoming the steric demand of the encumbered ketone at C6 by using 
samarium iodide and HMPA. Installation of the C2 nitrogen was carried out via oxime 443. 
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Reduction with zinc metal occurred selectively to yield amine 444 as a single isomer in 
excellent yield. After a series of standard operations, palladium catalyzed hydrogenolysis of 
437 gave the racemic natural product 1. 
 
Scheme 90. Fukuyama’s first generation synthesis of (±)-FR901483. 
The first generation Fukuyama synthesis is similar to the Funk synthesis, however, significant 
improvements were achieved over the established steps. Highlights of the synthesis include 
the inventive formation of the starting spirocycle via Dieckmann condensation, the excellent 
aldol yield and efficacy in their stereoselective reductions with SmI2 and Zn metal, leading to 
a more concise route without the need for inversion.  
3.1.2.8 Fukuyama’s second generation enantiocontrolled synthesis  
 
Scheme 91. Fukuyama’s second generation retrosynthetic strategy.  
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In 2012, the Fukuyama group reported a second generation, enantiocontrolled approach to 
FR901483,[266, 283] realizing the synthesis of optically active 445 via an Ugi reaction,[284] as 
earlier reported by the Sorensen group.[285] Dieckmann condensation and established steps 
from the racemic synthesis led to completion of the synthesis (Scheme 91).[272]  
 
Scheme 92. Fukuyama’s second generation synthesis of (−)-FR901483. 
The second generation sequence started with the synthesis of the allyl amine 447 for the Ugi 
reaction (Scheme 92).[266, 286] Combination of the optically active amine 447, ketone 397, 
isonitrile 446 and acetic acid in Fukuyama’s four-component Ugi reaction assembled allyl 
amine 451 in a single step with an impressive 85% yield. Methyl ester 445 was generated by 
methanolysis with CSA and HC(OMe)3, which also led to transacetalization. Dieckmann 
condensation closed the lactam ring to furnish spirolactam 452, followed by a series of 
reductive operations resulting in ketone 453. Oxidative cleavage of the aldehyde by 
ozonolysis was followed by aldol reaction with pyrrolidine in acetic acid.[261, 287-288] Similarly 
to Fukuyama’s prior work, a yield of 60% was obtained for diastereomer 454 featuring the 
epimeric alcohol at C6. Again, Evans-Saksena reduction[281-282] was employed, followed by a 
selective silyl protection of the C8 alcohol. Swern oxidation lead to key intermediate 455, 
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which was carried forward successfully according to the racemic synthesis, to arrive at the 
optically active natural product 1. 
In conclusion, the Fukuyama group complemented their racemic variant with an elegant 
enantiocontrolled synthesis. Fukuyama’s four component, high yielding Ugi reaction 
efficiently accessed the optically active spirolactam. Unfortunately, the starting chiral amine 
is difficult to obtain via a 7 step synthesis. The outcome of the aldol reaction, is slightly lower 
yielding than in the previous Fukuyama synthesis, illustrating the substrate dependence of the 
intramolecular aldol ring closure.  
3.1.2.9 Brummond’s formal synthesis of FR901483 
 
Scheme 93. Brummond‘s retrosynthetic strategy. 
Brummond and co-workers reported a formal synthesis of (−)-FR901483 in 2005 featuring a 
cascade of a cationic aza-Cope rearrangement and Mannich reaction to generate the tricyclic 
scaffold  in a single step,[273, 289] with all stereocenters except C2 pre-installed in the precursor 
prior to the key step (Scheme 93).  
The synthesis began with synthesis of hydroxy ketone 459 via aldol reaction (Scheme 94).[290] 
Reduction and benzylation yielded dibenzylether 460, which was elaborated to ketone 457, 
the immediate precursor for the tandem reaction, through a series of standard operations. 
Consecutive treatment with tosylic acid and (S)-phenylalanine triggered the cascade of aza-
Cope rearrangement to yield intermediate 456 via bridgehead iminium ion 462, from which 
Mannich reaction occurred to give aldehyde 463 in a single step. Unfortunately, a 2:1 mixture 
of diastereomers was obtained which could only be separated after reduction to the alcohol. 
Installation of the C2-nitrogen via the acyl azide led to N-Boc methylamine 464. Palladium 
catalyzed hydrogenation and phosphorylation gave Sorensen’s intermediate 415,[261] 
concluding the formal synthesis. In summary, the Brummond formal synthesis takes a novel, 
non-biomimetic approach with their splendid aza-Cope rearrangement / Mannich cascade 
reaction. Assembly of the precursor featuring a rare aldol reaction is rapid and efficient. 
Challenges arose later in the synthesis, when the installation of the C2 amine is slowed down 
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by a mixture of diastereomers obtained from the cascade, necessitating a detour via the 
alcohol to allow separation.  
 
Scheme 94. Brummond’s formal synthesis of FR901483. 
3.1.2.10 Kerr’s formal synthesis of FR901483 
The Kerr group published a formal synthesis of (−)-FR901483 in 2009, featuring a 
cyclopropane ring-opening annulation reaction.[274] The approach started from a precursor 
similar to Brummond’s synthesis with pre-installed stereocenters.  
 
Scheme 95. Kerr’s retrosynthetic strategy. 
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The synthesis commenced with desymmetrization of 467,[291-292] leading to β-hydroxy ketone 
472 in a short sequence including a Reformatsky reaction with aldehyde 471. Brummond’s 
method was used to obtain dibenzyl ether 473.[273] Addition of 473 to a heated solution of 
ytterbium triflate and paraformaldehyde triggered formation of imine 466 and initiated the 
cascade of cyclopropane opening and annulation through resulting enolate 474.[293-295] 
Krapcho decarboxylation[296-297] of diester 465 resulted in ester 475 and was followed by 
saponification to the corresponding acid. Reaction with diphenylphosphoryl azide (DPPA) 
induced Curtius rearrangement of the acyl azide in the presence of tert-butanol. The generated 
carbamate was directly methylated to yield Brummond’s intermediate 464, concluding the 
formal synthesis.  
 
Scheme 96. Kerr’s formal synthesis of FR901483. 
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In summary, Kerr and co-workers demonstrated the utility of the cyclopropane 
opening/annulation cascade in their formal synthesis of FR901483. The cascade reaction 
offered an alternative to the bridgehead iminium – aza cope reaction employed in the 
Brummond route. Kerr obtains high yield with exclusive formation of the desired isomer 465, 
albeit without the C2 stereocenter in place. However, challenges arose for Kerr with 
unselective Krapcho decarboxylation (d.r. 1:1) of the cascade product. An alternative mono-
saponification strategy was offered to increase the yield marginally.[274] In the final steps, Kerr 
and co-workers efficiently obtain the methylated N-Boc derivative in significantly fewer steps 
than required by Brummond from their cascade product,[273] completing an elegant formal 
synthesis.  
3.1.2.11 Tu’s total synthesis of FR901483 
In 2012 the Tu group published their approach to (−)-FR901483 (Scheme 97).[267] A Schmidt 
reaction of an alkyl azide, as explored by Aubé,[298-299] assembled the tricyclic scaffold 
selectively from a cyclobutanone precursor, which, similar to the approaches of 
Brummond[273] and Kerr,[274] featured all stereocenters except the C2 amine.  
 
Scheme 97. Tu’s retrosynthetic strategy. 
The total synthesis commenced with synthesis of dibenzylether 460 following the protocol of 
Brummond (Scheme 98).[273] An established sequence[273, 300] gave access to  azido compound 
479. Epoxide 480[301] was readily translated to key cyclobutanone 477, the precursor for the 
Schmidt reaction. Tu found the Schmidt reaction[298-299] to be promoted most suitably by 
chlorosulfonic acid at −30 °C to generate aza-tricyclic product 476 in 67% yield as a single 
isomer.[267] Efficient installation of the C2 nitrogen followed via treatment with LDA, 
diphenyl phosphoryl azide (DPPA),[302-303] and Boc2O, resulting in carbamate 482 in a 2:1 
mixture of diastereomers. In a final sequence of reductive transformations, Cbz protection and 
phosphitylation/oxidation, dibenzylphosphate ester 423 was obtained. Established 
hydrogenolysis yielded the natural product 1. 




Scheme 98. Tu’s total synthesis of FR901483. 
In conclusion Tu and co-workers have provided one of the most efficient approaches to 
FR901483 to date, with its brevity only paralleled by the Sorensen group synthesis.[261, 265] 
Selectivity issues in the semi-pinacol type rearrangement as well as in the installation of the 
amino group pose a challenge in this otherwise high yielding synthesis. Highlight of the 
synthesis is Tu’s highly selective Schmidt reaction giving rapid access to the triazacyclic 
scaffold. Notably, a similar study on the core fragment investigating the Schmidt reaction was 
published concurrently.[304] 
3.1.2.12 Huang’s Synthesis of FR901483 
In 2012 and 2013 the Huang group reported first their formal synthesis, followed by the 
completed enantioselective total synthesis of FR901483.[268-269] Huang’s approach accessed a 
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cyclic α-tertiary amine precursor for an aldol reaction to establish an morphan system. Ring 
closing metathesis then completed the FR901483 scaffold (Scheme 99).  
 
Scheme 99. Huang’s retrosynthetic strategy. 
The synthesis started from optically active N-allyl 3-benzoxy glutarimide 485.[305-309] 
Defunctionalization to chiral lactam 486 was achieved by reduction to the hemi-aminal 
followed by treatment with triethyl silane and Lewis acid. Generation of the α-tertiary amine 
487 was carried out by double Grignard addition in the presence of triflic anhydride and 
DTBMP in good yields and good diastereoselectivity (9:1).[310-311]  
 
Scheme 100. Huang’s total synthesis of FR901483. 
Chapter Three –Total synthesis of alkaloids FR901483 and TAN1251C 
 
106 
Intramolecular aldol addition was carried out from 484 using acidic conditions with ethylene 
glycol as an additive, steering the selectivity towards desired dioxolane 488. 488 was 
converted into its benzyl analogue,[270] and the N-allyl group replaced with an acryloyl 
substituent,[312-313] furnishing 483. After ring closure and deprotection of the ketone, α-
benzylation to incorporate the para-methoxybenzyl group gave ketone 490. A final sequence 
including Fukuyama’s samarium iodide reduction,[266, 272] and Sorensen’s Mitsunobu 
reaction[261] led to dibenzyl phosphate ester 492. Introduction of the Cbz-group followed by 
immediate hydrogenolysis gave the natural product. 
Huang’s synthesis used a novel approach with the early and efficient installation of the α-
tertiary amine center. The N-allyl group had to be exchanged to the acryloyl group to enable 
the use of Fukuyama’s samarium iodide method. In conclusion, Huang’s aldol reaction is an 
important contribution to the selective generation of the aza-tricyclic scaffold.  
3.1.2.13 Other approaches towards the FR901483 core structure 
Additionally to these elegant syntheses, a number of synthetic studies towards the core 
structure of FR901483 have been reported.[265] In 1997, Kibayashi and co-workers reported 
the synthesis of the 5-azatricyclo[6.3.1.01,5]-dodecane core structure of FR901483 using 
Lewis acid mediated opening of an N,O-acetal followed by alkylation of an anti-Bredt 
iminium ion.[314-316] In 2001, the Kibayashi group reported a modified strategy of this 
approach.[317] In the same year, Wardrop and co-workers disclosed their formal synthesis of 
racemic desmethylamino FR901483[275] featuring a 6-exo-trig radical cyclisation.[318] Both 
Bonjoch and Hayes reported studies towards the synthesis of FR901483,[253, 319-320] utilizing a 
palladium catalyzed cyclization of tethered vinyl bromides.[321-327] Bonjoch later expanded the 
work implementing an intramolecular Kharasch-type[328] cyclization.[329] In 2006, Weinreb 
and co-workers reported their approach towards racemic FR901483 via cyclisation of an 
iodoacetamide ketone.[330-331] The Martin group disclosed their approaches to the azatricyclic 
core of FR901483 via nucleophilic addition to a N-acyl iminium ion in 2006 and 2007.[332-333] 
Another approach towards FR901483 was published by the Reissig group in 2006 featuring a 
intramolecular aldol reaction of a spiroketone.[334] Sorensen and co-workers developed a 
second generation approach to FR901483 in 2008,[285] featuring a multicomponent Ugi 
reaction, later utilized by Fukuyama,[266] to access a spirolactam precursor and a highly 
selective sulfonate ester elimination in order to desymmetrize the cyclohexane ring. Rovis 
published an efficient enantioselective approach to the chiral tricyclic scaffold of FR901483 
in 2014 using a rhodium catalyzed [2+2+2] cycloaddition.[335-337] Recently, Jia reported an 
enantioselective methodology to access the azatricyclic core skeleton of FR901483.[338]  
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3.1.3 TAN1251C – Structure, isolation, bioactivity and proposed biosynthesis 
The TAN1251 alkaloids, namely TAN1251A (493a), TAN1251B (493b), TAN1251C (2), 
and TAN1251D (493d), are a series of anticholinergic alkaloids first isolated in 1991 from a 
penicillium thomii RA-89 fermentation broth by Takeda Chemical Industries, Osaka, Japan 
(Figure 15).[339]  
 
Figure 15. The TAN1251 series of alkaloids with TAN1251C (this work) highlighted. 
In their isolation work,[339] the Takeda team prepared a seed culture of the penicillium thomii 
RA-89 strain, obtained from soil in the Miyagi prefecture, Japan, which was incubated in an 
aerated reactor with 3600 liter fermentation medium for 90 hours. The broth was filtered, and 
multistep acid/base treatment of the filtrate followed by extraction gave crude material. 
Purification by column chromatography, and crystallization if applicable, furnished the 
alkaloids TAN1251A (925 mg), TAN1251B (1.2 g), TAN1251C (5.1 g), and TAN1251D 
(7.6 g) as their respective free bases. Elucidation of molecular structure and relative 
stereochemistry of TAN1251B was achieved via X-ray crystallographic analysis, 
complemented by spectroscopic (NMR, IR), chemical, and elemental analysis. Absolute 
configuration of TAN1251 B was established via circular dichroism (CD) spectroscopic 
analysis of the dibenzoate of the diol reduction product of TAN1251B.[340] Interestingly, 
resubjection of isolated TAN1251A to fresh seeded fermentation broth showed that ca. 60% 
of TAN1251A was converted to TAN1251B after 72 hours, which suggested that the absolute 
stereoconfiguration of the stereocenter in TAN1251A and TAN1251B were identical. The 
absolute stereochemistry of TAN1251C and TAN1251D was unambiguously determined 
through total synthesis by Snider and co-workers in 1999.[340] 
Structurally, the four natural products from the TAN1215 family share an interesting common 
diaza-tricyclic core structure featuring a 1,4-biazabicyclo[3.2.1]octane with a spiro-fused 
cyclohexanone.[253] All compounds but TAN1251D contain an enamine functionality 
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originating from the α-tertiary amine, which in case of TAN1251C constitutes an unusual 
dienamine moiety. TAN1251A and TAN1251C have a single stereocenter at the C1 position, 
whereas TAN1251D contains two stereocenters, in C1 and C4 position. TAN1251B bears 
three chiral centers, at the C1, C6, and C5’ carbons.  
 
Figure 16. Comparison of TAN1251B with known muscarinic antagonists atropine and scopolamine. 
The bioactivity of the TAN1251 series was assessed in the isolation report.[339] TAN1251A 
and TAN1251B are potent muscarinic antagonists, with potential use as mydriatic agents, 
antispasmodic and antiulcer agents. Muscarinic antagonists, such as atropine and scopolamine 
(Figure 16), have been employed for the treatment of nervous diseases (such as Parkinson’s 
and motion sickness), disorders of the digestive tract (such as peptic ulcer and irritable bowel 
syndrome), and respiratory illnesses (such as chronic obstructive pulmonary disease, and 
asthma). However, their unpleasant side effects (blurred vision, dry mouth, dizziness) has 
driven the search for newer, synthetic antimuscarinics.[341] TAN1251A and TAN1251B 
exhibited strong anticholinergic activity on the basis of a radio ligand receptor binding assay 
with 3H-quinuclidinyl benzilate and microsomal fractions of rat cerebral cortex.[339] The 
affinity of TAN1251B to muscarinic acetylcholine acceptors exceeds that of atropine, making 
it an attractive target for drug development.[342] TAN1251A was selective towards the M1 
subtype of the muscarinic receptor. Moreover, an animal study in the isolation work shows 
that TAN1251A and TAN1251B inhibit the acetylcholine-induced contraction of Guinea pig 
ileum quoting ED50 values of 8.0 and 10.0 nM respectively. Assessment of the acute toxicity 
of TAN1251A and TAN1251B, performed in mice showed no signs of toxicity at doses of up 
to 100 mg/kg for either of the two substances.[339]  
Similar to FR901483 (see Scheme 79), the TAN1251 series of alkaloids appear to be 
biosynthetically derived from a tyrosine-tyrosine dipeptide unit. In fact, it is likely that the 
TAN1251 alkaloids and FR901483 share a common biosynthetic precursor in the form of 
spirocycle 385 (Scheme 101). In the purported biosynthesis pathway,[260, 262, 340] tyrosinyl-
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tyrosine 388 undergoes intramolecular oxidative amidation to form the common antecedent 
spirocycle 385. The biosynthesis continues via attack of the C2 amine at the tyrosine 
aldehyde, to form the dienamine natural product TAN1251C (2). TAN1251C is of central 
importance as it is likely to serve as the precursor for the three other TAN1251 series 
alkaloids.[258] TAN1251D (493d) could be formed by reduction, while TAN1251A (493a) is 
the product of isomerization of the enamine double bond, notably eroding stereochemistry at 
C4. Lastly, the results from the isolation work indicate that TAN1251B (493b) is an oxidation 
product of TAN1251A (493a). 
 
Scheme 101. Purported biosynthetic pathway for the TAN1251 series of alkaloids. 
3.1.4 TAN1251 series – Previous syntheses 
3.1.4.1 Overview 
The TAN1251 alkaloid series has attracted considerable synthetic interest since its isolation in 
1991. To date, 13 total and formal syntheses have been dedicated to the TAN1251 series, with 
the first report in 1998 and the latest contribution in 2017. Starting with TAN1251A (493a), 6 
syntheses of the compound are reported, comprising of 2 enantiocontrolled total syntheses, 3 
formal syntheses, and one racemic total synthesis. Only one instance of the total synthesis of 
Chapter Three –Total synthesis of alkaloids FR901483 and TAN1251C 
 
110 
TAN1251B (493b) has been reported. (+)-TAN1251C (2) has received significant synthetic 
attention with four reported total syntheses of the optically active natural compound. Finally, 
two contributions report the enantiocontrolled synthesis of TAN1251D (493d). An overview 
of the synthetic work on the series is provided in Table 6. 
Table 6. Total syntheses of the TAN1251 series of alkaloids. 
Main authors Year Ref Enantiocontrol Note 
TAN1251A 
Kawahara-Nagumo 1998 [343-344] rac. first rac. 
Snider 2000 [340] (−) first 
Wardrop 2001 [345] (−)  
Honda 2002 [346-347] (−) formal 
Kawahara-Nagumo 2002 [348] (−) formal 
Hayes 2004 [349] (−) formal 
TAN1251B 
Snider 2000 [340] (+)  
TAN1251C 
Snider 2000 [340] (+)  
Ciufolini 2001 [262] (+)  
Honda 2005 [350] (+)  
Kan 2017 [351] (+)  
TAN1251D 
Snider 2000 [340] (+)  
Honda 2005 [350] (+)  
3.1.4.2 Kawahara and Nagumo’s first generation synthesis of TAN1251A 
In 1998, Kawahara and Nagumo published the first total synthesis of (±)-TAN1251A.[343-344] 
In their retrosynthetic strategy, Kawahara, Nagumo and co-workers utilized a Curtius 
rearrangement to install the key spiro α-tertiary amine. The plan included generation of the 
pyrrolidine ring via an intramolecular alkylation reaction (Scheme 102). 
 
Scheme 102. Kawahara and Nagumo’s retrosynthetic strategy. 
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The racemic synthesis starts from known carboxylic acid 498, which is converted to tosylate 
500 through a series of standard operations including a Curtius rearrangement (Scheme 103). 
Intramolecular N-alkylation resulted in aza-spirocycle 501, which was alkylated and the 
silylether cleaved with TBAF to furnish secondary alcohol 502. Installation of the C2 nitrogen 
via Mitsunobu reaction with DPPA and subsequent cyclisation delivered tricyclic lactam 503. 
Methylation and aldol reaction with LDA at low temperature gave an inconsequential 
diastereomeric mixture of alcohols 504 (d.r. 1.4:1). Finally, reduction of the derived 
conjugated lactam 505 with LiAlH4 and AlCl3 followed by transacetalization with acetone 
gave racemic TAN1251A (493a). In their early contribution, Kawahara and Nagumo present 
the first total synthesis of (±)-TAN1251A, employing an elegant and effective route. 
 
Scheme 103. The Kawahara-Nagumo Synthesis of racemic TAN1251A. 
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3.1.4.3 Snider’s synthesis of TAN1251A, B, C and D 
In a landmark paper in 2000, Snider and co-workers reported the synthesis of all members of 
the TAN1251 series, TAN1251A-D, all in their enantiopure form.[340] The four natural 
products were obtained via a common precursor 506, the acetal protected form of (+)-
TAN1251C. Snider and co-workers were able to employ methodology previously developed 
for their synthesis of FR901483. The retrosynthetic strategy to access key acetal 506 utilized a 
nitrone [3+2] dipolar cycloaddition to construct the pyrrolidine ring, and a biomimetic 
oxidative cyclization reaction (Scheme 104). 
 
Scheme 104. Snider’s retrosynthetic strategy towards acetal 506. 
The synthesis of precursor 506 sets out from O-benzyl tyrosine methyl ester which was 
accessed from commercial L-N-Boc-tyrosine (509) by simple benzylation and Boc-
deprotection in quantitative yield (Scheme 105).[340] The respective hydroxylamine 510 was 
obtained via Grundke’s procedure,[352] and subsequent condensation with monoketal 511 
afforded nitrone 512. Originally, the strategy was carried out with the mono dioxolane ketal 
instead of 511, however, while cleavage could be achieved in the synthesis TAN1251A, 
analogous deprotection protocols for TAN1251C and TAN1251D were unsuccessful. Hence 
the dioxepane ketal, which is easier to cleave,[353] was chosen. Nitrone 512 was treated with 
ethyl acrylate in toluene at reflux to afford an inseparable 6:1 diastereomeric mixture in favor 
of desired spiro-isoxazolidine 513. Conversion to 507 was achieved via hydrogenation 
followed by acid catalyzed lactam formation with a catalytic amount of acetic acid. Treatment 
with cesium bromide and cesium carbonate in acetone gave phenolic prenyl ether 514. The 
installation of the C1 nitrogen could be achieved via tosylation followed by azide substitution. 
At the stage of azide 515, separation of the diastereomeric mixture was achieved and yielded 
79% yield of the desired compound, and 12% of the unwanted diastereomer. The authors 
propose that Omura–Sharma–Swern oxidation[354] of the derived primary alcohol 516 
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concomitantly formed the trifluoroacetamide at the C1 methylamine, which was readily 
hydrolyzed under basic conditions to afford TAN1251C-acetal 506. Transacetalization in 
acidified acetone proceeded smoothly to give the first natural product of the series, 
TAN1251C (2).  
 
Scheme 105. Snider’s synthesis of key precursor acetal 506 and (+)-TAN1251C (2).[340] 
The synthesis of TAN1251A required the isomerization of the C3–C4 double bond. To this 
end, Snider opted for slow addition of DDQ to precursor acetal 506 in dry dichloromethane to 
obtain highly conjugated eniminium salt 517 (Scheme 106). The product was immediately 
reduced using sodium cyanoborohydride, and the isomerized TAN1251A-acetal deprotected 
in acidic acetone to afford TAN1251A (493a).  




Scheme 106. Snider’s synthesis of TAN1251A. 
It was considered likely that the biosynthesis of TAN1251D proceeded via the reduction of 
the protonated iminium ion of TAN1251C. Thus, Snider and co-workers decided to pursue a 
similar synthetic strategy. Initial reduction of TAN1251C-acetal 506 with sodium triacetoxy 
borohydride in acetic acid yielded a 1:9 mixture of products, of which the major component 
was found to be 519, the acetal of 4-epi-TAN1251D (520). By optimization of the reaction 
conditions, Snider and co-workers successfully inverted the selectivity of the reduction, a 
parameter which was most significantly influenced by the polarity of the solvent used. Under 
optimized conditions, reduction of 506 with NaCNBH3 in hexafluoroisopropanol (HFIP) 
proceeded smoothly, yielding TAN1251D-acetal 518 in 90% yield (d.r. >25:1). Facile 
transacetalization was achieved in acidified acetone to reveal the natural product (+)-
TAN1251D (493d), confirming its absolute stereoconfiguration (Scheme 107).  
 
Scheme 107. Snider’s reduction study of 506 and synthesis of (+)-TAN1251D (493d). 
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The first, and to date only synthesis of TAN1251B (493b) was achieved by Snider in the 
same report.[340] The transformation of the enolate of TAN1251A (493a) to TAN1251B 
(493b) presented a formidable challenge since four α-hydroxy ketones could be formed from 
493a. Furthermore, any oxidant employed needed to be compatible with readily oxidizable 
functionality in 493a such as amines and olefins. At the outset of Snider’s investigation into 
the synthesis of TAN1251B, oxidation of the trimethylsilyl enol ether prepared from 
TAN1251A (493a) with m-CPBA at 0 °C resulted in formation of the N-oxide of the C1 
amine and no formation of the desired isomer was observed (Scheme 108).  
 
Scheme 108. Snider’s oxidation study of TAN1251A (493a) and synthesis of (+)-TAN1251B (493b). 
Formation of the enolate with NaHMDS followed by treatment with (1S)-10-
(camphorsulfonyl)oxaziridine, as pioneered by Davis,[355-356] led to a 2:3 mixture of undesired 
isomers 521 and 522 respectively. Hydroxylation of the enolate with the opposite enantiomer, 
(1R)-10-(camphorsulfonyl)oxaziridine resulted in a 2:1 mixture of 521 and 522. The 
preference for hydroxylation on this undesired face of the six membered ring could only be 
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overcome when the mixture of pre-formed trimethylsilyl enol ethers was reacted with OsO4 
(20%) and NMO in aq. tert-butanol, resulting in a 2:1:8:4 mixture of 521, 522, TAN1251B 
(493b), and 523. Purification proved challenging and furnished a mixture of TAN1251B and 
523 which was inseparable by conventional methods. However, separation was ultimately 
achieved on a Chiralpak AD column, leading to an isolated sample of (+)-TAN1251B (493b).  
In summary, Snider’s report employs methodology originally developed for FR901483 and 
expanded the work significantly in this tour-de-force synthesis of the TAN1251 alkaloid 
family. This led to the elegant synthesis of all four members of the TAN1251 family in an 
enantiocontrolled fashion in a single report. To date, Snider’s study is the only report 
achieving the synthesis of the complete series. The work demonstrates the key role of 
TAN1251C in the synthesis of the series, and supports the purported biosynthesis. Access to 
TAN1251A,C and D was established readily, while synthesis of TAN1251B was most 
challenging, with a selective method for its generation yet to be achieved. 
3.1.4.4 Wardrop’s synthesis of TAN1251A 
In 2001, the Wardrop group published their approach to TAN1251A,[345] detailing an elegant 
N-methoxy-N-acylnitrenium ion-induced spirocyclization to generate the α-tertiary amine 
center (Scheme 109). The enantiocontrolled synthesis was merged with Kawahara and 
Nagumo’s first generation (racemic) route.[343]  
 
Scheme 109. Wardrop’s retrosynthetic strategy to TAN1251A.  
The key aza-spirocyclization was initiated from 526 (accessible from L-tyrosine)[357-358]  by 
treatment with bis(trifluoroacetoxy)iodobenzene, readily providing the resulting dienone in 
69% yield (Scheme 110). Hydrogenation of the dienone followed by ketal protection of the 
generated ketone led to spirocycle 528. Lithium aluminium hydride reduction unexpectedly 
generated the desired methyl amine selectively, which enabled differentiation between the 
two amines and consecutive protection of the C1 amine as the benzyl carbamate.  
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Zinc-mediated reduction of the N–O bond then afforded secondary amine 529. Kawahara-
Nagumo intermediate 524 was accessed via established steps. The benzyl group was 
introduced via aldol reaction with para-prenyloxybenzaldehyde, to give an inconsequential 
1.2:1 mixture of products 531 in a combined yield of 80%. The mixture was treated with 
mesyl chloride, and the resulting mesylates submitted to basic elimination conditions, 
destroying two of the three stereocenters and converging the mixture into resulting α,β-
unsaturated amide 532. Reduction of 532 with AlH3 in ether followed by transacetalization in 
a mixture of HCl and acetone completed Wardrop’s total synthesis of (−)-TAN1251A (493a). 
 
Scheme 110. Wardrop’s synthesis of (−)-TAN1251A (493a). 
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3.1.4.5 Kawahara and Nagumo’s 2nd generation synthesis of TAN1251A 
 
Scheme 111. The Kawahara-Nagumo second generation retrosynthetic strategy towards TAN1251A. 
In 2002, Kawahara, Nagumo and co-workers published their second generation synthesis of 
optically active (−)-TAN1251A (Scheme 111).[348] The formal synthesis centers around chiral 
intermediate 524.[343, 345] In contrast to prior work, Kawahara and Nagumo chose a proline 
derivative as the starting material in their synthesis. Aldol reaction to close the cyclohexanone 
ring was followed by Mitsunobu reaction to install the C1 nitrogen, allowing the completion 
of the core scaffold via intramolecular amidation.  
 
Scheme 112. Kawahara and Nagumo’s second generation formal synthesis of TAN1251A (493a). 
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The synthesis commences with alkylation of trans-4-hydroxy-L-proline derivative 535 with 
LDA to afford α-tertiary amine product 536 (67%) and its epimer (15%) (Scheme 112). Both 
diastereomers could be used for the outlined route to access methyl ketone 537. Closure of the 
cyclohexanone ring was followed by a series of standard operations to arrive at aza-
spirocyclic ketone 537. Acetal protection of the ketone followed by cleavage of the silylether 
delivered the secondary alcohol, which was transformed into azide 538 with the correct 
stereoconfiguration on C1 via established Mitsunobu reaction.[343] Removal of the Boc group 
was followed by N-alkylation to give ester 539. The azide was reduced via catalytic 
hydrogenation and the resulting amino ester hydrolyzed to give acid 540. DPPA induced 
cyclisation followed by methylation delivered the optically active first-generation 
intermediate 524 with the complete core structure in place. As 524 has been transformed into 
(−)TAN1251A by Wardrop, the second-generation synthesis of 524 by Kawahara and 
Nagumo constitutes a enantiocontrolled formal synthesis of TAN1251A. 
3.1.4.6 Ciufolini’s synthesis of TAN1251C 
In 2001, Ciufolini and co-workers published their approach to TAN1251C together with their 
synthesis of FR901483.[262] The Ciufolini group used a divergent approach, in which an 
intermediate from their FR901483 synthesis could be directly used as a late stage precursor in 
the synthesis of TAN1251C. The central intermediate 421 was obtained through the same 
methodology as in the synthesis of FR901483 (Scheme 113, see also Section 3.1.2.5).  
 
Scheme 113. Ciufolini’s divergent retrosynthetic strategy to TAN1251C. 
The advanced intermediate 421 was first converted into the free phenol by treatment with 
BBr3, followed by prenylation under standard conditions to furnish prenyl ether 541 (Scheme 
114). Subsequent global reduction with lithium aluminium hydride gave the respective diol. 
Ciufolini and co-workers opted for 2,2,2-trichloro-ethoxycarbonyl (Troc) protection of the 
secondary amine to obtain carbamate 542. The diol could be successfully oxidized using Ley-
oxidation conditions with TPAP and NMO, resulting in keto aldehyde 543. Deprotection 
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using the cadmium-lead couple led to intramolecular condensation forming the desired natural 
product TAN1251C in good yield (79%).   
 
Scheme 114. Ciufolini’s synthesis of (+)-TAN1251C. 
Overall, Ciufolini’s elegant approach was the first to allow construction of both the FR901483 
and TAN1251C scaffolds divergently, featuring a late stage common intermediate, albeit with 
the necessary removal of the phenolic methyl group. Suppression of the aldol reaction in the 
final oxidation step as encountered by the Ciufolini group remains an unsolved problem 
requiring protecting group manipulations late in the synthesis.  
3.1.4.7 Honda’s formal synthesis of TAN1251A 
 
Scheme 115. Honda’s retrosynthetic strategy to TAN1251A. 
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In 2002, Honda[346-347] developed a novel approach to the formal synthesis of (–)-TAN1251A, 
targeting synthetic intermediate 524 previously reported in the Kawahara-Nagumo[343-344, 348] 
and Wardrop[345] syntheses. The synthesis employed a oxidative spirocyclization mediated by 
hypervalent iodine reagents, as previously reported in the syntheses of Wardrop[345] and 
Ciufolini[262], however on a more challenging piperazinone ring system (545) (Scheme 115).  
Benzyl phenolether 547 (accessible from tyrosine methyl ester hydrochloride 546) was 
subjected to a series of standard operations to deliver amine 549, which in turn was cyclized 
to the respective piperazinone ring system after Boc-deprotection. Hydrogenolysis of the 
phenolic benzyl group gave the resulting piperazinone 545. In the key step of the synthesis, 
oxidative cyclization employing bis(acetoxy)iodobenzene in hexafluoroisopropanol (HFIP) 
proved particularly successful, delivering the desired diazabicyclic dienone product 544 in 
69% yield, which could be readily advanced to the Kawahara-Nagumo and Wardrop 
intermediate 524. 
 
Scheme 116. Honda’s formal synthesis of (−)-TAN1251A. 
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Honda detailed a concise formal route to TAN1251A employing the commonly used 
oxidative cyclization chemistry efficiently to access the diazabicyclic ring system of the 
TAN1251 series. Although the synthesis presents selectivity challenges in the reduction of 
dienone 544, the approach is appealing due to its brevity. 
3.1.4.8 Hayes’ formal synthesis of TAN1251A 
In 2004, the Hayes group published their formal synthesis of TAN1251A, utilizing an 
alkylidene carbene 1,5-C–H insertion approach[359] to access a [5,5]-spirocyclic precursor.[349] 
The synthesis involves ring expansion via an oxidative cleavage / aldol sequence to generate 
the cyclohexanone ring fragment, and an intramolecular amidation previously reported in 
Kawahara and Nagumo’s second generation approach (Scheme 117).[348] 
 
Scheme 117. Hayes’ retrosynthetic strategy towards TAN1251A. 
The Hayes synthesis commenced from proline derivative 552 (Scheme 118). Derived ketone 
553 was employed in the key 1,5-C–H insertion, following a procedure reported by Ohira,[360] 
delivering the desired [5,5]-spirocycle 550 in 40-86%. Due to reproducibility concerns, the 
reaction was optimized to start from vinyl chloride 551, obtained quantitatively from 553 via 
Wittig reaction, to produce the desired spirocyclic product 550 in improved 78-93% yield. 
The double bond in spirocycle 550 was cleaved following the Lemieux-Johnson protocol,[361] 
allowing ring expansion and elaboration to spirocycle 538. Removal of the Boc-group 
followed by treatment with ethyl bromoacetate under basic conditions installed the tether for 
subsequent intramolecular cyclization. Reduction of the azide gave known amine 539.[348] 
Conversion of amine 539 to the targeted Kawahara-Nagumo and Wardrop intermediate 524 
completed the formal synthesis.  
The Hayes group contributed a valuable methodology for construction of the challenging 
chiral α-tertiary amine spirocenter, present in all TAN1251 alkaloids. The method could also 
allow access to the related FR901483 scaffold. The reaction displays high levels of 
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diastereoselectivity and the chiral information in the precursor is derived from a readily 
available proline derivative. Notably, the total synthesis of TAN1251A was completed by the 
Hayes group via the established protocol in the same report.  
 
Scheme 118. Hayes formal synthesis of (−)-TAN1251A. 
3.1.4.9 Honda’s synthesis of TAN1251C and TAN1251D 
 
Scheme 119. Honda’s retrosynthetic strategy towards TAN1251D and TAN1251C. 
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In 2005, the Honda group published their second report on the synthesis of TAN1251-series 
compounds, achieving the synthesis of (+)-TAN1251C and (+)-TAN1251D.[350] Honda 
employed a similar method to that reported in their previous synthesis of TAN1251A,[346-347, 
362] relying on an oxidative cyclization of a piperazinone through treatment with hypervalent 
iodine reagents (Scheme 119). In the new approach, the cyclization precursor was derived 
from a di-tyrosine unit, rather than tyrosinyl-glycine, precluding the need for late-stage 
installation of the benzyl group. 
 
Scheme 120. Honda’s total synthesis of TAN1251D and TAN1251C. 
The synthesis began from the diamine 560, which was readily accessible from O-para-
methoxybenzyl (PMB) protected carbamate 557 (Scheme 120). Cyclization induced by 
sodium methoxide delivered the piperazinone, in which the PMB-group was removed by 
treatment with TFA to afford the key precursor piperazinone 556. Oxidative spirocyclization 
proceeded in moderate yield employing conditions from Honda’s previous study.[346] 
Established copper hydride reduction afforded cyclohexanone 561. After a sequence of 
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standard operations, prenyl ether 562 was obtained. Reduction followed by transacetalization 
in acetone gave the natural product (+)-TAN1251D (493d). Alternatively, 562 was subjected 
to DIBALH reduction to give dienamine 563, which was readily converted to the natural 
product TAN1251C (2) via transacetalization. 
With the synthesis of TAN1251C (2) and TAN1251D (493d), the Honda group expanded 
their methodology employed for the synthesis of TAN1251A. The study underpins the 
unusual piperazinone oxidative spirocyclization as an effective strategy to access the 
TAN1251-azabicyclic scaffold. To date, the Honda group is the second laboratory to achieve 
the total synthesis of TAN1251D, along with Snider.[340]   
3.1.4.10 Kan’s total synthesis of TAN1251C 
In a recent contribution by the Kan group in 2017,[351] a four-component Ugi reaction 
previously employed by Sorensen[285] and Fukuyama and Kan[266] is used to quickly access 
the TAN1251C core structure via a subsequent Dieckmann condensation / reduction sequence 
(Scheme 121). 
 
Scheme 121. Kan’s synthetic approach to TAN1251C.  
The synthesis commenced from imine 567, which was subjected to the four component Ugi 
reaction with isonitrile 565 and glycine derived acid 566 (Scheme 122). Ugi-product  
bromopyridine amide 569 underwent smooth Dieckmann condensation and conversion to the 
corresponding enol triflate 564. After defunctionalization of the triflate, hydrogenolysis of the 
phenolic benzyl ether and the Cbz-group was followed by conversion of the resulting methyl 
enamine to oxime 570. Remarkable stereoinduction was observed upon treatment of oxime 
570 with zinc and ammonium chloride in acetic acid,[271-272] delivering primary amine 571 as 
single diastereomer. Intermediate 572 was obtained after a series of standard operations. The 
natural product (+)-TAN1251C (2) was obtained following Snider’s protocol.[340]  




Scheme 122. Kan’s synthesis of TAN1251C. 
Kan’s recent approach offers the possibility of conducting this type of Ugi reaction with the 
respective glycine derivates, omitting the late stage installation of the C2 nitrogen, which has 
the potential to significantly shorten the synthesis of related scaffolds. Unfortunately, 
challenges in the reduction of the Dieckmann product made a moderately yielding conversion 
to the enol triflate necessary. Furthermore, planned stereoselective reduction of the conjugated 
lactam failed due to difficulties in separating the reduction products. This forced the authors 
to entirely abandon the installed, glycine derived C2 carbamate, and proceed with 
transformation to oxime 570, a pathway only made palatable by the subsequent astonishingly 
stereoselective zinc reduction. Overall, this recent approach constitutes an elegant 
contribution to access the TAN1251 scaffold via a versatile new multicomponent reaction.  
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3.2 Summary and Project aims 
Despite the wealth of elegant and efficient reports that has been published on both FR901483 
(1) and the TAN1251 alkaloid series, the construction of their unique azatricyclic molecular 
architectures remains a formidable challenge. Previous work on the construction of the 
azabicyclic scaffold of the two natural products (vide supra) suggests that two factors are of 
particular importance for a successful and succinct synthesis: (i) a rapid and efficient pathway 
to construct the α-tertiary amine spirocenter and (ii) incorporation of the two amino acid 
derived stereocenters, preferably from precursors from the chiral pool, such as L-tyrosine.  
 
Figure 17. Timeline of synthetic approaches towards the α-tertiary amine spirocenter in the FR901483 core 
scaffold. 
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A chronological summary of synthetic methods for the generation of the α-tertiary amine 
center in FR901483 is shown in Figure 17. Due to the structural similarity between FR901584 
and the TAN1251 family, methods in the construction of the spirocyclic α-tertiary amine 
center in TAN1251 alkaloids are oftentimes derived from approaches towards FR901483, 
with the oxidative spirocyclization in the case of Snider,[252, 340] Ciufolini,[262-263] Wardrop,[318, 
345] and Honda[362] being the by far most commonly employed method. Kawahara and 
Nagumo[343-344, 348] utilized a stereoselective alkylation, while Kan[351] used a variant of the 
Ugi reaction from earlier work on FR901483. Notably, a novel approach was pioneered by the 
Hayes group[327, 349] with their alkylidene carbene 1,5-C–H insertion followed by ring 
expansion.  
The use of a common precursor between the TAN1251 series and the FR901483 scaffold was 
only capitalized on by a small number of reports, most efficiently by Ciufolini,[262] and 
notably in some regards also by the work of Snider,[252, 340] as well as Fukuyama and Kan.[266, 
271-272, 283, 351] Indeed, an operationally simple, multicomponent approach to access a common, 
and possibly advanced, precursor for both syntheses still remained elusive in the literature. 
Based on this assessment, the goal of this project was set to develop a significantly shorter 
route to the two alkaloids 1 and 2, potentially accelerating the development of new therapeutic 
agents based on their highly bioactive profiles. In line with the previous work,[249] we 
recognized the photocatalytic multicomponent olefin-hydroaminoalkylation as a powerful 
method for construction of α-tertiary amine spirocenters.[249] It was envisaged to utilize this 
chemistry to generate the respective spirocenters in the FR901483 and TAN1251 scaffolds in 
a facile and efficient way. 
This multicomponent approach would allow installation of most of the functionality of the 
natural products in a single step. The only multicomponent strategy towards 1 and 2 to date 
was reported by Fukuyama and Kan,[266, 351] which required two different Ugi reactions for  
the construction of FR901483 and TAN1251C in the respective synthetic studies. While the 
Ugi reaction is a powerful tool, the required precursors were often not commercial, sometimes 
difficult to synthetize (e.g. 7 steps to synthetize the amine precursor in the Ugi reaction in 
Fukuyama’s second generation synthesis of FR901483),[266] and would require extensive 
functional group modifications after the multicomponent reaction, such as hydrolysis, 
transacetalization and protecting group operations. In contrast, the outlined strategy was 
designed to be capable of incorporating an easily accessible tyrosine precursor as amine 
component, a commercially obtainable ketone, and a radical acceptor containing the second 
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chiral center (Scheme 123). If realized, this idea would allow a more rapid and efficient 
assembly of the core structure of both natural products in a modular fashion, streamlining the 
syntheses and decreasing the number of synthetic operations. 
 
Scheme 123. Project outline for the total synthesis of FR901483 and TAN1251C. 
In line with this strategy, a common precursor, from which both the synthesis of FR901483 
and TAN1251C could be achieved in an efficient fashion, had to be proposed (Scheme 123). 
From this common intermediate, it was planned to establish two chemically distinct and 
efficient routes leading to the respective syntheses of FR901483 (1) and TAN1251C (2).  
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3.3 Results and Discussion 
3.3.1 Strategy for the total synthesis of (−)-FR901483 and (+)-TAN1251C 
A retrosynthetic analysis of FR901483 (1) and TAN1251C (2) was conducted, focused on 
utilizing a multicomponent photocatalytic olefin-hydroaminoalkylation approach (Scheme 
124).  
 
Scheme 124. Initial retrosynthesis analysis of FR901483. 
The retrosynthesis of FR901483 (1) can be divided into three fundamental stages, the tricyclic 
phase, in which functionalization of the established core scaffold is achieved, the bicyclic 
phase, an intermediate phase leading up to the completion of the core fragment, and the 
multicomponent stage, in which a precursor for the bicyclic phase is assembled. According to 
the initial strategy, in the tricyclic phase (Scheme 124a), the natural product 1 could be 
obtained from a secondary alcohol such as 585 via the Mitsunobu reaction developed by 
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Sorensen[261] followed by hydrogenation. This pathway was based on the known predicament 
that reductions of a C8 ketone would strongly favor the equatorial C8 alcohol.[252, 261-262] We 
hence chose to access 585 from ketone precursor 586, completing the tricyclic phase of the 
retrosynthesis.  
Pioneered by the studies of Snider,[252, 275] the azatricyclic scaffold is commonly constructed 
via intramolecular biomimetic aldol reaction. Reported instances of this aldol reaction have 
shown to be relatively unselective (vide supra), and sensitive to small changes in the substrate 
scaffold.[334] The groups of Ciufolini[262] and Sorensen[261] have also used Snider’s approach, 
albeit modified, and were able to obtain sufficient material from this challenging step to 
complete the respective total syntheses. In contrast to the work of Snider, in the retrosynthetic 
plan, it was envisaged to induce aldol reaction from the pyrrolidine tertiary amine, the 
reduced form of the spirolactam motif. Advantageously, this aspect is well reflected in the 
literature by the work of the Sorensen group (Scheme 125). Sorensen conducted the aldol 
reaction with the respective pyrrolidine precursor 407, bearing a carbamate on the C2 
nitrogen, albeit with limited experimental data available. Given this precedent, we were 
hopeful to obtain 586 in acceptable selectivity from keto aldehyde 587 (Scheme 124b), 
allowing access to the final tricyclic stage in the outlined synthesis.  
 
Scheme 125. Biomimetic aldol reactions towards FR901483 in the literature. 
Leading up to the aldol reaction in the bicyclic phase (Scheme 124b), access to aldol 
precursor keto aldehyde 587 was proposed via concomitant oxidation of both the secondary 
C8 alcohol and the primary alcohol on the tyrosine tether. A similar oxidation on the scaffold 
has been previously reported by Sorensen.[261] To avoid condensation of the resulting 
aldehyde with the secondary C2 amine, the amine functionality needed to be protected, 
precluding oxidative cyclization to the TAN1251 scaffold. The benzyl carbamate was selected 
as a preferred protecting group, due to its facile removal via a naturally occurring 
hydrogenolysis step later on in the synthesis. Moreover, it became clear that the protecting 
group strategy at this step would be the pivotal point of divergence between the FR901483 
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and TAN1251C syntheses. Diol 588 would then be readily available via global reduction from 
precursor 589, which in turn would stem from the photocatalytic multicomponent approach. It 
was envisaged that in the global reduction step, introduction of the methyl group on the C2 
nitrogen could occur via reduction of a carbamate, concomitantly with the generation of the 
diol from the ester and ketone motifs, and reduction of the lactam to the tertiary amine. 
Accordingly, key bicyclic spirolactam 589 would be generated from the product of the 
multicomponent step (590) by intramolecular condensation of the amine with the carbonyl 
group of a suitable radical acceptor (Scheme 126).  
 
Scheme 126. Design plan for construction of pyrrolidinone ring system. 
Therefore, it was envisioned that a product such as 592 from the multicomponent 
photocatalytic radical reaction had to be deprotected at the nitrogen, as, in the previous 
studies,[249] N-benzyl groups were required for the reaction to proceed. The free secondary 
nitrogen in 593 could then cyclize under action of activating reagents[363] with the available 
carbonyl (i.e. carboxylic acid) to close the pyrrolidinone ring system in 594.  
In the multicomponent stage (Scheme 124c) it was proposed to obtain the photocatalytic 
olefin-hydroaminoalkylation product via the previously established methodology.[249] A 
variant of this reported olefin-hydroaminoalkylation reaction enabled the generation of an α-
tertiary from a respective enamine. Accordingly, the retrosynthetic strategy proceeded from 
the respective iminium ion 595 (Scheme 127), which had to be obtained from condensation of 
a tyrosine derivative with 1,4-cyclohexanedione monoethylene ketal. After the iminium ion 
595 has formed either through condensation, or protonation of the respective enamine, single 
electron transfer would occur to generate the α-amino radical 596. The use of chiral 
dehydroalanine 360 as radical acceptor was proposed. The compound, initially introduced by 
Beckwith,[224] displays the ideal coupling partner for this multicomponent reaction, providing 
(i) an intermediate lactone for subsequent functionalization, (ii) a masked methyl group on the 
nitrogen in the form of a benzyl carbamate, accessible by reduction, and (iii) facile 
introduction of the stereocenter on C2 through a known stereoselective HAT process. Alkene 
360 is readily available in a three step sequence from S-benzyl cysteine and can be obtained in 
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high optical purity and on large scale (vide infra). Stereoselective HAT with a stoichiometric 
reductant, which has been demonstrated to proceed in high diastereoselectivity in the previous 
methodology, would give access to desired radical addition product 590. 
 
Scheme 127. Initial plan for the photocatalytic hydroaminoalkylation step. 
Given the divergent nature of the strategy, diversification of the scaffold accessible via the 
photocatalytic multicomponent reaction could give facile access to both FR901483 (1) and 
TAN1251C (2). It was envisaged that TAN1251C (2) could be accessed from a suitable 
ketoaldehyde 597, which could undergo either aldol reaction to form the FR901483 (1) 
scaffold or condensation between the aldehyde and the free amine to TAN1251C (2) (Scheme 
128a).[252, 260, 262] This strategy would also give formal access to the full TAN1251 series, as 
TAN1251C (2) serves as a synthetic gateway to the three other congeners of the family.[340] 
Consequently, the retrosynthesis followed the disconnection of a oxidative cyclization to 
dienamine TAN1251C from diol 598 (Scheme 128b), which corresponds to the respective 
diol 588 in the FR901483 synthesis, only differing in the O-alkylation on the phenol, as a 
phenolic prenyl ether is present. It was proposed that diol 598 can in turn be generated via 
global reduction of spirocyclic lactam 599, including the introduction of a N-methyl group 
through reduction of the benzyl carbamate. The remainder of the synthetic pathway to obtain 
599 would be equivalent to that laid out for the synthesis of FR901483, with a possible 
divergent introduction of the O-prenyl group present at the phenol, and would proceed via a 
photocatalytic multicomponent reaction to obtain spirolactam 600. 




Scheme 128. a. Divergent strategy to access natural compounds 1 and 2; b. Retrosynthetic analysis for the 
synthesis of 2. 
3.3.2 Development of the primary amine multicomponent reaction 
With the synthetic plan in hand, the synthesis of both natural products 1 and 2 commenced 
with the multicomponent photocatalytic olefin-hydroaminoalkylation method previously 
developed.[249] The closest example to the proposed reaction stemmed from the previous 
studies. Therein, commercial enamine 379e and chiral dehydroalanine acceptor 360 were 
reacted with O-methoxyethyl Hantzsch Ester 356 as stoichiometric reductant, with catalytic 
Ir(ppy)3 (1 mol%), propionic acid (20 mol%) and molecular sieves in dichloromethane under 
irradiation of blue light for two hours to obtain α-tertiary amine 380e in 60% yield (see 
Section 2.3.5, Scheme 75). 
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Scheme 129. Enamine photocatalytic olefin-hydroaminoalkylation. ◊Reaction conducted by Dr A. Trowbridge. 
Although the reaction stereoselectively incorporated the dehydroalanine fragment, and led to 
formation of the α-tertiary amine center, several challenges had to be met to render the 
reaction synthetically valuable in the proposed synthesis. Firstly, the used commercial 
enamine 379e was easily accessible from morpholine and cyclododecanone. However, while 
enamine generation from pyrrolidine, piperidine and morpholine and carbocyclic ketones is 
facile due to privileged stability, enamine formation can be challenging from less 
nucleophilic, acylic amines.[243-244] This was problematic due to the fact that the enamine had 
to feature an electron withdrawing, sterically demanding N-benzyl tyrosine derivative as the 
amine component to be a suitable substrate. Furthermore, the carbocyclic ketone component 
had to be altered to 1,4-cyclohexanedione monoethylene ketal 397. 
While the generation of enamines from hindered non-cyclic secondary amines and ketones 
can be very challenging,[244] imine formation from primary amines and ketones is common 
place,[364-365] and this feature is used frequently for their transient formation in 
organocatalysis.[366] We thus turned our attention to a possible in situ condensation reaction of 
a primary amine tyrosine derivative 602 with ketone 397 to form the respective imine. This 
species could potentially undergo protonation to iminium 603 followed by single electron 
reduction to the α-amino radical 604 (Scheme 130), which could be trapped by a suitable 
olefin. 
 
Scheme 130. In situ imine formation strategy to access α-amino radical 604. 
In contrast to the previous methodology, this reaction would require the use of ketones (rather 
than aldehydes or enamines), and the resulting α-amino radical and thus α-tertiary secondary 
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amine products could serve as a valuable extension to the existing methodology. To trial the 
reaction, starting primary amine 409 was synthesized from 448. 
 
Scheme 131. Synthesis of primary amine 409. 
The initial test reaction used the O-methyl tyrosine ester 409, 1,4-cyclohexanedione 
monoethylene ketal (1.1 equiv, 397), chiral dehydroalanine (1.5 equiv, 360), Hantzsch Ester 
(1.5 equiv, 316), and a 1 mol% loading of photocatalyst fac-Ir(ppy)3 under irradiation of a 
40W Kessil blue LED lamp. Trifluoroacetic acid (TFA) was chosen as catalytic acid (20 
mol%). The reaction was carried out on a 0.1 mmol scale in dry dichloromethane under the 
addition of activated 4 Å molecular sieves. We were delighted to observe the formation of the 
desired olefin-hydroaminoalkylation product 605 in 77% isolated yield as a single 
diastereomer (Scheme 132a).  
 
Scheme 132. a. Initial test reaction for the generation of 605 via photocatalytic olefin-hydroaminoalkylation 
using primary amine 409. b. Proposed mechanism for the transformation based on prior work[249] (PMB. para-
methoxybenzyl). 
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The proposed mechanism (Scheme 132b) for the transformation is in accordance with the 
previous findings on the photocatalytic olefin-hydroaminoalkylation, which were confirmed 
with mechanistic studies. The photocatalytic cycle starts with excitation of fac-Ir(ppy)3, 
generating the photoexcited [Ir(III)ppy3]*, a mild oxidant (*Ir(III)/Ir(II), E1/2
red = +0.31 V 
versus SCE in acetonitrile).[37] Although this species would be reducing enough 
(Ir(IV)/*Ir(III), E1/2
red = −1.73 V versus SCE in acetonitrile)[37] for SET to occur with 
protonated imine 606 (which could be as facile as E1/2
red = −1.14 V vs SCE)[182], in line 
with the previous study, SET with Hantzsch Ester (316) was proposed, which efficiently 
quenches [Ir(III)ppy3]* and is available in greater relative concentrations than the protonated 
imine, generating its radical cation 317 and the strongly reducing [Ir(II)ppy]-. This powerful 
reductant in turn undergoes SET with protonated imine 606 to generate α-amino radical 607 
and the ground-state photocatalyst fac-Ir(ppy)3. Radical 607 is efficiently trapped by radical 
acceptor dehydroalanine 360 resulting in radical 608. Importantly, due the strong stabilization 
of this radical by the neighboring heteroatom and carbonyl, a 1,5-HAT process to preclude 
polymerization processes is not necessary with this acceptor. Lastly, stereoselective HAT 
occurs from the sterically more available re-face (si-face is encumbered by tert-butyl 
substituent, Scheme 133) with a high degree of stereoselectivity (in this case only one 
diastereomer was obtained, generally the diastereoselectivity of the process is >20:1 d.r.),[228] 
affording the α-tertiary amine 605. The protonated Hantzsch pyridine 353 is the main reaction 
by-product and serves as proton source required to protonate the imine. Crucially, in a control 
experiment, it was found that the addition of trifluoroacetic acid (TFA) was instrumental in 
achieving high conversion to the intermediate secondary amine 605; presumably, protonation 
of the imine facilitates SET by lowering the reduction potential or via proton coupled electron 
transfer (PCET). 
 
Scheme 133. Diastereoselective HAT between α-carbonyl radical 608 and Hantzsch ester radical cation 317. 
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With 605 in hand, the total syntheses of 1 and 2 were deemed achievable, as all of the scaffold 
atoms of FR901483 (1) and TAN1251C (2) were already in place after this key step. The 
direct access to the secondary amine 605 from primary amine 409 also potentially reduced the 
number of necessary steps of the synthesis, as the expected removal of i.e. a N-benzyl group 
was not required. The closure of the spiro-piperidinone ring system would be the first required 
transformation towards the two natural product scaffolds. 
An investigation of the closure of the pyrrolidinone ring was carried out next (see Scheme 
126). The initial plan foresaw cleavage of the 5-oxazolidinone and concomitant removal of an 
N-benzyl group, for example through hydrogenolysis of the Cbz group reported by 
Beckwith.[224] Through direct access to secondary amine 605, the possibility emerged to 
conserve the N-Cbz group for later transformation into the native N-Me substitution of the 
natural product via reduction. This ‘masked methyl’ approach was desirable as it would 
further reduce the step count of the proposed synthesis, but it required direct pyrrolidinone 
ring closure through attack of the secondary nitrogen in 605 onto the 5-oxazolidinone 
carbonyl, forming spirolactam 609. Accordingly, cyclization conditions were screened to 
achieve this, on this scaffold, unprecedented transformation.  
Table 7. Exploration of different conditions for the cyclization of 605. aisolated yield.  
 
Entry Conditions reaction time yield 609a note 
1 80 °C, toluene 1 h - no reaction 
2 80 °C, toluene 2 h - no reaction 
3 80 °C, toluene, NEt3 2 h - no reaction 
4 excess LiAlH4, 0 °C 16 h - complex mixture 
5 amberlyst-15, CHCl3, r.t. 15 h observed slow conversion 
6 PPTS, wet acetone, 60 °C 1 h - selective ketal cleavage 
7 1 M aq. HCl in THF, r.t. 4 d 63 % - 
Given the presence of trace amounts of spirolactam ester 609 during the isolation of 5-
oxazolidinione 605 from the crude multicomponent reaction mixture, it was surprising that 
heating of 605 in toluene did not result in cyclization, and instead no reaction was observed 
(Table 7, entries 1,2). Addition of triethylamine led to no improvement. Next, treatment with 
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lithium aluminium hydride to cleave the oxazolidinone or increase the nucleophilicity of the 
secondary nitrogen resulted in a complex mixture. Pleasingly, acidic conditions were more 
favorable, and product (609) formation was observed when 605 was reacted with amberlyst-
15 resin in chloroform at room temperature for 15 h (Table 7, entry 5).[367] However reaction 
performance was sluggish, and a mixture of products was observed, mainly stemming from 
the incomplete hydrolysis of the dioxolane. Furthermore, in line with one literature report of a 
8 day reaction time,[367] conversion only reached an estimated  25% after 15 hours (LC-MS). 
Interestingly, it was observed that PPTS in wet acetone at 60 °C selectively deprotected the 
ketal when reaction times are kept relatively short (1 hour).[368] Finally, it was found that 
classic conditions for removal of the dioxolane-ketal,[369] treatment with aq. 1 M HCl in THF 
(15:85), gave the best results. Full conversion to the cyclized product 609 (including ketal 
deprotection) was observed after 4 days at room temperature. After purification, an isolated 
yield of 63% of spirolactam 609 was obtained. Despite the long reaction time, the mild 
conditions allowed cyclization, concomitant removal of the dioxolane, and conservation of the 
Cbz-group, delivering the chiral azaspiro-scaffold of 609 in a facile manner.  
With spirolactam 609 in hand, the relative stereoconfiguration of the two chiral centers was 
confirmed via X-ray crystallography (performed by A. Bond). Pleasingly, the data obtained 
showed the correct stereoconfiguration of both centers in regard to the natural product, and 
furthermore established the compound as a single enantiomer. While the absolute 
stereochemistry could not be determined with statistical certainty from the data, all evidence 
obtained from the X-ray crystallographic analysis indicated the proposed absolute 
stereoconfiguration was correct. Given that the synthesis started from L-tyrosine, the relative 
and absolute stereoconfiguration of the obtained scaffold was considered to be established 
with high confidence.  
 
 
Scheme 134. Crystal structure of 609. 
It was reasoned that the efficiency of the reaction could be increased if the reaction was run 
from commercial starting materials, (except for necessary alkene 360), with L-tyrosine methyl 
ester 610 as a suitable starting point. Furthermore, this would implement the desired divergent 
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synthesis strategy for FR901483 (1) and TAN1251C (2), by providing a common synthetic 
precursor in form of the resulting spirolactam ester 611, featuring a free phenol motif, from 
which rapid synthesis of both 1 and 2 could be achieved. O-Alkylation of the phenol with 
either methyl or prenyl would constitute the next step from the common spirolactam ester 611 
(Scheme 135a).  
 
Scheme 135. a. Divergent strategy from commercially available L-tyrosine methyl ester (610) followed by 
alkylation of the phenol, which displays the point of divergence (OMe → FR901483, O-prenyl → TAN1251C). 
b. Initial one-pot synthesis of key spirolactam ester 611.  
It was envisioned that the photocatalytic multicomponent reaction and subsequent cyclization 
could be streamlined into a one-pot process, by simple filtration and swapping the solvent to a 
mixture of aqueous HCl and THF. By applying these changes, it was found that commercial 
L-tyrosine methyl ester (610) was indeed a suitable substrate for the reaction, with the 
unprotected phenol side chain being well tolerated under the reaction conditions. The 
preliminary one-pot approach involved 3.5 hours of irradiation followed by treatment with a 
1:1 mixture of aq. HCl and THF (4 days), and delivered key spirolactam ester 611 in 81% 
yield (Scheme 135b). Furthermore, it was serendipitously discovered during the workup of 
the cyclization step, that the spirolactam product 611 is poorly soluble in most organic 
solvents and precipitates upon basification from the reaction mixture. A purification 
procedure by simple filtration and washing was thus developed. Using this procedure, pure 
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(within sensitivity of 1H-NMR) spirolactam ester 611 could be obtained, importantly omitting 
the need for chromatographic purification.  
Despite initial success of this approach, the long overall reaction time of the cyclization step 
was considered unsatisfactory. It was found that by increasing the concentration of HCl and 
conducting the reaction at a temperature of 50 °C, the reaction time of the cyclization step 
could be shortened to 20 h. Importantly, the reaction could be successfully conducted on 
gram-scale, although irradiation with two 40 W Kessil blue LED lamps was found to be 
necessary. Furthermore, reducing the loading of alkene 360 to 1.3 equivalents (rather than 1.5 
equiv) could be achieved without appreciable deterioration in yield. Under these optimized 
scaled-up conditions (4 mmol), irradiation of the reaction mixture for 4 hours, followed by 20 
h stirring in a 1:1 mixture of 3 M HCl and THF afforded the key spirolactam ester 611 in 73% 
yield on gram-scale. The reaction could be run in parallel (2 x 4 mmol) and combined at the 
cyclization stage to obtain up to 2.83 g (72%) per batch. 
 
Scheme 136. Optimized one-pot gram-scale synthesis (4 mmol) of key spirolactam ester 611. 
Subsequently, a large-scale synthesis of dehydroalanine radical acceptor 360 was established. 
With only few methods available in the literature,[370-371] the approach is based on recent work 
by Jui.[228] The synthesis commences from S-benzyl-L-cysteine (612), providing the 
stereocenter from the chiral pool (Scheme 137). The optimized sequence began with the 
deprotonation of 63 g (0.3 mol) of 612, and subsequent formation of the respective imine with 
pivaldehyde (613), forming the intermediate carboxylate 614. Intramolecular attack by the 
carboxylate is induced by addition of benzyl chloroformate, likely resulting in a reactive acyl-
iminium species from which cyclization occurs. The reaction temperature has to be carefully 
controlled to obtain good selectivity for the syn-diastereomer 615. Under the shown 
conditions the reaction usually exhibited good selectivity (>12:1 d.r.). Although the reaction 
is reported with slightly higher yields by the Jui group,[228, 372] the reaction was notoriously 
low yielding in the synthetic studies, and despite considerable efforts, no significant increase 
in efficiency could be achieved. Ultimately, sufficient amounts of 5-oxazolidinone 615 could 
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be obtained via this approach. Completion of the synthesis was achieved via oxidation of the 
thioether to the respective sulfone 616, followed by elimination under basic conditions, 
delivering chiral dehydroalanine acceptor 360 in high optical purity (98% ee) on 15 gram-
scale. 
 
Scheme 137. Large scale synthesis of dehydroalanine acceptor 360. a. Large scale reaction carried out together 
with Dr A. Trowbridge. 
3.3.3 Completion of the total synthesis of (+)-TAN1251C 
With key spirolactam ester 611 available, we turned our attention to the total synthesis of (+)-
TAN1251C (2). Prenylation of the phenol in spirolactam ester 611 was carried out under 
established conditions[340] with prenyl bromide and cesium carbonate in acetone at 50 °C 
(Scheme 138). The reaction proceeded smoothly and afforded phenolic prenyl ether 617 in 
97% yield after purification.  
 
Scheme 138. Synthesis of prenyl phenolic ether 617. 
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With 617 in hand, the subsequent global reduction step was attempted. Ideally, lithium 
aluminium hydride reduction would concomitantly reduce (i) the methyl ester to the primary 
alcohol, (ii) the ketone to the secondary alcohol, (iii) the lactam to the respective tertiary 
amine, and (iii) the benzyl carbamate to a methyl group. Pleasingly, full conversion was 
observed after treatment with an excess of lithium aluminum hydride in refluxing THF for 16 
hours. The resulting benzyl alcohol side-product had to be removed either during workup, or 
through column chromatography. Despite the high polarity of the resulting amino diol motif, 
perhaps surprisingly, chromatographic separation was found to give the best results, affording 
the product amino diol 598 in 80% yield (Scheme 139). The product was obtained as a single 
diastereomer within the limits of 1H-NMR spectroscopy. 
 
Scheme 139. Synthesis of diol 598. 
The geometrical configuration of the nitrogen and oxygen substituents on the cyclohexane 
ring can be either O-N-syn or O-N-trans. Unfortunately, it was found that this determination 
was non-trivial in the present case due the absence of indicating correlations in the 1H-1H-
NOESY data. The compound exhibited hygroscopic properties which prevented a crystalline 
sample to be obtained. Hence, the geometrical configuration, albeit inconsequential for the 
further synthesis, had to remain unassigned. However, a tentative assignment is possible 
based on the analogous compound from the FR901483 synthesis, in which NOESY 
correlation did occur (vide infra), suggesting the geometrical configuration is O-N-trans 
(Figure 18).  
 
Figure 18. Tentative assignment of the geometrical configuration of 598 . 
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One step formation of the natural product 2 from obtained diol 598 would be desirable as it 
provided a synthesis of TAN1251C (2) of unprecedented brevity (4 steps from known alkene 
360). It was reasoned that this task should be achievable via concurrent oxidation of the 
primary and secondary alcohol to their respective carbonyl compounds. This would induce 
intramolecular cyclization of the formed aldehyde with the C1 nitrogen, followed by 
dehydration to form the unusual dienamine moiety, and thus the natural product (2). Notably, 
this synthetic step destroys the chiral center at C4. Crucially, the chosen oxidation conditions 
needed to be compatible with the free methyl amine at C1. Two similar literature examples 
have been reported by Snider[340] and Ciufolini,[262] shown in Scheme 140. 
 
Scheme 140. Snider’s and Ciufolini’s endgame in their syntheses of TAN1251C. 
Snider developed arguably the most important method to date for the oxidative cyclization to 
the TAN1251 scaffold. By using Omura–Sharma–Swern oxidation of 516,[354] the free methyl 
amine is protected under the reaction conditions by in situ formation of the 
trifluoroacetamide. Methanolic potassium carbonate then liberates the amine, which 
immediately condenses under basic conditions. Importantly, this oxidation is carried out while 
the ketone in the molecule is protected as a ketal. Due to the absence of this ketone protection, 
Ciufolini’s attempts of an Omura–Sharma–Swern oxidation of substrate 598 essentially 
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failed, reporting only a 10% yield of the Snider sequence to the natural product. Ciufolini 
accordingly suspected that the starting material is diverted to aldol products, and opted for 
2,2,2-trichloro-ethoxycarbonyl (Troc) protection and subsequent Ley oxidation.[262] 
Deprotection with Cd/Pb then yielded the natural product 2. 
In line with Ciufolini’s findings, attempts to use Snider’s Omura–Sharma–Swern oxidation 
were unsuccessful. Treatment with trifluoroacetic acid anhydride (TFAA), DMSO and 
triethylamine at −78 °C followed by addition of triethylamine and basic work-up yielded a 
complex mixture (Scheme 141).  
 
Scheme 141. Attempted Omura–Sharma–Swern oxidation of 598. 
It was reasoned that an alternative 3-step sequence of protection-oxidation-deprotection as 
pioneered by Ciufolini would be undesirable due to the use of the toxic and potentially 
carcinogenic Cd/Pb couple in the last step of the synthesis. However, when trialing other 
standard oxidation methods such as direct oxidation with Dess-Martin-Periodinane or 
catalytic tetrapropylammonium perruthenate, a large degree of decomposition was obtained, 
most likely due to the unprotected amine intercepting electrophilic intermediate species.  
To this end, a compelling aerobic oxidation developed by Iwabuchi,[373] based on work by 
Stahl,[374] was considered. The method is one of few reported methodologies allowing  
conversion of primary and secondary alcohols to the respective aldehyde/ketone oxidation 
state in the presence of unprotected amines. The method using a 2‐azaadamantane N‐oxyl 
(AZADO, 620)/copper catalysis platform would be uniquely suited for the proposed one-step 
oxidation of diol 598 to the natural product 2. A similar oxidative cyclization was featured in 
Iwabuchi’s seminal work; aminoalcohol 618 was oxidized to imine myosmine (619) with 
AZADO, CuCl, 4,4′-bipyridine (byp) and DMAP in the presence of air at room temperature 
for 2 hours. Using this procedure, bioactive myosmine 619 was obtained by Iwabuchi in 60% 
yield (Scheme 142).  




Scheme 142. Iwabuchi’s aerobic oxidation of amino alcohol 618 to myosmine (619).[373] 
The oxidation of diol 598 was trialed accordingly. In line with seminal work by Stahl,[374] the 
investigation started with 9-azabicyclo[3.3.1]nonane N-oxyl (ABNO) instead of AZADO. To 
our delight, the natural product (+)-TAN1251C (2) was formed (by LC-MS) after stirring a 
mixture of diol 598, ABNO (10 mol%), copper(I) chloride (10 mol%), DMAP (20 mol%) and 
bpy (10 mol%) for two hours at room temperature under air. Purification proved challenging 
and isolation via preparative TLC delivered a low yield of 14% natural product (+)-
TAN1251C (2) (Scheme 143). Despite the low yield, the sample allowed us to confirm the 
identity of the natural product via NMR, IR and mass spectrometry. The data obtained was 
identical with those of the natural product. Importantly, the optical rotation exhibited by the 
fully synthetic natural product sample matched the reported literature,[339] confirming the 
correct absolute stereochemistry and enantiopurity.  
 
Scheme 143. Initial ABNO catalyzed Iwabuchi oxidation of diol 598 to (+)-TAN1251C (2). 
Given the low yield of the transformation, possible causes were investigated. Interestingly, 
1H-NMR of the crude reaction mixture revealed that the enamine product 2 was only present 
in 4% yield, indicating that the product might only be liberated in the work-up. Importantly, 
the intermediate aldehyde was not observed. Different work-up conditions were tested and 
basic aqueous conditions were found to be most suitable. A large degree of highly polar side 
products was observed, including the incomplete oxidation product, with the secondary 
alcohol of diol 598 intact.  
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Furthermore, as reported by Hayes and co-workers for (−)-TAN1251A,[349] purification of 
TAN1251C by silica-based chromatography seemed to incur significant losses of material. It 
was speculated that this behavior might be caused by the dienamine, suggesting that a more 
basic stationary phase would be more desirable. Indeed, better results were obtained with 
aluminium oxide based purification. Notwithstanding the challenges, having implemented 
these changes in conjunction with the use of more active AZADO (620), and a longer reaction 
time to decrease incomplete oxidation, the natural product TAN1251C (2) was obtained in 
24% yield after purification (Scheme 144). Despite its modest yield, the conversion of the N-
unprotected amino diol 598 to the natural product in a single step is unprecedented, avoids the 
use of protecting group manipulations in the synthesis, and is operationally simple. 
Ultimately, the reaction proved to be synthetically valuable, enabling facile access to 
sufficient amounts of 2. 
 
Scheme 144. Optimized Iwabuchi’s[373] conditions for the synthesis of (+)-TAN1251C (2). 
3.3.4 Synthesis of the keto-aldehyde towards FR901483 
With the synthesis of TAN1251C (2) completed, we turned our attention to the synthesis of 
FR901483. Given the divergent approach, the synthesis resumed from the common precursor 
key spirolactam ester 611. Analogous to the initial prenylation in the synthesis of TAN1251C, 
methylation is required at the free phenol on the tyrosine side chain. Treatment of spirolactam 
ester 611 with methyl iodide and cesium carbonate in acetone at 50 °C proceeded smoothly to 
afford the product phenolic methyl ether 609 in 99% yield. The synthesis proceeded with a 
global reduction of phenolic methyl ether 609 with lithium aluminium hydride. Concomitant 
reduction of the ester, ketone, lactam and benzyl carbamate gave amino diol 680. Despite its 
high polarity, amino diol 680 could be efficiently separated in good yields from by-product 
benzyl alcohol via chromatographic purification to afford the product in 89% yield (Scheme 
145).  




Scheme 145. Synthesis of amino diol 588 towards FR901483. 
Although, within the limits of 1H-NMR, a single geometric isomer was obtained, in line with 
the work on TAN1251C, unambiguous determination of the configuration of the secondary 
alcohol in 588 could not be achieved. Subsequent protection of the secondary methylamine to 
the benzyl carbamate 622 was necessary to preclude oxidative condensation towards the 
TAN1251 scaffold during the oxidation of the primary alcohol. The Cbz group was selected 
as its deprotection could occur concomitantly with the hydrogenation step later in the 
synthesis, without the need for a dedicated deprotection step. Accordingly, treatment of 
amino-diol 588 with benzyl chloroformate in the presence of sodium carbonate[375] gave 
smooth conversion to benzyl carbamate 622 (Scheme 146) in 78% yield.  
 
Scheme 146. Synthesis of benzyl carbamate 622 from amino diol 588, or via 3-step sequence from key 
spirolactam ester 611. 
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In an effort to further streamline the synthesis of benzyl carbamate 622, a three-step sequence 
was employed. Methylation of key spirolactam ester 611, followed by lithium aluminium 
hydride reduction, and finally Cbz protection of the crude reaction products required only a 
single chromatographic purification step to afford of benzyl carbamate 622 in 80% yield (3 
steps from 611, Scheme 146). Pleasingly, analysis of benzyl carbamate 622 by 2D-NMR 
revealed spatial correlation in the 1H-1H-NOESY experiment (Figure 19). The data allowed 
the tentative relative assignment of the geometric configuration of the heteroatom substituents 
at the cyclohexane ring fragment as O-N-trans. 
 
 
Figure 19. 1H-1H-NOESY correlation in compound 622, allowing tentative assignment of the geometric isomer 
of the cyclohexane ring as O,N-trans. 
Subsequently, the oxidation of the primary and secondary alcohols in benzyl carbamate 622 
was investigated. It was surprising to find that this supposedly standard operation proved 
challenging. Both oxidation with Dess-Martin-Periodinane and Ley oxidation[376] using 
freshly prepared[377] TPAP (10 mol%) and NMO as stoichiometric oxidant resulted in 
decomposition. While there was a possibility that during these oxidations an aldol reaction 
would be initiated, e.g. though mild Brønsted acid catalysis, aldol products could not be 









Scheme 147. Failed attempts for the oxidation of benzyl carbamate 622. 
In the search for further oxidation conditions, conditions reported by Sorensen for a similar 
intermediate in their synthesis of FR901483 were tested.[261] In this modified Swern-
oxidation, an excess of oxalyl chloride and DMSO is used with N,N-diisopropylethylamine 
(DIPEA) as amine base (Scheme 148).  
 
Scheme 148. Sorensen’s modified Swern oxidation of diol 623.[261] 
Starting from benzyl carbamate 622, the reaction proceeded with a significantly cleaner 
reaction profile than other tested oxidation conditions, and the formation of keto-aldehyde 626 
could be observed by 1H-NMR from the crude reaction mixtures. However, only moderate 
yields were obtained, possibly caused by formation of a side-product. The identity of the side 
product could not be determined with certainty. Initially we suspected the respective methyl 
thiomethyl ether, a common side product in Swern-type oxidations (Scheme 149).[378]  
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Scheme 149. Mechanism for formation of methyl thiomethyl ethers in the Swern reaction. 
The formation of this type of side product is usually caused by exposure of the Swern 
intermediate ylide 624 to temperatures significantly greater than −78 °C, leading to 
cyclization and formation of the respective mixed thioacetal 625. However, conducting the 
reaction on small scale with rigorous temperature control did not improve the obtained yield. 
However, the reaction could be performed on gram-scale in moderate yields with good 
reproducibility. In line with literature observations of stability of similar chiral aldehydes 
towards epimerization by Snider,[252, 275] but also earlier by Garner,[379]  the keto aldehyde 626 
exhibited sufficient stability to be purified via column chromatography and stored at low 
temperature without appreciable decomposition. Under the optimized conditions, Swern-
oxidation of diol 622 afforded key intermediate keto-aldehyde 626 in 61% on gram-scale after 
purification.  
 
Scheme 150. Synthesis of keto aldehyde 626 via modified Swern oxidation.[261] 
3.3.5 Biomimetic aldol-reaction 
With keto-aldehyde 626 in hand, the biomimetic aldol reaction pioneered by Snider,[252] and 
later used in a modified version by Ciufolini[262] and Sorensen,[261] was investigated. 
Selectivity and separation was anticipated to be problematic from literature reports. Relevant 
literature reactions and their obtained products with yields are shown in Scheme 151.  
 




Scheme 151. Possible four diastereomers for the proposed biomimetic aldol reaction with examples of similar 
aldol reaction from previous literature syntheses, and Sniders studies (PMB. para-methoxybenzyl). 
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As shown in Scheme 151, four different stereochemical outcomes (hydroxy ketones 627, 628, 
629, and 630) are possible for the aldol reaction of keto-aldehyde 626 due to (i) two 
enolizable carbons at the ketone (a and b, Scheme 151), and (ii) two possible configurations 
of the resulting C6 secondary alcohol in the aldol product. It has been shown that inherent 
selectivity for the desired diastereomer 628, exhibiting the identical configuration as the 
natural product, is generally low. Thus, only modest isolated yields are usually obtained for 
this diastereomer. The highest yield of a ‘desired’ diastereomer obtained as part of a total 
synthesis is reported by Ciufolini with 44% on a C2 sulfonamide protected lactam substrate 
(633).[262] Intramolecular asymmetric organocatalytic aldol cyclizations[380] were investigated 
by Fukuyama[266] and Reissig,[334] but did not lead to improved selectivities. Ultimately, 
Fukuyama and co-workers employed an acid-catalyzed aldol reaction to promote a different 
stereo-outcome (60% yield), albeit on a scaffold with less substitution.[266] This approach 
however requires subsequent inversion of the resulting C6 alcohol. Additionally to these 
challenges, small changes in the starting keto-aldehyde have been observed to have significant 
effects on the stereochemical outcome, such as reported by Reissig,[334] and Snider.[275] 
Although the planned transformation from the synthesized keto-aldehyde 626 was 
unprecedented, Sorensen’s work is closely similar in having a methylene group in C3 position 
(rather than a lactam), and featuring a carbamate protecting group (Boc) on the C2 nitrogen. 
Sorensen reported an isolated yield of 34% of the desired diastereomer 413 with a total yield 
of aldol products of 74%.  
The hypothesis for the transition state model for the transformation is depicted in Scheme 
152. Empirically, it is known from Snider’s studies that there is a preference for the desired 
carbon (C7, a in Scheme 151) to undergo enolization,[275] presumably due to equatorial 
position of the para-methoxy benzyl group (see Scheme 152, 635 and 636 vs 637). Possible 
factors for the selectivity of the reaction have also been discussed by Ciufolini and co-
workers[259-260] in order to explain the stereochemistry of the transformation.[381] In line with 
literature reports on the mechanistic origin of the diastereoselectivity of the reaction,[252, 259-260, 
266] a 6-membered chair-like transition-state is proposed. Importantly, the para-methoxy 
benzyl group preferably is in the equatorial position, allowing favorable enolization at C7 
(Scheme 152, 635 and 636). Attack of the enolate at the aldehyde closes the central piperidine 
ring. During the attack, the aldehyde can either reside in equatorial (635) or axial (636) 
conformation, determining the configuration of the resulting C6 alcohol in the aldol product, 
to form either the undesired C6-epimer 627, or desired product 628. It has been found that 
under acidic (HOAc, pyrrolidine),[261, 266] or apolar basic conditions, such as KOtBu in toluene 
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(Snider)[275] or DBU in CH2Cl2 (Ciufolini),
[259-260] the C6-epimer 627 is formed with relatively 
high selectivity. This might result from the energetically more favorable equatorial 
conformation of the aldehyde, but also from stabilizing metal chelation, as shown in 635, 
increasing the stability of this undesirable conformation. At the same time, it has been 
detailed by Snider, Sorensen, and Ciufolini that formation of the desired 
diastereoconfiguration, presumably originating from axial aldehyde configuration 636, is 
more favorable in highly polar solvents, such as methanol,[261, 275] aqueous methanol,[262] and  
tBuOH.[252] This might be caused by two factors, (i) the increased solvatization of metal ions, 
reducing their propensity to chelate (and thus makes entering transition state 635 less likely), 
and (ii) stabilization of the native, non-chelated transition state 636 by the solvent due to 
interaction with a larger dipole moment solvent-cage. 
 
Scheme 152. Hypothesis for the transition state of biomimetic aldol reaction. 
Given the literature precedent, the reaction was first trialed in a polar reaction medium, a 
mixture of water and methanol (1:9), using sodium methoxide as a base at room temperature 
(Scheme 153).  
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Scheme 153. Results from the initial study of intramolecular aldol reaction. 
Three diastereomeric products were obtained from the reaction and, pleasingly, isolation via 
preparative thin layer chromatography (TLC) was feasible for each diastereomer. Structural 
elucidation was achieved through 2D-NMR studies of each of the products. 1H-1H-NOESY 
and 1H-1H-ROESY studies were able to give important spatial correlations, on which the final 
structural assignment could be carried out. Interestingly, 1H-1H-NOESY experiments 
exhibited relatively low sensitivity for the compound, a known effect for intermediate sized 
compounds,[382] and in some instances 1H-1H-ROESY experiments gave better results. The 
study was aided by structural assignment using standard COSY, HSQC, HMBC, and TOCSY 
experiments. The results of the 2D-NMR study are summarized in (Figure 20). 
 
Figure 20. NOESY and ROESY correlations of compounds 627, 628 and 629. 
Based on these NMR studies, the structures of all three isolated diastereomers, including the 
desired diastereomer 628 could be confidently assigned. Unexpectedly, and contrary to 
literature precedent, the yield for the desired diastereomer was modest, with 4% isolated by 
preparative TLC. Furthermore, the total isolated yield of all aldol products was low with 45%. 
It was speculated that significant losses of material might have occurred during purification, 
especially for desired diastereomer 628, which exhibited the highest polarity of the three 
compounds. The purification method was subsequently changed to silica flash-column 
chromatography, which improved the obtained total yield of aldol products to 79% (2 steps 
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from diol 622). Encouragingly, this entailed a higher isolated yield of the desired diastereomer 
628 of 23%. Unfortunately, a series of inseparable mixed fractions were also obtained using 
this purification method. It was furthermore determined that the reaction exhibited poor 
reproducibility if crude starting aldehyde 626 was used. To overcome these problems, the 
two-step sequence strategy was abandoned, and isolated aldehyde 626, reasonably stable to 
purification and storage, was used as starting material for the aldol reaction. Moreover, it was 
found that the reaction could be carried out with improved reproducibility if the reaction was 
conducted in anhydrous methanol. After some optimization of the purification procedure, 
preparative TLC remained the purification method of choice, affording isolated yields of 30% 
of 628. In this fashion, significant amounts of desired hydroxy ketone 628 (Scheme 154) were 
routinely produced using this optimized procedure. 
 
Scheme 154. Optimized conditions for the intramolecular aldol reaction.  
With the prospect of uncovering conditions exhibiting superior selectivity, a set of aldol 
conditions was screened. However, due to the complexity of the product mixture, 1H-NMR 
based yield determination could not be employed. Due to high polarity of the hydroxy ketones 
and the extreme sensitivity of their chromatographic properties towards changes in pH and 
concentration, no suitable assay could be developed on HPLC and LC-MS instruments. In 
lieu of a suitable assay, conditions were screened and qualitatively monitored product 
generation via TLC. The results are summarized in Table 8. 
In this study, it was found that the generally favored product, in line with literature findings, 
was C6 epimer hydroxy ketone 627. HMPA was employed as solvent (Table 8, entry 2) in 
order to suppress chelating effects. This indeed changed product distribution but still provided 
diastereomer 627 as the major component of the product mixture. Analogously, 18-crown-6 
was employed with potassium tert-butoxide in order to mask the potassium cation (Table 8, 
entry 4), however with little effect on the product ratio in regards to the same conditions 
without the crown ether (Table 8, entry 3).  
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Table 8. Screen of different aldol conditions and the qualitative tentative product ratios (TLC). a not determined. 
 
Entry Conditions                                     Yield:  627 628 629 630 
1 NaOMe (2 eq.), MeOH, r.t., 1 h -a 30% -a -a 
2 KOtBu (1.2 eq.), HMPA (solvent), r.t., 24 h major minor - - 
3 KOtBu (1.2 eq.), THF, r.t., 1 h, major - minor - 
4 KOtBu (1.2 eq.), 18-crown-6, THF, r.t, 1 h major - minor - 
5 KOtBu (3.0 eq.), HFIP, r.t., 3 h no reaction 
6 Aq. NaOH (10%), HFIP, r.t., 12 h major - - - 
7 DBU (1.2 eq.), DCM, r.t., 1 h major minor minor - 
8 KHMDS (1.2 eq.), THF, -78°C, 1.5 h major - - - 
9 KHMDS (1.2 eq.), HMPA (6 eq.), THF, -78°C, 1.5 h major - - - 
10 DIPEA (1.1 eq.), Bu2BOTf (1.1 eq.), -78°C to 0°C, 2 h complex mixture 
 
In Ciufolini’s synthesis, fluorinated alcoholic solvents were suggested to increase the 
propensity of the solvent to hydrogen-bond. However, hexafluoroisopropanol (HFIP) did not 
give any conversion unless it was thoroughly basified with an excess of aq. sodium hydroxide 
(Table 8, entry 5+6), potentially due to the acidity of HFIP. Treatment with DBU in 
dichloromethane confirmed Ciufolini’s findings[259] for the present substrate (Table 8, entry 
7). Finally, the reaction was attempted under cryogenic temperatures (Table 8, entry 8-10) 
with potassium hexamethyldisilazide (KHMDS), but it was found that predominantly C6-
epimer 627 was formed, with the addition of HMPA ineffective of altering the diastereomeric 
ratio. DIPEA and Bu2BOTf gave decomposition resulting in a complex mixture. 
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3.3.6 Completion of the total synthesis of FR901483 
With significant amounts of hydroxy ketone 628 in hand, and the tricyclic scaffold in place, 
we turned our attention to the completion of the synthesis of the natural product 1. Reduction 
of the C8 ketone has previously been reported to favor the equatorial C8 alcohol, opposite to 
the configuration in the natural product. This preference can be explained by the obstruction 
of the re-face by the concave tricyclic scaffold. Excellent hydrogenative conditions developed 
by Sorensen are available for the selective transformation to the equatorial alcohol,[261] but 
this method could not be applied to hydroxy ketone 628 due to the incompatibility with the 
Cbz group. Ciufolini reported reduction of the ketone with L-selectride, albeit with acetyl 
protection employed on the C6 alcohol and on Ciufolini’s lactam (rather than tertiary amine) 
sulfonamide protected scaffold.[262] Despite the free alcohol and tertiary amine in starting 
material 628, direct reduction of keto aldehyde 628 was attempted with 2.5 equivalents of L-
selectride, taking into account the necessary deprotonation of the C6 alcohol. After 
conventional work up with sodium hydroxide and hydrogen peroxide (at 0 °C), an inseparable 
mixture of products was obtained, which through mass spectrometry were tentatively 
identified as the desired product 404 and its N-oxide 638 (Scheme 155). Despite being 
sterically highly encumbered, brief exposure to hydrogen peroxide seemed incompatible with 
the tertiary amine contained in the substrate.  
 
Scheme 155. Initial studies for the L-selectride reduction of 628. 
However, to confirm the identity of the product, conversion of the N-oxide portion of the 
mixture to the desired product was attempted via treatment with bis(pinacolato)diboron 
(B2pin2). To our delight, the remarkably efficient procedure by Lakshman
[383] converted the 
Chapter Three –Total synthesis of alkaloids FR901483 and TAN1251C 
 
  159 
mixture to single desired product 404 via treatment with an excess of B2pin2 in acetonitrile in 
less than 5 minutes. After purification, a 37% yield of equatorial alcohol 404 was obtained, 
which after analysis proved to be identical to the reported compound from Huang’s work.[269] 
Encouraged by these results, the reduction step was optimized by altering the oxidative work-
up to treatment with sodium hydroxide, allowing isolation of the desired equatorial alcohol 
404 in 77% yield. 
 
Scheme 156. Optimized synthesis of equatorial alcohol 404. 
Next, the inversion of the C8 alcohol was necessary. Sorensen’s efficient Mitsunobu 
conditions[261] allow for inversion and installation of the dibenzyl phosphate ester in a single 
step. We were mindful of the fact that in contrast to the Sorensen synthesis, the reaction was 
conducted in the presence of a carbamate instead of the free C2 amine. The reaction 
proceeded smoothly under the adapted conditions, employing dibenzyl phosphate, tris(4-
chlorophenyl)phosphine, diisopropyl azodicarboxylate (DIAD) and triethylamine in THF, 
affording the desired axial dibenzylphosphate ester 423 in 34% after purification via 
preparative TLC (Scheme 157). 
 
Scheme 157. Synthesis of dibenzyl ester 423. 
The last step of the total synthesis was identical to Snider’s reported hydrogenolysis of the 
dibenzyl phosphate ester and concomitant removal of the benzyl carbamate.[252] The reaction 
was carried out accordingly from 423, with the addition of 1.1 equivalents of hydrochloric 
acid, delivering the natural product (1). Conversion to the to the natural product proceeded as 
planned, and (−)-FR901483 (1) was isolated as the respective hydrochloride salt in 85% yield 
from the reaction mixture without the need of further purification (Scheme 158).  




Scheme 158. Final step of the synthesis affording natural product 1. 
 
Figure 21. a. 1H NMR spectrum (CD3OD, 400 MHz) from the isolation report of FR901483[250]; b. 1H NMR 
spectrum (CD3OD, 500 MHz) of fully synthetic sample of (−)-FR901483 prepared in this work. c. 13C NMR 
spectrum (CD3OD, 100 MHz) from the isolation report of FR901483[250]; d. 13C NMR spectrum (CD3OD, 126 





Chapter Three –Total synthesis of alkaloids FR901483 and TAN1251C 
 
  161 
The fully synthetic sample of  (−)-FR901483 (1) was identical in all respects with the 
spectroscopic data reported in the literature (e.g. see Figure 21). The measured optical rotation 
was near-identical to the reported values (measured [α]D
22 = −10.7 (c = 0.28, MeOH) [lit. 
[α]D
25 = −11 (c = 0.74, MeOH)].[250] It is notable that slow solvolysis of the phosphate ester in 
the natural product was observed in CD3OD solution at room temperature. 
3.3.7 Additional studies 
In a complementing study carried out by Dr A. Trowbridge, the substrate scope of the novel 
multicomponent photocatalytic olefin-hydroaminoalkylation reaction was investigated, 
showing the broad applicability and functional group tolerance of the reaction. Therein, the 
modularity of the method was showcased through facile synthesis of natural product analogue 
4’,4’-difluoro-(+)-TAN1251C from 4,4-difluorocyclohexanone (Figure 22). 
 
Figure 22. Substrate scope study and synthesis of 4’,4’-difluoro-(+)-TAN1251C by Dr A Trowbridge. ◊Reaction 
conducted by Dr A. Trowbridge.  




In summary, this chapter describes the development of an efficient photocatalytic 
multicomponent olefin-hydroaminoalkylation procedure utilizing abundant primary amines, 
in particular amino acids, to generate chiral spirolactam building blocks. The synthesis of key 
spirolactam precursor 611 was developed, from which the total syntheses of both natural 
products FR901483 (1) and TAN1251C (2) were successfully carried out (Scheme 159). 
 
Scheme 159. Synthesis of key spirolactam precursor 611 via primary amine photocatalytic multicomponent 
olefin-hydroaminoalkylation from tyrosine methyl ester 610. 
Commencing from spirolactam 611 (Scheme 160), the total synthesis of TAN1251 began 
with prenylation to generate the phenolic prenyl ether 617. Global reduction of the methyl 
ester, ketone, spirolactam and benzyl carbamate with an excess of lithium aluminium hydride 
in refluxing THF gave rise to diol 598, containing a free methyl amino group at C2. Oxidative 
intramolecular condensation to the dienamine was achieved under Iwabuchi’s aerobic 
oxidation conditions,[373] generating the natural product (+)-TAN1251C (2) directly from diol 
598 in synthetically useful yield.  
 
Scheme 160. Total synthesis of (+)-TAN1251C (2). 
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The synthesis of natural product FR901483 (1) started with methylation of key spirolactam 
611, delivering methyl ether 609, followed by global reduction resulting in diol 588. After 
Cbz protection of the generated C2 methyl amine with benzyl chloroformate, Swern oxidation 
afforded key keto aldehyde 626 (Scheme 161).  
 
Scheme 161. Total synthesis of (−)-FR901483 (1). 
A biomimetic intramolecular aldol reaction, similar as previously explored by Snider,[275] 
furnished hydroxy ketone 628, and two other diastereomers, which were fully characterized in 
a 2D NMR study. The reaction had sufficient selectivity for the desired diastereomer (30% 
yield) to produce significant amounts of material, and completed assembly of the tricyclic 
core structure of the natural product 1 with the C6 alcohol in the correct stereoconfiguration. 
Preliminary studies were conducted to improve the selectivity of the intramolecular aldol 
reaction but no results superior to Snider’s conditions could be obtained. Subsequent 
reduction of the ketone with L-selectride occurred from the open si-face resulting in 
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equatorial C8 alcohol 404. Sorensen’s conditions for an Mitsunobu-type reaction gave 
efficient inversion of the C8 alcohol with concomitant installation of a dibenzylphosphate 
ester delivering 423. In the final step, removal of the benzyl esters and benzyl carbamate via 
hydrogenolysis under acidic conditions yielded the natural product (−)-FR901483 (1) as its 
hydrochloride salt.  
In a complementing study by Dr A. Trowbridge, the broad applicability and functional group 
tolerance of the primary amine photocatalytic multicomponent olefin-hydroaminoalkylation 
has been demonstrated, and the synthesis of natural product analogue 4’,4’-difluoro-(+)-
TAN1251C was achieved. 
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4. Conclusions and Future Outlook 
In the last decade, the field of visible light photoredox chemistry has experienced exponential 
growth and risen to the forefront of synthetic organic chemistry. The emergence of a host of 
novel, valuable light-mediated photoredox transformations has reinvigorated the interest in 
single electron redox and radical chemistry. This development has caused practitioners of 
organic chemistry to move away from the use of hazardous radical initiators, a number of 
toxic reagents, and high temperatures or harmful ultra-violet light.[74] Due to their unique 
properties, the single electron chemistry of amines is intimately connected to the field of 
photoredox chemistry. A wealth of chemical transformations began to exploit these electron-
rich compounds through novel photoredox pathways, and due to the ubiquity of amine 
functionality in biologically active compounds, soon amines surpassed their use as mere 
reductive additives. The functionalization and synthesis of amines through visible light 
photoredox methods has since become a major point of interest for the synthetic community.  
Along these lines, visible light photoredox generated α-amino radicals have proven a uniquely 
useful and versatile synthetic tool for amine synthesis and functionalization. This avenue of 
reactivity has been extensively studied and combined with organocatalysis, transition metal 
catalysis, and Brønsted or Lewis acid catalysis to achieve a plethora of complex 
transformations via addition of the resulting α-amino radical into alkenes, nitrogen-containing 
double bonds or aromatic rings.[119] Most commonly, α-amino radicals are accessed via single 
electron oxidation or fragmentation of redox-active preinstalled groups. In the case of amine 
oxidation, single electron transfer with susceptible amines can lead to the formation of the 
respective radical cation, from which fragmentation can occur to directly afford the desired α-
amino radicals. Problematically, the fragmentation is inherently unselective and only gives 
poor control over the site of radical generation. On the other hand, α-silylamines, redox active 
esters and carboxylic acids are common examples for preinstalled functional groups which 
have been used heavily to induce radical generation in α-amine position.  
The uncommon reductive generation of α-amino radicals from the respective C=N double 
bonds is regiospecific, does not require prefunctionalization and is convergent. This desirable 
process, however, is hampered by high reduction potentials of alkyl iminium ions, 
interference of the respective enamines, and the generally poor outcome of additions of 
reductively generated α-amino radicals to radical acceptors. These factors rendered reductive 
α-amino radical generation both underexploited and underappreciated in chemical synthesis. 
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Prior to the work detailed in this thesis, only a single example of a visible light photoredox 
reduction of an all-alkyl iminium ion was reported in literature.[205]  
Overcoming these limitations, a general visible light photoredox reduction of all-alkyl 
iminium ions for the synthesis of complex tertiary amines was developed.[249] The 
multicomponent photocatalytic olefin-hydroaminoalkylation approach enables the union of 
amines, aldehydes and electron deficient olefins to furnish pharmaceutically relevant complex 
tertiary amine products via the single-electron reduction of an in situ formed iminium ion. The 
reaction proceeds under mild conditions, exhibits broad substrate scope, and is 
environmentally benign. Preliminary mechanistic studies revealed an enabling 1,5-HAT 
process and an unprecedented redox relay of iminium ions. An expansion of the methodology 
enabled the use of dialkylamines and alkylenamines as starting materials in the reaction, 
giving access to a series of α-tertiary amine products, an important substance class in 
bioactive natural compounds.[241]  
Although the biosynthetically related (−)-FR901483 and (+)-TAN1251C alkaloids have 
attracted significant attention from the synthetic community in the last 20 years due to their 
biological activity and architecturally complex structures. The concise construction of the 
amino-substituted, α-tertiary amine containing, azaspirocyclic scaffold of these natural 
products remains a formidable synthetic challenge. In line with the previous work, a variant of 
the photocatalytic olefin-hydroaminoalkylation methodology was developed, employing 
primary amines and ketones to specifically target α-tertiary amine products. The new 
methodology was identified to give rapid access to a series of chiral spirolactam building 
blocks, including a chiral spirolactam precursor, which served as starting point for a 
divergent, enantiocontrolled total synthesis strategy accessing both immunosuppressant (−)-
FR901483 and muscarinic antagonist (+)-TAN1251C. Demonstrating the utility of the olefin-
hydroaminoalkylation approach, the reaction was optimized to access the common 
spirolactam precursor on gram-scale with only a simple filtration as the single purification 
step. From this advanced precursor, both total syntheses of (−)-FR901483 and (+)-TAN1251C 
were completed significantly more rapid and efficient than previously reported in the 
literature. The novel multicomponent approach furthermore enables a modular synthetic 
strategy for the facile construction of chiral 3-amino-1-azaspiro[4.5]decane fragments. This 
modularity can significantly facilitate the generation of derivatives or library of these, 
previously elusive structural motives.  
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A possible future expansion of the photocatalytic olefin-hydroaminoalkylation could be 
achieved via enantioselective control over the generated α-amino stereocenter. A potentially 
valuable avenue to realizing this aim could be taken by investigating the face preference of 
attack on the radical acceptor by using chiral Lewis acid catalysis (Scheme 162). Similarly to 
a method reported by Yoon an co-workers,[132] enantioselective conjugate addition may be 
achieved by activation of a acryloyl dimethylpyrazolidin-3-one 647 with a lanthanide triflate 
complex aided by a suitable Pybox ligand 648, potentially leading to enantiomerically 
enriched tertiary amine products 649. 
 
Scheme 162. Concept for an enantioselective conjugate α-amino radical addition via Lewis acid catalysis. 
The primary amine variant of the olefin-hydroaminoalkylation generates the deceptively 
simple 1-azaspiro[4.5]decane structure, present in a large number of bioactive natural 
compounds.  Further development of the radical acceptor by modulating the pivotal stability 
of the resulting alkyl radical may allow for a general method for the generation of these 
scaffolds without the incorporation of the chiral 3-amino group. This approach may enable the 
total synthesis of Lycopodium (lycojaponicumins) and Clavelina (cylindricines and 
lepadiformines) alkaloids (Figure 23), which are renowned for their unique molecular 
architectures and potent bioactive properties.  
In conclusion, the two multicomponent photocatalytic olefin-hydroaminoalkylation 
methodologies detailed in the present thesis are of significant interest for chemical synthesis 
due to their utility, operational simplicity and environmentally benign conditions. They grant 
access to a number of challenging tertiary amine products, as well as previously elusive α-
tertiary amines and chiral spirolactam precursors. In line with the herein described rapid 
synthesis of two natural products featuring the important 1-azaspiro[4.5]decane core 
fragment, (−)-FR901483 and (+)-TAN1251C, further development of the olefin-
hydroaminoalkylation could significantly facilitate access to a number of architecturally 
challenging bioactive natural products.  




Figure 23. Selection of alkaloids featuring the 1-azaspiro[4.5]decane core. 
Finally, it is hoped that the described, facile reductive generation of alkyl-substituted α-amino 
radicals from alkyl iminium ions, and their use towards the synthesis of increasingly complex 
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5. Experimental Section 
5.1 Materials and Methods 
All reactions were run under an inert atmosphere (N2) unless otherwise stated, with oven-
dried glassware, using standard techniques. Anhydrous solvents were obtained from solvent 
stills (Et2O and THF was distilled from LiAlH4; MeCN, dichloromethane, hexane and toluene 
from CaH2). Dichloromethane for use in the photocatalytic reaction in Chapter 2 was dried 
using 4Å MS (beads), degassed (freeze-pump-thaw) and stored in a Schlenk flask under N2. 
No appreciable deterioration in yield was observed after use for 3 months. Anhydrous 
dichloromethane for the photocatalytic reaction in Chapter 3 was used as described without 
further drying or degassing. Identical results were obtained using commercial anhydrous 
dichloromethane (Acros Organics, 348461000). Commercially available activated powdered 
4Å molecular sieves (MS) were used as supplied (Alfa Aesar, A11535). Ir(ppy)3 was obtained 
from Sigma-Aldrich and used as supplied. Hantzsch ester was obtained from Matrix Scientific 
and used without further purification. All other commercial reagents were used as supplied 
unless otherwise stated.  
Irradiation of the reaction mixture was achieved using 40 W Kessil A160WE LED – Tuna 
Blue lights (setup: max blue, max intensity). Two lamps were used for larger scale 
experiments as specified. Small scale reactions were carried out in clear glass vials (4 mL) 
with PTFE/silicon septum lined screw caps (VWR, 548-0521). The Kessil lamps were 
positioned 5 cm from the reaction vessel, with a desk-fan provided for cooling. 
Analytical thin-layer chromatography (TLC) was performed on Merck Kieselgel 60 F254 
0.20 mm precoated, glass backed silica gel plates. Visualization of the developed 
chromatogram was performed by UV absorbance (λmax = 254 nm), and/or by using aq. 
KMnO4 TLC stain solution. Preparative thin-layer chromatography was performed on Merck 
PLC Silica gel 60 F254 1 mm plates using visualization by UV absorbance (λmax = 254 nm). 
Flash column chromatography was performed using silica gel (Merck Geduran Si 60 [40-63 
μm]) or aluminium oxide (EMD Millipore aluminium oxide 90, standardized) as specified 
with the indicated solvent system.  
Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker DPX 400 or DPX 500 
spectrometer, generally equipped with a cryoprobe. Data is reported as follows: chemical shift 
[integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, quint = quintet, sext 
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= sextet, spt = septet, m = multiplet, br = broad), coupling constant and molecular 
assignment]. Coupling constants (J) are quoted to the nearest 0.1 Hz. Chemical shifts (δ) for 
1H NMR spectra are recorded in ppm from Me4Si with the solvent resonance as the internal 
standard (CDCl3 = 7.26 ppm, DMSO-d6 = 2.50, CD3OD = 3.31 ppm, C6D6 = 7.16 ppm, 
CD3CN = 1.94 ppm). 
13C NMR spectra are reported in ppm from Me4Si with the solvent 
resonance as the internal standard (CDCl3 = 77.16 ppm, DMSO-d6 = 39.52, CD3OD = 49.00 
ppm, C6D6 = 128.06 ppm, CD3CN = 118.26 ppm). 
19F NMR spectra are reported in ppm from 
CFCl3 and are uncorrected. 
35P NMR spectra are reported in ppm from 85% H3PO4 and are 
uncorrected. Where applicable, assignment was carried out using DEPT135 and 2-
dimensional experiments (COSY, TOCSY, HMBC, HMQC, NOESY, ROESY). Atom 
numbering for assignment is provided for each assigned compound individually. 
Stern-Volmer quenching was performed using a Shimadzu RF-6000 spectrofluorometer. 
Experiments were recorded using a quartz cell equipped with septa-lined screw cap under Ar.  
UV-Vis analysis was performed on a Shimadzu UV-1800 spectrophotometer.  
Infrared spectra (FT-IR) were recorded using a Perkin-Elmer Paragon 1000 Fourier transform 
Spectrometer equipped with ATR, with absorption maxima (𝜈max) being quoted in 
wavenumbers (cm-1) and characteristic peaks being defined (br = broad). High Resolution 
Mass spectrometry (HRMS) was carried out on a Waters XEVO GII-S Q-TOF equipped with 
an ESI probe, by the Mass Spectrometry Service of the Department of Chemistry, University 
of Cambridge, and by ESPRC Mass Spectrometry Service at the University of Swansea using 
an LTQ Orbitrap XL spectrometer with positive ion nano-electrospray. Melting points (m.p.) 
were recorded using a Gallenkamp melting point apparatus and are reported uncorrected.  
Optical rotations were measured on a Perkin Elmer 343 Polarimeter and a Anton Paar MCP 
100 Polarimeter, using a sodium lamp (λ 589 nm, D-line). [α]D values (sodium D line) are 
reported at a given temperature (°C) in deg cm2 g
−1 with concentration (c) reported in g / 100 
mL. Chiral HPLC analysis was performed on a Shimadzu XR-LC apparatus with Chiralpak® 
columns in a mixed solvent system of n-hexane and iso-propanol. X-ray crystallography was 
performed by Dr Andrew Bond on a Bruker D8-QUEST PHOTON-100 diffractometer using 
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5.2 Experimental procedures 
5.2.1 Photocatalytic olefin-hydroaminoalkylation 
General Procedure A: Photocatalytic olefin-hydroaminoalkylation 
 
A 4 mL PTFE/Silicone-lined septa screw cap (PP) clear glass vial equipped with magnetic 
stirrer bar (10 mm, cylindrical) was charged with all solid reagents [typically Ir(ppy)3, 4Å MS 
and Hantzsch ester] under air. The vial was sealed and a needle was inserted through the septa 
and the contents evacuated/backfilled with N2 (3 cycles). Anhydrous dichloromethane was 
added followed by the remaining liquid reagents [typically dialkylamine, aldehyde, acceptor 
and propanoic acid] using a micro-syringe. The vial was sealed with additional parafilm™ 
and secured upon an upturned crystallizing basin using double-sided tape, in the center of a 
stirrer/hotplate. The Kessil lamp was positioned 5 cm from the vial along with a desk-fan for 
cooling. The vial was irradiated for a period of 2 hours with vigorous stirring (600-800 rpm), 
over which time the color of the reaction mixture (under light) typically turned from dark 
red/brown to bright yellow, indicating the consumption of the Hantzsch ester and completion 
of the reaction. Upon completion, the reaction mixture was analyzed by TLC and either 
directly loaded onto the column (in the case of dichloromethane/Et3N as an eluent) or filtered 
and the solvent removed in vacuo for purification using EtOAc/P.E. as an eluent. For non-
polar compounds purified by flash column chromatography using dichloromethane/Et3N as an 
eluent, the product regularly co-elutes with either the Ir(ppy)3 photocatalyst and/or the starting 
aldehyde. In this instance the column fractions were combined, the solvent removed in vacuo 
and the residue dried under hi-vac. The residue was dissolved in P.E. (Ir(ppy)3 insoluble) and 
filtered over celite® to afford the pure product. For non-volatile aldehydes, the product can be 
obtained either by purification using an SCX cartridge or acid/base workup.   
From enamines: The amine and aldehyde components can be replaced by the preformed 
enamine.  
From amine hydrochloride salts: If amine hydrochloride salts are used, one equivalent of 
triethylamine was added to the reaction prior to irradiation.  
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General Procedure B: Photocatalytic olefin-hydroaminoalkylation using paraformaldehyde 
The reaction is conducted as in General Procedure A, but solid paraformaldehyde (5 equiv) is 
used as the carbonyl component, and the reaction is heated in an oil bath at 45 °C for 1 h in 
the dark (covered in aluminium foil) prior to irradiation. 
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butyl 4-(dibenzylamino)heptanoate (348a) 
 
Prepared according to general procedure A using dibenzylamine (39 µL, 0.2 mmol), 
butyraldehyde (20 µL, 0.22 mmol), n-butyl acrylate (32 µL, 0.22 mmol), ethyl-Hantzsch Ester 
(76 mg, 0.3 mmol), 4Å MS (100 mg), propanoic acid (3 µL, 40 µmol) and fac-Ir(ppy)3 (1.4 
mg, 2 µmol) in anhydrous degassed dichloromethane (2 mL). The crude reaction mixture was 
purified by flash column chromatography (0.5% Et3N in dichloromethane) to afford the 
product as a colorless oil (64 mg, 84%). Rf  (5% EtOAc in P.E.): 0.21; IR max/cm
-1 (film): 
3027, 2957, 2932, 2870, 1732, 1602, 1494, 1453, 1360, 1244, 1170, 1141, 1072, 951, 744, 
697. 1H NMR (400 MHz, CDCl3) : 7.40 – 7.18 (10 H, m, H14,15,16), 4.07 – 3.96 (2 H, m, H8), 
3.69 (2 H, d, J = 13.7 Hz, H12a), 3.49 (2 H, d, J = 13.7 Hz, H12b), 2.56 – 2.43 (2 H, m, H6a,4), 
2.33 – 2.23 (1 H, m, H6b), 1.89 – 1.78 (1 H, m, H5a), 1.75 – 1.64 (2 H, m, H5b,3a), 1.63 – 1.54 
(2 H, m, H9), 1.44 – 1.32 (4 H, m, H2,10), 1.28 – 1.16 (1 H, m, H3b), 0.96 (3 H, t, J = 7.4 Hz, 
H11), 0.89 (3 H, t, J = 7.4 Hz, H1); 13C NMR (101 MHz, CDCl3) : 174.1 (C7), 140.4 (C13), 
128.9 (C14), 128.1 (C15), 126.7 (C16), 64.1 (C8), 56.5 (C4), 53.3 (C12), 31.8 (C6), 30.9 (C3), 
30.7 (C9), 25.5 (C5), 20.4 (C2), 19.2 (C10), 14.3 (C1), 13.8 (C11). m/z HRMS found [M + H]
+ 
382.2739, C25H36NO2
+ requires 382.2741. 
1-butyl 7-methyl 4-(dibenzylamino)heptanedioate (348b) 
 
Prepared according to general procedure A using dibenzylamine (39 µL, 0.2 mmol), methyl 4-
oxobutanoate (23 µL, 0.22 mmol), n-butyl acrylate (32 µL, 0.22 mmol), ethyl- Hantzsch Ester 
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(76 mg, 0.3 mmol), 4Å MS (100 mg), propanoic acid (3 µL, 40 µmol) and fac-Ir(ppy)3 (1.4 
mg, 2 µmol) in anhydrous degassed dichloromethane (2 mL). The crude reaction mixture was 
purified by flash column chromatography (1% EtOAc in dichloromethane) to afford the 
product as a colorless oil (50 mg, 59%). Rf (10% EtOAc in heptane): 0.44; IR max/cm
-1 
(film): 3028, 2958, 2872, 1731, 1453, 1362, 1171, 1117, 1074, 1027, 952, 745, 697. 1H NMR 
(500 MHz, CDCl3) : 7.35 – 7.18 (10 H, m, H15,16,17), 4.06 – 3.95 (2 H, m, H9), 3.60 (3 H, s, 
H1), 3.57 (4 H, s, H13), 2.47 – 2.34 (3 H, m, H3/7a,5), 2.33 – 2.26 (2 H, m, H3/7b), 1.99 – 1.88 (2 
H, m, H4/6a), 1.64 –1.53 (4 H, m, H4/6b,10), 1.36 (2 H, sext, J = 7.7 Hz, H11), 0.93 (3 H, t, J = 
7.5 Hz, H12); 13C NMR (126 MHz, CDCl3) : 174.2 (C2/8), 173.8 (C2/8), 140.1 (C14), 129.0 
(C15), 128.3 (C16), 126.9 (C17), 64.4 (C9), 56.4 (C5), 53.3 (C14), 51.6 (C1), 31.8 (C3/7), 31.6 




+ requires 425.2561. 
 
butyl 7-((tert-butyldimethylsilyl)oxy)-4-(dibenzylamino)heptanoate (348c) 
 
Prepared according to general procedure A using dibenzylamine (39 µL, 0.2 mmol), 4-((tert-
butyldimethylsilyl)oxy)butanal (45 mg, 0.22 mmol), n-butyl acrylate (32 µL, 0.22 mmol), 
ethyl- Hantzsch Ester (76 mg, 0.3 mmol), 4Å MS (100 mg), propanoic acid (3 µL, 40 µmol) 
and fac-Ir(ppy)3 (1.4 mg, 2 µmol) in anhydrous degassed dichloromethane (2 mL). The crude 
reaction mixture was purified by flash column chromatography (1% EtOAc in P.E.) to afford 
the product as a colorless oil (82 mg, 81%). Rf (20% EtOAc in P.E.): 0.64; IR max/cm
-1 
(film): 3029, 2954, 2928, 2856, 1732, 1494, 1454, 1360, 1252, 1167, 1094, 1027, 939, 833, 
774, 742, 697. 1H NMR (400 MHz, CDCl3) : 7.40 – 7.21 (10 H, m, H17,18,19), 4.07 – 3.98 (2 
H, m, H11), 3.70 (2 H, d, J = 14.0 Hz, H15a), 3.66 – 3.56 (2 H, m, H4), 3.52 (2 H, d, J = 14.0 
Hz, H15b), 2.55 – 2.45 (2 H, m, H7,9a), 2.35 – 2.25 (1 H, m, H9b), 1.94 – 1.76 (2 H, m, H6a,8a), 
1.75 – 1.66 (1 H, m, H8b), 1.65 – 1.50 (4 H, m, H5,12), 1.40 (2 H, sext, J = 7.8 Hz, H13), 1.35 – 
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1.24 (1 H, m, H6b), 0.97 (3 H, t, J = 7.4 Hz, H14), 0.95 (9 H, s, H1), 0.09 (6 H, s, H3); 13C 
NMR (101 MHz, CDCl3) : 174.0 (C10), 140.3 (C16), 128.9 (C17), 128.2 (C18), 126.8 (C19), 
64.2 (C11), 63.1 (C4), 56.7 (C7), 53.3 (C15), 31.8 (C9), 30.7 (C12), 30.6 (C5), 26.0 (C1), 25.4 




+ requires 512.3560. 
 
butyl 4-(dibenzylamino)-5-methylhexanoate (348l) 
 
Prepared according to general procedure A using dibenzylamine (39 µL, 0.2 mmol), 
isobutyraldehyde (20 µL, 0.22 mmol), n-butyl acrylate (32 µL, 0.22 mmol), ethyl- Hantzsch 
Ester (76 mg, 0.3 mmol), 4Å MS (100 mg), propanoic acid (3 µL, 40 µmol) and fac-Ir(ppy)3 
(1.4 mg, 2 µmol) in anhydrous degassed dichloromethane (2 mL). The crude reaction mixture 
was purified by flash column chromatography (1% EtOAc in P.E.) to afford the product as a 
colorless oil (47 mg, 62%). Rf (20% EtOAc in P.E.): 0.77; IR max/cm
-1 (film): 3063, 3029, 
2958, 2872, 1731, 1602, 1494, 1453, 1360, 1257, 1173, 1103, 1070, 1027, 954, 744, 697. 1H 
NMR (400 MHz, CDCl3) : 7.40 – 7.20 (10 H, m, H13,14,15), 4.11 – 4.01 (2 H, m, H7), 3.74 (2 
H, d, J = 13.6 Hz, H11a), 3.64 (2 H, d, J = 13.6 Hz, H11b), 2.57 – 2.47 (1 H, m, H5a), 2.36 – 
2.24 (2 H, m, H3,5b), 2.13 – 2.02 (1 H, m, H2), 1.97 – 1.84 (1 H, m, H4a), 1.76 – 1.66 (1 H, m, 
H4b), 1.65 – 1.57 (2 H, m, H8), 1.47 – 1.35 (2 H, m, H9), 1.03 – 0.92 (9 H, m, H1,10); 13C NMR 
(101 MHz, CDCl3) : 174.1 (C6), 140.4 (C12), 129.0 (C13), 128.1 (C14), 126.7 (C15), 64.2 (C7), 
61.9 (C3), 54.2 (C11), 32.7 (C5), 30.7 (C8), 28.2 (C2), 22.2 (C4), 22.1 (C1a), 19.9 (C1b), 19.2 
(C9), 13.8 (C10). m/z HRMS found [M + H]
+
 382.2742, C25H36NO2
+ requires 382.2741. 
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butyl 4-cyclohexyl-4-(dibenzylamino)butanoate (348m) 
 
Prepared according to general procedure A using dibenzylamine (39 µL, 0.2 mmol), 
cyclohexanecarboxaldehyde (48 µL, 0.40 mmol), n-butyl acrylate (57 µL, 0.40 mmol), 
methoxyethyl- Hantzsch Ester (94 mg, 0.3 mmol), 4Å MS (100 mg), propanoic acid (3 µL, 40 
µmol) and fac-Ir(ppy)3 (1.4 mg, 2 µmol) in anhydrous degassed dichloromethane (2 mL). The 
crude reaction mixture was purified by flash column chromatography (0.5% Et3N in 
dichloromethane) to afford the product as a colorless oil (60 mg, 71%). Rf (10% EtOAc in 
P.E.): 0.27; IR max/cm
-1 (film): 3063, 3028, 2924, 2851, 1732, 1602, 1494, 1452, 1261, 1167, 
1112, 1070, 1027, 958, 744, 697. 1H NMR (500 MHz, CDCl3) : 7.36 – 7.17 (10 H, m, 
H15,16,17), 4.06 – 3.97 (2 H, m, H9), 3.66 (2 H, d, J = 13.7 Hz, H13a), 3.60 (2 H, d, J = 13.7 Hz, 
H13b), 2.49 – 2.40 (1 H, m, H7a), 2.30 – 2.16 (2 H, m, H5,7b), 1.93 – 1.78 (2 H, m, H3a,6a), 
1.76 – 1.62 (6 H, m, H1a,2a,2'a,3'a,5,6b), 1.58 (2 H, quint, J = 7.3 Hz, H10), 1.36 (2 H, sext, J = 7.5 
Hz, H11), 1.31 – 1.18 (2 H, m, H2b,2'b), 1.16 – 0.97 (3 H, m, H1b,3b,3'b), 0.93 (3 H, t, J = 7.5 Hz, 
H12); 13C NMR (125.8 MHz, CDCl3) : 174.2 (C8), 140.6 (C14), 129.1 (C15), 128.2 (C16), 
126.8 (C17), 64.3 (C9), 61.8 (C5), 54.4 (C13), 38.8 (C4), 33.1 (C7), 32.1 (C3), 30.8 (C10), 30.7 
(C3'), 27.0 (C2), 26.8 (C2'), 26.7 (C1), 22.6 (C6), 19.3 (C11), 13.9 (C12). m/z HRMS found [M + 
H]+ 422.3060, C28H40NO2
+ requires 422.3059. 
tert-butyl 4-(4-butoxy-1-(dibenzylamino)-4-oxobutyl)piperidine-1-carboxylate (348n) 
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Prepared according to general procedure A using dibenzylamine (39 µL, 0.2 mmol), 1-Boc-
piperidine-4-carboxaldehyde (85 mg, 0.40 mmol), n-butyl acrylate (57 µL, 0.40 mmol), 
methoxyethyl-Hantzsch Ester (94 mg, 0.3 mmol), 4Å MS (100 mg), propanoic acid (3 µL, 40 
µmol) and fac-Ir(ppy)3 (1.4 mg, 2 µmol) in anhydrous degassed dichloromethane (2 mL). The 
crude reaction mixture was purified by flash column chromatography (0.5% Et3N in 
dichloromethane) to afford the product as a colorless oil (73 mg, 70%). Rf (20% EtOAc in 
P.E.): 0.22; IR max/cm
-1 (film): 2930, 2853, 1731, 1688, 1452, 1421, 1364, 1245, 1162, 1069, 
1027, 961, 869, 746, 698. 1H NMR (400 MHz, CDCl3) : 7.39 – 7.20 (10 H, m, H17,18,19), 
4.13 (2 H, br s, H4a), 4.08 – 4.00 (2 H, m, H11), 3.67 (4 H, s, H15), 2.68 (2 H, br t, J = 11.3 Hz, 
H4b), 2.50 – 2.40 (1 H, m, H9a), 2.38 – 2.24 (2 H, m, H7,9b), 2.01 – 1.91 (1 H, m, H8a), 1.87 (1 
H, br d, J = 12.0 Hz, H5a), 1.83 – 1.66 (2 H, m, H6,8b), 1.65 – 1.56 (3 H, m, H5'a,12), 1.48 (9 H, 
s, H1), 1.40 (2 H, sext, J = 7.5 Hz, H13), 1.28 – 1.08 (2 H, m, H5b,5'b), 0.97 (3 H, t, J = 7.4 Hz, 
H14); 13C NMR (101 MHz, CDCl3) : 173.7 (C10), 154.8 (C3), 140.0 (C16), 128.9 (C17), 128.2 
(C18), 126.9 (C19), 79.3 (C2), 64.3 (C11), 61.0 (C7), 54.3 (C15), 44.0 (br s, C4), 37.9 (C6), 32.9 
(C9), 30.69 (C5), 30.68 (C12), 29.7 (br s, C5'), 28.5 (C1), 22.4 (C8), 19.2 (C13), 13.8 (C14). m/z 
HRMS found [M + H]+ 523.3522, C32H47N2O4
+ requires 523.3522. 
 
butyl 4-(dibenzylamino)-4-(tetrahydro-2H-pyran-4-yl)butanoate (348o) 
 
Prepared according to general procedure A using dibenzylamine (39 µL, 0.2 mmol), 
tetrahydro-2H-pyran-4-carbaldehyde (45.6 mg, 0.40 mmol), n-butyl acrylate (57 µL, 0.40 
mmol), methoxyethyl-Hantzsch Ester (94 mg, 0.3 mmol), 4Å MS (100 mg), propanoic acid 
(3 µL, 40 µmol) and fac-Ir(ppy)3 (1.4 mg, 2 µmol) in anhydrous degassed dichloromethane (2 
mL). The crude reaction mixture was purified by flash column chromatography (0.5% Et3N in 
dichloromethane) to afford the product as a colorless oil (67 mg, 79%). Rf (20% EtOAc in 
P.E.): 0.42; IR max/cm
-1 (film): 3029, 2955, 2843, 1730, 1602, 1494, 1453, 1361, 1264, 1238, 
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1171, 1115, 1094, 1027, 966, 823, 733, 697. 1H NMR (400 MHz, CDCl3) : 7.35 – 7.16 (10 
H, m, H14,15,16), 4.02 (2 H, dt, J = 2.1, 6.8 Hz, H8), 3.99 – 3.91 (2 H, m, H1a,1'a), 3.67 (2 H, d, J 
= 13.7 Hz, H12a), 3.63 (2 H, d, J = 13.7 Hz, H12b), 3.42 – 3.33 (2 H, m, H1b,1'b), 2.48 – 2.39 (1 
H, m, H6a), 2.35 – 2.22 (2 H, H4,6b), 1.97 – 1.81 (2 H, m, H5a,3), 1.81 – 1.74 (1 H, m, H2a), 1.73 
– 1.63 (1 H, m, H5b), 1.58 (2 H, quint, J = 6.9 Hz, H9), 1.54 – 1.47 (1 H, m, H2b), 1.44 – 1.29 
(4 H, m, H2'a,2'b,10), 0.93 (3 H, t, J = 7.4 Hz, H11); 13C NMR (101 MHz, CDCl3) : 173.8 (C7), 
140.0 (C13), 128.9 (C14), 128.2 (C15), 126.9 (C16), 68.4 (C1), 68.1 (C1'), 64.3 (C8), 61.1 (C4), 
54.2 (C12), 36.9 (C3), 32.9 (C6), 31.7 (C2), 30.8 (C2'), 30.7 (C9), 22.4 (C5), 19.2 (C10), 13.8 
(C11). m/z HRMS found [M + H]
+
  424.2849, C27H38NO3
+ requires 424.2852.  
 
tert-butyl 3-(4-butoxy-1-(dibenzylamino)-4-oxobutyl)azetidine-1-carboxylate (348p) 
 
Prepared according to general procedure A using dibenzylamine (39 µL, 0.2 mmol), 1-Boc-
azetidine-3-carboxaldehyde (74 mg, 0.4 mmol), n-butyl acrylate (57 µL, 0.4 mmol), 
methoxyethyl-Hantzsch Ester (94 mg, 0.3 mmol), 4Å MS (100 mg), propanoic acid (3 µL, 40 
µmol) and fac-Ir(ppy)3 (1.4 mg, 2 µmol) in anhydrous degassed dichloromethane (2 mL). The 
crude reaction mixture was purified by flash column chromatography (0.5% Et3N in 
dichloromethane) to afford the product as a colorless oil (63 mg, 64%). Rf (20% EtOAc in 
P.E.): 0.29; IR max/cm
-1 (film): 2960, 2881, 1695 (br), 1453, 1391, 1365, 1253, 1134, 939, 
859, 748, 699. 1H NMR (400 MHz, CDCl3) : 7.37 – 7.21 (10 H, m, H16,17,18), 4.09 – 3.98 (3 
H, m, H4a,10), 3.93 (1 H, t, J = 7.7 Hz, H4b), 3.88 – 3.77 (1 H, m, H4c), 3.70 – 3.61 (3 H, m, 
H4d,14a), 3.51 (2 H, d, J = 13.6 Hz, H14b), 2.94 – 2.82 (1 H, m, H5), 2.81 – 2.72 (1 H, m, H6), 
2.52 – 2.42 (1 H, m, H8a), 2.37 – 2.26 (1 H, m, H8b), 1.97 – 1.95 (1 H, m, H7a), 1.71 – 1.53 (3 
H, m, H7b,11), 1.45 (9 H, s, H1), 1.39 (2 H, sext, J = 7.6 Hz, H12), 0.96 (3 H, t, J = 7.6 Hz, H13);
 
13C NMR (101 MHz, CDCl3) : 173.4 (C9), 156.2 (C3), 139.6 (C15), 128.9 (C16), 128.3 (C17), 
127.1 (C18), 79.3 (C2), 64.4 (C10), 59.3 (C6), 54.2 (C14), 53.2 (br s, C4), 31.6 (C8), 30.7 (br s, 
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+ requires 495.3217. 
 
butyl 4-(dibenzylamino)-4-(3,3-difluorocyclobutyl)butanoate (348q) 
 
Prepared according to general procedure A using dibenzylamine (39 µL, 0.2 mmol), 3,3-
difluorocyclobutane-1-carbaldehyde (48 mg, 0.4 mmol), n-butyl acrylate (57 µL, 0.4 mmol), 
methoxyethyl-Hantzsch Ester (94 mg, 0.3 mmol), 4Å MS (100 mg), propanoic acid (3 µL, 40 
µmol) and fac-Ir(ppy)3 (1.4 mg, 2 µmol) in anhydrous degassed dichloromethane (2 mL). The 
crude reaction mixture was purified by flash column chromatography (0.5% Et3N in 
dichloromethane) to afford the product as a colorless oil (69 mg, 80%). Rf (20% EtOAc in 
P.E.): 0.47; IR max/cm
-1 (film): 3029, 2958, 1731, 1494, 1454, 1374, 1294, 1238, 1169, 1123, 
1072, 1027, 900, 746, 699. 1H NMR (400 MHz, CDCl3) : 7.41 – 7.22 (10 H, m, H14,15,16), 
4.11 – 3.97 (2 H, m, H8), 3.72 (2 H, d, J = 13.5 Hz, H12a), 3.57 (2 H, d, J = 13.5 Hz, H12b), 
2.81 – 2.68 (1 H, m, H2a), 2.66 – 2.54 (2 H, m, H2'a,4), 2.54 – 2.31 (4 H, m, H2b,6a,6b,3), 2.30 – 
2.15 (1 H, m, H2'b), 1.91 – 1.80 (1 H, m, H5a), 1.70 – 1.57 (3 H, m, H5b,9), 1.40 (2 H, sext, J = 
7.5 Hz, H10), 0.97 (3 H, t, J = 7.5 Hz, H11); 13C NMR (101 MHz, CDCl3) : 173.5 (C7), 139.7 
(C13), 128.8 (C14), 128.3 (C15), 127.1 (C16), 119.7 (dd, J = 269.1, 287.4 Hz, C1), 64.4 (C8), 
60.7 (C4), 54.1 (C12), 40.3 (dd, J = 21.3, 23.1 Hz, C2), 39.7 (dd, J = 21.2, 23.4 Hz, C2'), 31.6 
(C6), 30.7 (C9), 25.5 (dd, J = 2.7, 14.3 Hz, C3), 23.7 (C5), 19.2 (C10), 13.7 (C11); 19F [1H] 
NMR (376 MHz, CDCl3) : −80.7 (d, J = 192.6 Hz), −101.1 (d, J = 192.2 Hz).  m/z HRMS 
found [M + H]+  430.2556, C26H34F2NO2
+ requires 430.2558. 
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butyl 4-(dibenzylamino)-6-phenylhexanoate (348v) 
 
Prepared according to general procedure A using dibenzylamine (39 µL, 0.2 mmol), 3-
phenylpropionaldehyde (29 µL, 0.22 mmol), n-butyl acrylate (32 µL, 0.22 mmol), ethyl- 
Hantzsch Ester (76 mg, 0.3 mmol), 4Å MS (100 mg), propanoic acid (3 µL, 40 µmol) and 
fac-Ir(ppy)3 (1.4 mg, 2 µmol) in anhydrous degassed dichloromethane (2 mL). The crude 
reaction mixture was purified by flash column chromatography (gradient elution: 100% P.E. 
to 4% EtOAc in P.E.) to afford the product as a colorless oil (71 mg, 81%). Rf (10% EtOAc in 
P.E.): 0.39; IR max/cm
-1 (film): 3063, 3028, 2930, 2871, 1730, 1602, 1494, 1453, 1360, 1244, 
1176, 1116, 1070, 1027, 949, 908, 744, 696. 1H NMR (400 MHz, CDCl3) : 7.33 – 7.09 
(15 H, m, H1,2,3,17,18,19), 4.05 – 3.94 (2 H, m, H11), 3.65 (2 H, d, J = 13.6 Hz, H15a), 3.45 (2 H, 
d, J = 13.6 Hz, H15b), 2.68 – 2.55 (2 H, m, H5), 2.53 – 2.40 (2 H, m, H7, 9a), 2.29 – 2.17 (1 H, 
m, H9b), 2.05 – 1.94 (1 H, m, H6a), 1.93 – 1.81 (1 H, m, H8a), 1.79 – 1.68 (1 H, m, H8b), 1.61 – 
1.50 (3 H, m, H6b,12), 1.36 (2 H, sext, J = 7.6 Hz, H13), 0.94 (3 H, t, J = 7.5 Hz, H14);
 13C 
NMR (101 MHz, CDCl3) : 174.0 (C10), 142.6 (C4), 140.2 (C16), 129.0 (C17), 128.43 (C3), 
128.40 (C2), 128.2 (C18), 126.8 (C19), 125.8 (C1), 64.2 (C11), 56.4 (C7), 53.3 (C15), 33.5 (C5), 




+ requires 444.2897. 
tert-butyl 3-(6-butoxy-3-(dibenzylamino)-6-oxohexyl)-1H-indole-1-carboxylate (348w) 
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Prepared according to general procedure A using dibenzylamine (39 µL, 0.2 mmol), 1-Boc-3-
(3-oxopropyl)indole[384] (109 mg, 0.4 mmol), n-butyl acrylate (57 µL, 0.4 mmol), 
methoxyethyl- Hantzsch Ester (94 mg, 0.3 mmol), 4Å MS (100 mg), propanoic acid (3 µL, 40 
µmol) and fac-Ir(ppy)3 (1.4 mg, 2 µmol) in anhydrous degassed dichloromethane (2 mL). The 
crude reaction mixture was purified by flash column chromatography (0.5% Et3N in 
dichloromethane) to afford the product as a colorless oil (95 mg, 81%). Rf (20% EtOAc in 
P.E.): 0.48; IR max/cm
-1 (film): 3029, 2930, 1727, 1603, 1494, 1452, 1368, 1252, 1155, 1080, 
1018, 910, 857, 766, 743, 697. 1H NMR (400 MHz, CDCl3) : 8.17 (1 H, br s, H6), 7.53 (1 H, 
d, J = 7.7 Hz, H9), 7.35 (1 H, t, J = 7.8 Hz, H7), 7.30 – 7.18 (12 H, m, H4, 8, 24,25,26), 4.09 – 3.95 
(2 H, m, H18), 3.68 (2 H, d, J = 13.6 Hz, H22a), 3.42 (2 H, d, J = 13.6 Hz, H22b), 2.71 (2 H, t, J 
= 7.6 Hz, H12), 2.60 – 2.46 (2 H, m, H14,16a), 2.36 – 2.26 (1 H, m, H16b), 2.19 – 2.08 (1 H, m, 
H13a), 1.97 – 1.76 (2 H, m, H15), 1.69 (9 H, s, H1), 1.65 – 1.54 (3 H, m, H13b,19), 1.38 (2 H, 
sext, J = 7.6 Hz, H20), 0.96 (3 H, t, J = 7.4 Hz, H21);
 13C NMR (101 MHz, CDCl3) : 174.0 
(C17), 149.8 (C3), 140.1 (C23), 135.7 (C5), 130.6 (C4/8/10/11), 128.8 (C24), 128.1 (C25), 126.8 
(C26), 124.3 (C7), 122.5 (C4/8/10/11), 122.3 (C4/8/10/11), 120.8 (C4/8/10/11), 118.9 (C9), 115.4 (C6), 
83.2 (C2), 64.2 (C18), 56.3 (C14), 53.3 (C22), 31.6 (C16), 30.7 (C19), 28.3 (C1), 28.1 (C13), 25.2 
(C15), 22.6 (C12), 19.2 (C20), 13.8 (C21). m/z HRMS found [M + H]
+




butyl 4-(dibenzylamino)-6-(5-methylfuran-2-yl)hexanoate (348x) 
 
Prepared according to general procedure A using dibenzylamine (39 µL, 0.2 mmol), 3-(5-
methyl-2-furyl)propionaldehyde (53 µL, 0.4 mmol), n-butyl acrylate (57 µL, 0.4 mmol), 
methoxyethyl- Hantzsch Ester (94 mg, 0.3 mmol), 4Å MS (100 mg), propanoic acid (3 µL, 40 
µmol) and fac-Ir(ppy)3 (1.4 mg, 2 µmol) in anhydrous degassed dichloromethane (2 mL). The 
crude reaction mixture was purified by flash column chromatography (0.5% Et3N in 
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dichloromethane) to afford the product as a colorless oil (75 mg, 84%). Rf (10% EtOAc in 
P.E.): 0.46; IR max/cm
-1 (film): 3029, 2934, 1730, 1494, 1453, 1360, 1217, 1173, 1115, 950, 
780, 745, 697. 1H NMR (400 MHz, CDCl3) : 7.42 – 7.21 (10 H, m, H18,19,20), 5.86 (1 H, s, 
H3), 5.79 (1 H, d, J = 2.8 Hz, H4), 4.10 – 4.00 (2 H, m, H12), 3.68 (2 H, d, J = 13.9 Hz, H16a), 
3.56 (2 H, d, J = 13.8 Hz, H16b), 2.74 – 2.64 (1 H, m, H6a), 2.63 – 2.40 (3 H, m, H6b,8,10a), 2.34 
– 2.24 (4 H, m, H1,10b), 2.12 – 2.00 (1 H, m, H7a), 1.99 – 1.88 (1 H, m, H9a), 1.77 – 1.66 (1 H, 
m, H9b), 1.65 – 1.54 (3 H, m, H7b,13), 1.40 (2 H, sext, J = 7.7 Hz, H14), 0.98 (3 H, t, J = 7.5 Hz, 
H15);
 13C NMR (101 MHz, CDCl3) : 173.9 (C11), 154.1 (C5), 150.2 (C2), 140.2 (C17), 129.0 
(C18), 128.2 (C19), 126.8 (C20), 105.9 (C3), 105.5 (C4), 64.2 (C12), 56.4 (C8), 53.3 (C16), 31.8 
(C10), 30.7 (C13), 27.7 (C7), 25.8 (C6), 25.0 (C9), 19.2 (C14), 13.8 (C15), 13.6 (C1). m/z HRMS 
found [M]+ 447.2784, C29H37NO3
+ requires 447.2779. 
 
butyl 4-(dibenzylamino)butanoate (348ak) 
 
Prepared according to general procedure B using dibenzylamine (39 µL, 0.2 mmol), 
paraformaldehyde (18 mg, 0.60 mmol), n-butyl acrylate (32 µL, 0.22 mmol), ethyl- Hantzsch 
Ester (76 mg, 0.3 mmol), 4Å MS (100 mg), propanoic acid (3 µL, 40 µmol) and fac-Ir(ppy)3 
(1.4 mg, 2 µmol) in anhydrous degassed dichloromethane (2 mL). The crude reaction mixture 
was purified by flash column chromatography (0.5% Et3N in dichloromethane) to afford the 
product as a colorless oil (28 mg, 41%). Rf (10% EtOAc in P.E.): 0.42; IR max/cm
-1 (film): 
3063, 3029, 2958, 2872, 2799, 1731, 1494, 1452, 1364, 1245, 1171, 1117, 1071, 1027, 956, 
732, 697. 1H NMR (500 MHz, CDCl3) : 7.41 – 7.18 (10 H, m, H11,12,13), 4.01 (2 H, t, J = 6.8 
Hz, H5), 3.55 (4 H, s, H9), 2.45 (2 H, t, J = 6.9 Hz, H1), 2.31 (2 H, t, J = 7.5 Hz, H3), 1.83 
(2 H, quint, J = 6.9 Hz, H2), 1.57 (2 H, quint, J = 6.9 Hz, H6), 1.36 (2 H, sext, J = 7.5 Hz, H7), 
0.93 (3 H, t, J = 7.4 Hz, H8);
 13C NMR (126 MHz, CDCl3) : 173.8 (C4), 139.7 (C10), 128.8 
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(C11), 128.2 (C12), 126.8 (C13), 64.2 (C5), 58.3 (C9), 52.5 (C1), 32.0 (C3), 30.7 (C6), 22.4 (C2), 
19.2 (C7), 13.7 (C8). m/z HRMS found [M + H]
+
  340.2273, C22H30NO2
+ requires 340.2271. 
 
N,N-dibenzyl-2-methyl-1-(phenylsulfonyl)hexan-3-amine (359u)  
 
Prepared according to general procedure A using dibenzylamine (39 µL, 0.2 mmol), 
butyraldehyde (36 µL, 0.4 mmol), 1-propenyl phenyl sulfone[385] (73 mg, 0.4 mmol), ethyl- 
Hantzsch Ester (76 mg, 0.3 mmol), 4Å MS (100 mg), propanoic acid (3 µL, 40 µmol) and 
fac-Ir(ppy)3 (1.4 mg, 2 µmol) in anhydrous degassed dichloromethane (2 mL). The crude 
reaction mixture was purified twice by flash column chromatography (0.5% Et3N in 
dichloromethane and subsequently 2% diethylether in toluene) to afford the product as a 
colorless oil (47.3 mg, 54%, 1:1 d.r.). Rf (20% ethyl acetate in petroleum ether): 0.26; IR 
max/cm
-1 (film): 3027, 2958, 2925, 2871, 1494, 1447, 1303, 1147, 1086, 1027, 965; 1H NMR 
(400 MHz, CDCl3) : [7.86 (d, J = 7.6 Hz), 7.71 (d, J = 7.6 Hz) total 2 H, H9], 7.68 – 7.61 (1 
H, m, H11), 7.56 – 7.49 (2 H, m, H10), 7.34 – 7.19 (10 H, m, H14,15,16), [3.88 (d, J = 13.8 Hz), 
2.98 – 2.90 (m) total 1 H, H7a], [3.66 (d, J = 13.8 Hz), 3.64 (d, J = 13.8 Hz) total 2 H, H12a], 
[3.44 (d, J = 13.8 Hz), 3.41 (d, J = 13.8 Hz) total 2 H, H12b], [2.88 – 2.81 (m), 2.51 – 2.44 (m), 
total 1 H, H7b)], [2.50 – 2.43 (m), 2.22 – 2.16 (m) total 1 H, H4], [2.42 – 2.32 (m), 2.30  – 2.22 
(m) total 1 H, H5), [1.77 – 1.65 (m), 1.65 – 1.58 (m) total 1 H, H3a], 1.46 – 1.19 (3 H, m, 
H2,3b], [1.16 (d, J = 7.0 Hz), 1.12 (d, J = 6.5 Hz) total 3 H, H6], [0.94 (t, J = 7.2 Hz), 0.86 (t, J 
= 7.2 Hz) total 3 H, H1].
 13C NMR (126 MHz, CDCl3) : [140.6, 140.0 (C8)], [139.9, 139.6 
(C13)], [133.30, 133.28 (C11)], 129.11 (C10), [129.1, 129.00 (C14)], [128.2, 128.3 (C15)], 
[127.8, 127.7 (C9)], [127.1, 126.9 (C16)], [61.4, 61.0 (C4)], [61.3, 60.5 (C7)], [55.4, 53.7 
(C12)], [31.0, 29.9 (C5)], [29.5, 27.7 (C3)], [22.5, 20.9 (C2)], [17.5, 16.4 (C6)], [14.7, 14.2 
(C1)]. m/z HRMS found [M + H]
+ 436.2301, C27H34NO2S
+ requires 436.2305. 
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3-(1-(dibenzylamino)butyl)cyclohexan-1-one (359v)  
 
Prepared according to general procedure A using dibenzylamine (39 µL, 0.2 mmol), 
butyraldehyde (36 µL, 0.4 mmol), 2-cyclohexene-1-one (39 µL, 0.4 mmol), ethyl-Hantzsch 
Ester (76 mg, 0.3 mmol), 4Å MS (100 mg), propanoic acid (3 µL, 40 µmol) and fac-Ir(ppy)3 
(1.4 mg, 2 µmol) in anhydrous degassed dichloromethane (2 mL). The crude reaction mixture 
was purified by flash column chromatography (0.5% Et3N in dichloromethane) to afford the 
product as a colorless oil (45 mg, 65%, 1:1 d.r.). Rf (20% ethyl acetate in petroleum ether): 
0.45; IR max/cm
-1 (film): 3026, 2955, 2931, 2869, 1710, 1602, 1494, 1453, 1374, 1315, 1261, 
1227, 1133, 1073, 1027; 1H NMR (400 MHz, CDCl3) : 7.36 – 7.19 (10 H, m, H13,14,15), [3.71 
(d, J = 14.0 Hz), 3.67 (d, J = 14.0 Hz) total 2 H, H11a), [3.50 (d, J = 13.9 Hz), 3.49 (d, J = 13.9 
Hz) total 2 H, H11b), [2.79 – 2.73 (m), 2.25 – 2.19 (m) total 1 H, H6a], [2.45 – 2.38 (app q, J = 
7.0 Hz), 2.37 – 2.32 (m) total 1 H, H4], [2.37 – 2.30 (m), 2.24 – 2.15 (m) total 2 H, H8], [2.18 
– 2.11 (m), 1.92 – 1.84 (m) total 1 H, H6b], [2.17 – 2.11 (m), 1.82 – 1.75 (m) total 1 H, H3/10], 
2.08 – 1.93 (2 H, m, H9a,5), 1.74 – 1.58 (2 H, m, H3/10), 1.58 – 1.47 (1 H, m, H9b), 1.40 – 1.26 
(3 H, m, H2,3/10), 0.94 – 0.84 (3 H, m, H1); 13C NMR (101 MHz, CDCl3) : [212.8, 212.4 
(C7)], [140.1, 140.0 (C12)], [129.0, 128.9 (C13)], 128.2 (C14), [126.90, 126.86 (C15)], [61.8, 
61.1 (C4)], [54.8, 54.3 (C11)], [46.7, 46.5 (C6)], [41.6, 41.2 (C5)], 41.5 (C8), [29.4, 29.2, 28.9, 
28.8 (C3/10)], [25.64, 25.57 (C9)], [22.3, 21.9 (C2)], [14.6, 14.5 (C1)]. m/z HRMS found [M + 
H]+ 350.2482, C24H32NO
+ requires 350.2478. 
N,N-dibenzyl-1-(5-(trifluoromethyl)pyridin-2-yl)hexan-3-amine (359ag) 
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Prepared according to general procedure A using dibenzylamine (39 µL, 0.2 mmol), 
butyraldehyde (36 µL, 0.4 mmol), 5-(trifluoromethyl)-2-vinylpyridine (69 mg, 0.4 mmol), 
methoxyethyl-Hantzsch Ester (94 mg, 0.3 mmol), 4Å MS (100 mg), propanoic acid (3 µL, 40 
µmol) and fac-Ir(ppy)3 (1.4 mg, 2 µmol) in anhydrous degassed dichloromethane (2 mL). The 
crude reaction mixture was purified by flash column chromatography (0.5% Et3N in 
dichloromethane) to afford the product as a colorless oil (36 mg, 42%). Rf (15% EtOAc in 
P.E.): 0.40; IR max/cm
-1 (film): 3029, 2958, 1731, 1602, 1494, 1454, 1294, 1238, 1169, 1123, 
1072, 1027, 900, 746, 699. 1H NMR (400 MHz, CDCl3) : 8.74 (1 H, br s, H11), 7.68 (1 H, 
dd, J = 2.3, 8.1 Hz, H9), 7.38 – 7.17 (10 H, m, H15,16,17), 6.96 (1 H, d, J = 8.1 Hz, H8), 3.63 (2 
H, d, J = 13.7 Hz, H13a), 3.51 (2 H, d, J = 13.7 Hz, H13b), 3.02 – 2.93 (1 H, m, H6a), 2.81 – 
2.72 (1 H, m, H6b), 2.48 (1 H, quint, J = 6.8 Hz, H4), 2.04 – 1.93 (1 H, m, H5a), 1.79 – 1.63 (2 
H, m, H3a,5b), 1.36 – 1.21 (3 H, m, H2,3b), 0.82 (3 H, t, J = 7.1 Hz, H1); 13C NMR (101 MHz, 
CDCl3) : 166.6 (C7), 146.1 (q, J = 4.1 Hz C11), 140.5 (C14), 133.1 (q, J = 3.4 Hz, C9), 128.9 
(C15), 128.1 (C16), 126.7 (C17), 123.9 (q, J = 32.8 Hz, C10), 123.8 (q, J = 272.2 Hz, C12), 122.5 
(C8), 56.3 (C4), 53.4 (C13), 35.7 (C6), 31.2 (C3), 29.9 (C5), 20.3 (C2), 14.3 (C1); 19F[1H] NMR 
(376 MHz, CDCl3) : −63.2. m/z HRMS found [M + H]
+




N-benzyl-N-(2-methylpropylidene)-1-phenylmethanaminium tetrafluoroborate (364) 
Procedure modified from Melchiorre et al.[231] 
 
An oven dried Schlenk flask was cooled under a stream of nitrogen, charged with 
dibenzylammonium tetrafluoroborate (preparation see below, 500 mg, 1.75 mmol), 
isobutyraldehyde (1.6 mL, 17.5 mmol), powdered activated molecular sieves (4 Å, 250 mg) 
and anhydrous dichloromethane (6 mL). The flask was sealed under nitrogen and heated for 
24 h at 40°C with vigorous stirring. The cooled reaction mixture was Schlenk-filtered and the 
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filtrate added via cannula into stirred anhydrous Et2O (200 mL). The colorless precipitate was 
immediately collected by Schlenk-filtration, washed with anhydrous Et2O (3 x 6 mL) and 
dried in vacuo. N-benzyl-N-(2-methylpropylidene)-1-phenylmethanaminium tetrafluoroborate 
(373 mg, 63%) was obtained as a moisture sensitive colorless powder. The product was stored 
in a nitrogen glovebox at ambient temperature with no decomposition observed after several 
months of storage. 1H NMR (400 MHz, DMSO-d6) : 8.96 (1 H, d, J = 9.5 Hz, H3), 7.53 – 
7.39 (8 H, m, H5/6/7), 7.35 – 7.28 (2 H, m, H5/6/7), 5.06 (4 H, d, J = 10.7 Hz, H4), 3.35 – 3.20 (1 
H, m, H2), 1.21 (6 H, d, J = 6.5 Hz, H1); 13C NMR (101 MHz, DMSO-d6) : 189.1, 132.0, 
131.8, 130.0, 129.7, 129.6, 129.4, 128.5, 64.1, 55.3, 31.4, 18.7. 19F[1H] NMR (376 MHz, 
DMSO-d6) : −149.2. m/z HRMS found [M − BF4]
+
  252.1735, C18H22N
+ requires 252.1747. 
Dibenzylammonium tetrafluoroborate was obtained by dissolving dibenzylamine (5 mmol) in 
dry Et2O (15 mL) followed by dropwise addition of tetrafluoroboric acid diethyl ether 
complex (5.5 mmol) and collection of the precipitate. Dibenzylammonium tetrafluoroborate 
(4.3 mmol, 86%) was dried in vacuo and stored with the exclusion of moisture. 
 
butyl 4-(benzyl(phenylmethyl-d)amino)heptanoate (d1-348a) 
 
Prepared according to general procedure A using dibenzylamine (39 µL, 0.2 mmol), 
butyraldehyde (20 µL, 0.22 mmol), n-butyl acrylate (32 µL, 0.22 mmol), diethyl 2,6-
dimethyl-1,4-dihydropyridine-3,5-dicarboxylate-4,4-d2 (77 mg, 0.3 mmol), 4Å MS (100 mg), 
propanoic acid (3 µL, 40 µmol) and fac-Ir(ppy)3 (1.4 mg, 2 µmol) in anhydrous degassed 
dichloromethane (2 mL). The crude reaction mixture was purified by flash column 
chromatography (1% EtOAc in P.E.) to afford the product as a colorless oil (53 mg, 70%). Rf 
(10% EtOAc in P.E.): 0.47; IR max/cm
-1 (film): 3058, 3027, 2957, 2929, 2871, 1732, 1602, 
1494, 1453, 1245, 1172, 1071, 1027, 738, 697. 1H NMR (400 MHz, CDCl3) : 7.50 – 7.20 
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(10 H, m, H14,15,16,19,20,21), 4.11 – 3.96 (2 H, m, H8), 3.74 – 3.66 (1 H, m, H12/17), 3.55 – 3.45 (2 
H, m, H12/17), 2.57 – 2.54 (2 H, m, H4,6a), 2.35 – 2.24 (1 H, m, H6b), 1.19 – 1.78 (1 H, m, H5a), 
1.77 – 1.65 (2 H, m, H3a,5b), 1.61 (2 H, quint, J = 7.0 Hz, H9), 1.45 – 1.32 (4 H, m, H2,10), 1.29 
– 1.18 (1 H, m, H3b), 0.97 (3 H, t, J = 7.4 Hz, H11), 0.91 (3 H, t, J = 7.3 Hz, H1);
 2H NMR 
(76.8 MHz, CHCl3/CDCl3) : 3.66 (br s, D12/17), 3.47 (br s, D12/17); 13C NMR (101 MHz, 
CDCl3) : 174.1 (C7), 140.4 (C13,18), 128.9 (C14,19), 128.1 (C15,20), 126.7 (C16,21), 64.1 (C8), 
56.5 (C4), 53.3 (C12,17), 31.8 (C6), 31.0 (C3), 30.7 (C9), 25.5 (C5), 20.4 (C2), 19.2 (C10), 14.3 
(C1), 13.8 (C11). m/z HRMS found [M]
+
  382.2728, C25H34DNO2
+ requires 382.2725. 
 
butyl 4-((phenylmethyl-d)(phenylmethyl-d2)amino)heptanoate-2-d (d4-348a) 
 
Prepared according to general procedure A using bis(phenylmethyl-d2)amine (39 µL, 0.2 
mmol), butyraldehyde (20 µL, 0.22 mmol), n-butyl acrylate (32 µL, 0.22 mmol), ethyl-
Hantzsch Ester (76 mg, 0.3 mmol), 4Å MS (100 mg), propanoic acid (3 µL, 40 µmol) and 
fac-Ir(ppy)3 (1.4 mg, 2 µmol) in anhydrous degassed dichloromethane (2 mL). The crude 
reaction mixture was purified by flash column chromatography (1% EtOAc in P.E.) to afford 
the product as a colorless oil (52 mg, 67%). Rf  (10% EtOAc in P.E.): 0.39; IR max/cm
-1 
(film): 3025, 2956, 2930, 2871, 1731, 1602, 1493, 1448, 1380, 1238, 1176, 1073, 1026, 836, 
728, 696. 1H NMR (400 MHz, CDCl3) : 7.47 – 7.17 (10 H, m, H14,15,16,19,20,21), 4.09 – 3.08 (2 
H, m, H8), [3.68 (s), 3.49 (s) total 1 H, H12,17], 2.55 – 2.44 (1 H, m, H4,6a), 2.28 (1 H, t, J = 7.3 
Hz, H6b), 1.90 – 1.79 (1 H, m, H5a), 1.77 – 1.65 (2 H, m, H3a,5b), 1.61 (2 H, quint, J = 7.0 Hz, 
H9). 1.46 – 1.33 (4 H, m, H2,10), 1.29 – 1.18 (1 H, m, H3b), 0.97 (3 H, t, J = 7.3 Hz, H11), 0.91 
(3 H, t, J = 7.1 Hz, H1);
 2H NMR (76.8 MHz, CHCl3/CDCl3) : 3.67 (br s, D12/17), 3.50 (br s, 
D12/17), 2.50 (br s, D6), 2.29 (br s, D6); 13C NMR (101 MHz, CDCl3) : 174.1 (C7), 140.3 
(C13,18), 128.9 (C14,19), 128.1 (C15,20), 126.7 (C16,21), 64.1 (C8), 56.5 (C4), 52.7 (C12,17), 31.6 
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(C6), 31.0 (C3), 30.7 (C9), 25.5 (C5), 20.4 (C2), 19.2 (C10), 14.3 (C1), 13.8 (C11). m/z HRMS 
found [M + H]+  386.2997, C25H32D4NO2
+ requires 386.2996. 
 
butyl 6-((tert-butoxycarbonyl)amino)-4-(dibenzylamino)hexanoate (369) 
 
Prepared according to general procedure A using dibenzylamine (39 µL, 0.2 mmol), tert-butyl 
3-oxopropylcarbamate (38 mg, 0.22 mmol), n-butyl acrylate (32 µL, 0.22 mmol), ethyl- 
Hantzsch Ester (76 mg, 0.3 mmol), 4Å MS (100 mg), propanoic acid (3 µL, 40 µmol) and 
fac-Ir(ppy)3 (1.4 mg, 2 µmol) in anhydrous degassed dichloromethane (2 mL). The crude 
reaction mixture was purified by flash column chromatography (1‒8% EtOAc in 
dichloromethane) to afford the product as a colorless oil (28 mg, 29%). Rf (10% EtOAc in 
dichloromethane): 0.80; IR max/cm
-1 (film): 3363, 3030, 2959, 2930, 1711, 1494, 1453, 
1364, 1245, 1166, 1071, 1027, 950, 746, 698. 1H NMR (500 MHz, CDCl3) : 7.34 – 7.20 (10 
H, m, H16,17,18), 4.63 (1 H, br s, N–H), 4.04 – 3.95 (2 H, m, H10), 3.55 (4 H, s, H14), 3.27 – 
3.18 (1 H, m, H4a), 3.12 – 3.02 (1 H, m, H4b), 2.50 (1 H, quint, J = 6.9 Hz, H6), 2.32 (2 H, br t, 
J = 7.2 Hz, H8), 2.00 – 1.91 (1 H, m, H7a), 1.83 – 1.75 (1 H, m, H5a), 1.63 – 1.52 (3 H, m, 
H7b,11), 1.48 – 1.39 (10 H, m, H1,5b), 1.36 (2 H, sext, J = 7.4 Hz, H12), 0.94 (3 H, t, J = 7.5 Hz, 
H13); 13C NMR (126 MHz, CDCl3) : 173.7 (C9), 155.9 (C3), 139.9 (C15), 129.1 (C16), 128.3 
(C17), 127.0 (C18), 78.8 (C2), 64.3 (C10), 54.5 (C6), 53.2 (C14), 38.4 (C4), 31.6 (C8), 30.6 (C11), 
29.1 (C5), 28.5 (C1), 24.3 (C7), 19.2 (C12), 13.7 (C13). m/z HRMS found [M + H]
+
  483.3208, 
C29H43N2O4
+ requires 483.3217. Cyclization product tert-butyl 3-benzyl-4-(3-butoxy-3-
oxopropyl)-2-phenyltetra-hydropyrimidine-1(2H)-carboxylate (370) was also isolated from 
the reaction mixture as a colorless oil (21 mg, 22 %, mixture of diastereomers d. r. 5.5 : 1). 
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Major diastereomer: 1H NMR (500 MHz, CDCl3) : 7.47 (2 H, d, J = 7.7 Hz, H16), 7.39 – 
7.16 (8 H, m, H17,18,21,22,23), 5.83 (1 H, s, H19), 4.28 (1 H, dd, J = 5.0, 13.4 Hz, H4a), 4.06 (2 H, 
t, J = 6.7 Hz, H10), 3.90 (1 H, d, J = 14.1 Hz, H14a), 3.72 (1 H, d, J = 14.1 Hz, H14b), 3.08 – 
2.99 (1 H, m, H6), 2.95 (1 H, dd, J = 3.9, 13.1 Hz, H4b), 2.67 – 2.59 (1 H, m, H8a), 2.51 – 2.43 
(1 H, m, H8b), 1.98 – 1.88 (1 H, m, H7a), 1.88 – 1.78 (1 H, m, H5a), 1.78 – 1.69 (1 H, m, H7b), 
1.63 – 1.55 (2 H, m, H11), 1.37 (2 H, sext, J = 7.7 Hz, H12), 1.30 (9 H, s, H1), 1.18 (1 H, d, J = 
13.2 Hz, H5b), 0.93 (3 H, t, J = 7.6 Hz, H13). 13C NMR (126 MHz, CDCl3) : 173.5 (C9), 
155.9 (C3), 139.3 (C15), 138.6 (C20), 128.74 (C16), 128.65 (C21), 128.4 (C17), 127.15 (C18), 
127.08 (C23), 126.9 (C22), 79.9 (C2), 71.0 (C19), 64.4 (C10), 52.0 (C6), 47.5 (C14), 38.7 (C4), 
30.8 (C8), 30.7 (C11), 28.2 (C1), 28.1 (C7), 25.3 (C5), 19.2 (C12), 13.7 (C13). m/z HRMS found 
[M + H]+  481.3057, C29H41N2O4




Prepared according to general procedure A using 4-(trifluoromethyl)piperidine hydrochloride 
(32 mg, 0.2 mmol), triethylamine (28 µL, 0.2 mmol), butyraldehyde (36 µL, 0.4 mmol), 1,1-
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diphenylethene (71 µL, 0.4 mmol), ethyl-Hantzsch Ester (76 mg, 0.3 mmol), 4Å MS (100 
mg), propanoic acid (3 µL, 40 µmol) and fac-Ir(ppy)3 (1.4 mg, 2 µmol) in anhydrous 
degassed dichloromethane (2 mL). The crude reaction mixture was filtered, the solvent 
removed in vacuo and subsequently dissolved in a solution of lithium hydroxide monohydrate 
(84 mg, 20 mmol) in THF/H2O (6 mL, 5:1). The mixture was heated to a vigorous reflux for 2 
hours, cooled to room temperature and diluted with saturated aqueous NaHCO3 (10 mL). The 
aqueous was extracted with EtOAc (3 x 10 mL) and the organics combined. The mixture was 
acidified using 10% HCl (aq.) (25 mL), the organics separated and the aqueous washed with 
Et2O (2 x 20 mL). The aqueous was cooled in an ice bath and carefully basified using solid 
NaOH until pH = 10. The aqueous was extracted with dichloromethane (3 x 20 mL), the 
organics combined and washed with brine (25 mL), dried over Na2SO4, filtered and the 
solvent removed in vacuo. The subsequent residue was purified by flash column 
chromatography (gradient elution: 0.5% Et3N in dichloromethane to 1% MeOH, 0.5% Et3N in 
dichloromethane) to afford the product as a viscous colorless oil (42 mg, 54%). Rf (5% 
EtOAc in P.E.): 0.25; IR max/cm
-1 (film): 3027, 2954, 2929, 2864, 2804, 1735, 1599, 1494, 
1451, 1382, 1338, 1281, 1253, 1136, 1080, 1030, 905, 747, 699. 1H NMR (500 MHz, CDCl3) 
: 7.31 – 7.15 (10 H, m, H8,9,10), 4.22 (1 H, dd, J = 6.0, 9.7 Hz), 2.76 (1 H, br d, J = 10.9 Hz, 
H11a), 2.54 (1 H, 1 H, br d, J = 10.9 Hz, H11a'), 2.36 (1 H, dt, J = 10.9, 2.0 Hz, H11b), 2.24 – 
2.13 (2 H, m, H4, H11b'), 2.10 – 1.99 (2 H, m, H5), 1.97 – 1.88 (1 H, m, H13), 1.84 – 1.77 (2 H, 
m, H12a), 1.63 – 1.53 (2 H, m, H12b), 1.48 – 1.41 (1 H, m, H3a), 1.34 – 1.27 (1 H, m, H2a), 1.21 
– 1.14 (2 H, m, H2b,3b), 0.82 (3 H, t, J = 7.1 Hz, H1); 13C NMR (126 MHz, CDCl3) : 145.6 
(C7), 145.0 (C7'), 128.3 (C8/8'/9/9'), 128.3 (C8/8'/9/9'), 128.1 (C8/8'/9/9'), 127.8 (C8/8'/9/9'), 127.6 (q, 
J = 277.9 Hz, C14), 126.0 (C10), 125.9 (C10'), 61.0 (C4), 49.4 (C11), 47.6 (C6), 45.1 (C11'), 41.1 
(q, J = 27.4 Hz, C13), 36.6 (C5), 31.1 (C3), 25.5 (C12), 25.3 (C12'), 20.4 (C2), 14.2 (C1); 19F[1H] 
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Prepared according to general procedure A using (2-methoxyethyl)methylamine (22 µL, 0.2 
mmol), butyraldehyde (36 µL, 0.4 mmol), 1,1-diphenylethene (71 µL, 0.4 mmol), ethyl- 
Hantzsch Ester (76 mg, 0.3 mmol), 4Å MS (100 mg), propanoic acid (3 µL, 40 µmol) and 
fac-Ir(ppy)3 (1.4 mg, 2 µmol) in anhydrous degassed dichloromethane (2 mL). The crude 
reaction mixture was filtered, the solvent removed in vacuo and subsequently dissolved in a 
solution of lithium hydroxide monohydrate (84 mg, 20 mmol) in THF/H2O (6 mL, 5:1). The 
mixture was heated to a vigorous reflux for 2 hours, cooled to room temperature and diluted 
with saturated aqueous NaHCO3 (10 mL). The aqueous was extracted with EtOAc (3 x 10 
mL) and the organics combined. The mixture was acidified using 10% HCl (aq.) (25 mL), the 
organics separated and the aqueous washed with Et2O (2 x 20 mL). The aqueous was cooled 
in an ice bath and carefully basified using solid NaOH until pH = 10. The aqueous was 
extracted with dichloromethane (3 x 20 mL), the organics combined and washed with brine 
(25 mL), dried over Na2SO4, filtered and the solvent removed in vacuo. The subsequent 
residue was purified by flash column chromatography (gradient elution: 0.5% MeOH in 
dichloromethane to 10% MeOH in dichloromethane) to afford the product as a colorless oil 
(56 mg, 86%). Rf (10% MeOH in dichloromethane): 0.44; IR max/cm
-1 (film): 2955, 2929, 
2868, 1599, 1493, 1450, 1119, 1068, 1030, 967, 746, 699. 1H NMR (400 MHz, CDCl3) : 
7.30 – 7.21 (8 H, m, H8/9), 7.18 – 7.11 (2 H, m, H10), 4.22 (1 H, dd, J = 6.7, 8.7 Hz, H6), 3.33 
– 3.25 (5 H, m, H13,14), 2.62 – 2.53 (1 H, m, H12a), 2.52 – 2.44 (1 H, m, H12b), 2.29 – 2.22 (1 
H, m, H4), 2.20 (3 H, s, H11), 2.08 – 1.96 (2 H, m, H5), 1.49 – 1.37 (1 H, m, H3a), 1.34 – 1.13 
(3 H, m, H2a,2b,3b), 0.81 (3 H, t, J = 7.0 Hz, H1); 13C NMR (101 MHz, CDCl3) : 145.8 (C7), 
145.0 (C7'), 128.3 (C8/9), 128.3 (C8/9), 128.2 (C8/9), 127.9 (C8/9), 126.0 (C10), 125.9 (C10'), 71.8 
(C13), 60.0 (C4), 58.7 (C14), 52.8 (C12), 47.6 (C6), 37.4 (C11), 36.8 (C5), 31.1 (C3), 20.3 (C2), 
14.3 (C1). m/z HRMS found [M + H]
+ 326.2483, C22H32NO
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Prepared according to general procedure A using dimethylamine (40 wt.% in H2O, 25 µL, 0.2 
mmol), butyraldehyde (36 µL, 0.4 mmol), 1,1-diphenylethene (71 µL, 0.4 mmol), ethyl-
Hantzsch Ester (76 mg, 0.3 mmol), 4Å MS (100 mg), propanoic acid (3 µL, 40 µmol) and 
fac-Ir(ppy)3 (1.4 mg, 2 µmol) in anhydrous degassed dichloromethane (2 mL). The crude 
reaction mixture was filtered, the solvent removed in vacuo and subsequently dissolved in a 
solution of lithium hydroxide monohydrate (84 mg, 20 mmol) in THF/H2O (6 mL, 5:1). The 
mixture was heated to a vigorous reflux for 2 hours, cooled to room temperature and diluted 
with saturated aqueous NaHCO3 (10 mL). The aqueous was extracted with EtOAc (3 x 10 
mL) and the organics combined. The mixture was acidified using 10% HCl (aq.) (25 mL), the 
organics separated and the aqueous washed with Et2O (2 x 20 mL). The aqueous was cooled 
in an ice bath and carefully basified using solid NaOH until pH = 10. The aqueous was 
extracted with dichloromethane (3 x 20 mL), the organics combined and washed with brine 
(25 mL), dried over Na2SO4, filtered and the solvent removed in vacuo. The subsequent 
residue was purified by flash column chromatography (gradient elution: 0.5% MeOH in 
dichloromethane to 8% MeOH in dichloromethane) to afford the product as a colorless oil (50 
mg, 88%). Rf (5% MeOH in dichloromethane): 0.10; IR max/cm
-1 (film): 3026, 2956, 2929, 
2856, 2771,1599, 1493, 1450, 1378, 1263, 1154, 1030, 912, 774, 746, 697. 1H NMR (400 
MHz, CDCl3) : 7.33 – 7.26 (8 H, m, H8,9), 7.22 – 7.15 (2 H, m, H10), 4.20 (1 H, dd, J = 6.5, 
8.5 Hz, H6), 2.21 (7 H, br s, H4,11), 2.17 – 2.08 (1 H, m, H5a), 2.04 – 1.94 (1 H, m, H5b), 1.52 – 
1.41 (1 H, m, H3a), 1.37 – 1.16 (3 H, m, H3b,2a,2b), 0.85 (3 H, t, J = 7.2 Hz, H1); 13C NMR (126 
MHz, CDCl3) : 145.1 (br s, C7), 128.4 (C8/9), 128.3 (C8/9), 128.1 (C8/9), 127.9 (C8/9), 126.0 
(br s, C10), 60.6 (br s, C4), 47.7 (C6), 40.1 (C11), 36.1 (C5), 30.6 (C3), 20.2 (C2), 14.2 (C1). m/z 
HRMS found [M + H]+ 282.2223, C20H28N




Prepared according to general procedure A using 4-cyclohex-1-enylmorpholine (34 µL, 0.2 
mmol), 1,1-diphenylethene (71 µL, 0.4 mmol), ethyl-Hantzsch Ester (76 mg, 0.3 mmol), 4Å 
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MS (100 mg), propanoic acid (3 µL, 40 µmol) and fac-Ir(ppy)3 (1.4 mg, 2 µmol) in anhydrous 
degassed dichloromethane (2 mL). The crude reaction mixture was filtered, the solvent 
removed in vacuo and subsequently dissolved in a solution of lithium hydroxide monohydrate 
(84 mg, 20 mmol) in THF/H2O (6 mL, 5:1). The mixture was heated to a vigorous reflux for 2 
hours, cooled to room temperature and diluted with saturated aqueous NaHCO3 (10 mL). The 
aqueous was extracted with Et2O (3 x 10 mL) and the organics combined, washed with brine 
(25 mL), dried over Na2SO4, filtered and the solvent removed in vacuo. The subsequent 
residue was purified by flash column chromatography (1% EtOAc and 0.5% Et3N in P.E.) to 
afford the product as a colorless oil (41 mg, 59%). Rf (20% EtOAc in P.E.): 0.55; IR max/cm
-
1 (film): 3024, 2932, 2849, 1598, 1492, 1451, 1266, 1118, 1030, 979, 854, 743, 702. 1H NMR 
(400 MHz, CDCl3) : 7.33 – 7.20 (8 H, m, H10/11/12), 7.17 – 7.08 (2 H, m, H10/11/12), 4.10 (1 H, 
t, J = 6.4 Hz, H8), 3.65 – 3.60 (4 H, m, H6), 2.59 – 2.48 (4 H, m, H5), 2.24 (2 H, d, J = 6.3 Hz, 
H7), 1.57 – 1.35 (5 H, m, H2/3/4), 1.30 – 1.14 (5 H, m, H2/3/4); 13C NMR (101 MHz, CDCl3) : 
146.8 (C9), 128.4 (C10), 127.7 (C11), 125.9 (C12), 68.1 (C6), 58.1 (C1), 47.1 (C8), 44.9 (C5), 








Prepared according to general procedure A using 1-(cyclohex-1-en-1-yl)-4-
methylpiperazine[386] (36 mg, 0.2 mmol), 2-(1-(benzo[d][1,3]dioxol-5-yl)vinyl)pyridine (90 
mg, 0.4 mmol), ethyl-Hantzsch Ester (76 mg, 0.3 mmol), 4Å MS (100 mg), propanoic acid 
(3 µL, 40 µmol) and fac-Ir(ppy)3 (1.4 mg, 2 µmol) in anhydrous degassed dichloromethane (2 
mL). The crude reaction mixture was purified by flash column chromatography (1% aqueous 
ammonia, 9% MeOH in dichloromethane) to afford the product as a brown oil (26 mg, 32%). 
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Rf (EtOAc): 0.05; IR max/cm
-1 (film): 2919, 2849, 2790, 1588, 1485, 1432, 1243, 1094, 
1037, 937, 799, 747. 1H NMR (400 MHz, C6D6) : 8.47 (1 H, br d, J = 4.6 Hz, H18), 7.27 (1 
H, d, J = 1.6 Hz, H11), 6.99 (1 H, dt, J = 1.9, 7.6 Hz, H20), 6.94 – 6.88 (2 H, m, H15,21), 6.65 (1 
H, d, J = 8.0 Hz, H14), 6.53 (1 H, ddd, J = 1.2, 4.8, 7.4 Hz, H19), 5.28 (1 H, d, J = 1.4 Hz, 
H16a), 5.25 (1 H, d, J = 1.4 Hz, H16b), 4.31 (1 H, br t, J = 5.9 Hz, H9), 2.98 (1 H, dd, J = 7.3, 
14.7 Hz, H8a), 2.59 (4 H, br t, J = 4.8 Hz, H5), 2.30 (4 H, br s, H6), 2.16 (3 H, s, H7), 2.15 (1 
H, dd, J = 4.7, 14.5 Hz, H8b), 1.62 – 1.17 (10 H, m, H2,3,4); 13C NMR (101 MHz, C6D6) : 
165.4 (C17), 149.4 (C18), 148.3 (C12), 146.4 (C13), 140.9 (C10), 135.9 (C20), 123.0 (C21), 121.2 
(C15), 120.9 (C19), 109.0 (C11), 108.3 (C14), 100.7 (C16), 58.2 (C1), 56.7 (C6), 49.3 (C9), 46.2 
(C7), 44.4 (C5), 39.0 (C8), 32.9 (C2/2'/3/4), 30.2 (C2/2'/3/4), 26.7 (C2/2'/3/4), 22.0 (C2/2'/3/4). m/z 
HRMS found [M + H]+ 408.2643, C25H34N3O2




carboxylic acid (384) 
 
Prepared according to general procedure A using ciprofloxacin (66 mg, 0.2 mmol), methyl 4-
oxobutanoate (42 µL, 0.4 mmol), (S)-2-(tert-butyl)-3-Cbz-4-methyleneoxazolidin-5-one 360  
(87 mg, 0.3 mmol, 93% ee), ethyl-Hantzsch Ester (76 mg, 0.3 mmol), 4Å MS (100 mg), 
propanoic acid (3 µL, 40 µmol) and fac-Ir(ppy)3 (1.4 mg, 2 µmol) in anhydrous degassed 
dichloromethane (2 mL). The crude reaction mixture was concentrated in vacuo and purified 
by flash column chromatography (gradient elution: 5% MeOH in dichloromethane to 1% 
aqueous ammonia, 9% MeOH in dichloromethane) to afford the product as a pale yellow gum 
(92 mg, 64%, d.r. 1:1). Rf (10% MeOH in dichloromethane): 0.43; IR max/cm
-1 (film): 2956, 
1787, 1718, 1626, 1492, 1452, 1391, 1334, 1303, 1255, 1227, 1197, 1138, 1039, 1010, 968, 
910, 888, 832, 807, 782, 726. 1H NMR (500 MHz, CDCl3) : 15.03 (1 H, s, CO2H), 8.73 (1 
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H, s, H23), [7.98 (d, J = 13.1 Hz), 7.96 (d, J = 13.1 Hz) total 1 H, H27], 7.41 – 7.27 (6 H, m, 
H15,16,17,21), [5.57 (s), 5.55 (s) total 1 H, H9], [5.19 (d, J = 11.9 Hz), 5.18 (d, J = 11.9 Hz) total 
1 H, H13a], [5.14 (d, J = 11.9 Hz), 5.13 (d, J = 11.9 Hz) total 1 H, H13b], [4.78 (br d, J = 5.9 
Hz), 4.60 (br s) total 1 H, H7], 3.67 (3 H, s, H1), 3.56 – 3.48 (1 H, m, H29), 3.33 – 3.07 (4 H, 
m, H19), [3.06 – 3.03 (m), 2.90 (br s) total 1 H, H5], 2.80 – 2.54 (4 H, m, H18), 2.38 – 2.25 (2 
H, m, H3), 2.16 – 1.93 (2 H, m, H6a,4a), [1.86 – 1.77 (m), 1.72 – 1.64 (m) total 1 H, H6b], 1.65 
– 1.54 (1 H, m, H4b), 1.41 – 1.35 (2 H, m, H30a), 1.20 – 1.16 (2 H, m, H30b), 0.97 (9 H, s, H11); 
13C NMR (126 MHz, CDCl3) : 177.1 (C25), 173.7 (C2), [173.5, 172.5 (C8)], 167.0 (C31), 
155.7 (C12), 153.6 (d, J = 251.6 Hz, C28), 147.4 (C23), 146.1 (d, J = 10.2 Hz, C20), 139.1 (C22), 
135.1 (C14), [128.8, 128.7, 128.7, 128.7 (C15/16/17)], 119.7 (C26), 112.3 (d, J = 23.6 Hz, C27), 
108.1 (C24), [104.8, 104.7 (C21)], [96.2, 96.1 (C9)], [68.6, 68.5 (C13)], [60.5, 59.5 (C5)], [54.7, 
54.1 (C7)], 51.6 (C1), 50.3 (C19), 47.4 (C18), 37.1 (C10), 35.3 (C29), [34.2, 33.7 (C6)], [31.8, 
31.7 (C3)], 24.9 (C11), [24.4, 24.3 (C4)], 8.2 (C30); 19F[1H] NMR (376 MHz, CDCl3) : 
−121.6, −121.7.  m/z HRMS found [M + H]+ 721.3245, C38H46FN4O9
+ requires 721.3243. 
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5.2.2 Total synthesis of (−) FR901483 and (+)-TAN1251C 




A 4 mL PTFE/Silicone-lined septa screw cap (PP) clear glass vial equipped with magnetic stir 
bar was charged with methyl (S)-2-amino-3-(4-methoxyphenyl)propanoate 409 (21 mg, 0.10 
mmol, 1.0 equiv), 1,4-cyclo-hexanedione monoethylene acetal (17 mg, 0.11 mmol, 1.1 equiv), 
benzyl (S)-2-(tert-butyl)-4-methylene-5-oxooxazolidine-3-carboxylate 360 (43 mg, 0.15 
mmol, 1.5 equiv), Hantzsch Ester (38 mg, 0.15 mmol, 15 equiv), fac-Ir(ppy)3 (0.7 mg, 1.5 
µmol, 0.01 equiv) and activated 4 Å molecular sieves (50 mg). The vial was sealed and a 
needle inserted through the septa and the contents evacuated and backfilled with nitrogen 
(3 x). Anhydrous dichloromethane (1 mL) and trifluoroacetic acid (1.5 µL, 20 µmol) were 
added via syringe. The vial was positioned 5 cm from a 40 W Kessil A160WE LED light and 
irradiated for 2 h with vigorous stirring and fan-cooling, at which time the color of the 
reaction mixture had changed to a fluorescent canary yellow. Upon completion, the reaction 
mixture was filtered through a small plug of celite and the solvent removed in vacuo. The 
crude oil was purified by flash column chromatography (20 % EtOAc in petroleum ether) to 
afford the product (49 mg, 77 µmol, 77%) as a white amorphous solid. Rf (40% EtOAc in 
hexane): 0.35. IR max/cm
-1 (solid): 2960, 1789, 1714, 1612, 1513, 1481, 1455, 1392, 1365, 
1317, 1246, 1227, 1177, 1108, 1035, 994, 966. 1H NMR (500 MHz, CDCl3) : 7.40 – 7.32 (5 
H, m, H24,25,26), 7.08 (2 H, d, J = 8.6 Hz, H6), 6.78 (2 H, d, J = 8.6 Hz, H7), 5.54 (1 H, s, H18), 
5.18 (1 H, d, J = 11.8 Hz, H22a), 5.12 (1 H, d, J = 11.8 Hz, H22b), 4.55 (1 H, d, J = 6.1 Hz, 
H16), 3.92 – 3.82 (4 H, m, H14), 3.77 (3 H, s, H9), 3.56 – 3.54 (1 H, m, H1), 3.53 (3 H, s, H3), 
2.85 – 2.71 (2 H, m, H4), 2.04 (1 H, dd, J = 7.8, 14.6 Hz, H15a), 1.79 (1 H, br s, N–H), 1.76 – 
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1.67 (2 H, m, H15b,11/12), 1.64 – 1.28 (7 H, m, H11/12), 0.92 (9 H, s, H20); 13C NMR (126 MHz, 
CDCl3) : 177.3 (C2), 173.7 (C17), 158.5 (C8), 155.9 (C21), 135.2 (C23), 130.6 (2 C, C6), 129.7 
(C5), 129.2 (C26), 128.9 (2 C, C24/25), 128.8 (2 C, C24/25), 113.8 (2 C, C7), 108.5 (C13), 96.3 
(C18), 68.6 (C22), 64.3 (C14), 64.2 (C14), 56.5 (C1), 55.4 (C9), 54.1 (C10), 53.3 (C16), 51.7 (C3), 
43.5 (br s, C15), 41.1 (C4), 37.1 (C19), 33.3 (C11/12), 31.5 (br s, C11/12), 30.7 (C11/12), 30.4 
(C11/12), 25.0 (3 C, C20). [α]D25 = +8.6 (c = 1.0, CHCl3) m/z HRMS found [M + H]
+ 639.3262, 
C35H47N2O9






Method 1: Methylation of 611 
A Schlenk tube equipped with a magnetic stir bar was charged with methyl (S)-2-((S)-3-
(((benzyloxy)carbonyl)amino)-2,8-dioxo-1-azaspiro [4.5] decan-1-yl)-3-(4-hydroxy-phenyl)-
propanoate 611 (2.47 g, 5.0 mmol, 1.0 equiv) and cesium carbonate (2.44 g, 7.5 mmol, 1.5 
equiv). Acetone (50 mL) was added, followed by methyl iodide (405 µL, 6.5 mmol, 1.3 
equiv) in one portion, and the vessel was sealed under a nitrogen atmosphere and heated to 50 
°C for 5 h with vigorous stirring. The mixture was allowed to cool to ambient temperature and 
filtered through a short pad of celite. The filter cake was washed copiously with 
dichloromethane and the filtrate concentrated to dryness in vacuo to yield the product (2.51 g, 
4.93 mmol, 99%) as a colorless solid, which can be recrystallized from methanol/Et2O (5:1, 
50 °C to −20 °C). m.p. 206 – 208 °C (diffusion. methanol, petroleum ether). Rf (70% EtOAc 
in dichloromethane): 0.21. IR max/cm
-1 (solid): 3302, 2949, 1740, 1692, 1584, 1543, 1510, 
1444, 1418, 1368, 1344, 1326, 1301, 1262, 1243, 1174, 1146, 1109, 1085, 1058, 1032, 1007, 
969. 1H NMR (400 MHz, CDCl3) : 7.43 – 7.31 (5 H, m, H17,18,19), 7.05 (2 H, d, J = 8.5 Hz, 
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H6), 6.81 (2 H, d, J = 8.5 Hz, H7), 5.44 (1 H, br s, N–H), 5.14 (2 H, s, H15), 4.39 – 4.30 (1 H, 
m, H11), 3.77 (3 H, s, H9), 3.76 (3 H, s, H3), 3.70 (1 H, dd, J = 4.5, 11.0 Hz, H1), 3.54 (1 H, 
dd, J = 11.0, 13.9 Hz, H4a), 3.38 (1 H, dd, J = 4.5, 13.9 Hz, H4b), 3.10 (1 H, dd, J = 9.1, 11.6 
Hz, H12a), 2.54 – 2.32 (2 H, m, H21a,21b), 2.20 (1 H, dt, J = 5.3, 14.3 Hz, H21c), 2.11 – 1.97 (2 
H, m, H20a,21d), 1.75 (1 H, dt, J = 5.6, 13.4 Hz, H20b),1.52 (1 H, t, J = 11.6 Hz, H12b), 1.34 (1 
H, dt, J = 4.7, 13.6 Hz, H20c), 0.37 (1 H, d, J = 13.0 Hz, H20d); 13C NMR (101 MHz, CDCl3) 
: 208.3 (C22), 172.6 (C10), 170.0 (C2), 158.8 (C8), 156.6 (C14), 136.2 (C16), 130.9 (2 C, C6), 
130.0 (C5), 128.8 (2 C, C17/18), 128.5 (C19), 128.3 (2 C, C17/18), 114.1 (2 C, C7), 67.4 (C15), 
60.4 (C13), 57.3 (C1), 55.5 (C9), 53.0 (C3), 51.2 (C11), 38.2 (C21), 37.4 (C21), 37.3 (br s, C12), 
35.5 (C20), 34.3 (C4), 32.2 (C20). [α]D25 = −114.1 (c = 0.32, CHCl3); m/z HRMS found [M + 
H]+ 509.2276, C28H33N2O7
+ requires 509.2282. X-ray structure deposited with the Cambridge 
Crystallographic Data Centre: CCDC 1934845. 
Method 2: Cyclization of 605 
To a solution of benzyl (2S,4S)-2-(tert-butyl)-4-((8-(((S)-1-methoxy-3-(4-methoxyphenyl)-1-
oxopropan-2-yl) amino)-1,4-dioxaspiro[4.5]decan-8-yl)methyl)-5-oxooxazolidine-3-carboxyl-
ate 605 (20 mg, 31 µmol, 1.0 equiv) in THF (0.85 mL) was added aq.1M HCl (0.15 mL), and 
the resulting solution stirred for 4 days. The mixture was then basified by addition of aq. sat. 
sodium bicarbonate solution and the aqueous phase extracted with Et2O (3x). The combined 
organic phases were dried, filtered and concentrated in vacuo. The residue was purified by 
flash column chromatography (50 % EtOAc in dichloromethane) to yield the product (9.9 mg, 
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A 100 mL Schlenk tube (ø = ca. 35 mm) equipped with a magnetic stir bar was charged with 
L-tyrosine methyl ester (781 mg, 4.0 mmol, 1.0 equiv), 1,4-cyclohexanedione monoethylene 
acetal (687 mg, 4.4 mmol, 1.1 equiv), benzyl (S)-2-(tert-butyl)-4-methylene-5-
oxooxazolidine-3-carboxylate 360 (1.50 g, 5.2 mmol, 1.3 equiv), Hantzsch Ester (1.52 g, 6.0 
mmol, 1.5 equiv), fac-Ir(ppy)3 (26 mg, 40 µmol, 0.01 equiv) and activated 4 Å molecular 
sieves (2.0 g). The vessel was fitted with a rubber septum and the contents evacuated and 
backfilled with nitrogen (3 x). Dichloromethane (40 mL) and trifluoroacetic acid (61 µL, 0.8 
mmol, 0.2 equiv) were added successively via syringe, the septum replaced by a glass stopper, 
and the vessel sealed. The Schlenk tube was positioned between two 40 W Kessil A160WE 
LED lights (distance 5 cm each) and irradiated for 4 h with vigorous stirring and fan-cooling, 
at which time the color of the reaction mixture had changed to a fluorescent canary yellow. 
Upon completion the crude reaction mixture was filtered through Celite, the filter cake 
washed with copious amounts of dichloromethane and the resulting filtrate concentrated in 
vacuo. The viscous yellow oil was redissolved in tetrahydrofuran (40 mL) and aq. 3 M HCl 
(40 mL) was added. The mixture was placed under a nitrogen atmosphere and heated to 50 °C 
for 20 h with stirring. The solution was allowed to cool and quenched with aq. sat. sodium 
bicarbonate solution until pH 8, at which point a sticky precipitate formed. EtOAc was then 
added to the mixture and the aqueous phase extracted with EtOAc (3 x 500 mL). The 
combined organic phases were dried (MgSO4), filtered, and the solvent removed in vacuo. 
The residue was resuspended in a 1:1 mixture of petroleum ether and Et2O and sonicated. The 
voluminous precipitate was collected by vacuum filtration and washed with a 1:1 mixture of 
petroleum ether and Et2O and a minimal amount of Et2O. The obtained solid was dried under 
high vacuum to afford the product (1.44 g, 2.92 mmol, 73 %) as an off-white amorphous 
solid. Rf (60% EtOAc in dichloromethane): 0.33. IR max/cm
-1 (solid): 3447, 3312, 2956, 
1723, 1694, 1612, 1591, 1547, 1514, 1441, 1415, 1372, 1347, 1325, 1267, 1241, 1214, 1191, 
1168, 1149, 1127, 1103, 1086, 1056, 1036, 1001, 982. 1H NMR (400 MHz, DMSO-d6) : 
9.15 (1 H, s, O–H), 7.82 (1 H, d, J = 8.8 Hz, N–H), 7.43 – 7.30 (5 H, m, H16,17,18), 6.97 (2 H, 
d, J = 8.4 Hz, H6), 6.64 (2 H, d, J = 8.4 Hz, H7), 5.09 (2 H, s, H14), 4.30 – 4.22 (1 H, m, H10), 
4.15 (1 H, t, J = 7.5 Hz, H1), 3.60 (3 H, s, H3), 3.14 (2 H, d, J = 7.5 Hz, H4), 2.83 (1 H, dd, J = 
8.5, 12.1 Hz, H11a), 2.61 – 2.53 (1 H, m, H20a), 2.25 (1 H, dt, J = 5.6, 14.7 Hz, H20'a), 2.09 (1 
H, d, J = 14.7 Hz, H20b), 1.91 – 1.72 (3 H, m, H19,20'b), 1.51 – 1.38 (2 H, m, H11b,19'a), 0.15 (1 
H, br d, J = 10.8 Hz, H19'b). 13C NMR (101 MHz, DMSO-d6) : 208.7 (C21), 172.3 (C9), 170.6 
(C2), 156.1 (C13), 155.8 (C8), 137.0 (C15), 131.1 (2 C, C6), 128.4 (2 C, C16/17), 128.2 (C5), 
128.0 (2 C, C16/17), 127.9 (C18), 114.9 (2 C, C7), 65.6 (C14), 59.0 (C12), 55.6 (C1), 52.1 (C3), 
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50.2 (C10), 37.7 (C20), 36.9 (C20'), 34.9 (C11), 33.7 (2 C, C4,19), 30.8 (C19').  [α]D25 = −136.1 (c 
= 0.23, MeOH). m/z HRMS found [M + H]+ 495.2119, C27H31N2O7
+ requires 495.2126. 
 




A Schlenk tube equipped with a magnetic stir bar was charged with methyl (S)-2-((S)-3-
(((benzyloxy)-carbonyl)amino)-2,8-dioxo-1-azaspiro [4.5] decan-1-yl)-3-(4-hydroxy-phenyl)-
propanoate 611 (989 mg, 2.0 mmol, 1.0 equiv) and cesium carbonate (977 mg, 3.0 mmol, 1.5 
equiv). Acetone (20 mL) was added, followed by prenyl bromide (462 µL, 4.0 mmol, 2.0 
equiv) in one portion, and the vessel was sealed under a nitrogen atmosphere and heated to 50 
°C for 3 h with vigorous stirring. The mixture was allowed to cool to ambient temperature and 
filtered through a short pad of celite. The filter cake was washed copiously with 
dichloromethane and the filtrate concentrated to dryness and dried under high vacuum to yield 
the product (1.09 g, 1.94 mmol, 97%) as an off-white amorphous solid. Rf (60% EtOAc in 
dichloromethane): 0.46. IR max/cm
-1 (solid): 3297, 2946, 1741, 1716, 1690, 1610, 1557, 
1538, 1508, 1445, 1408, 1375, 1328, 1264, 1237, 1221, 1195, 1176, 1146, 1111, 1061, 1051, 
1038, 981. 1H NMR (400 MHz, CDCl3) : 7.40 (5 H, m, H24,25,26), 7.03 (2 H, d, J = 8.5 Hz, 
H6), 6.81 (2 H, d, J = 8.5 Hz, H7), 5.56 (1 H, s, N–H), 5.45 (1 H, tt, J = 1.4, 6.7 Hz, H10), 5.13 
(2 H, s, H22), 4.46 (2 H, br d, J = 6.7 Hz, H9), 4.39 – 4.30 (1 H, m, H15), 3.74 (3 H, s, H3), 3.69 
(1 H, dd, J = 4.5, 11.0 Hz, H1), 3.56 (1 H, dd, J = 11.0, 13.9 Hz, H4a), 3.40 (1 H, dd, J = 4.5, 
13.9 Hz, H4b), 3.14 – 3.00 (1 H, m, H16a), 2.53 – 2.30 (2 H, m, H19a,19b), 2.18 (1 H, dt, J = 5.2, 
14.5 Hz, H19'a), 2.10 – 1.94 (2 H, m, H19'b,18a), 1.78 (3 H, s, H12/13), 1.76 – 1.73 (1 H, m, H18b), 
1.72 (3 H, s, H12/13), 1.51 (1 H, t, J = 11.6 Hz, H16b), 1.33 (1 H, dd, J = 4.7, 13.7 Hz, H18'a), 
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0.37 – 0.27 (1 H, m, H18'b); 13C NMR (101 MHz, CDCl3) : 208.3 (C20), 172.5 (C14), 170.0 
(C2), 158.0 (C8), 156.6 (C21), 138.3 (C11), 136.2 (C23), 130.8 (2 C, C6), 129.9 (C5), 128.7 (2 C, 
C24/25), 128.4 (C26), 128.3 (2 C, C24/25), 119.6 (C10), 114.8 (2 C, C7), 67.3 (C22), 64.9 (C9), 60.4 
(C17), 57.2 (C1), 52.9 (C3), 51.2 (C15), 38.2 (C19), 37.3 (C19'), 37.2 (br s, C16), 35.4 (C18), 34.3 
(C4), 32.1 (C18'), 25.9 (C12/13), 18.3 (C12/13). [α]D25 = −104.8  (c = 1.0, CHCl3). m/z HRMS 
found [M + H]+ 563.2745, C32H38N2O7





A solution of methyl (S)-2-((S)-3-(((benzyloxy)carbonyl)amino)-2,8-dioxo-1-
azaspiro[4.5]decan-1-yl)-3-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)propanoate 617 (1.00 g, 
1.78 mmol, 1.0 equiv) in anhydrous THF (60 mL) was cooled to 0 °C and LiAlH4 (674 mg, 
17.8 mmol, 10.0 equiv) was carefully added portion-wise with stirring. The cooling was 
removed and the stirred reaction mixture heated to a vigorous reflux for 16 h. The reaction 
mixture was allowed to cool to room temperature, then diluted with Et2O, and solid 
NaSO4·10H2O was carefully added until no more gas evolution was observed. Methanol (10 
mL) was added to the mixture and the suspension stirred for 1 hour. The formed off-white 
precipitate was removed by filtration through a pad of Celite, washed with ethyl acetate, and 
the filtrate concentrated in vacuo. The residue was purified by column chromatography (6% 
MeOH, 1% sat. aq. NH3, 93% dichloromethane) to furnish the product (572 mg, 1.42 mmol, 
80%) as a yellow amorphous solid. Rf (15% MeOH, 1% sat. aq. NH3, 84% dichloromethane): 
0.22. IR max/cm
-1 (solid): 3316 (br), 2928, 2854, 1675, 1610, 1581, 1508, 1444, 1365, 1327, 
1297, 1231, 1175, 1139, 1112, 1065, 1041, 1002, 930. 1H NMR (400 MHz, CDCl3) : 7.02 (2 
H, d, J = 8.5 Hz, H5), 6.83 (2 H, d, J = 8.5 Hz, H6), 5.48 (1 H, dt, J = 1.4, 6.8 Hz, H9), 4.48 (2 
H, d, J = 6.7 Hz, H8), 3.63 – 3.54 (1 H, m, H19), 3.32 (1 H, dd, J = 4.9, 10.1 Hz, H2a), 3.22 – 
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3.10 (3 H, m, H2b,13a,14), 3.06 – 2.96 (1 H, m, H1), 2.90 (1 H, dd, J = 3.1, 13.5 Hz, H3a), 2.64 (1 
H, t, J = 7.9 Hz, H13b), 2.46 (3 H, s, H20), 2.44 (1 H, dd, J = 10.6, 13.5 Hz, H3b), 2.19 (1 H, dd, 
J = 8.2, 12.6 Hz, H15a), 2.09 – 1.90 (2 H, m, H17,18a), 1.82 – 1.76 (4 H, m, H17,11/12), 1.74 (3 H, 
s, H11/12), 1.66 – 1.55 (2 H, m, H17,18'a), 1.54 – 1.47 (1 H, m, H15b), 1.46 – 1.34 (2 H, m, 
H17,18b), 1.29 (1 H, dd, J = 3.0, 12.9 Hz, H18'b). 13C NMR (101 MHz, CDCl3) : 157.5 (C7), 
138.3 (C10), 131.0 (C4), 129.8 (2 C, C5), 119.8 (C9), 114.9 (2 C, C6), 70.3 (C19), 64.9 (C8), 
62.6 (C16), 60.6 (C2), 57.7 (C14), 56.5 (C1), 49.6 (C13), 43.1 (C15), 36.5 (C18), 36.4 (C3), 35.4 
(C20), 33.9 (C18), 32.7 (2 C, C17), 26.0 (C11/12), 18.3 (C11/12). [α]D25 = −5.5 (c = 1.0, CHCl3). 
m/z HRMS found [M + H]+ 403.2957, C24H39N2O3
+ requires 403.2955. Configuration at C19 
was tentatively assigned based on compound 622. The data are in accordance with those 
previously reported in the literature.[262] 
 
(1S)-2-methyl-4-(4-((3-methylbut-2-en-1-yl)oxy)benzyl)-2,5-
diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexan]-3-en-4'-one, (+)-TAN1251C (2) 
 
A 10 mL microwave vial equipped with a magnetic stir bar was charged with (3S,5r,8S)-1-
((S)-1-hydroxy-3-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)propan-2-yl) -3- (methylamino)-1-
azaspiro[4.5]decan-8-ol 598 (20 mg, 50 µmol, 1.0 equiv), AZADO (0.8 mg, 5 µmol, 0.1 
equiv), CuCl (0.5 mg, 5 µmol, 0.1 equiv), DMAP (1.2 mg, 10 µmol, 0.2 equiv) and 2,2′-
bipyridine (0.8 mg, 5 µmol, 0.1 equiv). The vial was sealed with a septum cap under air, and a 
needle was inserted through the septum to allow exchange of atmosphere. Acetonitrile (0.7 
mL) was then added and the reaction mixture stirred for 16 h at room temperature. The 
reaction was quenched by addition of sat. aq. sodium bicarbonate solution (5 mL) and stirred 
for 5 min. The aqueous layer was extracted with EtOAc (3 x) and the combined organic 
phases dried over anhydrous Na2SO4 and filtered and concentrated in vacuo. The residue was 
purified by flash column chromatography on neutral aluminium oxide (gradient elution: 100 
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% dichloromethane to 40 % EtOAc in dichloromethane) to yield the product (4.5 mg, 12 
µmol, 24%) as a yellow oil. Rf (50% EtOAc in dichloromethane): 0.21. IR max/cm
-1 (film): 
2922 (br), 1715, 1672, 1640, 1609, 1582, 1507, 1445, 1373, 1324, 1297, 1231, 1172, 1121, 
1054, 1003, 950. 1H NMR (500 MHz, CDCl3) : 7.08 (2 H, d, J = 8.6 Hz, H10), 6.82 (2 H, d, 
J = 8.6 Hz, H11), 5.50 (1 H, tt, J = 1.4, 6.8 Hz, H14), 5.24 (1 H, s, H2), 4.48 (2 H, d, J = 6.7 Hz, 
H13), 3.41 – 3.37 (1 H, m, H1), 3.21 (2 H, s, H8), 3.20 (1 H, dd, J = 2.8, 11.4 Hz, H6a), 2.78 (1 
H, dd, J = 1.8, 11.4 Hz, H6b), 2.63 – 2.56 (1 H, m, C19a), 2.51 (3 H, s, H7), 2.49 – 2.43 (1 H, 
m, H19'a), 2.43 – 2.30 (2 H, m, H18a,19b), 2.29 – 2.17 (2 H, m, H18b,19'b), 1.97 (1 H, ddd, J = 4.8, 
10.7, 13.7 Hz, H18'a), 1.90 – 1.82 (3 H, m, H18'b,5), 1.79 (3 H, s, H16/17), 1.74 (3 H, s, H16/17). 
13C NMR (126 MHz, CDCl3) : 211.8 (C20), 157.3 (C12), 138.1 (C15), 132.1 (C9), 130.0 (2 C, 
C10), 128.4 (C3), 127.9 (C2), 120.0 (C14), 114.5 (2 C, H11), 71.6 (C4), 64.9 (C13), 59.2 (C1), 
52.3 (C6), 43.1 (C5), 41.6 (C8), 40.5 (C7), 39.7 (C19), 38.0 (C19'), 37.4 (C18'), 34.8 (C18), 26.0 
(C16/17), 18.3 (C16/17); [α]D25 =  +24.2 (c = 0.45, MeOH) [lit. +24 (c = 0.44, MeOH)
[339]]; m/z 
HRMS found [M + H]+ 381.2535, C24H33N2O2
+ requires 381.2537. The obtained data are 
identical with those of the natural product.[339] 
 




A solution of methyl (S)-2-((S)-3-(((benzyloxy)carbonyl)amino)-2,8-dioxo-1-
azaspiro[4.5]decan-1-yl)-3-(4-methoxyphenyl)propanoate 609 (192 mg, 0.377 mmol, 1.0 
equiv) in anhydrous THF (15 mL) was cooled to 0 °C and LiAlH4 (143 mg, 3.77 mmol, 10.0 
equiv) was carefully added portion-wise with stirring. The cooling was removed and the 
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stirred reaction mixture heated to a vigorous reflux for 16 h. The reaction mixture was 
allowed to cool to room temperature, then diluted with Et2O, and solid NaSO4·10H2O was 
carefully added until no more gas evolution was observed. Methanol (2 mL) was added to the 
mixture and the suspension stirred overnight. The formed off-white precipitate was removed 
by filtration through a pad of Celite, washed with ethyl acetate, and the filtrate concentrated 
under reduced pressure. The residue was purified by flash column chromatography (12% 
MeOH, 1% sat. aq. NH3, 87% dichloromethane) to yield the product (117 mg, 336 µmol, 
89%) as a pale red viscous oil. Rf (12% MeOH, 1% sat. aq. NH3, 87% dichloromethane): 
0.18. IR max/cm
-1 (solid): 3391 (br), 2933, 2856, 1645, 1611, 1583, 1510, 1442, 1366, 1325, 
1299, 1243, 1176, 1139, 1064, 1029, 987. 1H NMR (500 MHz, CDCl3) : 7.03 (2 H, d, J = 
8.6 Hz, H5), 6.82 (2 H, d, J = 8.5 Hz, H6), 3.79 (3 H, s, H8), 3.64 – 3.55 (1 H, m, H16), 3.31 (1 
H, dd, J = 5.0, 10.1 Hz, H2a), 3.22 – 3.11 (3 H, m, H2b,9a,10), 3.05 – 2.97 (1 H, m, H1), 2.91 (1 
H, dd, J = 3.2, 13.5 Hz, H3a), 2.65 (1 H, t, J = 8.1 Hz, H9b), 2.46 (3 H, s, H13), 2.45 (1 H, dd, J 
= 10.7, 13.5 Hz, H3b), 2.20 (1 H, dd, J = 8.1, 12.6 Hz, H11a), 2.04 – 1.92 (2 H, m, H14,15a), 1.80 
(1 H, dq, J = 3.1, 12.5 Hz, H14), 1.65 – 1.48 (3 H, m, H11b,14,15'a), 1.44 – 1.35 (2 H, m, H14,15b), 
1.29 (1 H, dq, J = 3.2, 12.8 Hz, H15'b); 13C NMR (126 MHz, CDCl3) : 158.3 (C7), 131.1 (C4), 
129.8 (2 C, C5), 114.1 (2 C, C6), 70.3 (C16), 62.6 (C12), 60.6 (C2), 57.7 (C10), 56.5 (C1), 55.4 
(C8), 49.6 (C9), 43.1 (C11), 36.5 (C15'), 36.4 (C3), 35.4 (C13), 33.9 (C15), 32.7 (2 C, C14). [α]D25 
= −2.74 (c = 1.06, CHCl3). m/z HRMS found [M + H]
+ 349.2490, C20H33N2O3
+ requires 
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Method 1: Cbz-protection of 588 
To a stirred solution of (3S,5r,8S)-1-((S)-1-hydroxy-3-(4-methoxyphenyl)propan-2-yl)-3-
(methylamino)-1-azaspiro[4.5]decan-8-ol 588 (75 mg, 215 µmol, 1.0 equiv) in anhydrous 
THF (1 mL) was added Na2CO3 (68 mg, 0.65 mmol, 3.0 equiv) and benzyl chloroformate (37 
µL, 0.26 mmol, 1.2 equiv) in one portion at room temperature. The reaction mixture was 
stirred at room temperature for 16 h, filtered through a pad of Celite, and the filter cake 
washed with dichloromethane. The filtrate was concentrated in vacuo and the residue purified 
by flash column chromatography (gradient elution: 1% MeOH in dichloromethane to 6% 
MeOH in dichloromethane) to yield the product (81 mg, 168 µmol, 78%) as a pale yellow 
amorphous solid.  
Method 2: Reduction and protection of 609 (2 steps) 
Methyl (S)-2-((S)-3-(((benzyloxy)carbonyl)amino)-2,8-dioxo-1-azaspiro[4.5]decan-1-yl)-3-
(4-methoxy-phenyl)propanoate 609 (2.51 g, 4.93 mmol, 1.0 equiv) was dissolved in 
anhydrous THF (60 mL) with gentle heating and then carefully added to a stirred solution of 
LiAlH4 (1.87 g, 49.3 mmol, 10.0 equiv) in anhydrous THF (100 mL) at 0 °C. The cooling was 
removed and the reaction mixture heated to a vigorous reflux for 16 h. The mixture was 
allowed to cool to room temperature, then diluted with Et2O and solid NaSO4·10H2O was 
carefully added until no more gas evolution was observed. Methanol (10 mL) and water (2 
mL) was successively added to the mixture and the suspension stirred for 3 h at room 
temperature, at which point anhydrous Na2SO4 was added to the suspension. The off-white 
precipitate was then removed by filtration through a pad of Celite, the filter cake washed with 
ethyl acetate, and the filtrate concentrated in vacuo. The residue was dried under high vacuum 
and then redissolved in anhydrous THF (100 mL) and Na2CO3 (1.57 g, 14.8 mmol, 3.0 equiv) 
was added in one portion. Benzyl chloroformate (840 µL, 5.92 mmol, 1.2 equiv) was added 
dropwise with stirring and the resulting suspension stirred at room temperature for 16 h. The 
mixture was filtered through a pad of Celite, and the filter cake washed with dichloromethane. 
The filtrate was concentrated in vacuo and the residue purified by flash column 
chromatography (gradient elution: 80% EtOAc in dichloromethane to 100% EtOAc) to yield 
the product (1.63 g, 3.38 mmol, 69%) as pale yellow amorphous solid. Rf (80% EtOAc in 
dichloromethane): 0.11. IR max/cm
-1 (solid): 3390 (br), 2935, 2856, 1677, 1611, 1584, 1510, 
1442, 1408, 1319, 1301, 1244, 1150, 1028, 986. 1H NMR (400 MHz, CDCl3) : 7.40 – 7.29 
(5 H, m, H16,17,18), 7.03 (2 H, d, J = 8.6 Hz, H5), 6.82 (2 H, d, J = 8.6 Hz, H6), 5.17 (1 H, d, J = 
12.5, H14a), 5.14 (1 H, d, J = 12.5, H14b), 4.63 (1 H, br s, H10), 3.79 (3 H, s, H8), 3.64 – 3.54 
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(1 H, m, H22), 3.31 (1 H, dd, J = 4.7, 10.3 Hz, H2a), 3.15 (1 H, t, J = 10.1 Hz, H2b), 3.05 – 2.92 
(3 H, m, H1,9), 2.91 – 2.84 (4 H, m, H19,3a), 2.78 (1 H, br s, OH), 2.43 (1 H, dd, J = 10.9, 13.3 
Hz, H3b), 2.08 (1 H, dd, J = 9.6, 12.8 Hz, H11a), 2.05 – 1.91 (2 H, m, H20,21a), 1.76 – 1.68 (2 H, 
m, H11b,20), 1.63 – 1.58 (2 H, H20,21'a), 1.42 – 1.30 (3 H, m, H20,21b,21'b); 13C NMR (101 MHz, 
CDCl3) : 158.3 (C7), 156.6 (C13), 136.8 (C15), 130.9 (C4), 129.8 (2 C, C5), 128.7 (2 C, C16/17), 
128.2 (C18), 128.1 (2 C, C16/17), 114.1 (2 C, C6), 70.2 (C22), 67.4 (C14), 62.3 (C12), 60.8 (C2), 
56.7 (C1), 55.4 (C8), 53.6 (C10), 44.4 (br s, C9), 37.8 (br s, C11), 36.4 (C3), 36.1 (C21'), 33.9 
(C21), 32.6 (2 C, C20), 30.1 (C19). [α]D25 = −4.8 (c = 1.0, CHCl3). m/z HRMS found [M + H]
+ 
483.2861, C28H39N2O5
+ requires 483.2853. Configuration at C22 was tentatively assigned due 






Oxalyl chloride (910 µL, 10.8 mmol, 8.0 equiv) was dissolved in anhydrous dichloromethane 
(30 mL) and cooled to −78 °C. Anhydrous dimethyl sulfoxide (1.53 mL, 21.5 mmol, 16.0 
equiv) was added dropwise as a solution in dichloromethane (2.5 mL). The mixture was 
stirred for 15 min at −78 °C, then a solution of benzyl ((3S,5r,8S)-8-hydroxy-1-((S)-1-
hydroxy-3-(4-methoxyphenyl)propan-2-yl)-1-azaspiro[4.5]decan-3-yl)(methyl)carbamate 622 
(650 mg, 1.35 mmol, 1.0 equiv) in dichloromethane (18 mL) was added dropwise over the 
course of 30 min. The reaction mixture was stirred for a further 30 min at −78 °C, at which 
point the mixture was allowed to gradually warm to 0 °C. The mixture was stirred for 30 min 
at 0 °C, then H2O (30 mL) and brine (10 mL) was added, and the aqueous layer extracted with 
dichloromethane (3 x). The combined organic phases were dried (MgSO4), filtered and 
Chapter Five – Experimental Section 
 
  207 
concentrated in vacuo. The oily residue was purified by flash column chromatography 
(gradient elution: 30% EtOAc in petroleum ether to 50 % EtOAc in petroleum ether) to yield 
the product (395 mg, 0.824 mol, 61%) as a viscous yellow gum, which can be stored for 
several days at −20 °C. Rf (50% EtOAc in petroleum ether): 0.22. IR max/cm
-1 (solid): 2935, 
2836, 1691, 1611, 1584, 1511, 1441, 1410, 1383, 1314, 1301, 1245, 1145, 1031, 978, 958. 1H 
NMR (400 MHz, CDCl3) : 9.65 (1 H, s, H2), 7.40 – 7.28 (5 H, m, H16,17,18), 7.07 (2 H, d, J = 
8.6 Hz, H5), 6.80 (2 H, d, J = 8.6 Hz, H6), 5.15 (2 H, s, H14), 4.88 (1 H, br s, H10), 3.77 (3 H, s, 
H8), 3.50 (1 H, t, J = 7.2 Hz, H1), 3.19 (1 H, t, J = 8.6 Hz, H9a), 3.12 – 3.06 (2 H, m, H9b,3a), 
2.83 (3 H, s, H19), 2.64 (1 H, dd, J = 7.8, 13.9 Hz, H3b), 2.46 – 2.26 (5 H, m, H21,11a), 1.93 – 
1.81 (1 H, m, H20a), 1.80 – 1.60 (3 H, m, H11b,20'a,20b), 1.36 – 1.29 (1 H, m, H20'b). 13C NMR 
(101 MHz, CDCl3) : 210.1 (C22), 201.1 (C2), 158.4 (C7), 156.5 (C13), 136.8 (C15), 130.4 (C4), 
130.2 (2 C, C5), 128.7 (2 C, C16/17), 128.2 (C18), 128.1 (2 C, C16/17), 114.0 (2 C, C6), 67.4 
(C14), 63.9 (C1), 62.0 (C12), 55.4 (C8), 52.9 (C10), 46.8 (br s, C9), 39.2 (C21), 39.1 (C21'), 37.4 
(br s, C11), 35.5 (C20'), 34.7 (C20), 32.7 (C3), 29.4 (br s, C19). [α]D25 = −94.2 (c = 1.0, CHCl3). 
m/z HRMS found [M + H]+ 479.2538, C28H35N2O5





To a stirred solution of benzyl ((S)-1-((S)-1-(4-methoxyphenyl)-3-oxopropan-2-yl)-8-oxo-1-
azaspiro[4.5]decan-3-yl)(methyl)carbamate 626 (200 mg, 418 µmol, 1.0 equiv) in anhydrous 
MeOH (8 mL) was added sodium methoxide (45 mg, 836 µmol, 2.0 equiv) in one portion at 
room temperature. The mixture was stirred for 1 h at room temperature, then poured into half-
saturated brine, and the mixture extracted with EtOAc (4 x). The combined organic phases 
were dried (MgSO4), filtered and concentrated under reduced pressure. Separation of the 
mixture of diastereomers in the crude material by preparative TLC (60% EtOAc in 
dichloromethane) yielded the product (60 mg, 125 µmol, 30%) as a pale yellow foam. Rf 
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(40% EtOAc in dichloromethane): 0.10. IR max/cm
-1 (solid): 3435 (br), 2938, 1690, 1611, 
1584, 1511, 1443, 1409, 1329, 1308, 1244, 1211, 1176, 1152, 1032, 984. 1H NMR (500 
MHz, CDCl3) : 7.41 – 7.29 (5 H, m, H21,22,23), 7.10 (2 H, d, J = 8.6 Hz, H14), 6.80 (2 H, d, J 
= 8.6 Hz, H15), 5.12 (2 H, s, H19), 4.85 (1 H, br s, H2), 3.77 (3 H, s, H17), 3.54 – 3.50 (1 H, m, 
H5), 3.47 (1 H, br s, H3a), 2.89 – 2.82 (1 H, m, H4), 2.81 – 2.74 (3 H, m, H3b,12), 2.77 (3 H, s, 
H24), 2.68 (1 H, q, J = 3.0 Hz, H6), 2.55 (1 H, ddd, J = 8.2, 10.9, 18.0 Hz, H8a), 2.44 (1 H, 
ddd, J = 3.8, 8.2, 18.0 Hz, H8b), 2.25 – 2.08 (3 H, m, H1a,9a,11a), 2.20 (1 H, d, J = 7.2 Hz, OH), 
1.97 (1 H, t, J = 11.8 Hz, H9b), 1.79 (1 H, dd, J = 3.0, 13.4 Hz, H11b), 1.67 (1 H, dd, J = 6.1, 
13.7 Hz, H1b); 13C NMR (126 MHz, CDCl3) : 213.0 (C7), 158.3 (C16), 156.5 (C18), 136.9 
(C20), 130.1 (3 C, C13,14), 128.6 (2 C, C21/22), 128.2 (C23), 128.1 (2 C, C21/22), 114.1 (2 C, C15), 
69.0 (C5), 67.4 (C19), 58.7 (C10), 57.8 (C4), 55.4  (C17), 52.1 (2 C, C2,6), 49.2 (C3), 43.7 (br s, 
C1), 37.9 (C8), 35.8 (C12), 29.9 (br s, C9), 29.3 (C24), 27.5 (br s, C11). [α]D25 = −27.2 (c = 1.0, 
CHCl3). m/z HRMS found [M + H]
+
 479.2545, C28H35N2O5
+ requires 479.2540. The 
following correlations were observed in a 1H-1H-NOESY experiment: [H4–H8b], [H4–H5]; 





Rf (40% EtOAc in dichloromethane): 0.21. IR max/cm
-1 (solid):  3416 (br), 2936, 2835, 1690, 
1611, 1584, 1511, 1442, 1410, 1329, 1307, 1244, 1210, 1177, 1153, 1114, 1061, 1031, 995. 
1H NMR (500 MHz, CDCl3) : 7.39 – 7.29 (5 H, m, H21,22,23), 7.16 (2 H, d, J = 8.5 Hz, H14), 
6.80 (2 H, d, J = 8.5 Hz, H15), 5.08 (2 H, s, H19), 4.85 (1 H, br s, H2), 3.82 –3.77 (1 H, m, H5), 
3.77 (3 H, s, H17), 3.29 (1 H, dd, J = 3.7, 15.3 Hz, H12a), 3.27 – 3.18 (1 H, m, H3a), 3.04 (1 H, 
dt, J = 3.8, 10.5 Hz, H4), 2.80 (1 H, d, J = 8.0 Hz, OH), 2.77 (1 H, dd, J = 3.6, 10.5 Hz, H3b), 
2.72 (1 H, br s, H6), 2.67 – 2.54 (2 H, m, H8), 2.51 (1 H, dd, J = 10.2, 15.1 Hz, H12b), 2.46 (3 
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H, s, H24), 2.17 – 1.93 (4 H, m, H1a,9,11a), 1.88 (1 H, dd, J = 3.8, 13.7 Hz, H11b), 1.56 (1 H, dd, 
J = 6.7, 13.4, H1b). 13C NMR (126 MHz, CDCl3) : 216.8 (C7), 158.0 (C16), 156.4 (C18), 
136.9 (C20), 131.3 (C13), 129.6 (2 C, C14), 128.6 (2 C, C21/22), 128.1 (C23), 128.0 (2 C, C21/22), 
113.8 (2 C, C15), 69.0 (br s, C5), 67.2 (C19), 59.2 (C4), 58.3 (C10), 55.4 (C17), 51.7 (C2), 50.0 
(C6), 47.8 (br s, C3), 43.1 (br s, C1), 38.7 (C8), 35.1 (C12), 31.1 (C9), 30.6 (br s, C11), 28.4 (br 
s, C24). m/z HRMS found [M + H]
+ 479.2544, C28H35N2O5
+ requires 479.2540. The following 
correlations were observed in a 1H-1H-NOESY experiment: [H4–H5], [H4–H12a], [H4–H8], 





Rf (40% EtOAc in dichloromethane): 0.36. IR max/cm
-1 (solid): 3416 (br), 1692, 1610, 1584, 
1510, 1441, 1412, 1386, 1343, 1314, 1299, 1246, 1209, 1176, 1149, 1105, 1069, 1028, 987. 
1H NMR (500 MHz, CDCl3) : 7.40 – 7.30 (5 H, m, H21,22,23), 7.17 (2 H, d, J = 8.5 Hz, H14), 
6.82 (2 H, d, J = 8.5 Hz, H15), 5.17 (2 H, s, H19), 4.93 (1 H, br s, H2), 3.79 (3 H, s, H17), 3.54 
(1 H, t, J = 7.4 Hz, H3a), 3.49 (1 H, dd, J = 2.8, 8.2 Hz, H5), 2.99 (1 H, dd, J = 3.8, 14.1 Hz, 
H12a), 2.87 (3 H, s, H24), 2.86 – 2.83 (1 H, m, H4), 2.77 (1 H, dd, J = 5.6, 14.1 Hz, H12b), 2.57 
(1 H, dd, J = 9.0, 10.6 Hz, H3b), 2.47 (1 H, br s, H6), 2.46 – 2.39 (1 H, m, H8a), 2.23 (1 H, dt, J 
= 3.3, 13.5 Hz, H11a), 2.07 (1 H, br d, J = 15.0 Hz, H8b), 1.91 – 1.82 (3 H, m, H11b,9a,1a), 1.79 
(1 H, dd, J = 6.3, 11.6 Hz, H1b), 1.56 (1 H, br s, OH), 1.48 (1 H, dt, J = 5.1, 12.8 Hz, H9b). 13C 
NMR (126 MHz, CDCl3) : 212.5 (C7), 158.5 (C16), 156.7 (C18), 136.8 (C20), 131.0 (2 C, 
C14), 129.5 (C13), 128.7 (2 C, C21/22), 128.2 (C23), 128.1 (2 C, C21/22), 114.1 (2 C, C15), 70.9 
(C5), 67.5 (C19), 65.5 (C4), 58.1 (C10), 56.4 (br s, C3), 55.4 (C17), 54.4 (C6), 52.6 (C2), 40.4 (br 
s, C1), 39.4 (C9), 37.7 (br s, C12), 35.8 (C8), 32.9 (C11), 28.8 (C24). m/z HRMS found [M + H]
+ 
479.2546, C28H35N2O5
+ requires 479.2540. The following correlations were observed in a 1H-
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1H-ROESY experiment: [H4–H12b], [H4–H3b], [H4–H11a], [H4–H5], [H4–H12a]; [H5–H12a], [H5–





A solution of benzyl ((2S,5S,6S,7R,10aS)-6-hydroxy-5-(4-methoxybenzyl)-8-oxooctahydro-
1H-7,10a-methanopyrrolo[1,2-a]azocin-2-yl)(methyl)carbamate 628 (70 mg, 0.146 mmol, 1.0 
equiv) in THF (2.2 mL) was cooled to −78 °C and L-selectride (364 µL, 1 M in THF, 0.364 
mmol, 2.5 equiv) was added dropwise with stirring. The reaction was stirred for 4 h at −78 
°C, at which point residual hydride was quenched by the careful dropwise addition of H2O at 
−78 °C, followed by warming to room temperature with stirring. The mixture was poured into 
aq. 10% NaOH solution (8 mL) and stirred vigorously for 1 h at room temperature (monitored 
by TLC). Upon completion, the biphasic mixture was diluted with brine and the aqueous 
phase extracted with EtOAc (3 x). The combined organic phases were dried over MgSO4, 
filtered and concentrated in vacuo. Purification of the residue by flash column 
chromatography (gradient elution: 2% MeOH in dichloromethane to 9% MeOH, 1% sat. aq. 
NH3, 90% dichloromethane) yielded the product (54 mg, 0.112 mmol, 77%) as a colorless 
foam. Rf (7.5% MeOH in dichloromethane): 0.05. IR max/cm
-1 (solid): 3376 (br), 2938, 1674, 
1611, 1584, 1511, 1442, 1410, 1329, 1302, 1245, 1210, 1150, 1030, 978. 1H NMR (400 
MHz, CD3CN) : 7.42 – 7.48 (5 H, m, H21,22,23), 7.25 (2 H, d, J = 8.3 Hz, H14), 6.84 (2 H, d, J 
= 8.3 Hz, H15), 5.05 (2 H, s, H19), 4.67 (1 H, br s, H2), 3.88 (1 H, br s, H7), 3.75 (3 H, s, H17), 
3.68 – 3.45 (3 H, m, H5,4,3a), 2.83 (5 H, br s, H3b,12), 2.65 (3 H, br s, H24), 2.15 (2 H, br s, 
H6,11a),  1.91 – 1.70 (4 H, m, H8,9), 1.65 (1 H, br s), 1.40 (1 H, br s), 0.99 (1 H, br s, H11b). 13C 
NMR (101 MHz, CD3CN) : 159.0 (C16), 156.9 (C18), 138.5 (C20), 132.8 (C13), 131.2 (2 C, 
C14), 129.4 (2 C, C21/22), 128.8 (C23), 128.6 (2 C, C21/22), 114.5 (2 C, C15), 70.3 (br s, C7), 67.4 
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(C19), 66.3 (br s, C4), 60.5 (br s, C5), 59.4 (br s, C10), 55.8 (C17), 52.8 (C2), 51.6 (C3), 44.9 (br 
s, C6), 43.1 (br s, C1), 36.1 (br s, C12), 34.7, 31.5 (C9), 29.6 (C24), 28.3 (C11). [α]D22 = −2.3 (c 
= 0.6 , CHCl3). m/z HRMS found [M + H]
+ 481.2702, C28H37N2O5
+ requires 481.2697. The 
following correlations were observed in a 1H-1H-NOESY experiment: [H7–H11], [H7–H9], 







To a stirred solution of benzyl ((2S,5S,6S,7S,8R,10aS)-6,8-dihydroxy-5-(4-
methoxybenzyl)octahydro-1H-7,10a-methanopyrrolo [1,2-a] azocin-2-yl)(methyl)carbamate 
404 (54 mg, 0.112 mmol, 1.0 equiv) in anhydrous THF (2.3 mL) was added, successively at 
room temperature, dibenzyl phosphate (187 mg, 0.673 mmol, 6.0 equiv) in anhydrous THF 
(1.6 mL), tris(4-chlorophenyl)phosphine (122 mg, 0.336 mmol, 3.0 equiv) in anhydrous THF 
(1.6 mL), DIAD (66 µL, 0.336 mmol, 3.0 equiv) and anhydrous triethylamine (156 µL, 1.12 
mmol, 10.0 equiv). The mixture was stirred for 1 h at room temperature, poured into half-
saturated brine and the resulting mixture extracted with EtOAc (3 x). The combined organic 
phases were dried (MgSO4), filtered and concentrated in vacuo. The residue was purified by 
preparative TLC (3% MeOH, 97% EtOAc) to yield the product (28 mg, 38 µmol, 34%) as a 
colorless foam. Rf (3% MeOH in EtOAc): 0.44. IR max/cm
-1 (film): 3424 (br), 3030, 2936, 
1691, 1610, 1584, 1511, 1497, 1455, 1410, 1379, 1327, 1301, 1245, 1214, 1152, 1107, 990. 
1H NMR (500 MHz, CDCl3) : 7.40 – 7.28 (15 H, m, H27,28,29), 7.15 (2 H, d, J = 8.6 Hz, H14), 
6.82 (2 H, d, J = 8.6 Hz, H15), 5.11 (2 H, s, H19), 5.05 – 4.94 (4 H, m, H25), 4.79 (1 H, br s, 
C2), 4.33 (1 H, br s, H7), 3.79 (3 H, s, H17), 3.44 (1 H, br s, H3a), 3.30 (1 H, t, J = 7.0 Hz, H4), 
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3.17 – 3.14 (1 H, m, H5), 2.81 – 2.79 (2 H, m, H12), 2.78 (3 H, s, H24), 2.74 (1 H, dd, J = 5.4, 
9.8 Hz, H3b), 2.13 (1 H, br s, H6), 2.09 – 1.99 (1 H, m, H8a), 1.94 – 1.73 (4 H, m, H1a,8b,9a,11a), 
1.71 (1 H, d, J = 5.6 Hz, OH), 1.65 – 1.56 (1 H, m, H9b), 1.49 (1 H, d, J = 12.9 Hz, H11b), 1.42 
(1 H, dd, J = 6.5, 13.4 Hz, H1b). 13C NMR (126 MHz, CDCl3) : 158.2 (C16), 156.5 (C18), 
137.0 (C20), 136.0 (2 C, d, JC–P = 6.3 Hz, C26), 130.9 (br s, C13), 130.2 (2 C, C14), 128.69 (4 
C), 128.65, 128.64, 128.60 (2 C), 128.07 (3 C), 128.04 (2 C), 128.00 (2 C), 113.9 (2 C, C15), 
75.1 (d, JC–P = 6.0 Hz, C7), 69.4 (d, JC–P = 5.7 Hz, C25), 69.3 (d, JC–P = 5.7 Hz, C25), 67.2 
(C19), 67.1 (C5), 58.6 (C4), 58.4 (C10), 55.4 (C17), 52.0 (C2), 50.3 (C3), 43.6 (d, JC–P = 4.2 Hz, 
C6), 43.1 (C1), 35.8 (C12), 30.0 (br s, C9), 29.1 (br s, C24), 28.8 (d, JC–P = 4.2 Hz, C8), 24.0 (br 
s, C11). 31P NMR (202 MHz, CDCl3) : −1.33 (s). [α]D22 = +7.7 (c = 1.0, CHCl3). m/z HRMS 
found [M + H]+ 741.3291, C42H50N2O8P
+ requires 741.3299. The data are in accordance with 
those previously reported in the literature.[252] 
 
(2S,5S,6S,7R,8S,10aS)-6-hydroxy-5-(4-methoxybenzyl)-2-(methylamino)octahydro-1H-
7,10a-methanopyrrolo[1,2-a]azocin-8-yl dihydrogen phosphate, (−)-FR901483 (1) 
 
To a solution of benzyl ((2S,5S,6S,7R,8S,10aS)-8-((bis(benzyloxy)phosphoryl)oxy)-6-
hydroxy-5-(4-methoxybenzyl)octahydro-1H-7,10a-methanopyrrolo[1,2-a]azocin-2-yl)-(meth-
yl)carbamate 423 (19 mg, 26 µmol, 1.0 equiv) in MeOH (3 mL) was added aq. 3 M HCl (9.6 
µL, 28.8 µmol, 1.1 equiv), and the resulting solution was concentrated in vacuo. The residue 
was dried for 1 h under high vacuum and redissolved in methanol (1.5 mL) under a nitrogen 
atmosphere. Pd/C (8.4 mg, 10%, 7.9 µmol, 0.3 equiv) was then added in one portion, the 
atmosphere exchanged to 1 atm of H2, and the solution stirred at r.t. for 4 h. The mixture was 
filtered through a pad of celite, the filter cake washed with MeOH, and the filtrate 
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concentrated under reduced pressure to yield (−)-FR901483·HCl (10 mg, 22 µmol, 85%) as a 
colorless solid. m.p. = 220 – 225 °C, decomp. (MeOH/Et2O) (lit. 210 – 213 °C).
[250] IR 
max/cm
-1 (solid): 3329 (br), 3276 (br), 2937, 2706, 2450, 1611, 1513, 1443, 1301, 1246, 
1178, 999. 1H NMR (500 MHz, methanol-d4) : 7.32 (2 H, d, J = 8.4 Hz, H14), 6.88 (2 H, d, J 
= 8.4 Hz, H15), 4.47 (1 H, dd, J = 9.8, 12.9 Hz, H3a), 4.25 (1 H, br s, H7), 4.23 – 4.16 (1 H, m, 
H2), 3.88 – 3.80 (2 H, m, H3b,4), 3.78 (3 H, s, H17), 3.60 (1 H, br s, H5), 3.30 – 3.25 (1 H, m, 
H12a), 3.05 (1 H, d, J = 10.6 Hz, H12b), 2.72 (3 H, s, H18), 2.65 – 2.56 (1 H, m, H1a), 2.45 (1 H, 
br s, H6), 2.31 – 2.20 (2 H, m, H11a,8a), 2.19 – 2.03 (4 H, m, H8b,9,1b), 1.90 (1 H, d, J = 13.7 Hz, 
H11b). 13C NMR (126 MHz, methanol-d4) : 160.4 (C16), 131.7 (2 C, C14), 128.6 (C13), 115.3 
(2 C, C15), 71.1 (d, JC–P = 5.3 Hz, C7), 68.3 (C10), 64.0 (C5), 61.7 (C4), 55.7 (C17), 54.9 (C2), 
51.8 (C3), 42.9 (d, JC–P = 3.7 Hz, C6), 41.8 (C1), 34.0 (C12), 32.3 (C18), 28.3 (C8), 27.9 (C9), 
22.4 (C11). 31P NMR (162 MHz, methanol-d4) : −0.09 (s). [α]D
22 = −10.7 (c = 0.28, MeOH) 
[lit. [α]D
25 = −11 (c = 0.74, MeOH)[250]] m/z HRMS found [M + H]+ 427.1997, C20H32N2O6P
+ 
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(E)-1-propenyl phenyl sulfone (657)[385] 
 
Allyl phenyl sulfone (1.82 g, 10 mmol) was dissolved in dichloromethane (10 mL), and 1 M 
aq. NaOH (5 mL) and Bu4NOH (0.26 g, 1 mmol) was added. The reaction mixture was stirred 
for 4 h at room temperature, diluted with dichloromethane (40 mL), washed with water (20 
mL) and brine (20 mL). The organic phase was dried (MgSO4), filtered, and concentrated 
under reduced pressure. The obtained mixture of isomers was purified by recrystallization 
from triethylamine to afford the product (207 mg, 1.13 mmol, 11%) as a crystalline solid. Rf 
(20% EA in petroleum ether): 0.17. 1H NMR (400 MHz, CDCl3) : 7.93 – 7.85 (2 H, m, H5), 
7.64 – 7.57 (1 H, m, H7), 7.57 – 7.49 (2 H, m, H6), 6.99 (1 H, dq, J = 6.9, 15.0 Hz, H2), 6.34 
(1 H, dq, J = 1.6, 15.0 Hz, H1), 1.93 (3 H, dd, J = 1.6, 6.9 Hz, H3). 13C NMR (101 MHz, 
CDCl3) : 142.7 (C2), 140.8 (C4), 133.4 (C7), 132.0 (C1), 129.4 (2 C, C6), 127.7 (2 C, C5), 





N-benzoylbenzamide (225 mg, 1.0 mmol) was dissolved in THF (10 mL). After careful 
addition of lithium aluminium deuteride (126 mg, 3.0 mmol) the reaction mixture was heated 
to reflux with stirring for 18 h. The purple solution was allowed to cool to ambient 
temperature and then quenched by slow addition of solid sodium sulphate hexahydrate under 
vigorous stirring. The resulting slurry was diluted with Et2O and filtered. The colorless filtrate 
was concentrated in vacuo. The resulting oil was purified using flash column chromatography 
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(50% EtOAc in P.E.) to afford bis(phenylmethyl-d2)amine (141 mg, 70%) as a colorless oil. 
Rf (50% EtOAc in P.E.): 0.35; IR max/cm
-1 (film): 3059, 3024, 2160, 2061, 1947, 1493, 
1447, 1420, 1234, 1131, 1071, 1025, 912, 842, 787, 695. 1H NMR (400 MHz, CDCl3) : 7.43 
– 7.26 (10 H, m, H3,4,5), 1.68 (1 H, br s, N–H); 13C NMR (101 MHz, CDCl3) : 140.3 (C2), 
128.4 (C3/4), 128.2 (C3/4), 127.0 (C5), 52.4 (quint, J = 20.5 Hz, C1). m/z HRMS found [M + 




Benzamide (15 g, 124 mmol) was dissolved in pyridine (75 mL) and cooled to 0°C. After the 
dropwise addition of benzoyl chloride (17.5 mL, 125 mmol) the reaction mixture was stirred 
at 0 °C for 8 h, then H2O (300 mL) was added in one portion to the reaction. The reaction 
mixture was extracted with Et2O (2 x 100 mL). The combined organic phases were washed 
with 10% aqueous H2SO4 (2 x) leading to the formation of a colorless crystalline precipitate, 
which was collected by filtration. A second crop of crystals can be obtained from the organic 
layer upon standing. The combined precipitate was recrystallized from EtOAc to afford N-
benzoylbenzamide (3.26 g, 12%) as colorless needles. m.p. 139 – 140 °C;  IR max/cm
-1 
(neat): 3246, 3061, 1703, 1674, 1600, 1582, 1498, 1464, 1443, 1218, 1175, 1114, 1070, 1024, 
1000, 972, 851, 806, 706. 1H NMR (400 MHz, CDCl3) : 8.97 (1 H, br s, N–H), 7.90 (4 H, d, 
J = 7.3 Hz, H3), 7.64 (2 H, t, J = 7.3 Hz, H5), 7.53 (4 H, t, J = 7.4 Hz, H4); 13C NMR (101 
MHz, CDCl3) : 166.3 (C1), 133.4 (C2), 133.1 (C5), 128.9 (C3/4), 127.9 (C3/4). m/z HRMS 
found [M + H]+  226.0863, C14H12NO2 requires 226.0863. The data are in accordance with 
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4-(cyclohex-1-en-1-yl)-1-methylpiperidine (659)[386] 
 
A solution of 1-methyl piperazine (5.54 mL, 50 mmol, 1.0 equiv), cyclohexanone (6.22 mL, 
60 mmol, 1.2 equiv) and PTSA (50 mg) in toluene (30 mL) was heated to reflux using a 
Dean-Stark trap for 24 h. After removal of the solvent by distillation. Purification of the 
residue by vacuum distillation afforded the product (6.80 g, 37.7 mmol, 75%) as a colorless 
liquid. b.p. 64 °C (0.09 mbar). 1H NMR (400 MHz, CDCl3) : 4.52 (1 H, br s), 2.67 (4 H, br 
s), 2.30 (4 H, br s), 2.15 (3 H, s), 1.91 (4 H, br s), 1.52 (2 H, br s), 1.40 (2 H, br s); 13C NMR 
(101 MHz, CDCl3) : 145.2, 100.2, 55.2, 47.7, 46.0, 27.1, 24.4, 23.2, 22.7. Product obtained 





2-Bromopyridine (3.95 g, 2.38 mL, 25.0 mmol) was dissolved in anhydrous Et2O (100 mL) 
and cooled to −78 °C under N2. n-Butyllithium (2.5 M in hexanes, 10.0 mL, 25.0 mmol) was 
added dropwise and the resulting solution stirred at −78 °C for 45 min. A solution of 3′,4′-
(methylenedioxy)acetophenone in warm THF (20 mL) was added dropwise at −78 °C and the 
resulting mixture stirred for 18 h while gradually being allowed to warm to ambient 
temperature. After the addition of aqueous saturated NH4Cl solution (75 mL) the biphasic 
mixture was diluted with Et2O, the organic phase separated, and the aqueous phase extracted 
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once with Et2O. The organics were combined and aqueous HCl (3 M, 100 mL) was added. 
The layers were separated and the aqueous layer extracted twice with Et2O. The aqueous layer 
was basified by addition of aqueous NaOH (2.5 M) to pH = 10 and extracted three times with 
Et2O. The organic phases were combined, dried (MgSO4), and removed in vacuo to give 
crude 1-(benzo[d][1,3]dioxol-5-yl)-1-(pyridin-2-yl)ethan-1-ol as a brown oil which was used 
without further purification. 1H NMR (400 MHz, CDCl3) : 4.63 (1 H, d, J = 5.2 Hz), 7.67 (1 
H, t, J = 7.5 Hz), 7.29 (1 H, d, J = 7.5 Hz), 7.20 (1 H, dd, J = 5.3, 7.1 Hz), 7.00 – 6.93 (2 H, 
m), 6.76 (1 H, d, J = 8.8 Hz), 5.93 (2 H, s), 5.82 (1 H, s), 1.90 (3 H, s). 
 
Step 2 (prepared according to modified procedure)[204] 
The crude benzo[d][1,3]dioxol-5-yl)-1-(pyridin-2-yl)ethan-1-ol from step 1 was dissolved in 
dichloromethane (125 mL) and cooled to 0 °C. After the addition of triethylamine (14 mL, 
100 mmol), methanesulfonyl chloride (5.80 mL, 75 mmol) was added dropwise to the 
reaction mixture. The cooling was then removed and the reaction mixture stirred at ambient 
temperature for 24 h. After addition of aqueous saturated NH4Cl solution the biphasic mixture 
was extracted three times with dichloromethane and the combined organic phases dried 
(MgSO4), filtered and concentrated in vacuo. The residue was purified by flash column 
chromatography (gradient elution: 20% EtOAc in P.E. to 30 % EtOAc in P.E.) to afford the 
product 2-(1-(benzo[d][1,3]dioxol-5-yl)vinyl)pyridine as a pale brown oil that turned dark 
brown on standing (3.64 g, 64% over 2 steps). Rf (20% EtOAc in P.E.): 0.20; IR max/cm
-1 
(film): 3048, 3005, 2891, 2777, 1582, 1562, 1500, 1486, 1429, 1354, 1324, 1230, 1104, 1035, 
935, 916, 863, 800, 747, 733. 1H NMR (400 MHz, CDCl3) : 8.62 (1 H, d, J = 4.5 Hz), 7.63 
(1 H, dt, J = 7.7, 1.8 Hz), 7.30 (1 H, d, J = 7.7 Hz), 7.19 (1 H, dd, J = 7.5, 5.2 Hz), 6.85 – 6.76 
(3 H, m), 5.96 (2 H, s), 5.84 (1 H, d, J = 1.2 Hz), 5.54 (1 H, d, J = 1.2 Hz); 13C NMR (101 
MHz, CDCl3) : 158.8, 149.3, 148.8, 147.5, 147.4, 136.3, 134.5, 122.9, 122.4, 122.1, 116.8, 
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diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate-1-d (N-d-316) 
 
N-d-316 was prepared according to Inouye et al.[248] Commercial ethyl-Hantzsch Ester (2.03 
g, 8.00 mmol) was dissolved in a 2:1 mixture of THF (10 mL) and D2O (5 mL), brought to 
reflux until all solids were dissolved. The heating was removed and the mixture slowly 
allowed to cool to −5 °C. The mother liquor was decanted and the described recrystallization 
repeated. The obtained crystals were collected via vacuum filtration, and dried in vacuum, 
yielding  N-d-316 (1.31 g, 5.14 mmol, 64%, 97% N-d1 via 
1H-NMR). 1H NMR (400 MHz, 
DMSO-d6) : 4.05 (4 H, q, J = 7.0 Hz), 3.11 (2 H, br s), 2.11 (6 H, s), 1.18 (6 H, t, J = 7.0 
Hz); 13C NMR (101 MHz, DMSO-d6) : 167.1, 146.4, 97.0, 58.9, 24.7, 17.8, 14.4. 
 
methyl (S)-2-((tert-butoxycarbonyl)amino)-3-(4-methoxyphenyl)propanoate (448) 
 
Boc-L-tyrosine methyl ester (25.0 g, 84.6 mmol, 1.0 equiv) was dissolved in anhydrous DMF 
(85 mL). After the addition of solid K2CO3 (23.4 g, 169 mmol, 2.0 equiv) and methyl iodide 
(5.79 mL, 93.1 mmol, 1.1 equiv) the mixture was stirred for 16 h at ambient temperature 
(monitored by TLC). The reaction mixture was diluted with water (1.5 L) and extracted with 
dichloromethane (3 x 500 mL). The combined organic phases were successively washed with 
water and brine, dried (MgSO4), and concentrated under reduced pressure. The crude oil was 
purified by flash column chromatography (gradient elution: 10% EtOAc in petroleum ether to 
20% EtOAc in petroleum ether) to furnish the product (25.5 g, 82.3 mmol, 97%) as an 
amorphous colorless solid. Rf (20% EtOAc in petroleum ether): 0.27. IR max/cm
-1 (solid): 
3394, 2970, 2840, 1736, 1698, 1612, 1585, 1515, 1501, 1440, 1392, 1370, 1295, 1244, 1221, 
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1162, 1138, 1118, 1063, 1032, 1017, 983. 1H NMR (400 MHz, CDCl3) : 7.03 (2 H, d, J = 
8.6 Hz, H6), 6.82 (2 H, d, J = 8.6 Hz, H7), 4.97 (1 H, d, J = 7.4 Hz, N–H), 4.58 – 4.48 (1 H, m, 
H1), 3.77 (3 H, s, H9), 3.70 (3 H, s, H3), 3.09 – 2.95 (2 H, m, H4), 1.41 (9 H, s, H12); 13C NMR 
(101 MHz, CDCl3) : 172.5 (C2), 158.8 (C8), 155.2 (C10), 130.4 (2 C, C6), 128.0 (C5), 114.1 
(2 C, C7), 80.0 (C11), 55.3 (C9), 54.6 (C1), 52.3 (C3), 37.6 (C4), 28.4 (3 C, C12); [α]D25 = + 50.3 
(c =1.0, CHCl3); m/z HRMS found [M + H]
+ 310.1653, C16H24NO5
+ requires 310.1649. The 
data are in accordance with those previously reported in the literature.[389] 
 
methyl (S)-2-(benzylamino)-3-(4-methoxyphenyl)propanoate (661) 
 
Methyl (S)-2-((tert-butoxycarbonyl)amino)-3-(4-methoxyphenyl)propanoate 448 (3.09 g, 10 
mmol, 1.0 equiv) was dissolved in a mixture of dichloromethane (30 mL) and trifluoroacetic 
acid (10 mL). The solution was stirred for 2 h at room temperature, and all volatiles removed 
under reduced pressure. The residue was redissolved in dichloromethane (40 mL), cooled to 0 
°C, and triethylamine (1.39 mL, 10 mmol, 1.0 equiv) was added, and the resulting solution 
stirred for 5 min. Benzaldehyde (1.12 mL, 11 mmol, 1.1 equiv) and NaBH(OAc)3 (3.18 g, 15 
mmol, 1.5 equiv) were added successively in one portion.  Cooling was removed and the 
resulting solution was allowed to stir for 16 h at ambient temperature. The mixture was 
quenched by addition of saturated aq. NaHCO3 solution, stirred for 30 min, and the aqueous 
phase extracted with dichloromethane (3 x). The combined organic phases were washed with 
water, dried (MgSO4) and concentrated in vacuo. The crude residue was purified by flash 
column chromatography (20% EtOAc in petroleum ether) to yield the product (2.31 g, 7.72 
mmol, 77%) as a colorless oil. Rf (20% EtOAc in petroleum ether): 0.12. IR max/cm
-1 (film): 
3028, 2997, 2950, 2836, 1731, 1611, 1584, 1511, 1453, 1440, 1300, 1245, 1197, 1174, 1128, 
1111, 1032, 990. 1H NMR (400 MHz, CDCl3) : 7.31 – 7.20 (5 H, m, H12,13,14), 7.07 (2 H, d, 
J = 8.5 Hz, H6), 6.81 (2 H, d, J = 8.5 Hz, H7), 3.83 – 3.77 (4 H, m, H4a,9), 3.66 – 3.60 (4 H, m, 
H3,4b), 3.50 (1 H, t, J = 6.8 Hz, H1), 2.91 (2 H, d, J = 6.8 Hz, H4), 1.79 (1 H, br s, N–H); 13C 
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NMR (101 MHz, CDCl3) : 175.2 (C2), 158.5 (C8), 139.7 (C11), 130.3 (2 C, C6), 129.4 (C5), 
128.5 (2 C), 128.3 (2 C), 127.1 (C14), 113.9 (2 C, C7), 62.3 (C1), 55.4 (C9), 52.1 (C10), 51.8 
(C3), 39.0 (C4).  [α]D25 = + 2.6  (c = 1.0, CHCl3); m/z HRMS found [M + H]
+ 300.1597, 
C18H22NO3





LiAlH4 (150 mg, 3.96 mmol, 1.2 equiv) was suspended in anhydrous THF (30 mL) at 0 °C, 
and a solution of methyl (S)-2-(benzylamino)-3-(4-methoxyphenyl)propanoate 661 (1.0 g, 3.3 
mmol, 1.0 equiv) in anhydrous THF (10 mL) is added dropwise. The cooling was removed 
and the reaction mixture was allowed to stir at ambient temperature for 16 h. The suspension 
was then diluted with Et2O, and solid NaSO4·10H2O was carefully added until no more gas 
evolution was observed. Methanol (5 mL) was added to the mixture and the suspension stirred 
for 1 hour. The formed off-white precipitate was removed by filtration through a plug of 
Celite, washed with dichloromethane, and the filtrate concentrated under reduced pressure. 
The residue was dried under high vacuum to yield the product (775 mg, 2.85 mmol, 87%) as 
an colorless solid. m.p. 87 – 89 °C (MeOH). IR max/cm
-1 (solid): 3294, 3058, 3030 (br), 
2998, 2915, 2832, 1611, 1583, 1511, 1463, 1454, 1441, 1376, 1344, 1300, 1247, 1202, 1183, 
1177, 1156, 1113, 1073, 1053, 1035, 959. 1H NMR (400 MHz, CDCl3) : 7.33 – 7.15 (5 H, 
m, H11,12,13), 7.05 (2 H, d, J = 8.5 Hz, H5), 6.82 (2 H, d, J = 8.5 Hz, H6), 3.78 (3 H, s, H8), 3.75 
(2 H, s, H9), 3.63 (1 H, dd, J = 3.8, 10.7 Hz, H2a), 3.32 (1 H, dd, J = 5.2, 10.7 Hz, H2b), 2.93 – 
2.86 (1 H, m, H1), 2.78 – 2.65 (2 H, m, H3); 13C NMR (101 MHz, CDCl3) : 158.4 (C7), 
140.2 (C10), 130.5 (C4), 130.3 (2 C, C5), 128.6 (2 C), 128.1 (2 C), 127.2 (C13), 114.1 (2 C, C6), 
62.5 (C2), 59.5 (C1), 55.4 (C8), 51.2 (C9), 37.3 (C3).  [α]D25 = − 6.1 (c = 1.0, CHCl3); m/z 
HRMS found [M + H]+ 272.1647, C17H22NO2
+ requires 272.1645. 
 





To a solution of (S)-2-(benzylamino)-3-(4-methoxyphenyl)propan-1-ol 662 (1.09 g, 4.00 
mmol, 1.0 equiv) in anhydrous THF (40 mL) was carefully added sodium hydride (176 mg, 
60% in mineral oil, 4.40 mmol, 1.1 equiv) and the resulting mixture was heated to reflux for 
30 min. The reaction mixture was allowed to cool and benzyl bromide (571 µL, 4.8 mmol, 1.2 
equiv) was added dropwise at room temperature with stirring. The reaction mixture was 
heated to reflux for 14 h, quenched by careful addition of methanol, and concentrated under 
reduced pressure. The residue was taken up in dichloromethane (40 mL) and sat. aq. sodium 
bicarbonate solution (40 mL). The phases were separated and the aqueous phase was 
extracted three times with dichloromethane. The combined organic phases were dried 
(MgSO4), filtered and concentrated in vacuo. The crude material was purified by flash column 
chromatography (20% EtOAc in petroleum ether) to yield the product (984 mg, 2.72 mmol, 
68%) as a colorless oil. Rf (40% EtOAc in petroleum ether): 0.20. IR max/cm
-1 (film): 3061, 
3028, 2906 (br), 2855, 2835, 1611, 1583, 1510, 1495, 1453, 1362, 1300, 1244, 1205, 1176, 
1090, 1071, 1028, 909. 1H NMR (400 MHz, CDCl3) : 7.36 – 7.19 (10 H, m, H5,4,7,16,17,18), 
7.06 (2 H, d, J = 8.5 Hz, H10), 6.81 (2 H, d, J = 8.5 Hz, H11), 4.48 (2 H, s, H3), 3.81 (2 H, br s, 
H14), 3.79 (3 H, s, H13), 3.47 – 3.37 (2 H, m, H2), 3.00 (1 H, quint, J = 6.0 Hz, H1), 2.81 – 2.70 
(2 H, m, H8), 1.76 (1 H, br s, N–H); 13C NMR (101 MHz, CDCl3) : 158.1 (C12), 140.7 (C15), 
138.5 (C4), 131.1 (C9), 130.4 (2 C, C10), 128.49 (2 C), 128.47 (2 C), 128.2 (2 C), 127. 8 (2 C), 
127.7, 126.9, 113.9 (2 C, C11), 73.3 (C3), 71.8 (C2), 58.2 (C1), 55.4 (C13), 51.6 (C14), 37.4 
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(S)-2-(benzylamino)-3-(4-methoxyphenyl)propan-1-ol 662 (1.0 g, 3.69 mmol, 1.0 equiv) and 
1,4-cyclo-hexanedione monoethylene acetal (2.30 g, 14.7 mmol, 4.0 equiv) were suspended in 
xylene (10 mL). After addition of activated molecular sieves (3 Å, 800 mg) and PTSA (70 
mg) the mixture was set to reflux for 48 h with vigorous stirring. The reaction mixture was 
allowed to cool, taken up in dichloromethane, filtered and concentrated in vacuo. The residue 
was subjected to flash column chromatography (gradient elution: 10% EtOAc in petroleum 
ether to 20% EtOAc in petroleum ether) to yield the product (795 mg, 1.94 mmol, 53%) as a 
yellow oil. Rf (50% EtOAc in petroleum ether): 0.54. IR max/cm
-1 (film): 3026, 2931, 2878, 
2835, 1716, 1611, 1583, 1511, 1494, 1441, 1373, 1337, 1300, 1245, 1208, 1177, 1138, 1102, 
1032, 967. 1H NMR (400 MHz, CDCl3) : 7.42 (2 H, d, J = 7.3 Hz, H12), 7.32 (2 H, t, J = 7.3 
Hz, H13), 7.24 (1 H, t, J = 7.3 Hz, H14), 6.87 (2 H, d, J = 8.6 Hz, H6), 6.73 (2 H, d, J = 8.6 Hz, 
H7), 4.02 (1 H, d, J = 14.1 Hz, H10a), 3.96 – 3.89 (4 H, m, H18), 3.79 – 3.75 (1 H, m, H2a), 3.75 
(3 H, s, H9), 3.69 – 3.69 (2 H, m, H2a,10b), 3.26 – 3.17 (1 H, m, H1), 2.53 (1 H, d, J = 3.6, 13.5 
Hz, H4a), 2.24 (1 H, d, J = 10.3, 13.5 Hz, H4b), 2.00 – 1.76 (4 H, m, H15/16), 1.75 – 1.64 (4 H, 
m, H15/16); 13C NMR (101 MHz, CDCl3) : 158.1 (C8), 141.1 (C11), 131.4 (C5), 129.9 (2 C, 
C6), 128.5 (2 C, C12), 128.3 (2 C, C13), 127.0 (C14), 113.9 (2 C, C7), 108.6 (C17), 95.7 (C3), 
68.7 (C2), 64.5 (C18), 64.5 (C18), 64.3 (C1), 55.3 (C9), 52.5 (C10), 40.1 (C4), 34.2 (C15/16), 32.2 
(C15/16), 31.7 (C15/16), 27.2 (C15/16). [α]D25 = −15.9 (c = 1.0, CHCl3); m/z HRMS found [M + 
H]+ 410.2321, C25H32NO4
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methyl (S)-2-amino-3-(4-methoxyphenyl)propanoate (409) 
 
Methyl (S)-2-((tert-butoxycarbonyl)amino)-3-(4-methoxyphenyl)propanoate 448 (6.18 g, 20 
mmol, 1.0 equiv) was dissolved in dichloromethane (20 mL) and trifluoroacetic acid (20 mL). 
The resulting solution was stirred for 3 h. The solvent was removed under reduced pressure 
and the oily residue was taken up in aq. sat. sodium bicarbonate solution. The resulting 
aqueous phase extracted with dichloromethane (3 x). The combined organic phases were dried 
(MgSO4), filtered and concentrated in vacuo to yield the product (3.64 g, 13.8 mmol, 69%) as 
a pale orange oil. The product slowly forms insoluble decomposition products at ambient 
temperature. Storage at -20 °C allowed the product to remain sufficiently pure for several 
weeks. IR max/cm
-1 (film): 2998, 2951, 2837, 1733, 1611, 1583, 1511, 1440, 1300, 1244, 
1195, 1175, 1111, 1032, 817. 1H NMR (400 MHz, CDCl3) : 7.09 (2 H, d, J = 8.6 Hz, H6), 
6.83 (2 H, d, J = 8.6 Hz, H7), 3.77 (3 H, s, H9), 3.70 (3 H, s, H3), 3.68 (1 H, dd, J = 5.3, 7.8 
Hz, H1), 3.01 (1 H, dd, J = 5.3, 13.6 Hz, H4a), 2.80 (1 H, dd, J = 7.7, 13.6 Hz, H4b), 1.43 (2 H, 
s, NH2); 13C NMR (101 MHz, CDCl3) : 175.6 (C2), 158.6 (C8), 130.3 (2 C, C6), 129.2 (C5), 
114.1 (2 C, C7), 56.0 (C1), 55.3 (C9), 52.0 (C3), 40.3 (C4). m/z HRMS found [M + H]
+ 
210.1132, C11H16NO3
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In a three-neck round-bottom flask, S-benzyl-L-cysteine (63.3 g, 0.3 mol, 1.0 equiv) was 
suspended in anhydrous methanol (2.0 L) and freshly powdered NaOH (12 g, 0.3 mol, 1.0 
equiv) was added in one portion under N2. The resulting mixture was stirred at room 
temperature for 10 minutes until clear and pivaldehyde (33 mL, 0.3 mol, 1.0 equiv) and 
activated molecular sieves (200 g) were added. The reaction mixture was stirred under a 
nitrogen atmosphere for 16 h at room temperature, rapidly filtered through a plug of celite, 
washed with methanol and the solvent removed in vacuo. The residue was dried at 60°C 
under high vacuum for 6 hours. The resulting white solid was dissolved in dichloromethane 
(2.0 L) and the solution cooled to −5 °C. The flask was fitted with an addition funnel and 
benzyl chloroformate (63.4 mL, 0.45 mol, 1.5 equiv) was added dropwise over 2 h at −5 °C to 
the stirred solution. The mixture was stirred at −5 °C for a further 18 h, then warmed to room 
temperature and stirred for an additional 16 h. Aqueous ammonia (10M, 100 mL) was added 
and the biphasic mixture stirred for 2 h. The mixture was washed with aqueous sodium 
hydroxide solution (3%, 750 mL) and brine, and the organic phase dried (MgSO4), filtered 
and concentrated. Purification of the resulting yellow residue by sequential flash column 
chromatography (silica, 0% to 10% EtOAc in petroleum ether) furnished the product (26.1 g, 
63.1 mmol, 21%) as a colorless oil. Rf (7.5% EtOAc in toluene): 0.47. IR max/cm
-1 (film): 
3064, 3031, 2961, 1790, 1716, 1481, 1454, 1390, 1324, 1281, 1221, 1195, 1168, 1117, 1035, 
1016, 968; 1H NMR (400 MHz, CDCl3) : 7.37 – 7.32 (5 H, m, H15,16,17), 7.28 – 7.20 (5 H, m, 
H7,8,9), 5.51 (1 H, s, H2), 5.20 (1 H, d, J = 12.0 Hz, H13a), 5.15 (1 H, d, J = 12.0 Hz, H13b), 4.51 
(1 H, t, J = 6.9 Hz, H3), 3.78 (1 H, d, J = 13.4 Hz, H5a), 3.71 (1 H, d, J = 13.4 Hz, H5b), 2.90 
(1 H, dd, J = 7.9, 14.0 Hz, H4a), 2.75 (1 H, dd, J = 6.2, 14.0 Hz, H4b), 0.89 (9 H, s, H11); 13C 
NMR (101 MHz, CDCl3) : 171.4 (C1), 156.0 (C12), 137.9 (C6), 135.2 (C14), 192.2 (2 C), 
128.9 (3 C), 128.71 (2 C), 128.66 (2 C), 127.3 (C9), 96.5 (C2), 68.7 (C13), 57.7 (C3), 37.1 
(C10), 36.7 (C5), 33.5 (C4), 25.0 (3 C, C11); m/z HRMS found [M + H]
+ 414.1736, 
C23H28NO4S










To a stirred solution of benzyl (2S,4R)-4-((benzylthio)methyl)-2-(tert-butyl)-5-
oxooxazolidine-3-carboxylate 718 (26.1 g, 63.2 mmol, 1.0 equiv) in dichloromethane (1.0 L) 
was added m-chloroperoxybenzoic acid (70 %, 38.9 g, 158 mmol, 2.5 equiv) portionwise. The 
solution was stirred at room temperature for 16 h and then washed with aq. sodium hydroxide 
(1 M, 3 x 500mL). The organic phase was dried (MgSO4), filtered and evaporated in vacuo. 
The residue was dried under high vacuum overnight to obtain the pure product as a white 
amorphous solid (26.9 g, 60.3 mmol, 95%). IR max/cm
-1 (solid): 2969, 1790, 1719, 1496, 
1482, 1456, 1393, 1310, 1285, 1225, 1198, 1178, 1118, 1038, 1015, 966. 1H NMR (400 
MHz, CDCl3) : 7.44 – 7.33 (10 H, m, H7,8,9,15,16,17), 5.62 (1 H, s, H2), 5.28 (1 H, d, J = 12.1 
Hz, H13a), 5.21 (1 H, d, J = 12.1 Hz, H13b), 5.08 (1 H, dd, J = 4.1, 8.0 Hz, H3), 4.67 (1 H, d, J 
= 14.0 Hz, H5a), 4.42 (1 H, d, J = 14.0 Hz, H5b), 3.44 (1 H, dd, J = 8.0 Hz, 15.3 Hz, H4a), 3.15 
(1 H, dd, J = 4.1, 15.3 Hz, H4b), 0.89 (9 H, s, H11). 13C NMR (101 MHz, CDCl3) : 170.8 
(C1), 155.4 (C12), 135.0, 131.1 (2 C), 129.3, 129.2 (2 C), 129.0, 128.92 (2 C), 128.89 (2 C), 
128.0, 97.0 (C2), 69.1 (C13), 60.5 (C5), 53.8 (C3), 52.8 (C4), 37.3 (C10), 24.7 (3 C, C11). m/z 
HRMS found [M + H]+ 446.1634, C23H28NO6S
+ requires 446.1632. The data are in 
accordance with those previously reported in the literature.[228] 
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benzyl (S)-2-(tert-butyl)-4-methylene-5-oxooxazolidine-3-carboxylate (360) 
 
A stirred solution of benzyl (2S,4R)-4-((benzylsulfonyl)methyl)-2-(tert-butyl)-5-
oxooxazolidine-3-carboxylate 719 (26.9 g, 60.3 mmol, 1.0 equiv) in dichloromethane (600 
mL) was cooled to 0 °C, then DBU (9.9 mL, 66.3 mol, 1.1 equiv) was added dropwise with 
stirring over the course of 10 min. The reaction was stirred for a further 5 minutes or until 
complete by TLC. The mixture was then quenched by addition of saturated aq. ammonium 
chloride solution (250 mL) at 0 °C, and the aqueous phase extracted with dichloromethane (3 
x 150 mL). The combined organic phases were dried (MgSO4), filtered and evaporated under 
reduced pressure. The residue was purified by flash column chromatography (10% EtOAc in 
petroleum ether) to yield the product as a colorless oil that solidifies on standing (15.8 g, 54.6 
mmol, 91%). Rf (20% EtOAc in petroleum ether): 0.45; IR max/cm
-1 (solid): 2959, 2904, 
2871, 1777, 1718, 1661, 1481, 1467, 1456, 1388, 1367,1327, 1268, 1255, 1205, 1160, 1132, 
1093, 1033, 1009, 962; 1H NMR (400 MHz, CDCl3) : 7.43 – 7.35 (5 H, m, H10,11,12), 5.72 (2 
H, s, H4), 5.69 (1 H, br s, H2), 5.26 (2 H, s, H8), 0.93 (9 H, s, H6); 13C NMR (101 MHz, 
CDCl3) : 164.7 (C1), 152.5 (br s, C7), 134.8 (C9), 130.3 (C3), 129.0, 128.9 (2 C), 128.8 (br s, 
2 C), 104.5 (C4), 94.1 (C2), 68.9 (C8), 38.8 (C5), 24.5 (3 C, C6). [α]D25 = −36.6 (c = 1.0, 
CHCl3). m/z HRMS found [M + H]
+ 290.1391, C16H20NO4
+ requires 290.1387. Chiral 
HPLC tR(major) = 14.5 min, tR(minor) = 18.9 min (98%ee, Daicel CHIRALPAK®-IC, 4.6 
mm x 250 mm, eluted with 2% i-propanol in hexane, flow 1.0 mLmin-1; see Appendix II). The 
data are in accordance with those previously reported in the literature.[371] 
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Appendix II: Supplementary data 
i) 1H NMR study of the reaction mixture 
 
 
Figure 24. NMR study to determine the predominant species in the crude reaction mixture. Crude mixture of 
dibenzylamine, butyraldehyde, propionic acid (0.2 equiv) in CD2Cl2. Data recorded after 105 min. Internal 
standard 1,1,2,2-tetrachloroethane (1.0 equiv). 
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ii) Stern Volmer quenching studies 
Emission intensities were recorded using a Shimadzu RF-6000 spectrofluorometer. 
Experiments were recorded using a quartz cell equipped with septa-lined screw cap under Ar. 
All fac-Ir(ppy)3 solutions were excited at 320 nm and the emission intensity recorded at 518 
nm. The iminium ion was weighed in a glove box and a stock solution formed in anhydrous 
degassed dichloromethane and stored in a Schlenk tube. The appropriate amount of fac-
Ir(ppy)3, as a solution in anhydrous degassed dichloromethane, and iminium tetrafluoroborate 
364 was added to the dry quartz cell equipped with septa-lined screw cap under Ar and the 
emission spectra collected. The emission of each concentration was recorded 5 times and an 
average was taken.  
 
 
Figure 25. Stern Volmer quenching study recording emission intensities of fac-Ir(ppy)3 (c = 10 µM in 
dichloromethane) with varying concentration of iminium salt 364. 
 
 
Stern Volmer equation: F0/F = 1 + kq0[Q] 
kq0 = 1.176 L·mol-1 
0 =1.9 µs 
kq = 6.2 x 105 L·mol-1s-1 














concentration iminium salt 364 [mM]
Stern Volmer quenching study
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iii) UV-Vis studies 
 
Figure 26 UV-Vis studies on iminium salt 364 and Hantzsch ester 316. Study performed by A. Trowbridge. 
 
UV-Vis analysis was performed on a Shimadzu UV-1800 spectrophotometer. Experiments 
were recorded using a quartz cell equipped with septa-lined screw cap under Ar. In a typical 
experiment, the iminium salt 364 was weighed in a glove box and a stock solution formed in 
anhydrous degassed dichloromethane and stored in a Schlenk tube (2 mM). The appropriate 
amount of Hantzsch ester, as a solution in anhydrous degassed dichloromethane (2 mM), and 
iminium ion was added to the dry quartz cell equipped with septa-lined screw cap under Ar 
and made up to a total volume of 3.5 mL with anhydrous degassed dichloromethane (0.057 




















Determination of EDA complex
I (iminium) I (Combination) I (HEH)
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iv) Deuterium labelling study 1 
 
Figure 27. 1H- and 2H-NMR data for deuterium labelling study 1 using deuterated Hantzsch Ester d2-316. 
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v) Deuterium labelling study with enamines and 1,1- diphenylethylene acceptor 
 
Figure 29. 1H and 2H NMR of deuterium labelling study with enamines and 1,1- diphenylethylene acceptor. 
HEP. Hantzsch Ester pyridine.  
d1-380b 
(contains Hantzsch ester pyridine, HEP) 
2
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vi) Deuterium labelling study with enamines and deuterium labelled Brønsted acid 
 
Figure 30. 1H and 2H NMR of deuterium labelling study with enamines and 1,1- diphenylethylene acceptor and  
deuterium labelled Brønsted acid. HEP. Hantzsch Ester pyridine. 
d1/2-380b 










H NMR (400 MHz, CDCl
3
) 





Deuterated compound d1-380b was prepared according to general procedure A using 4-
cyclohex-1-enylmorpholine (34 µL, 0.2 mmol), 1,1-diphenylethene (71 µL, 0.4 mmol), d2-
316 (77 mg, 0.3 mmol), propanoic acid (3 µL, 40 µmol) and fac-Ir(ppy)3 (1.4 mg, 2 µmol) in 
anhydrous degassed dichloromethane (2 mL). The solvent removed in vacuo and the residue 
purified by flash column chromatography (gradient elution: 1% EtOAc to 3% EtOAc in P.E.) 
to afford the product as a colorless oil (12 mg, 17%). Rf (20% EtOAc in P.E.): 0.54. 2H NMR 
(76.8 MHz, CHCl3/CDCl3) : 4.10 (br s, Ph2CDR, major), 1.43 (br s), 1.20 (br s). m/z HRMS 




Deuterated compound d1/2-380b was prepared according to general procedure A using 4-
cyclohex-1-enylmorpholine (34 µL, 0.2 mmol), 1,1-diphenylethene (71 µL, 0.4 mmol), N-d-
316 (76 mg, 0.3 mmol), d4-acetic acid (2.3 µL, 40 µmol) and fac-Ir(ppy)3 (1.4 mg, 2 µmol) in 
anhydrous degassed dichloromethane (2 mL). The crude reaction mixture was purified by 
flash column chromatography (0.5% Et3N in dichloromethane) to afford the product as a 
colorless oil (33 mg, 47%). Rf (20% EtOAc in P.E.): 0.54. 2H NMR (76.8 MHz, 
CHCl3/CDCl3) : 4.10 (br s, minor), 1.43 (br s, major), 1.17 (br s, major). m/z HRMS found 
[M + H]+ 351.2541 (major), C24H31DNO requires 351.2541, found [M + H]
+
 352.2597 
(minor), C24H30D2NO requires 352.2604. 
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Daicel CHIRALPAK®-IC, 4.6 mm x 250 mm, 2% i-propanol in hexane, flow 1.0 mLmin-1 
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viii) X-ray crystallography, 609 
 
Identification code MG_B1_0047  
Empirical formula C28 H32 N2 O7  
Formula weight 508.55  
Temperature 180(2) K  
Wavelength 1.54178 Å  
Crystal system Monoclinic  
Space group P21  
Unit cell dimensions a = 23.1440(7) Å a= 90°. 
 b = 9.0587(3) Å b= 91.403(2)°. 
 c = 25.1442(8) Å g = 90°. 
Volume 5270.0(3) Å3  
Z 8  
Density (calculated) 1.282 Mg/m3  
Absorption coefficient 0.761 mm-1  
F(000) 2160  
Crystal size 0.300 x 0.080 x 0.040 mm3  
Theta range for data collection 2.564 to 66.699°.  
Index ranges -27<=h<=27, -10<=k<=10, -29<=l<=29  
Reflections collected 69895  
Independent reflections 18016 [R(int) = 0.0891]  
Completeness to theta = 66.699° 99.9 %  
Absorption correction Semi-empirical from equivalents  
Max. and min. transmission 0.7528 and 0.6561  
Refinement method Full-matrix least-squares on F2  
Data / restraints / parameters 18016 / 673 / 1333  
Goodness-of-fit on F2 1.021  
Final R indices [I>2sigma(I)] R1 = 0.0776, wR2 = 0.1979  
R indices (all data) R1 = 0.1128, wR2 = 0.2233  
Absolute structure parameter -0.24(14)  
Extinction coefficient n/a  
Largest diff. peak and hole 0.662 and -0.370 e.Å-3  
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